data_1q5f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q5f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.51 -35.74 11.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.366 1.066 . . . . 0.0 110.932 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -30.25 10.35 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 124.271 0.938 . . . . 0.0 113.205 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -39.89 -47.1 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.012 1.325 . . . . 0.0 113.891 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.32 -39.0 59.97 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.239 0.927 . . . . 0.0 112.449 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.4 -47.78 82.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.361 0.6 . . . . 0.0 110.394 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 p -66.48 -37.69 85.66 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 117.669 -1.158 . . . . 0.0 110.725 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -59.06 -54.55 45.81 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.274 1.397 . . . . 0.0 112.203 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -57.13 -46.22 82.87 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.011 -1.055 . . . . 0.0 111.339 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.4 -27.48 68.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.516 0.726 . . . . 0.0 112.619 173.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -49.34 71.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.671 1.188 . . . . 0.0 108.861 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.99 -40.55 96.04 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 118.933 0.788 . . . . 0.0 109.669 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB3' ' CD2' ' A' ' 179' ' ' TYR . . . -62.4 -42.85 99.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.726 0.694 . . . . 0.0 111.895 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -33.12 47.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.126 0.97 . . . . 0.0 113.121 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -70.31 -64.04 0.97 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.224 -0.922 . . . . 0.0 108.523 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.87 -21.18 27.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.801 1.24 . . . . 0.0 112.64 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -44.93 -33.26 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.196 0.999 . . . . 0.0 111.98 171.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.04 50.93 0.2 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.68 1.134 . . . . 0.0 112.868 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.5 tpt -113.71 -63.82 1.4 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.694 0.798 . . . . 0.0 111.121 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.44 34.32 0.46 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.693 1.197 . . . . 0.0 112.357 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 31.48 0.27 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.637 1.175 . . . . 0.0 113.165 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.16 49.14 2.29 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.245 0.926 . . . . 0.0 112.108 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.482 1.13 0 C-N-CA 125.737 1.615 . . . . 0.0 110.456 176.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.17 -62.75 1.37 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.052 0.941 . . . . 0.0 113.018 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -25.58 60.05 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.372 172.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mtp -53.47 -57.14 11.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.908 0.883 . . . . 0.0 111.867 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -69.73 -40.12 76.39 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.37 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -50.73 -47.24 59.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -70.16 -42.33 72.65 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.0 111.14 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tp -59.27 -51.44 69.95 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.889 1.222 . . . . 0.0 112.014 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -52.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 120.766 -1.209 . . . . 0.0 110.015 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -62.27 -23.58 66.78 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.907 -1.121 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -2.9 23.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 113.796 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.65 78.88 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.089 1.804 . . . . 0.0 112.886 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.11 -76.9 0.24 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 117.73 0.765 . . . . 0.0 111.289 -177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.39 -50.66 36.33 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 111.8 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.45 132.42 8.78 Favored 'General case' 0 C--O 1.211 -0.926 0 C-N-CA 124.703 1.201 . . . . 0.0 109.85 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.63 59.37 4.6 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 119.419 1.008 . . . . 0.0 113.251 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.06 176.73 7.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.102 0.961 . . . . 0.0 112.475 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.16 147.64 38.34 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.705 -0.622 . . . . 0.0 110.685 172.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.23 157.51 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 109.007 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.38 101.93 11.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.74 112.91 4.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -35.92 115.79 0.6 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.603 1.161 . . . . 0.0 113.341 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -71.49 -18.14 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.301 1.334 . . . . 0.0 112.026 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.33 -4.79 41.42 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.86 1.264 . . . . 0.0 113.262 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 86.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.133 1.373 . . . . 0.0 113.057 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.77 -40.57 0.02 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.182 -0.949 . . . . 0.0 114.136 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 p -158.37 114.31 2.71 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.307 1.443 . . . . 0.0 111.638 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.66 161.38 7.86 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 122.743 1.258 . . . . 0.0 111.811 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 t -135.85 127.46 28.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.528 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -99.41 136.75 38.89 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.304 1.05 . . . . 0.0 109.403 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -93.26 104.64 16.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.574 1.15 . . . . 0.0 110.651 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.31 112.09 23.54 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.319 0.648 . . . . 0.0 110.168 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -57.86 5.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.641 -0.662 . . . . 0.0 111.815 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -68.03 -46.21 71.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.128 0.571 . . . . 0.0 112.002 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.84 -123.08 0.11 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.337 0.97 . . . . 0.0 111.923 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -143.65 -98.09 0.26 Allowed Glycine 0 N--CA 1.465 0.596 0 O-C-N 122.093 -0.651 . . . . 0.0 112.266 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.53 149.29 52.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.062 0.934 . . . . 0.0 110.261 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 mt -130.63 145.24 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.362 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.27 109.59 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 m -94.93 122.0 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.54 131.74 11.95 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.054 -1.029 . . . . 0.0 109.446 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.5 152.4 43.37 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.179 1.253 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -145.82 66.85 1.21 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.476 1.911 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.9 p -100.14 97.96 8.72 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.319 1.057 . . . . 0.0 109.251 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.329 0 O-C-N 120.849 -1.157 . . . . 0.0 110.84 -177.866 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.626 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.33 135.81 48.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.258 1.529 . . . . 0.0 109.033 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.7 p -122.06 116.77 24.86 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.2 mt -124.41 104.5 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.84 142.55 42.18 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.248 173.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 p -140.66 128.28 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.87 0.843 . . . . 0.0 108.989 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.72 99.6 4.67 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -172.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.514 1.126 . . . . 0.0 112.393 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.2 t -48.61 101.95 0.29 Allowed Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 127.001 2.12 . . . . 0.0 109.09 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.13 -171.21 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.773 1.649 . . . . 0.0 110.758 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.4 tm0? -59.81 -44.25 94.08 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.944 -1.097 . . . . 0.0 112.544 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 p -56.54 -42.4 78.45 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.051 -1.03 . . . . 0.0 112.002 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.97 -29.37 43.84 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.057 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -30.41 14.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.895 1.68 . . . . 0.0 110.496 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.42 -55.78 6.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 125.451 1.5 . . . . 0.0 111.335 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.2 m -57.64 -48.73 78.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.778 1.172 . . . . 0.0 113.327 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.6 mm -56.13 -47.2 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 C-N-CA 125.615 1.566 . . . . 0.0 110.981 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -62.92 -45.69 91.31 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.167 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 m -51.01 -42.47 60.44 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 111.365 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.06 -39.23 33.07 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 121.933 -0.479 . . . . 0.0 113.137 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 11.4 ttm -67.85 -20.5 65.15 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.467 -1.608 . . . . 0.0 112.466 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 -28.17 57.44 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.753 1.221 . . . . 0.0 111.888 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -16.14 63.34 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 112.836 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.08 46.94 0.92 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.386 1.474 . . . . 0.0 110.716 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -35.58 -64.88 0.49 Allowed Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.571 1.558 . . . . 0.0 113.293 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 17.78 75.59 0.01 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 127.308 2.385 . . . . 0.0 113.355 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 20.4 p -51.54 167.2 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.897 1.679 . . . . 0.0 112.466 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -33.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.502 -0.749 . . . . 0.0 111.812 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.79 51.0 0.04 OUTLIER Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.636 0.636 . . . . 0.0 112.891 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.4 mt -86.84 113.42 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -119.46 103.15 9.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 108.362 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.87 166.95 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -51.9 119.18 4.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.008 1.323 . . . . 0.0 112.675 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.28 27.44 5.53 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.484 0.564 . . . . 0.0 113.909 -173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.72 32.85 4.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.877 2.071 . . . . 0.0 109.024 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -36.62 98.96 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.114 1.366 . . . . 0.0 111.129 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -142.42 -174.07 4.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.456 1.502 . . . . 0.0 108.691 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.7 p -147.98 -46.48 0.16 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.212 -0.93 . . . . 0.0 109.107 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.52 18.56 1.82 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.591 1.556 . . . . 0.0 112.881 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.06 111.6 2.26 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.417 -0.802 . . . . 0.0 110.717 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 105.75 17.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.91 129.26 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.763 1.225 . . . . 0.0 110.027 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 175.2 9.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.794 1.238 . . . . 0.0 110.945 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.96 39.76 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.785 -0.572 . . . . 0.0 112.473 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -61.27 -33.15 73.07 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.654 0.782 . . . . 0.0 111.969 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -51.39 39.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.588 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.98 66.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 119.192 0.905 . . . . 0.0 112.138 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -28.96 68.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.751 0.821 . . . . 0.0 112.648 171.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.94 -48.95 3.49 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.135 1.374 . . . . 0.0 112.838 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--O 1.233 0.22 0 C-N-CA 126.449 1.9 . . . . 0.0 111.307 177.287 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.7 p . . . . . 0 C--O 1.24 0.57 0 CA-C-O 120.445 0.164 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -45.53 146.7 2.32 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 122.98 0.324 . . . . 0.0 112.295 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 20.1 p -46.59 118.62 2.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.019 1.328 . . . . 0.0 111.567 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.17 85.2 6.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 122.405 1.097 . . . . 0.0 109.182 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 m -75.13 116.04 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.316 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.1 119.0 23.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.634 0.774 . . . . 0.0 109.204 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.74 128.81 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -103.11 127.63 50.31 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.04 139.45 46.39 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.287 0.635 . . . . 0.0 110.283 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -130.57 111.82 12.59 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.274 1.029 . . . . 0.0 110.234 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.64 142.39 27.67 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.137 0.575 . . . . 0.0 110.896 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 C-N-CA 124.462 1.03 . . . . 0.0 112.697 -177.377 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.39 -35.91 9.04 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.693 1.197 . . . . 0.0 112.05 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.03 -29.87 9.05 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 117.863 -1.521 . . . . 0.0 111.908 170.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -49.54 -38.59 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.197 1.399 . . . . 0.0 112.779 171.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -79.82 -38.17 33.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.145 -0.972 . . . . 0.0 111.282 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -71.35 -47.29 57.32 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.411 0.624 . . . . 0.0 110.349 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -60.61 -41.21 94.35 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.916 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -59.86 -46.27 89.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.764 1.62 . . . . 0.0 111.796 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -48.91 -62.68 1.39 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.933 0.893 . . . . 0.0 109.738 174.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -21.14 66.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.758 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.44 68.45 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.308 1.443 . . . . 0.0 109.483 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.54 -38.7 87.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.885 1.221 . . . . 0.0 110.011 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 179' ' ' TYR . . . -65.56 -45.95 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.36 0.664 . . . . 0.0 111.893 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -76.57 -38.84 54.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.266 1.027 . . . . 0.0 112.034 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -64.4 -56.76 12.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 t -58.35 -26.81 63.57 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.689 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.06 -26.73 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.65 53.81 0.28 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.903 1.24 . . . . 0.0 113.03 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.64 -71.49 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.184 0.994 . . . . 0.0 111.079 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.6 mmt -139.73 53.25 1.69 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.77 1.228 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -109.85 2.66 20.04 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.695 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.17 -30.3 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.213 0.911 . . . . 0.0 113.534 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.473 0.68 0 CA-C-N 118.293 1.047 . . . . 0.0 109.707 171.813 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.954 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.3 -67.57 0.38 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.67 0.735 . . . . 0.0 110.501 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -59.3 -33.52 71.19 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.402 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -46.28 90.95 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.668 0.667 . . . . 0.0 111.357 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -64.3 -42.32 96.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.371 -0.824 . . . . 0.0 110.081 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -50.02 75.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.278 0.944 . . . . 0.0 110.68 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -66.88 -40.87 87.91 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 124.563 1.145 . . . . 0.0 111.12 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.47 -52.83 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.355 1.462 . . . . 0.0 110.83 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.1 mt -59.13 -51.32 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.095 -1.003 . . . . 0.0 111.251 176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -63.29 -25.8 68.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.593 -0.692 . . . . 0.0 112.737 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.72 21.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.023 1.329 . . . . 0.0 112.743 171.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.59 58.39 5.42 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.787 1.184 . . . . 0.0 111.628 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.21 -81.16 0.64 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.46 -59.82 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -136.26 -163.06 1.35 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.755 1.622 . . . . 0.0 110.242 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.58 21.1 1.04 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.756 1.169 . . . . 0.0 112.937 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.7 mmt -90.68 173.72 7.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.594 1.158 . . . . 0.0 112.144 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.22 120.49 13.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.024 0.916 . . . . 0.0 109.576 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.47 122.72 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -67.82 115.84 7.82 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 166.17 54.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.45 128.09 7.51 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 122.426 -0.455 . . . . 0.0 111.046 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.57 -17.56 29.88 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.679 2.253 . . . . 0.0 113.021 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.01 60.47 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 0.0 112.654 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.45 65.11 1.42 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.423 1.089 . . . . 0.0 112.329 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.56 37.45 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 p -175.43 57.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.477 1.111 . . . . 0.0 111.391 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.43 150.17 21.94 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.294 1.045 . . . . 0.0 110.766 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.5 p -136.26 126.06 25.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -96.95 127.35 42.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.935 0.874 . . . . 0.0 108.879 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -101.17 116.71 33.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -72.94 170.76 14.11 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.137 0.494 . . . . 0.0 110.79 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.77 -55.34 6.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.119 0.967 . . . . 0.0 112.43 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.52 152.29 16.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 110.621 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.25 25.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.008 0.813 . . . . 0.0 112.805 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.25 128.68 2.07 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -133.8 136.96 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.991 0.901 . . . . 0.0 108.86 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.37 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.363 1.065 . . . . 0.0 108.252 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.33 111.05 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.1 m -102.81 122.45 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 126.18 14.49 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.042 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -70.34 150.45 64.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.542 1.494 . . . . 0.0 110.688 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -141.11 77.37 1.59 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.026 1.393 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 p -87.51 156.24 19.63 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.933 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.33 0 C-N-CA 123.343 0.657 . . . . 0.0 110.034 176.723 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.78 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -53.61 142.91 21.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.799 1.299 . . . . 0.0 112.099 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.2 p -128.83 104.82 7.83 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.06 0.944 . . . . 0.0 109.314 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 mt -108.07 93.12 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -67.9 138.25 55.87 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 172.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -135.6 127.66 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -136.34 104.2 5.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.356 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.43 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.824 1.249 . . . . 0.0 111.962 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 22.6 m -53.5 107.06 0.75 Allowed Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.23 1.812 . . . . 0.0 107.881 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -74.85 -169.47 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.851 1.034 . . . . 0.0 110.768 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -19.14 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.41 -0.806 . . . . 0.0 113.112 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 t -77.95 -46.29 21.59 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.097 -1.627 . . . . 0.0 111.076 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.24 -28.48 62.18 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.12 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -52.92 -28.84 25.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.817 1.644 . . . . 0.0 111.329 176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.4 -55.68 6.03 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 C-N-CA 125.972 1.709 . . . . 0.0 110.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 m -60.31 -44.1 95.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.226 -1.546 . . . . 0.0 113.2 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.7 mm -56.57 -42.79 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.737 1.615 . . . . 0.0 109.772 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 p -65.32 -45.35 84.65 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 119.187 0.903 . . . . 0.0 112.42 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.9 m -60.55 -30.02 69.52 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.873 1.269 . . . . 0.0 110.904 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.91 -32.85 13.5 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 123.567 0.603 . . . . 0.0 113.493 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.5 tpp -74.39 -24.77 59.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.997 1.398 . . . . 0.0 111.304 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 p -66.46 -24.18 66.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.805 1.642 . . . . 0.0 111.494 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -70.47 -4.92 25.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.793 1.237 . . . . 0.0 113.491 171.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.61 48.44 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.548 1.139 . . . . 0.0 111.103 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -40.53 -51.63 3.79 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.743 1.163 . . . . 0.0 114.711 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.75 73.53 0.48 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.791 1.186 . . . . 0.0 112.307 169.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.468 ' HG1' HD13 ' A' ' 142' ' ' ILE . 3.3 m -69.55 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.629 0.772 . . . . 0.0 110.452 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t 172.86 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.256 1.422 . . . . 0.0 111.794 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.78 73.74 0.07 OUTLIER Glycine 0 C--N 1.341 0.848 0 O-C-N 121.78 -0.575 . . . . 0.0 113.667 -177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.468 HD13 ' HG1' ' A' ' 139' ' ' THR . 13.2 mt -94.64 99.68 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.996 0.919 . . . . 0.0 111.708 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -91.95 94.81 9.47 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.874 -0.516 . . . . 0.0 110.691 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.5 mt -68.85 153.12 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.24 1.016 . . . . 0.0 110.489 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -52.68 116.92 2.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.931 -1.106 . . . . 0.0 110.498 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.86 -43.96 0.99 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.412 1.006 . . . . 0.0 113.835 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.59 34.34 0.53 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.869 2.068 . . . . 0.0 111.682 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -46.32 93.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.837 1.655 . . . . 0.0 111.886 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -113.94 -168.22 1.32 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.104 1.361 . . . . 0.0 109.565 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.4 p -138.7 -49.71 0.53 Allowed 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.818 -0.551 . . . . 0.0 110.856 -175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 20.25 2.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.541 1.537 . . . . 0.0 112.25 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -45.23 126.12 5.98 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-O 121.559 0.695 . . . . 0.0 111.061 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -117.91 70.62 0.8 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 122.33 1.062 . . . . 0.0 108.391 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -91.68 130.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.93 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.44 176.1 7.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.91 1.284 . . . . 0.0 110.412 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.33 58.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.653 0.66 . . . . 0.0 112.078 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -61.51 -32.53 72.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.703 0.801 . . . . 0.0 112.551 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.35 -50.69 29.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.458 1.027 . . . . 0.0 111.476 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 p -69.39 -32.0 70.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.299 0.64 . . . . 0.0 111.87 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.7 t -92.4 -50.94 5.38 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.31 1.044 . . . . 0.0 112.18 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 . . . . . 0 C--O 1.234 0.241 0 C-N-CA 127.265 2.226 . . . . 0.0 111.867 179.95 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 35.06 -135.51 0.39 Allowed Glycine 0 C--N 1.339 0.734 0 O-C-N 124.394 1.059 . . . . 0.0 111.57 -174.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.1 p -149.03 123.84 9.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.83 136.23 38.92 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.118 -0.988 . . . . 0.0 110.749 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 m -109.47 112.46 24.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.22 109.86 10.72 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -81.98 135.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE1' ' CE1' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -100.67 120.26 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -97.94 144.36 27.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.105 0.562 . . . . 0.0 111.586 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 43' ' ' ALA . 16.2 t80 -142.67 105.71 4.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.336 0.654 . . . . 0.0 111.594 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.19 140.13 37.76 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.392 0.677 . . . . 0.0 110.386 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.046 -1.419 . . . . 0.0 111.896 178.24 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.1 -45.13 8.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.684 1.194 . . . . 0.0 110.71 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.31 -27.8 1.92 Allowed Glycine 0 C--O 1.212 -1.251 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.596 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 p -38.3 -43.43 0.8 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.641 1.576 . . . . 0.0 114.756 168.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.12 -35.52 31.48 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.065 0.848 . . . . 0.0 112.493 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.09 -50.11 67.39 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.038 0.935 . . . . 0.0 110.704 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.5 p -60.08 -38.29 82.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.093 1.357 . . . . 0.0 110.632 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.96 -47.24 81.21 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.017 0.826 . . . . 0.0 112.496 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.58 ' CD1' ' CZ ' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -49.05 -59.04 3.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 109.235 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -66.04 -24.92 66.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.45 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -47.74 73.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 110.184 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -41.05 98.7 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 119.733 1.152 . . . . 0.0 109.051 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.26 96.35 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.767 0.712 . . . . 0.0 112.395 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.12 -31.6 58.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.704 1.202 . . . . 0.0 112.941 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -75.57 -63.61 1.25 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -17.7 7.13 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.401 1.081 . . . . 0.0 113.063 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -44.42 -35.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.989 1.316 . . . . 0.0 112.194 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.0 26.84 0.14 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.698 1.142 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.1 tpp -86.04 -69.89 0.64 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.042 0.937 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.5 mtt -154.74 60.42 0.67 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.821 1.296 . . . . 0.0 111.002 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -104.1 -29.8 10.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.41 36.13 0.04 OUTLIER Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.615 1.102 . . . . 0.0 111.715 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 N--CA 1.473 0.722 0 C-N-CA 123.528 0.731 . . . . 0.0 110.602 176.823 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.922 0 N-CA-C 113.576 0.19 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.98 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.407 -1.055 . . . . 0.0 111.897 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -25.98 68.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.533 0.733 . . . . 0.0 112.364 171.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.427 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 14.2 ttm -58.36 -49.09 78.45 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.499 0.72 . . . . 0.0 110.21 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -72.8 -41.5 64.88 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.551 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -52.65 -53.43 47.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.006 1.276 . . . . 0.0 111.505 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.3 m -68.0 -43.21 79.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.054 1.342 . . . . 0.0 110.984 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.55 -47.1 80.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.662 0.785 . . . . 0.0 111.294 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.38 -50.22 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.405 175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.86 -20.25 55.96 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.158 -0.964 . . . . 0.0 112.448 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.54 9.93 6.72 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.48 1.512 . . . . 0.0 113.73 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.93 48.07 84.83 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.422 1.487 . . . . 0.0 112.589 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.34 -83.86 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.464 0.706 . . . . 0.0 111.275 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -47.15 72.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.796 0.438 . . . . 0.0 111.654 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -156.2 172.7 17.99 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.063 1.345 . . . . 0.0 109.902 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.78 34.77 3.63 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.796 1.189 . . . . 0.0 112.165 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.71 178.81 4.25 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.649 1.18 . . . . 0.0 112.004 -177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.42 136.99 54.15 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.438 175.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.57 109.78 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.7 t -57.81 137.06 56.97 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.54 169.24 47.82 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.871 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.74 113.66 46.67 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.755 0.822 . . . . 0.0 111.182 174.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -79.51 -64.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.03 1.82 . . . . 0.0 111.557 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.37 -40.37 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.886 0.874 . . . . 0.0 112.174 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.36 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.023 2.529 . . . . 0.0 112.998 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.69 95.85 0.14 Allowed Glycine 0 N--CA 1.466 0.666 0 C-N-CA 123.47 0.557 . . . . 0.0 111.759 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.8 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.02 2.128 . . . . 0.0 109.149 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.84 159.14 17.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 110.918 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -141.88 144.91 34.06 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.743 -1.223 . . . . 0.0 109.518 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.13 124.46 43.12 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 122.538 1.161 . . . . 0.0 109.675 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -88.07 129.5 35.27 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 123.978 0.911 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.6 113.87 18.08 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.538 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.4 t -54.31 -58.45 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.435 0.694 . . . . 0.0 112.0 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -56.35 -55.57 31.8 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 110.011 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.4 141.43 3.19 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 123.671 0.653 . . . . 0.0 111.963 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.79 -178.86 16.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.202 0.906 . . . . 0.0 112.631 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.87 143.78 36.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.551 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mt -130.55 151.76 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.339 1.456 . . . . 0.0 109.178 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.2 t -135.29 110.32 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.0 m -101.26 105.94 18.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.864 1.266 . . . . 0.0 108.466 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.31 146.58 58.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 120.043 -1.661 . . . . 0.0 110.355 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -73.22 151.46 49.04 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.557 1.505 . . . . 0.0 110.587 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -144.79 80.9 1.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.929 1.347 . . . . 0.0 110.435 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -92.29 118.8 31.26 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.151 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.56 0 O-C-N 121.561 -0.712 . . . . 0.0 110.292 176.642 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 CA-C-O 122.149 0.861 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.13 150.94 51.93 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.071 0.948 . . . . 0.0 111.1 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -133.92 115.05 13.95 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.839 0.828 . . . . 0.0 110.344 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.0 mt -120.1 99.81 8.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.6 OUTLIER -70.53 141.59 51.9 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.007 172.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.4 p -134.35 123.76 24.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -134.94 122.46 21.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 109.727 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt 160.38 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.179 2.192 . . . . 0.0 110.325 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.9 m -45.87 103.64 0.36 Allowed Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 125.064 1.478 . . . . 0.0 110.483 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -74.23 -172.81 1.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.831 1.688 . . . . 0.0 109.996 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -27.08 34.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.698 -1.252 . . . . 0.0 113.003 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -72.22 -50.17 29.59 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.202 -0.936 . . . . 0.0 111.472 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.49 -13.56 61.07 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 121.902 -0.499 . . . . 0.0 111.197 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -30.58 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 119.513 -1.992 . . . . 0.0 110.069 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.18 -47.02 14.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 124.68 1.192 . . . . 0.0 109.531 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 m -61.26 -39.21 89.51 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.466 1.03 . . . . 0.0 112.708 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.8 mm -70.55 -49.07 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.046 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.9 m -57.83 -44.86 86.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 119.71 1.141 . . . . 0.0 112.563 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 m -59.44 -43.47 93.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.903 1.281 . . . . 0.0 111.476 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.51 -24.68 69.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.306 0.479 . . . . 0.0 113.517 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.2 25.75 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.963 -1.316 . . . . 0.0 111.338 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -26.01 63.67 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.963 1.705 . . . . 0.0 111.972 175.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -27.32 60.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.872 0.869 . . . . 0.0 112.391 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.3 t -154.97 48.64 0.56 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.853 1.661 . . . . 0.0 110.494 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.38 -80.86 0.81 Allowed Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 38.14 43.41 1.38 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 125.934 1.731 . . . . 0.0 114.915 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 m 61.57 144.63 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.711 1.604 . . . . 0.0 112.696 -170.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 t -166.47 -40.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.535 -1.353 . . . . 0.0 110.81 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 143.18 50.78 0.04 OUTLIER Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.975 1.274 . . . . 0.0 112.236 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.0 100.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.77 95.7 10.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.656 0.382 . . . . 0.0 110.571 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.8 mt -69.39 154.66 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.692 1.197 . . . . 0.0 109.911 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.33 115.75 2.45 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.89 -1.131 . . . . 0.0 111.448 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.98 -40.86 0.7 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.269 0.938 . . . . 0.0 114.538 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -86.28 41.12 0.91 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.324 1.85 . . . . 0.0 110.689 168.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -55.8 93.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.586 1.154 . . . . 0.0 111.05 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -116.96 -168.28 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.445 1.498 . . . . 0.0 109.094 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -136.25 -41.96 0.64 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 110.989 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.5 p30 -89.79 20.95 3.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.89 2.076 . . . . 0.0 113.547 170.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.98 83.91 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 111.076 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 76.9 2.04 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.184 1.394 . . . . 0.0 109.443 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.3 m -75.96 154.75 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.009 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.94 164.54 16.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.784 1.233 . . . . 0.0 111.021 -172.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.07 -53.34 20.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.881 1.272 . . . . 0.0 112.178 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.78 -34.1 73.97 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.005 0.922 . . . . 0.0 112.143 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -51.27 63.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 O-C-N 121.721 -0.612 . . . . 0.0 109.653 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.36 -21.3 66.58 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.934 0.788 . . . . 0.0 111.312 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.39 65.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 113.211 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.73 -51.24 3.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.187 1.395 . . . . 0.0 112.607 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 . . . . . 0 C--O 1.233 0.226 0 C-N-CA 126.967 2.107 . . . . 0.0 110.843 175.798 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 C--O 1.239 0.539 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -46.18 139.36 6.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.5 p -47.61 120.41 3.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.096 1.358 . . . . 0.0 110.899 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.39 127.44 32.19 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 120.934 -1.104 . . . . 0.0 109.232 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 14.6 m -102.2 111.91 24.37 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.84 109.81 11.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -80.22 132.07 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.58 ' CZ ' ' CD1' ' A' ' 39' ' ' TYR . 2.6 t80 -97.83 115.16 27.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -101.27 107.33 18.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.234 0.614 . . . . 0.0 110.002 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -77.35 109.21 11.07 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.951 0.901 . . . . 0.0 110.92 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -108.15 106.13 16.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.787 0.835 . . . . 0.0 109.907 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 CA-C-O 117.935 -1.481 . . . . 0.0 112.734 178.06 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.846 0.355 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -92.7 -28.65 16.51 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.493 1.117 . . . . 0.0 110.968 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -19.51 14.22 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 113.569 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t -44.89 -52.44 8.63 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.858 1.329 . . . . 0.0 113.612 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -78.33 -33.9 48.91 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.674 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -56.47 -51.58 67.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.771 0.714 . . . . 0.0 110.909 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.5 p -65.95 -34.14 77.43 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.602 1.161 . . . . 0.0 111.079 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.85 -47.55 82.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.159 0.984 . . . . 0.0 112.32 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -57.29 -52.94 63.33 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 120.873 -1.142 . . . . 0.0 111.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -65.14 -24.13 67.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.204 172.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -47.46 81.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.289 0.95 . . . . 0.0 109.465 174.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tt -65.0 -41.64 95.21 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.918 0.781 . . . . 0.0 109.317 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' CD2' ' A' ' 179' ' ' TYR . . . -64.05 -43.24 96.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.39 0.431 . . . . 0.0 111.587 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -35.64 63.17 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.533 1.133 . . . . 0.0 112.132 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.15 -62.42 1.44 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -54.82 -25.92 31.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.936 0.894 . . . . 0.0 111.835 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -31.61 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.244 1.018 . . . . 0.0 112.774 171.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.5 51.67 0.25 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.329 1.442 . . . . 0.0 113.396 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.1 tpt -126.52 -77.02 0.58 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.382 1.073 . . . . 0.0 110.563 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.3 mtt -154.89 58.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.681 1.229 . . . . 0.0 111.235 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -106.38 -5.87 18.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.14 39.37 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.529 1.062 . . . . 0.0 112.579 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.476 0.872 0 O-C-N 122.181 -0.599 . . . . 0.0 110.838 178.101 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.921 0 CA-C-O 120.796 0.109 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.07 -56.0 4.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.801 0.84 . . . . 0.0 109.81 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -25.46 66.84 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.931 171.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -52.01 67.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.631 1.105 . . . . 0.0 111.298 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -68.63 -39.45 80.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.051 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -60.04 -48.81 80.17 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 111.026 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.5 m -68.35 -41.45 80.69 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 125.342 1.457 . . . . 0.0 110.286 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.22 -54.09 50.67 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.085 1.311 . . . . 0.0 111.203 172.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.96 -51.28 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.805 -1.184 . . . . 0.0 110.964 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -60.0 -26.13 65.81 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.711 -1.243 . . . . 0.0 112.592 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.7 -14.12 59.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.21 1.004 . . . . 0.0 113.088 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.74 34.13 9.41 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.167 1.365 . . . . 0.0 112.697 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.91 -73.46 0.56 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.065 0.546 . . . . 0.0 111.81 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -63.6 1.21 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.011 0.434 . . . . 0.0 110.22 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -134.24 -164.36 1.49 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.135 1.374 . . . . 0.0 109.698 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.42 23.49 1.37 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.659 1.123 . . . . 0.0 112.732 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.7 mmt -93.19 174.76 7.05 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.104 1.361 . . . . 0.0 112.029 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.01 138.75 58.66 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.35 0.595 . . . . 0.0 110.351 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.74 132.2 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 t -92.99 150.64 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.66 142.11 12.36 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.05 99.42 46.63 Favored Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 124.545 1.138 . . . . 0.0 108.005 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -74.22 -29.36 9.75 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.523 2.149 . . . . 0.0 112.26 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.81 68.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.452 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.29 -65.23 1.2 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.113 . . . . 0.0 111.818 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.93 52.81 0.24 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.051 1.31 . . . . 0.0 112.382 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.3 m -144.16 105.31 4.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.186 0.995 . . . . 0.0 109.828 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.55 145.61 45.39 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 122.111 0.958 . . . . 0.0 110.517 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -126.16 127.46 45.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -101.12 135.17 43.02 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.746 0.784 . . . . 0.0 109.261 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -96.21 119.71 35.19 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -171.84 0.9 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.768 0.427 . . . . 0.0 111.339 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -57.92 4.11 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.959 0.904 . . . . 0.0 112.254 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.99 132.99 3.8 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.145 0.978 . . . . 0.0 110.617 173.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.66 -57.61 4.5 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.657 1.123 . . . . 0.0 112.563 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -46.38 139.13 7.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 123.872 0.748 . . . . 0.0 112.611 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -132.64 152.67 51.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.479 1.133 . . . . 0.0 109.601 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -132.97 146.76 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.164 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.15 113.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 m -95.16 123.72 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.34 40.02 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.546 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -71.52 152.77 60.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.98 1.787 . . . . 0.0 110.784 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -149.66 84.99 1.42 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 123.749 1.738 . . . . 0.0 108.953 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.4 p -89.79 144.33 26.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.143 -1.844 . . . . 0.0 108.907 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 177.109 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 CA-C-O 122.181 0.879 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -129.46 150.26 50.88 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.973 0.909 . . . . 0.0 110.883 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.01 119.16 8.85 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.077 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mt -119.01 115.91 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.351 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.7 OUTLIER -78.45 140.82 38.61 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.908 174.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 123.58 25.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -131.82 123.62 27.95 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.455 0.702 . . . . 0.0 110.041 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HE3' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER 161.57 -31.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.615 1.966 . . . . 0.0 113.268 -175.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.42 HG22 ' HE3' ' A' ' 120' ' ' LYS . 18.3 t -50.02 111.28 2.01 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.056 176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.16 -173.72 1.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.946 2.431 . . . . 0.0 110.743 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.75 -24.17 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.876 -1.14 . . . . 0.0 113.076 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -52.68 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.952 0.796 . . . . 0.0 111.211 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.46 -17.05 61.81 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.548 173.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 14.2 t -62.55 -45.57 92.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 120.902 1.683 . . . . 0.0 109.248 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.35 -45.6 40.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-O 118.216 -0.897 . . . . 0.0 108.998 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.412 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -57.74 -43.12 85.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.691 1.587 . . . . 0.0 113.768 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.7 mm -74.32 -44.7 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.073 1.749 . . . . 0.0 110.279 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.1 m -63.84 -26.73 68.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.0 m -82.35 -44.18 16.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.721 2.008 . . . . 0.0 110.258 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.78 -42.65 78.44 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.07 -27.21 67.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.825 1.312 . . . . 0.0 112.774 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.78 -21.77 63.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.206 0.602 . . . . 0.0 111.932 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.55 -25.81 39.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.585 1.154 . . . . 0.0 112.775 174.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -151.81 49.66 0.8 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.393 1.477 . . . . 0.0 110.212 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -36.56 -63.63 0.68 Allowed Glycine 0 C--N 1.344 1.024 0 C-N-CA 125.628 1.585 . . . . 0.0 113.18 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 25.21 78.22 0.01 OUTLIER Glycine 0 C--N 1.346 1.085 0 C-N-CA 126.971 2.224 . . . . 0.0 113.273 167.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.2 p -51.67 171.31 0.04 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.78 1.632 . . . . 0.0 112.937 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 p 178.92 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.647 0.779 . . . . 0.0 111.811 -170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.55 42.68 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.496 0.57 . . . . 0.0 113.949 176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.6 mt -80.12 117.07 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 123.321 0.648 . . . . 0.0 109.574 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.56 104.36 9.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.589 1.155 . . . . 0.0 108.036 -176.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.3 mm -78.6 168.09 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -50.06 116.22 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.29 1.436 . . . . 0.0 112.439 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.59 28.61 6.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 123.52 0.581 . . . . 0.0 114.11 -173.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.95 38.52 3.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.378 2.271 . . . . 0.0 108.398 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.63 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.668 1.987 . . . . 0.0 112.129 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -138.2 -173.43 3.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.624 1.57 . . . . 0.0 109.347 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.9 p -146.8 -52.14 0.22 Allowed 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.084 -1.01 . . . . 0.0 109.461 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -80.03 31.39 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.221 2.209 . . . . 0.0 113.521 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 105.43 13.45 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.839 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.88 128.36 35.35 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.13 134.43 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 178.5 7.22 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.959 0.904 . . . . 0.0 110.644 -170.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.54 -54.51 42.22 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 172.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.53 -32.46 72.52 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.899 0.88 . . . . 0.0 111.986 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.31 -54.35 17.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.62 -18.57 64.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.424 1.011 . . . . 0.0 111.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.07 -38.76 92.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.926 0.89 . . . . 0.0 111.945 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.4 m -111.25 -51.6 2.85 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.095 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.468 0.44 0 C-N-CA 126.287 1.835 . . . . 0.0 113.513 178.263 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.573 0.702 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.19 5.68 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 123.72 0.676 . . . . 0.0 113.077 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 46.4 m -152.05 99.52 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.152 1.381 . . . . 0.0 109.171 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -134.16 116.58 15.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.356 1.062 . . . . 0.0 110.123 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.9 m -115.92 107.14 14.62 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.2 123.15 40.82 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.578 0.751 . . . . 0.0 109.103 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -94.79 122.8 46.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -98.93 122.57 42.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.402 0.681 . . . . 0.0 110.046 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.09 138.94 41.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.587 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -145.05 136.4 25.12 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.888 177.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -48.41 149.64 1.54 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.022 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.914 -179.54 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 t0 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.647 0.26 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.07 -34.13 19.26 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.01 -25.76 2.62 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 120.879 -1.138 . . . . 0.0 114.088 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 p -48.31 -41.6 28.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.822 1.649 . . . . 0.0 114.316 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.43 -34.99 47.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.9 mt -57.79 -53.28 59.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.141 0.882 . . . . 0.0 112.356 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.9 p -60.76 -36.83 79.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.711 176.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -50.84 72.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.859 1.263 . . . . 0.0 112.42 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.426 ' CZ ' HG23 ' A' ' 118' ' ' THR . 12.2 m-30 -57.98 -46.49 85.07 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.892 -1.13 . . . . 0.0 111.649 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -62.96 -31.96 73.17 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.008 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -45.74 89.22 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 123.663 0.785 . . . . 0.0 109.713 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tp -59.47 -49.57 77.29 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 120.374 1.443 . . . . 0.0 110.071 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.53 95.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.98 -33.37 59.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.615 1.166 . . . . 0.0 112.524 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -71.45 -61.12 1.89 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 t -56.51 -19.75 17.04 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.17 0.988 . . . . 0.0 112.332 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -32.22 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.735 0.814 . . . . 0.0 112.248 171.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.83 45.94 0.17 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.648 1.118 . . . . 0.0 113.009 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -113.64 -66.4 1.09 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.995 0.918 . . . . 0.0 110.128 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.02 31.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.693 1.197 . . . . 0.0 112.564 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.446 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.36 -21.91 48.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 176.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.07 47.1 0.13 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.302 0.953 . . . . 0.0 112.332 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 123.384 0.674 . . . . 0.0 111.418 178.379 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.937 0 CA-C-O 119.938 -0.368 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.445 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . . . -85.07 -70.0 0.61 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -23.74 50.07 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 123.436 0.695 . . . . 0.0 112.302 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 51' ' ' LYS . 7.4 tpt -53.5 -71.61 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.512 0.725 . . . . 0.0 110.36 172.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -65.95 -32.98 74.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.494 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.68 -53.05 62.15 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.094 0.861 . . . . 0.0 111.02 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.1 m -68.18 -41.05 82.04 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.42 1.088 . . . . 0.0 110.891 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.072 0.851 . . . . 0.0 111.754 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.18 -52.06 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.067 -1.02 . . . . 0.0 110.48 176.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.06 -20.44 53.28 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.364 -1.46 . . . . 0.0 113.094 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.54 13.65 3.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.509 1.524 . . . . 0.0 113.615 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 53.18 40.8 60.27 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.865 1.698 . . . . 0.0 112.8 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.83 -70.29 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 -54.27 5.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -149.25 178.13 9.03 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.089 1.356 . . . . 0.0 109.538 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.69 31.46 3.38 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 124.787 1.184 . . . . 0.0 112.105 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.38 171.28 8.06 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.353 1.061 . . . . 0.0 111.639 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -61.88 131.44 49.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.446 0.641 . . . . 0.0 110.497 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.13 136.94 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.799 1.24 . . . . 0.0 108.464 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 t -88.02 126.94 35.35 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.75 103.42 2.91 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -50.14 105.39 0.51 Allowed Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.481 1.112 . . . . 0.0 111.373 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.16 -17.25 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.504 2.136 . . . . 0.0 112.388 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.31 -7.09 58.76 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.99 1.316 . . . . 0.0 112.594 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m 60.04 68.45 0.78 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.436 1.494 . . . . 0.0 112.05 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.03 -52.89 0.1 OUTLIER Glycine 0 N--CA 1.467 0.747 0 C-N-CA 124.006 0.812 . . . . 0.0 112.215 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -177.25 124.29 0.14 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.832 1.253 . . . . 0.0 110.965 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -64.81 164.58 12.06 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 122.355 1.074 . . . . 0.0 112.029 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.6 t -133.86 142.21 47.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.65 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -109.23 123.84 49.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.059 0.944 . . . . 0.0 109.099 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -82.04 119.56 24.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.802 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -70.27 176.6 3.81 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.282 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.68 -53.65 4.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.036 1.334 . . . . 0.0 113.01 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -149.6 -51.36 0.15 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 0.0 111.779 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.46 98.83 0.86 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.82 132.99 1.57 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 124.012 0.815 . . . . 0.0 111.535 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.03 127.41 50.21 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.81 136.82 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 108.684 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.26 109.49 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 m -87.32 122.98 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.97 136.94 18.74 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.337 -0.852 . . . . 0.0 109.209 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -76.08 152.38 35.79 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.734 1.623 . . . . 0.0 110.554 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -143.75 69.04 1.28 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 111.667 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.3 p -97.61 104.53 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.281 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.428 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.184 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -108.18 135.56 49.3 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.507 0.723 . . . . 0.0 110.333 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 p -124.03 102.44 7.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.748 1.261 . . . . 0.0 110.9 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.44 110.25 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.425 ' CB ' HG22 ' A' ' 176' ' ' VAL . 0.6 OUTLIER -76.84 141.95 40.44 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.285 173.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 39' ' ' TYR . 5.8 p -133.91 130.32 37.59 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.43 -173.88 3.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.352 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 89.84 -31.11 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.576 2.75 . . . . 0.0 110.418 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.7 t -47.61 104.39 0.41 Allowed Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 127.19 2.196 . . . . 0.0 108.405 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -73.66 -170.09 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.991 1.794 . . . . 0.0 110.431 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.401 ' HB3' ' HG1' ' A' ' 170' ' ' THR . 4.9 pp0? -59.54 -31.14 69.14 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.873 -1.142 . . . . 0.0 112.277 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.0 p -73.72 -50.54 20.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.501 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.97 -17.83 62.04 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.91 172.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.45 -45.91 92.29 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 120.878 1.672 . . . . 0.0 108.385 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.98 -42.04 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.629 0.649 . . . . 0.0 111.467 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.47 -45.1 92.35 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.4 mm -63.25 -52.99 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 C-N-CA 124.957 1.303 . . . . 0.0 109.52 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.7 m -56.26 -42.44 77.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 119.121 0.873 . . . . 0.0 112.226 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -56.8 -52.44 65.04 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.127 1.371 . . . . 0.0 110.969 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.6 -29.01 72.8 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 122.867 0.27 . . . . 0.0 112.682 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.429 ' HE1' ' HA ' ' A' ' 133' ' ' MET . 0.0 OUTLIER -76.57 -35.3 58.26 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.245 1.018 . . . . 0.0 111.201 176.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -25.06 65.67 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.929 0.892 . . . . 0.0 112.126 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -60.91 -30.15 70.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.247 0.619 . . . . 0.0 112.605 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 t -153.76 50.75 0.68 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.285 1.034 . . . . 0.0 111.428 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.55 -85.51 1.65 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 44.03 49.91 7.69 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.471 1.034 . . . . 0.0 113.618 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.2 m 66.22 147.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.529 1.532 . . . . 0.0 112.326 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.1 p -179.7 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.142 -0.974 . . . . 0.0 110.961 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.85 48.62 0.07 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.575 1.083 . . . . 0.0 112.216 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.5 mt -88.91 99.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.038 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -90.56 97.08 10.97 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.816 0.446 . . . . 0.0 110.016 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.4 mt -73.87 146.82 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 124.4 1.062 . . . . 0.0 109.516 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -48.36 114.58 0.98 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.467 1.507 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.88 -39.64 0.96 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.302 0.953 . . . . 0.0 113.983 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.57 35.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.265 1.826 . . . . 0.0 111.428 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -51.85 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.378 1.471 . . . . 0.0 110.473 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -123.05 -169.24 1.89 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.976 1.31 . . . . 0.0 109.204 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 p -139.68 -41.69 0.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.784 0.834 . . . . 0.0 110.852 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -90.89 24.44 2.76 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.574 1.949 . . . . 0.0 113.412 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.59 125.76 24.37 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.509 0.671 . . . . 0.0 110.079 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -113.39 74.73 0.88 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 122.479 1.133 . . . . 0.0 108.315 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.66 135.18 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.494 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.7 p -136.56 -179.04 5.44 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.072 0.949 . . . . 0.0 111.449 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.29 81.88 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.605 -0.684 . . . . 0.0 112.386 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.56 -35.54 78.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.584 0.754 . . . . 0.0 111.421 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -46.08 36.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.786 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.47 66.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.1 0.864 . . . . 0.0 111.124 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -39.26 87.74 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 170.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.36 -31.59 24.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.694 1.597 . . . . 0.0 113.792 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 CA--C 1.539 0.52 0 C-N-CA 125.899 1.68 . . . . 0.0 110.462 178.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.401 ' HG1' ' HB3' ' A' ' 123' ' ' GLN . 67.5 p . . . . . 0 C--O 1.238 0.455 0 CA-C-O 120.627 0.251 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.59 136.05 2.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.746 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 95.3 m -50.81 135.12 24.49 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.26 110.26 20.4 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.0 m -110.77 112.09 23.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.06 109.55 11.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.425 HG22 ' CB ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -85.93 137.75 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -111.18 113.01 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.309 0.644 . . . . 0.0 109.726 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -101.46 118.32 36.71 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 109.689 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.46 122.71 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.093 0.957 . . . . 0.0 110.209 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -113.23 95.35 5.33 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.363 1.065 . . . . 0.0 108.91 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.204 0 CA-C-O 118.513 -1.159 . . . . 0.0 112.349 -174.484 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.72 -36.18 13.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.398 1.079 . . . . 0.0 111.249 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.92 -26.07 32.64 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.201 -0.777 . . . . 0.0 112.827 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -46.14 -43.34 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.003 1.321 . . . . 0.0 113.196 172.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.19 -34.31 49.58 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.739 -0.601 . . . . 0.0 111.805 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.28 -50.82 68.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 110.341 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.6 p -63.48 -38.1 89.83 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.308 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -58.56 -53.12 61.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.896 1.225 . . . . 0.0 112.416 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -51.25 -52.16 47.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.036 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -67.14 -23.66 65.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.38 69.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.052 1.341 . . . . 0.0 108.685 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.57 -41.46 98.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.269 0.94 . . . . 0.0 109.498 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.5 92.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 117.978 0.354 . . . . 0.0 111.075 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -78.53 -39.03 39.15 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.241 0.616 . . . . 0.0 112.618 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -60.68 -57.92 10.67 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -41.36 62.33 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.606 1.162 . . . . 0.0 111.089 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -42.89 -31.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.771 1.629 . . . . 0.0 112.996 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -150.62 50.62 0.54 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.307 1.432 . . . . 0.0 112.678 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.7 tpp -137.26 -60.27 0.67 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.026 0.93 . . . . 0.0 110.569 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.1 tpt -162.12 39.67 0.12 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.72 5.66 38.78 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.2 38.02 0.51 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.9 1.238 . . . . 0.0 112.801 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.0 t . . . . . 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 0.0 109.157 -179.624 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.793 0 CA-C-O 119.593 -0.559 . . . . 0.0 113.597 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 -61.49 1.54 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.234 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -61.92 -28.57 69.62 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 123.757 0.823 . . . . 0.0 112.481 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.458 ' HE2' ' CZ ' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -56.54 -49.71 74.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.788 0.722 . . . . 0.0 110.322 173.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.611 ' HG1' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -72.26 -41.13 67.1 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.285 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -55.84 -52.58 63.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.923 0.868 . . . . 0.0 110.62 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.4 m -68.99 -43.1 75.55 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.933 1.293 . . . . 0.0 110.715 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.88 -43.49 90.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.706 1.593 . . . . 0.0 111.989 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.75 -53.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.282 0.633 . . . . 0.0 111.027 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -64.57 -17.2 63.74 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.168 -0.958 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.07 -19.44 30.23 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 112.35 174.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.1 76.17 1.21 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.998 1.285 . . . . 0.0 112.544 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.25 -97.9 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.001 0.52 . . . . 0.0 112.166 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.74 -40.69 60.68 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.005 0.922 . . . . 0.0 111.368 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -165.71 -178.77 4.99 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.017 1.727 . . . . 0.0 110.185 173.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.37 18.02 7.83 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.315 1.436 . . . . 0.0 112.783 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.0 ttt -92.45 171.38 9.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.611 1.165 . . . . 0.0 111.553 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.94 145.98 44.05 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.27 -0.894 . . . . 0.0 111.097 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.3 t -120.67 129.37 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.76 132.68 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.44 136.61 14.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -42.51 113.52 1.29 Allowed Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.907 1.283 . . . . 0.0 112.78 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -76.51 -68.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.943 1.762 . . . . 0.0 111.375 -173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.73 13.18 20.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.762 1.225 . . . . 0.0 112.138 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.24 56.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.225 1.41 . . . . 0.0 111.632 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.02 -56.94 0.78 Allowed Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p 169.79 137.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.676 1.59 . . . . 0.0 110.47 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 87.63 0.19 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.447 0.699 . . . . 0.0 111.049 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 t -63.08 139.22 58.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 110.431 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -114.34 131.57 56.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.401 1.48 . . . . 0.0 108.909 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -91.93 115.54 28.15 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.365 1.066 . . . . 0.0 110.101 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.36 -179.63 2.54 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.61 0.719 . . . . 0.0 112.058 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 -51.51 6.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -45.7 87.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.38 0.672 . . . . 0.0 111.462 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.8 41.68 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.679 1.133 . . . . 0.0 112.705 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -104.97 170.16 17.54 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.155 0.883 . . . . 0.0 111.748 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -123.48 138.97 54.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.753 0.787 . . . . 0.0 109.262 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.13 119.4 56.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.54 115.22 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.611 HG13 ' HG1' ' A' ' 65' ' ' THR . 1.7 m -100.22 132.11 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.34 137.21 9.2 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.987 -0.446 . . . . 0.0 110.899 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.3 154.23 61.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.215 1.943 . . . . 0.0 111.608 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.9 65.42 1.11 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.575 1.655 . . . . 0.0 111.099 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -86.48 172.04 10.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.443 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.382 0 C-N-CA 123.341 0.656 . . . . 0.0 111.111 177.425 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.458 ' CZ ' ' HE2' ' A' ' 64' ' ' MET . 2.0 m-85 -87.47 155.68 19.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.708 -0.878 . . . . 0.0 111.18 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.86 118.21 9.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 122.023 0.916 . . . . 0.0 110.822 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mt -113.57 108.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -71.17 131.34 43.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.125 0.97 . . . . 0.0 108.807 172.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -130.38 124.72 32.83 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -131.15 128.18 39.55 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt 164.74 -38.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.771 2.029 . . . . 0.0 110.872 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -45.19 103.35 0.34 Allowed Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.711 1.604 . . . . 0.0 110.492 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -74.82 -172.1 1.14 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 110.363 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -22.54 53.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.545 -1.347 . . . . 0.0 114.324 173.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.8 t -79.34 -52.01 8.66 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.964 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.32 -23.9 60.32 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 121.866 -0.521 . . . . 0.0 110.86 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.26 -27.54 62.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.791 1.178 . . . . 0.0 110.164 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.59 -50.87 11.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 CA-C-O 117.871 -1.062 . . . . 0.0 110.609 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -45.22 68.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.943 1.247 . . . . 0.0 113.38 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.09 -38.61 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.206 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -67.2 -43.78 81.23 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.463 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.4 m -65.15 -27.89 69.03 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.243 1.383 . . . . 0.0 111.957 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.02 20.68 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.227 0.917 . . . . 0.0 113.75 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 1.9 ttp -84.71 -24.78 28.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.289 1.435 . . . . 0.0 112.43 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.6 p -69.59 -21.36 63.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.917 1.287 . . . . 0.0 111.888 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.0 mtt-85 -60.57 -17.91 49.35 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 113.133 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 t -154.04 53.44 0.7 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.255 1.022 . . . . 0.0 110.593 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -38.09 -65.39 0.7 Allowed Glycine 0 C--N 1.345 1.075 0 C-N-CA 125.34 1.448 . . . . 0.0 112.961 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 22.39 72.29 0.01 OUTLIER Glycine 0 C--N 1.347 1.187 0 C-N-CA 126.991 2.234 . . . . 0.0 113.217 167.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.9 p -53.28 171.16 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.531 1.532 . . . . 0.0 112.668 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.39 -33.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.67 -0.644 . . . . 0.0 111.315 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.12 43.5 0.03 OUTLIER Glycine 0 C--N 1.338 0.643 0 CA-C-O 119.58 -0.567 . . . . 0.0 113.399 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.0 mt -77.2 116.3 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.166 0.586 . . . . 0.0 110.812 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.79 96.45 5.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.574 1.15 . . . . 0.0 108.897 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.7 mt -74.96 167.14 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -49.53 115.83 1.51 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.35 1.46 . . . . 0.0 111.981 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.65 27.19 8.6 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 123.444 0.545 . . . . 0.0 114.138 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.34 39.94 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.06 2.544 . . . . 0.0 107.615 -176.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -42.53 95.91 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.657 1.183 . . . . 0.0 111.593 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -142.8 -173.52 3.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.221 1.408 . . . . 0.0 108.784 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.3 p -146.29 -47.57 0.2 Allowed 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.548 -0.72 . . . . 0.0 110.193 -174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.57 18.53 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.259 1.824 . . . . 0.0 112.142 172.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.97 97.71 0.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.304 -0.873 . . . . 0.0 111.146 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.62 125.1 29.58 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.07 170.06 16.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.151 0.98 . . . . 0.0 110.809 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.05 -37.67 72.12 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.5 -42.3 43.93 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.185 0.994 . . . . 0.0 110.891 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -45.51 94.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 173.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.84 -17.95 61.5 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.761 -0.587 . . . . 0.0 111.972 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -40.6 76.67 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.243 -0.91 . . . . 0.0 111.531 172.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 70.1 m -107.96 -58.01 2.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.805 0.842 . . . . 0.0 112.12 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 126.365 1.866 . . . . 0.0 113.037 176.585 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.7 p . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 121.507 0.67 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.07 0.65 Allowed Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 67.4 p -89.28 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.348 1.459 . . . . 0.0 109.7 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.32 84.28 2.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.974 1.71 . . . . 0.0 109.792 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.0 m -77.16 123.87 27.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.199 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.26 112.68 11.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -82.67 131.52 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 171.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -108.88 111.34 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -85.79 141.82 29.39 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.022 0.439 . . . . 0.0 111.498 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -142.22 118.71 10.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.824 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.66 142.39 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.677 0.391 . . . . 0.0 110.489 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 C-N-CA 124.276 0.941 . . . . 0.0 113.961 175.262 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 t0 . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.114 0.483 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.11 -38.39 20.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.341 1.056 . . . . 0.0 111.24 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.73 -28.85 1.19 Allowed Glycine 0 C--O 1.216 -1.0 0 CA-C-O 117.868 -1.518 . . . . 0.0 113.142 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 t -40.3 -46.15 2.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.293 1.546 . . . . 0.0 113.649 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -73.62 -39.23 64.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.17 0.896 . . . . 0.0 111.517 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mt -66.44 -51.85 52.62 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.848 0.859 . . . . 0.0 112.017 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 p -62.69 -35.76 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.35 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -58.62 -54.44 47.07 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.117 1.326 . . . . 0.0 111.588 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -56.7 -45.63 81.71 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.206 -0.934 . . . . 0.0 111.638 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -65.01 -28.56 69.59 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 112.222 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -43.23 81.61 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 109.688 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.89 -44.09 97.04 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.083 -1.011 . . . . 0.0 109.994 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.75 86.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.455 0.57 . . . . 0.0 112.264 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.34 -30.94 63.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.39 1.076 . . . . 0.0 112.656 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.85 -60.83 2.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 t -55.27 -21.15 13.35 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.948 0.899 . . . . 0.0 112.587 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -47.39 -33.84 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.545 1.138 . . . . 0.0 113.087 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.93 37.31 0.42 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.611 1.101 . . . . 0.0 112.283 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.9 tpt -109.47 -70.41 0.81 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.518 0.727 . . . . 0.0 110.583 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.76 64.03 0.73 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.8 1.286 . . . . 0.0 111.297 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.49 -9.52 15.37 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.68 37.77 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.236 1.398 . . . . 0.0 111.924 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.611 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 CA-C-O 120.134 -0.259 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . . . -83.07 -49.85 9.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.38 -22.91 34.32 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 123.679 0.791 . . . . 0.0 112.106 169.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -60.46 -51.48 69.28 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.071 0.85 . . . . 0.0 110.076 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.649 ' HG1' HG23 ' A' ' 100' ' ' VAL . 11.4 m -74.85 -40.75 60.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.049 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -56.04 -52.5 64.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.194 0.906 . . . . 0.0 110.738 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.4 m -68.57 -39.64 80.91 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 110.928 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.58 -51.29 70.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.626 1.557 . . . . 0.0 111.557 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -51.93 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 120.694 -1.253 . . . . 0.0 110.863 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -61.88 -18.34 59.8 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.484 -1.385 . . . . 0.0 112.711 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.08 12.11 5.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.493 1.517 . . . . 0.0 113.295 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.62 40.83 80.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.977 1.275 . . . . 0.0 112.743 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.19 -77.73 0.54 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.01 0.524 . . . . 0.0 110.861 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.39 -59.57 2.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -140.04 179.66 6.49 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.178 1.391 . . . . 0.0 109.9 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.16 35.37 2.45 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.104 1.335 . . . . 0.0 112.161 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.2 mtt -103.72 179.77 4.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.801 1.24 . . . . 0.0 111.982 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -69.77 133.74 47.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.587 0.708 . . . . 0.0 110.473 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.26 134.36 59.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.53 1.132 . . . . 0.0 108.515 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.26 152.15 36.59 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.184 0.516 . . . . 0.0 110.803 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.95 158.05 14.54 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -145.36 127.85 8.08 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 122.766 0.426 . . . . 0.0 110.552 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.29 -17.02 27.82 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.639 2.226 . . . . 0.0 112.514 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.1 61.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.508 0.723 . . . . 0.0 112.842 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 t 66.56 63.69 0.51 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 112.296 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.76 41.16 0.02 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.727 -0.608 . . . . 0.0 114.127 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.35 25.39 0.3 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.942 0.897 . . . . 0.0 111.761 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -60.26 126.97 29.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.215 1.007 . . . . 0.0 109.914 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 t -117.58 140.44 49.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.19 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -106.62 127.11 53.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -87.37 113.83 23.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.764 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -74.48 170.55 15.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.769 0.795 . . . . 0.0 111.643 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -87.75 -36.0 17.58 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.078 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -87.73 46.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 112.162 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 46.94 61.25 4.49 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.023 1.297 . . . . 0.0 112.832 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -130.15 160.31 22.92 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 123.774 0.702 . . . . 0.0 112.329 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.43 133.93 48.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.796 1.284 . . . . 0.0 108.95 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.08 135.81 59.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.911 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.32 110.37 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.649 HG23 ' HG1' ' A' ' 65' ' ' THR . 3.0 m -90.32 125.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.33 125.55 13.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.538 -0.726 . . . . 0.0 109.248 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.86 153.96 58.55 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.488 1.459 . . . . 0.0 111.203 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -147.56 73.14 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.935 1.694 . . . . 0.0 110.852 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.7 p -104.55 82.46 1.91 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.775 1.274 . . . . 0.0 109.807 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.376 0 O-C-N 120.627 -1.295 . . . . 0.0 111.124 -175.21 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.477 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.47 133.05 56.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.085 0.942 . . . . 0.0 109.674 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.0 p -116.55 124.01 48.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 122.135 0.969 . . . . 0.0 108.968 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.3 mp -120.8 98.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -69.38 135.68 50.66 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.56 172.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.6 p -125.28 121.86 35.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -120.58 175.42 6.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.545 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 84.19 -18.42 0.41 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.959 2.104 . . . . 0.0 111.897 -175.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -49.38 107.68 0.83 Allowed Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.283 1.833 . . . . 0.0 109.011 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -73.71 -174.47 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.352 2.035 . . . . 0.0 110.026 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -59.47 -28.13 66.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.383 -0.823 . . . . 0.0 111.863 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.4 t -70.24 -43.59 70.26 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.497 -1.377 . . . . 0.0 111.524 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 119.425 -0.322 . . . . 0.0 111.387 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -26.94 63.03 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.937 -1.102 . . . . 0.0 111.614 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.02 -53.58 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 124.49 1.116 . . . . 0.0 110.674 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 p -57.08 -44.72 83.4 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.681 1.128 . . . . 0.0 113.249 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.53 -38.4 56.5 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 C-N-CA 124.851 1.26 . . . . 0.0 109.338 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.9 m -73.38 -46.6 48.01 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.963 0.801 . . . . 0.0 112.469 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 m -56.99 -32.36 66.01 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.468 1.485 . . . . 0.0 111.727 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.45 -37.36 9.75 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.105 0.86 . . . . 0.0 113.394 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.3 ttm -74.34 -15.5 60.95 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.003 -1.292 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.2 t -84.84 -21.64 29.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.323 -1.486 . . . . 0.0 111.193 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -62.64 -41.95 99.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.095 0.558 . . . . 0.0 112.086 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.2 t -161.75 55.53 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.178 0.991 . . . . 0.0 110.688 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.25 -83.55 0.19 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.81 149.13 0.01 OUTLIER Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.759 1.2 . . . . 0.0 111.827 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.0 m -49.84 143.03 8.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.986 -1.302 . . . . 0.0 111.555 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.97 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.267 0.627 . . . . 0.0 111.717 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 153.98 54.49 0.01 OUTLIER Glycine 0 C--N 1.337 0.615 0 C-N-CA 123.902 0.763 . . . . 0.0 112.488 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.62 98.38 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.358 0.599 . . . . 0.0 109.941 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -91.42 93.91 9.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.0 tt -77.32 148.87 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 111.027 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -54.29 122.43 10.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.669 -0.644 . . . . 0.0 112.23 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.56 -52.73 3.53 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.403 1.001 . . . . 0.0 113.327 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -79.7 31.03 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.983 1.313 . . . . 0.0 111.968 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -48.81 98.18 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.253 1.421 . . . . 0.0 110.676 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -126.22 -165.86 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.915 1.286 . . . . 0.0 109.089 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.6 p -132.2 -37.63 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.009 0.924 . . . . 0.0 110.921 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.95 12.14 18.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.371 1.868 . . . . 0.0 113.646 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.58 137.42 19.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.768 0.794 . . . . 0.0 109.881 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 120.15 25.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.25 133.9 63.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 171.15 12.62 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.333 1.053 . . . . 0.0 110.245 -169.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.16 -52.19 63.41 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 111.784 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.43 -37.65 78.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.879 0.871 . . . . 0.0 111.982 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.74 42.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.322 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.34 67.47 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.581 1.082 . . . . 0.0 111.985 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -34.93 78.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.497 1.119 . . . . 0.0 112.194 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -43.06 8.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.293 1.037 . . . . 0.0 112.299 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--O 1.234 0.277 0 C-N-CA 126.702 2.001 . . . . 0.0 111.113 -179.902 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.7 p . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.439 0.161 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.19 130.73 2.77 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.022 0.82 . . . . 0.0 112.589 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.2 p -45.73 108.24 0.12 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.789 1.636 . . . . 0.0 110.804 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.5 125.94 30.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 m -96.5 108.24 20.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.76 102.17 7.19 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.578 1.151 . . . . 0.0 108.576 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -81.69 131.32 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 173.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -111.39 101.08 9.57 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.777 0.831 . . . . 0.0 109.224 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -87.01 144.16 27.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.41 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -138.59 111.52 7.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.812 1.245 . . . . 0.0 109.912 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.93 129.01 38.99 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.346 0.658 . . . . 0.0 109.408 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.589 0 CA-C-O 116.81 -2.106 . . . . 0.0 115.661 173.534 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.612 0.244 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.9 -42.31 8.37 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.206 1.402 . . . . 0.0 112.07 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.58 -29.25 5.53 Favored Glycine 0 C--O 1.212 -1.27 0 CA-C-O 117.065 -1.964 . . . . 0.0 111.838 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.1 p -40.43 -34.92 0.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.172 2.189 . . . . 0.0 114.743 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -88.08 -38.03 15.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.25 . . . . 0.0 110.785 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.7 -47.63 30.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.399 1.08 . . . . 0.0 111.032 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -56.87 -40.3 75.9 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 109.763 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -59.13 -51.84 68.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.468 1.486 . . . . 0.0 111.692 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -50.74 -52.04 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.022 -0.424 . . . . 0.0 111.478 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -67.4 -23.91 65.61 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.1 81.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.368 1.467 . . . . 0.0 109.062 176.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 tt -67.24 -43.25 82.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.792 0.724 . . . . 0.0 109.7 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 179' ' ' TYR . . . -62.59 -43.3 99.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.082 0.239 . . . . 0.0 111.309 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.18 -33.68 59.32 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.065 1.346 . . . . 0.0 112.634 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -67.07 -62.91 1.19 Allowed 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -29.92 59.75 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.79 0.836 . . . . 0.0 111.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.61 -34.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.814 1.246 . . . . 0.0 112.389 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 44.49 0.63 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.178 1.37 . . . . 0.0 112.373 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -134.0 -70.3 0.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.951 0.9 . . . . 0.0 111.46 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.67 71.57 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.75 1.262 . . . . 0.0 111.784 -173.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -116.5 14.08 15.49 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.962 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.66 2.52 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.596 1.093 . . . . 0.0 113.032 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.478 0.96 0 CA-C-N 118.103 0.951 . . . . 0.0 111.012 178.312 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . . . -84.77 -55.44 4.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.47 0.708 . . . . 0.0 111.927 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.56 -27.92 68.97 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.166 170.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -53.8 52.43 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.714 0.688 . . . . 0.0 110.311 175.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.573 ' HG1' HG13 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -70.85 -37.76 73.14 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 118.595 -0.717 . . . . 0.0 112.232 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -57.83 -56.42 22.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.82 0.736 . . . . 0.0 110.834 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 m -68.3 -35.21 77.48 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.019 1.327 . . . . 0.0 110.389 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.29 -50.82 70.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.37 1.441 . . . . 0.0 111.324 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.36 -52.86 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 O-C-N 120.825 -1.172 . . . . 0.0 110.994 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.72 -18.32 62.31 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.701 -1.249 . . . . 0.0 112.38 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.84 10.22 6.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.711 1.604 . . . . 0.0 112.908 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.18 51.25 60.27 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.98 1.276 . . . . 0.0 112.307 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.08 -85.07 0.63 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.512 0.725 . . . . 0.0 111.017 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.49 -52.15 35.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 122.638 0.375 . . . . 0.0 111.646 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -149.98 -179.94 7.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.09 25.22 5.25 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.992 1.282 . . . . 0.0 112.489 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.58 168.6 10.93 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.226 1.01 . . . . 0.0 111.567 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -60.92 136.21 58.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.326 0.584 . . . . 0.0 110.403 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.94 136.34 53.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.421 1.088 . . . . 0.0 108.347 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.58 128.97 50.76 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.18 154.55 33.04 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -44.69 110.42 1.04 Allowed Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.502 0.721 . . . . 0.0 112.852 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.17 -31.75 4.58 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.508 1.472 . . . . 0.0 111.694 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.73 11.85 21.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.269 1.427 . . . . 0.0 112.606 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m 62.07 98.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 112.996 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.57 38.16 1.49 Allowed Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.914 0.769 . . . . 0.0 114.037 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 p -175.52 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.809 1.244 . . . . 0.0 111.69 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -75.62 100.41 4.6 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.007 -1.058 . . . . 0.0 111.174 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -69.87 134.92 48.99 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.762 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.07 126.3 50.43 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.58 1.552 . . . . 0.0 108.81 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -81.16 111.64 17.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.286 1.035 . . . . 0.0 110.065 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.26 179.09 4.08 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.78 0.8 . . . . 0.0 111.724 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -82.76 -55.23 4.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.115 0.566 . . . . 0.0 111.946 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -83.17 50.77 1.81 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.092 0.957 . . . . 0.0 112.14 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.1 69.7 0.84 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.269 1.414 . . . . 0.0 112.928 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -129.54 163.8 22.56 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 123.28 0.467 . . . . 0.0 112.373 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.48 131.91 42.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.49 120.41 56.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.325 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.23 113.99 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.573 HG13 ' HG1' ' A' ' 65' ' ' THR . 2.1 m -97.63 139.99 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.23 135.57 9.22 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.515 0.726 . . . . 0.0 109.058 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -76.19 150.54 33.34 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 121.809 1.672 . . . . 0.0 111.057 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.23 76.0 1.52 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.224 1.488 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.33 114.53 28.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.764 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 O-C-N 121.476 -0.765 . . . . 0.0 110.87 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.061 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -70.74 120.41 16.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.385 -1.656 . . . . 0.0 111.607 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.6 p -108.63 110.71 22.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.67 1.224 . . . . 0.0 111.428 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.8 mt -117.36 105.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 O-C-N 120.94 -1.1 . . . . 0.0 108.25 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -74.85 139.94 43.53 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.976 171.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -131.38 122.5 26.44 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -136.29 110.13 8.16 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.796 -0.565 . . . . 0.0 110.61 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.03 -31.47 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.551 1.54 . . . . 0.0 113.058 -173.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.2 m -50.89 109.47 1.36 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.138 1.375 . . . . 0.0 109.878 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.62 -169.55 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.044 2.496 . . . . 0.0 110.692 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -33.93 69.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.646 -1.284 . . . . 0.0 113.413 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.4 p -65.99 -48.13 72.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.528 1.058 . . . . 0.0 111.222 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.45 -34.05 63.06 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.507 0.723 . . . . 0.0 111.144 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.3 t -49.62 -31.46 10.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.445 -1.409 . . . . 0.0 111.099 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.36 -54.98 6.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 124.434 1.093 . . . . 0.0 112.239 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -46.61 72.4 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.007 1.276 . . . . 0.0 113.96 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.1 mm -56.37 -38.81 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.638 1.575 . . . . 0.0 110.701 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -74.12 -39.67 63.19 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.362 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.4 m -58.45 -35.76 72.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.56 1.527 . . . . 0.0 111.768 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.44 -32.14 28.79 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.833 -0.542 . . . . 0.0 112.122 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 40.9 tpp -78.65 -19.93 51.46 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 118.213 1.007 . . . . 0.0 111.41 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 17.9 p -77.54 -20.5 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.408 -1.432 . . . . 0.0 111.695 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -41.44 93.61 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.069 0.948 . . . . 0.0 112.037 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.3 t -162.1 62.36 0.23 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.34 -77.78 0.15 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.3 143.83 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.408 1.004 . . . . 0.0 111.455 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.3 p -41.92 111.2 0.21 Allowed 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.632 -1.511 . . . . 0.0 112.804 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 p -145.02 28.49 1.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.228 1.811 . . . . 0.0 110.529 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.05 45.76 94.86 Favored Glycine 0 CA--C 1.523 0.542 0 O-C-N 121.276 -0.89 . . . . 0.0 113.102 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.5 mt -83.48 112.52 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.66 0.784 . . . . 0.0 109.947 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -115.63 97.36 6.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.044 0.938 . . . . 0.0 109.108 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 88.1 mt -73.95 164.66 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.203 0.601 . . . . 0.0 109.53 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -47.15 116.34 1.36 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.71 25.33 6.73 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 123.632 0.634 . . . . 0.0 114.156 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -131.61 37.35 3.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.617 2.767 . . . . 0.0 107.818 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -36.98 90.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.086 1.755 . . . . 0.0 112.924 167.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -142.03 -174.6 4.14 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.36 1.464 . . . . 0.0 109.065 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.6 p -146.68 -41.8 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -85.87 8.98 18.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.944 2.097 . . . . 0.0 113.864 168.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.08 136.67 8.45 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.173 0.987 . . . . 0.0 110.448 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 100.31 4.71 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.643 1.211 . . . . 0.0 108.443 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.8 t -117.79 119.77 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.512 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 134' ' ' SER . 0.6 OUTLIER -108.24 179.92 4.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.346 -174.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.9 62.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.824 -0.548 . . . . 0.0 111.599 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.07 -35.65 80.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.339 0.655 . . . . 0.0 112.287 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.87 -52.52 22.19 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.47 67.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.5 1.046 . . . . 0.0 111.934 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.7 m -63.92 -43.98 94.28 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.531 -0.731 . . . . 0.0 111.648 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.5 t -105.54 -56.81 2.12 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.628 0 C-N-CA 126.412 1.885 . . . . 0.0 112.354 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.236 0.386 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.44 -80.56 0.55 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 72.4 p -135.98 116.97 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.11 129.45 34.5 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 109.85 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.3 m -89.8 116.85 28.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.81 122.87 21.48 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.583 0.753 . . . . 0.0 109.266 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -94.06 143.75 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.05 0.54 . . . . 0.0 109.663 174.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.72 114.0 18.72 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.838 0.855 . . . . 0.0 109.642 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -99.61 118.73 36.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.039 0.936 . . . . 0.0 110.966 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 36.7 t80 -102.11 103.54 14.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.442 0.697 . . . . 0.0 110.955 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -71.94 136.25 46.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.957 0.503 . . . . 0.0 110.838 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.275 0 CA-C-O 117.581 -1.677 . . . . 0.0 113.095 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.02 -29.55 11.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.292 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.48 -32.2 5.33 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.918 0.77 . . . . 0.0 112.833 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -42.2 21.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.114 1.766 . . . . 0.0 113.852 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -68.2 -36.17 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.654 -1.279 . . . . 0.0 113.114 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.85 -48.2 66.8 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.551 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.0 p -64.78 -38.61 91.58 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.943 0.897 . . . . 0.0 110.828 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -58.51 -51.85 68.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.639 1.176 . . . . 0.0 111.17 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 177' ' ' PHE . 10.9 t80 -56.47 -48.26 77.47 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.171 -0.955 . . . . 0.0 112.075 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -26.54 68.58 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -42.12 88.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.459 1.104 . . . . 0.0 109.971 173.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.56 -44.99 92.5 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 117.582 -1.199 . . . . 0.0 108.918 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.75 92.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.159 0.891 . . . . 0.0 111.368 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -38.17 69.27 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.195 -0.94 . . . . 0.0 112.837 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -69.22 -57.0 5.94 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -51.98 -30.9 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.57 1.548 . . . . 0.0 112.008 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.17 -25.46 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.157 1.383 . . . . 0.0 113.373 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.41 25.5 1.85 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.67 1.605 . . . . 0.0 113.617 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -157.8 0.63 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.319 1.048 . . . . 0.0 110.489 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.08 52.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.307 1.843 . . . . 0.0 113.577 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -115.25 -60.69 1.85 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.91 1.284 . . . . 0.0 111.255 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.06 0.66 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.572 1.082 . . . . 0.0 111.03 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 125.665 1.586 . . . . 0.0 108.64 -177.507 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 CA-C-O 119.103 -0.831 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.49 -75.87 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.415 1.108 . . . . 0.0 112.334 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -32.69 70.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.81 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.1 ttp -57.37 -40.57 78.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.903 1.281 . . . . 0.0 111.789 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -72.0 -47.36 52.5 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.843 174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -50.09 -49.42 51.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.666 1.121 . . . . 0.0 111.314 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -68.32 -46.63 69.73 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.646 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.43 -42.02 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.199 0.909 . . . . 0.0 110.512 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 121.188 -0.945 . . . . 0.0 110.573 175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -61.39 -23.55 65.87 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.698 -0.626 . . . . 0.0 111.97 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.8 -3.47 28.75 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.374 1.47 . . . . 0.0 113.439 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.5 50.38 9.8 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.943 1.735 . . . . 0.0 112.487 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.32 -88.75 0.61 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.424 0.689 . . . . 0.0 112.271 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.56 83.43 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 122.94 0.496 . . . . 0.0 111.716 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -160.61 146.89 15.19 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 125.169 1.387 . . . . 0.0 109.586 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.11 55.4 1.13 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.655 1.121 . . . . 0.0 112.824 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 -179.87 5.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.632 1.173 . . . . 0.0 112.349 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.14 141.9 41.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.32 0.581 . . . . 0.0 110.579 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.44 152.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.491 1.116 . . . . 0.0 109.058 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.57 122.04 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.256 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.73 101.05 2.7 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -56.25 109.78 1.9 Allowed Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.825 0.85 . . . . 0.0 110.992 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.22 -25.0 14.01 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.77 -13.39 59.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.484 1.114 . . . . 0.0 112.661 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.08 75.39 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.344 1.458 . . . . 0.0 111.755 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.03 -53.57 0.07 OUTLIER Glycine 0 N--CA 1.465 0.609 0 C-N-CA 124.135 0.874 . . . . 0.0 111.574 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.7 t -172.16 122.95 0.48 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.122 0.969 . . . . 0.0 111.51 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.56 126.03 28.05 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.498 1.142 . . . . 0.0 110.551 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 p -95.83 138.45 33.46 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.027 -1.045 . . . . 0.0 108.747 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.76 121.19 42.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.54 124.63 29.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.697 0.799 . . . . 0.0 110.815 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.02 109.2 22.01 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -54.84 -53.27 57.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.43 0.692 . . . . 0.0 112.358 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -107.26 47.26 0.89 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 110.634 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.22 -142.16 3.32 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.261 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -114.4 -121.3 3.57 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 124.318 0.961 . . . . 0.0 111.516 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -131.15 148.66 52.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.763 0.792 . . . . 0.0 110.397 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.13 149.93 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.229 1.411 . . . . 0.0 108.561 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.98 113.03 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.51 114.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 122.368 1.08 . . . . 0.0 108.869 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.68 138.34 31.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 O-C-N 120.473 -1.392 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.98 154.05 47.54 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.078 1.185 . . . . 0.0 110.731 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.34 68.42 1.14 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 123.432 1.586 . . . . 0.0 110.021 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 p -86.78 169.54 12.52 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.117 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 110.451 175.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -117.5 144.85 44.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.882 0.873 . . . . 0.0 110.333 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -134.98 113.32 11.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.444 1.116 . . . . 0.0 111.0 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.0 mt -115.58 108.89 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.409 ' CB ' HG22 ' A' ' 176' ' ' VAL . 0.7 OUTLIER -78.2 142.09 38.18 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.246 173.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -134.81 125.92 27.84 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.35 98.34 4.85 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -38.87 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.465 1.106 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.5 m -52.62 104.33 0.43 Allowed Pre-proline 0 C--N 1.342 0.256 0 O-C-N 125.304 1.627 . . . . 0.0 108.249 -173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -74.35 -168.08 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.604 1.536 . . . . 0.0 110.097 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.04 -29.42 65.33 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.118 -0.989 . . . . 0.0 112.502 174.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.2 p -71.73 -40.96 69.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.783 1.174 . . . . 0.0 112.429 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.75 49.97 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.5 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.5 -30.85 13.84 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.037 1.289 . . . . 0.0 109.995 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.1 t -78.39 -57.87 4.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 123.642 0.777 . . . . 0.0 111.536 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.8 m -55.91 -25.09 41.31 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.63 -47.84 16.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 C-N-CA 126.215 1.806 . . . . 0.0 110.228 170.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.7 m -58.44 -30.4 66.89 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 121.191 1.814 . . . . 0.0 111.846 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.1 t -86.5 -49.03 7.88 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.098 -1.001 . . . . 0.0 112.044 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.94 91.85 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -33.51 76.1 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 118.555 1.177 . . . . 0.0 110.736 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.34 -20.47 19.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -26.85 65.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.262 1.025 . . . . 0.0 113.296 172.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.5 t -159.03 46.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.451 1.9 . . . . 0.0 110.856 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.3 -86.59 1.72 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.58 49.41 1.81 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 125.67 1.605 . . . . 0.0 114.785 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.5 m 63.96 142.86 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.657 1.583 . . . . 0.0 112.224 -172.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.95 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.841 -1.162 . . . . 0.0 111.257 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.37 48.52 0.04 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 124.531 1.063 . . . . 0.0 112.269 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.1 mt -89.42 102.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -91.87 98.99 11.93 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 122.957 0.503 . . . . 0.0 109.713 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -73.26 141.23 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 123.584 0.753 . . . . 0.0 109.8 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -47.61 119.99 3.07 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.383 -0.823 . . . . 0.0 111.612 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.06 -45.87 1.45 Allowed Glycine 0 CA--C 1.541 1.697 0 O-C-N 120.056 -1.653 . . . . 0.0 114.882 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.48 38.84 0.8 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.347 1.859 . . . . 0.0 111.242 170.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -51.35 95.76 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.968 1.307 . . . . 0.0 110.655 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -118.36 -168.77 1.58 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.099 1.359 . . . . 0.0 108.96 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -139.84 -40.11 0.45 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.723 0.809 . . . . 0.0 110.783 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.52 17.45 6.32 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.1 1.76 . . . . 0.0 114.026 169.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.01 126.1 7.07 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.587 0.708 . . . . 0.0 110.326 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -113.64 85.49 2.21 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.594 1.187 . . . . 0.0 107.865 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.23 121.47 63.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.399 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.1 p -131.41 -179.79 5.57 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.809 1.644 . . . . 0.0 110.914 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.35 85.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.57 1.532 . . . . 0.0 114.136 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -58.54 -41.64 86.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.241 0.616 . . . . 0.0 110.765 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.84 19.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 122.817 0.447 . . . . 0.0 111.039 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.79 -55.29 17.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 p -69.53 -29.33 66.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -66.8 -61.07 2.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.871 0.868 . . . . 0.0 111.065 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.236 0.374 0 C-N-CA 129.381 3.072 . . . . 0.0 108.421 -177.291 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.222 0.534 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -98.68 -46.43 2.12 Favored Glycine 0 N--CA 1.469 0.886 0 O-C-N 121.628 -0.67 . . . . 0.0 111.758 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.0 m -128.83 89.45 2.88 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.33 1.052 . . . . 0.0 108.967 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -79.59 102.49 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.87 0.868 . . . . 0.0 109.057 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.8 m -68.94 105.26 2.33 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.62 1.168 . . . . 0.0 109.879 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.97 112.41 16.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.409 HG22 ' CB ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -85.6 137.05 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.422 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 13.0 m-85 -111.86 117.98 34.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -107.9 145.14 34.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 109.727 173.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -142.65 109.01 5.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.696 1.198 . . . . 0.0 109.154 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -100.09 98.19 8.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.539 1.136 . . . . 0.0 109.549 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 124.849 1.214 . . . . 0.0 113.633 178.276 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 111.121 0.045 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -75.72 -39.98 56.39 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.643 0.777 . . . . 0.0 110.96 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.61 -27.06 0.8 Allowed Glycine 0 C--O 1.216 -0.984 0 CA-C-O 116.326 -2.375 . . . . 0.0 113.311 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -38.55 -48.26 1.4 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.485 2.142 . . . . 0.0 114.341 166.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -30.35 60.51 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.782 -1.199 . . . . 0.0 112.207 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.6 -50.23 18.66 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.046 0.939 . . . . 0.0 111.065 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 t -58.55 -45.16 89.52 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.48 1.112 . . . . 0.0 110.468 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -60.96 -49.68 76.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.309 0.958 . . . . 0.0 112.094 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -59.74 3.68 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.467 0.707 . . . . 0.0 111.348 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -59.6 -27.37 66.24 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 118.805 -0.616 . . . . 0.0 110.795 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -46.56 67.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.745 1.218 . . . . 0.0 111.393 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 tp -54.65 -44.66 73.44 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 179' ' ' TYR . . . -69.54 -43.48 72.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.6 -15.04 63.4 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.981 1.712 . . . . 0.0 112.709 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -95.47 -52.03 4.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -22.41 2.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.974 0.909 . . . . 0.0 111.84 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.1 pt -41.8 -41.99 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.634 1.174 . . . . 0.0 113.012 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.8 21.46 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.279 0.943 . . . . 0.0 114.375 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.09 -55.38 5.79 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.22 1.008 . . . . 0.0 109.422 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.71 21.16 0.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -96.52 80.83 3.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.254 -1.529 . . . . 0.0 110.038 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 44.64 49.47 8.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.595 1.184 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.3 t . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 123.718 0.807 . . . . 0.0 110.384 -172.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 N-CA-C 114.063 0.385 . . . . 0.0 114.063 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.43 -63.26 1.33 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.351 1.86 . . . . 0.0 110.276 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -38.35 66.0 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.269 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -59.77 -51.38 69.99 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 112.342 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -36.8 84.5 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.414 -0.327 . . . . 0.0 111.625 175.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -51.52 69.72 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.919 0.887 . . . . 0.0 110.441 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 p -68.18 -35.35 77.88 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 111.384 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -50.08 68.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.791 1.178 . . . . 0.0 110.708 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.4 mt -63.14 -50.58 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.893 -1.129 . . . . 0.0 110.061 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -60.78 -32.67 72.0 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.096 -1.002 . . . . 0.0 112.321 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.42 65.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.82 0.848 . . . . 0.0 112.848 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.79 4.81 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 124.998 1.285 . . . . 0.0 112.397 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.07 -64.01 1.08 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.59 -63.18 1.38 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.917 0.389 . . . . 0.0 110.247 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -132.61 -170.66 2.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.02 1.328 . . . . 0.0 109.062 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -140.59 16.71 2.87 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.26 0.933 . . . . 0.0 112.831 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.9 ttt -92.58 171.36 9.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.384 1.074 . . . . 0.0 111.329 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.41 141.81 53.75 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.346 0.593 . . . . 0.0 110.603 174.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.89 148.18 21.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 108.583 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.32 130.48 53.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.053 0.541 . . . . 0.0 110.08 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.03 130.71 9.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -114.34 101.61 54.27 Favored Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 124.365 1.066 . . . . 0.0 108.541 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -74.33 -35.82 3.6 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.766 2.31 . . . . 0.0 112.197 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.01 66.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.996 0.918 . . . . 0.0 112.125 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -59.86 1.76 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.916 0.886 . . . . 0.0 111.838 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.27 24.52 7.49 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.819 1.676 . . . . 0.0 113.582 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -135.06 88.33 2.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.647 1.579 . . . . 0.0 108.462 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.94 151.43 11.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.833 0.825 . . . . 0.0 111.686 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.0 p -129.06 147.17 50.9 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.719 0.808 . . . . 0.0 108.959 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -127.37 122.22 33.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.716 0.77 . . . . 0.0 109.265 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -80.84 120.82 25.18 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.491 0.716 . . . . 0.0 110.309 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -76.28 132.33 39.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.559 . . . . 0.0 109.861 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t -54.38 -47.64 72.43 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.9 0.48 . . . . 0.0 111.723 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -140.24 76.1 1.54 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 110.591 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.8 -103.23 0.16 Allowed Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.232 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.81 -119.77 0.91 Allowed Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.77 154.81 48.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 122.649 1.214 . . . . 0.0 110.744 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.4 mt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 125.473 1.509 . . . . 0.0 107.789 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.33 116.13 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 125.08 1.352 . . . . 0.0 107.371 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.6 124.84 52.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.98 145.52 22.65 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.513 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -77.31 154.56 32.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 121.912 1.742 . . . . 0.0 111.213 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.58 74.79 1.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.03 1.732 . . . . 0.0 110.641 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -111.94 140.84 46.28 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.829 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 C-N-CA 123.223 0.609 . . . . 0.0 110.052 -178.767 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.82 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.83 145.39 27.02 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 174.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.5 p -131.57 107.08 8.61 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.838 1.304 . . . . 0.0 110.929 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.21 106.98 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.3 OUTLIER -71.73 135.23 46.7 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.61 0.764 . . . . 0.0 109.545 171.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.6 p -134.39 120.04 19.35 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.67 119.24 26.5 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.72 -0.612 . . . . 0.0 109.697 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.55 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.857 1.663 . . . . 0.0 112.731 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.18 103.03 0.33 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.396 1.878 . . . . 0.0 109.844 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -75.17 -167.83 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.384 2.056 . . . . 0.0 110.776 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -22.08 65.31 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.745 -1.222 . . . . 0.0 113.549 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.8 p -78.16 -52.0 9.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.917 0.887 . . . . 0.0 110.321 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.61 -21.62 61.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.668 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -52.6 -32.37 41.05 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.697 -1.252 . . . . 0.0 110.187 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.91 -41.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.135 1.374 . . . . 0.0 111.872 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.454 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 19.3 m -59.75 -34.8 73.44 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 119.903 -1.748 . . . . 0.0 113.152 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.72 -34.5 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.6 p -63.85 -41.98 97.68 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 120.753 1.615 . . . . 0.0 112.431 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.4 t -77.07 -39.51 49.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.753 0.821 . . . . 0.0 111.34 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.24 -38.29 71.77 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 5.3 ttm -83.03 -32.21 27.01 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 110.282 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.8 t -62.9 -26.65 68.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.659 1.572 . . . . 0.0 112.413 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -62.74 -26.87 68.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -154.75 46.77 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.68 -83.0 1.71 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 40.5 58.84 2.43 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.76 1.171 . . . . 0.0 113.222 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 151' ' ' ASP . 3.7 m 70.17 135.06 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.4 1.48 . . . . 0.0 111.727 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 p 179.77 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.061 -1.024 . . . . 0.0 111.696 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.01 49.49 23.58 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.42 1.01 . . . . 0.0 113.499 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 2.7 mt -92.07 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.397 0.617 . . . . 0.0 109.999 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -89.3 94.13 9.79 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.037 -0.414 . . . . 0.0 110.449 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.0 mt -70.62 144.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.373 1.069 . . . . 0.0 110.467 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -48.33 118.55 2.5 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.01 -48.32 1.69 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.935 0.778 . . . . 0.0 113.466 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.43 36.83 0.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.438 1.895 . . . . 0.0 112.141 172.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -54.22 96.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.565 1.146 . . . . 0.0 110.019 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -119.64 -169.13 1.71 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.378 1.471 . . . . 0.0 109.772 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -134.67 -40.59 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.581 0.753 . . . . 0.0 110.866 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.415 ' HA ' HG22 ' A' ' 139' ' ' THR . 5.8 p-10 -91.63 17.81 8.32 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.304 1.842 . . . . 0.0 113.863 170.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 142' ' ' ILE . . . -42.77 130.22 4.18 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.628 0.728 . . . . 0.0 111.574 174.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 77.8 1.81 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.328 1.061 . . . . 0.0 109.044 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.1 t -98.68 135.84 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.522 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.2 167.03 22.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.813 1.245 . . . . 0.0 110.673 -172.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.83 -34.98 63.45 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.963 -0.461 . . . . 0.0 111.977 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.31 -44.11 22.27 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.073 1.349 . . . . 0.0 110.586 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -52.55 59.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.579 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.6 71.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.016 0.825 . . . . 0.0 111.228 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -45.68 71.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.263 0.625 . . . . 0.0 111.619 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.0 t -85.25 -55.9 3.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.515 0.726 . . . . 0.0 111.937 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 127.531 2.332 . . . . 0.0 112.756 -178.934 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 C--O 1.24 0.574 0 CA-C-O 120.711 0.291 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -48.21 160.41 0.57 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.379 0.433 . . . . 0.0 112.085 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 60.3 p -43.07 126.72 4.04 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.493 1.117 . . . . 0.0 110.982 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.43 87.4 3.39 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.725 -1.235 . . . . 0.0 108.812 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.5 m -83.53 125.13 31.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.12 102.32 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.831 1.252 . . . . 0.0 108.146 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -76.5 131.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -107.59 111.87 24.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.063 0.545 . . . . 0.0 109.907 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.28 106.35 18.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.018 0.913 . . . . 0.0 110.335 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.432 ' CG ' ' HB3' ' A' ' 43' ' ' ALA . 90.5 t80 -86.49 110.33 19.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 110.362 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -123.72 145.51 48.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.76 1.224 . . . . 0.0 109.893 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.217 0 C-N-CA 124.438 1.018 . . . . 0.0 113.122 176.377 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.51 0.671 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -128.96 -66.13 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 43.61 -140.97 2.83 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 69.11 -62.1 0.41 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.072 2.149 . . . . 0.0 111.835 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -134.97 137.89 43.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 128.405 2.682 . . . . 0.0 109.833 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.59 -9.75 58.71 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.743 1.217 . . . . 0.0 112.849 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.51 -35.74 11.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.366 1.066 . . . . 0.0 110.932 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -30.25 10.35 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 124.271 0.938 . . . . 0.0 113.205 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -39.89 -47.1 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.012 1.325 . . . . 0.0 113.891 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.32 -39.0 59.97 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.239 0.927 . . . . 0.0 112.449 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.4 -47.78 82.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.361 0.6 . . . . 0.0 110.394 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 p -66.48 -37.69 85.66 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 117.669 -1.158 . . . . 0.0 110.725 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -59.06 -54.55 45.81 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.274 1.397 . . . . 0.0 112.203 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -57.13 -46.22 82.87 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.011 -1.055 . . . . 0.0 111.339 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.4 -27.48 68.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.516 0.726 . . . . 0.0 112.619 173.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -49.34 71.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.671 1.188 . . . . 0.0 108.861 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.99 -40.55 96.04 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 118.933 0.788 . . . . 0.0 109.669 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB3' ' CD2' ' A' ' 179' ' ' TYR . . . -62.4 -42.85 99.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.726 0.694 . . . . 0.0 111.895 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -33.12 47.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.126 0.97 . . . . 0.0 113.121 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -70.31 -64.04 0.97 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.224 -0.922 . . . . 0.0 108.523 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.87 -21.18 27.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.801 1.24 . . . . 0.0 112.64 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -44.93 -33.26 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.196 0.999 . . . . 0.0 111.98 171.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.04 50.93 0.2 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.68 1.134 . . . . 0.0 112.868 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.5 tpt -113.71 -63.82 1.4 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.694 0.798 . . . . 0.0 111.121 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.44 34.32 0.46 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.693 1.197 . . . . 0.0 112.357 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 31.48 0.27 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.637 1.175 . . . . 0.0 113.165 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.16 49.14 2.29 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.245 0.926 . . . . 0.0 112.108 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.69 57.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.737 1.615 . . . . 0.0 110.456 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.96 -50.02 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.939 1.296 . . . . 0.0 110.841 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.79 73.03 1.27 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.804 0.716 . . . . 0.0 111.571 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -104.52 168.58 8.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.81 1.244 . . . . 0.0 111.927 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.27 166.8 5.82 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.842 0.457 . . . . 0.0 111.171 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 58.66 166.25 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 122.736 1.255 . . . . 0.0 113.214 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.9 m -80.61 -35.02 34.64 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.629 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m 49.51 53.78 12.11 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.102 0.961 . . . . 0.0 112.188 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.34 4.5 6.41 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.082 0.849 . . . . 0.0 114.195 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.17 -62.75 1.37 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.052 0.941 . . . . 0.0 113.018 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -25.58 60.05 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.372 172.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mtp -53.47 -57.14 11.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.908 0.883 . . . . 0.0 111.867 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -69.73 -40.12 76.39 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.37 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -50.73 -47.24 59.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -70.16 -42.33 72.65 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.0 111.14 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tp -59.27 -51.44 69.95 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.889 1.222 . . . . 0.0 112.014 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -52.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 120.766 -1.209 . . . . 0.0 110.015 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -62.27 -23.58 66.78 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.907 -1.121 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -2.9 23.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 113.796 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.65 78.88 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.089 1.804 . . . . 0.0 112.886 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.11 -76.9 0.24 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 117.73 0.765 . . . . 0.0 111.289 -177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.39 -50.66 36.33 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 111.8 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.45 132.42 8.78 Favored 'General case' 0 C--O 1.211 -0.926 0 C-N-CA 124.703 1.201 . . . . 0.0 109.85 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.63 59.37 4.6 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 119.419 1.008 . . . . 0.0 113.251 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.06 176.73 7.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.102 0.961 . . . . 0.0 112.475 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.16 147.64 38.34 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.705 -0.622 . . . . 0.0 110.685 172.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.23 157.51 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 109.007 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.38 101.93 11.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.74 112.91 4.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -35.92 115.79 0.6 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.603 1.161 . . . . 0.0 113.341 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -71.49 -18.14 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.301 1.334 . . . . 0.0 112.026 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.33 -4.79 41.42 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.86 1.264 . . . . 0.0 113.262 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 86.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.133 1.373 . . . . 0.0 113.057 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.77 -40.57 0.02 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.182 -0.949 . . . . 0.0 114.136 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 p -158.37 114.31 2.71 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.307 1.443 . . . . 0.0 111.638 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.66 161.38 7.86 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 122.743 1.258 . . . . 0.0 111.811 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 t -135.85 127.46 28.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.528 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -99.41 136.75 38.89 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.304 1.05 . . . . 0.0 109.403 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -93.26 104.64 16.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.574 1.15 . . . . 0.0 110.651 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.31 112.09 23.54 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.319 0.648 . . . . 0.0 110.168 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -57.86 5.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.641 -0.662 . . . . 0.0 111.815 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -68.03 -46.21 71.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.128 0.571 . . . . 0.0 112.002 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.84 -123.08 0.11 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.337 0.97 . . . . 0.0 111.923 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -143.65 -98.09 0.26 Allowed Glycine 0 N--CA 1.465 0.596 0 O-C-N 122.093 -0.651 . . . . 0.0 112.266 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.53 149.29 52.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.062 0.934 . . . . 0.0 110.261 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 mt -130.63 145.24 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.362 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.27 109.59 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.9 m -94.93 122.0 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.54 131.74 11.95 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.054 -1.029 . . . . 0.0 109.446 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.5 152.4 43.37 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.179 1.253 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -145.82 66.85 1.21 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.476 1.911 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.9 p -100.14 97.96 8.72 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.319 1.057 . . . . 0.0 109.251 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.57 113.91 4.89 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.849 -1.157 . . . . 0.0 110.84 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.03 73.8 1.23 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -110.59 165.85 12.29 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.324 0.964 . . . . 0.0 112.057 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.8 p -142.1 -43.95 0.34 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.945 0.898 . . . . 0.0 111.772 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.13 58.05 0.71 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 125.685 1.612 . . . . 0.0 111.38 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 53.68 43.12 31.54 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.992 0.901 . . . . 0.0 112.632 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -92.68 115.98 28.6 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.642 -0.661 . . . . 0.0 109.765 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -102.72 138.82 39.11 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.344 0.658 . . . . 0.0 109.792 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.57 112.46 3.97 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.33 135.81 48.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.258 1.529 . . . . 0.0 109.033 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.7 p -122.06 116.77 24.86 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.2 mt -124.41 104.5 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.84 142.55 42.18 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.248 173.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 p -140.66 128.28 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.87 0.843 . . . . 0.0 108.989 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.72 99.6 4.67 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -172.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.514 1.126 . . . . 0.0 112.393 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.2 t -48.61 101.95 0.29 Allowed Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 127.001 2.12 . . . . 0.0 109.09 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.13 -171.21 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.773 1.649 . . . . 0.0 110.758 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.4 tm0? -59.81 -44.25 94.08 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.944 -1.097 . . . . 0.0 112.544 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 p -56.54 -42.4 78.45 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.051 -1.03 . . . . 0.0 112.002 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.97 -29.37 43.84 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.057 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -30.41 14.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.895 1.68 . . . . 0.0 110.496 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.42 -55.78 6.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 125.451 1.5 . . . . 0.0 111.335 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.2 m -57.64 -48.73 78.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.778 1.172 . . . . 0.0 113.327 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.6 mm -56.13 -47.2 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 C-N-CA 125.615 1.566 . . . . 0.0 110.981 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -62.92 -45.69 91.31 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.167 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 m -51.01 -42.47 60.44 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 111.365 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.06 -39.23 33.07 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 121.933 -0.479 . . . . 0.0 113.137 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 11.4 ttm -67.85 -20.5 65.15 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.467 -1.608 . . . . 0.0 112.466 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 -28.17 57.44 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.753 1.221 . . . . 0.0 111.888 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -16.14 63.34 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 112.836 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.08 46.94 0.92 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.386 1.474 . . . . 0.0 110.716 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -35.58 -64.88 0.49 Allowed Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.571 1.558 . . . . 0.0 113.293 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 17.78 75.59 0.01 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 127.308 2.385 . . . . 0.0 113.355 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 20.4 p -51.54 167.2 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.897 1.679 . . . . 0.0 112.466 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -33.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.502 -0.749 . . . . 0.0 111.812 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.79 51.0 0.04 OUTLIER Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.636 0.636 . . . . 0.0 112.891 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.4 mt -86.84 113.42 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -119.46 103.15 9.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 108.362 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.87 166.95 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -51.9 119.18 4.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.008 1.323 . . . . 0.0 112.675 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.28 27.44 5.53 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.484 0.564 . . . . 0.0 113.909 -173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.72 32.85 4.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.877 2.071 . . . . 0.0 109.024 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -36.62 98.96 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.114 1.366 . . . . 0.0 111.129 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -142.42 -174.07 4.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.456 1.502 . . . . 0.0 108.691 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.7 p -147.98 -46.48 0.16 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.212 -0.93 . . . . 0.0 109.107 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.52 18.56 1.82 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.591 1.556 . . . . 0.0 112.881 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.06 111.6 2.26 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.417 -0.802 . . . . 0.0 110.717 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 105.75 17.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.91 129.26 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.763 1.225 . . . . 0.0 110.027 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 175.2 9.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.794 1.238 . . . . 0.0 110.945 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.96 39.76 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.785 -0.572 . . . . 0.0 112.473 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -61.27 -33.15 73.07 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.654 0.782 . . . . 0.0 111.969 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -51.39 39.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.588 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.98 66.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 119.192 0.905 . . . . 0.0 112.138 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -28.96 68.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.751 0.821 . . . . 0.0 112.648 171.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.94 -48.95 3.49 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.135 1.374 . . . . 0.0 112.838 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -51.77 -47.07 64.31 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.449 1.9 . . . . 0.0 111.307 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 35.5 m -81.98 133.73 35.32 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.4 m -54.55 155.22 4.19 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.786 1.234 . . . . 0.0 110.516 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -39.7 -56.75 1.65 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.791 1.236 . . . . 0.0 112.499 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -177.21 117.05 0.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.158 1.783 . . . . 0.0 109.512 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -125.24 38.09 4.25 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.381 1.072 . . . . 0.0 110.743 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 53.79 -99.22 0.05 OUTLIER Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.302 1.429 . . . . 0.0 112.281 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -100.68 79.89 2.13 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.037 1.335 . . . . 0.0 110.415 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.7 p -56.8 156.94 5.96 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.869 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -45.53 146.7 2.32 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 122.98 0.324 . . . . 0.0 112.295 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 20.1 p -46.59 118.62 2.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.019 1.328 . . . . 0.0 111.567 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.17 85.2 6.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 122.405 1.097 . . . . 0.0 109.182 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 m -75.13 116.04 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.316 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.1 119.0 23.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.634 0.774 . . . . 0.0 109.204 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.74 128.81 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -103.11 127.63 50.31 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.04 139.45 46.39 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.287 0.635 . . . . 0.0 110.283 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -130.57 111.82 12.59 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.274 1.029 . . . . 0.0 110.234 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.64 142.39 27.67 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.137 0.575 . . . . 0.0 110.896 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 C-N-CA 124.462 1.03 . . . . 0.0 112.697 -177.377 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.328 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -168.59 161.89 11.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.421 1.088 . . . . 0.0 110.601 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.35 153.77 15.46 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.375 0.512 . . . . 0.0 111.978 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -135.74 -66.96 0.54 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.265 1.026 . . . . 0.0 110.664 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -148.68 179.77 7.58 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.698 1.599 . . . . 0.0 111.468 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.43 -40.61 73.71 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.318 1.047 . . . . 0.0 111.944 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.39 -35.91 9.04 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.693 1.197 . . . . 0.0 112.05 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.03 -29.87 9.05 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 117.863 -1.521 . . . . 0.0 111.908 170.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -49.54 -38.59 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.197 1.399 . . . . 0.0 112.779 171.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -79.82 -38.17 33.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.145 -0.972 . . . . 0.0 111.282 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mt -71.35 -47.29 57.32 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.411 0.624 . . . . 0.0 110.349 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -60.61 -41.21 94.35 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.916 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -59.86 -46.27 89.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.764 1.62 . . . . 0.0 111.796 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -48.91 -62.68 1.39 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.933 0.893 . . . . 0.0 109.738 174.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -21.14 66.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.758 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.44 68.45 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.308 1.443 . . . . 0.0 109.483 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.54 -38.7 87.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.885 1.221 . . . . 0.0 110.011 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 179' ' ' TYR . . . -65.56 -45.95 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.36 0.664 . . . . 0.0 111.893 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -76.57 -38.84 54.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.266 1.027 . . . . 0.0 112.034 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -64.4 -56.76 12.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 t -58.35 -26.81 63.57 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.689 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.06 -26.73 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.65 53.81 0.28 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.903 1.24 . . . . 0.0 113.03 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.64 -71.49 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.184 0.994 . . . . 0.0 111.079 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.6 mmt -139.73 53.25 1.69 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.77 1.228 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -109.85 2.66 20.04 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.695 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.17 -30.3 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.213 0.911 . . . . 0.0 113.534 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -48.15 120.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.293 1.047 . . . . 0.0 109.707 171.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 t70 65.0 110.74 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.163 1.385 . . . . 0.0 113.18 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.8 158.35 34.57 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.332 -0.855 . . . . 0.0 112.764 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -154.27 100.41 2.3 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.282 1.033 . . . . 0.0 109.878 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.95 166.69 25.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.162 0.985 . . . . 0.0 111.113 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.59 162.79 28.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.322 1.049 . . . . 0.0 110.556 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.4 m 57.17 86.16 0.07 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 122.544 1.164 . . . . 0.0 111.488 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.06 81.12 1.65 Allowed 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.89 -55.59 0.06 OUTLIER Glycine 0 N--CA 1.47 0.931 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.954 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.3 -67.57 0.38 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.67 0.735 . . . . 0.0 110.501 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -59.3 -33.52 71.19 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.402 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -46.28 90.95 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.668 0.667 . . . . 0.0 111.357 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -64.3 -42.32 96.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.371 -0.824 . . . . 0.0 110.081 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -50.02 75.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.278 0.944 . . . . 0.0 110.68 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -66.88 -40.87 87.91 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 124.563 1.145 . . . . 0.0 111.12 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.47 -52.83 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.355 1.462 . . . . 0.0 110.83 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.1 mt -59.13 -51.32 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.095 -1.003 . . . . 0.0 111.251 176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -63.29 -25.8 68.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.593 -0.692 . . . . 0.0 112.737 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.72 21.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.023 1.329 . . . . 0.0 112.743 171.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.59 58.39 5.42 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.787 1.184 . . . . 0.0 111.628 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.21 -81.16 0.64 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.46 -59.82 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -136.26 -163.06 1.35 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.755 1.622 . . . . 0.0 110.242 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.58 21.1 1.04 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.756 1.169 . . . . 0.0 112.937 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.7 mmt -90.68 173.72 7.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.594 1.158 . . . . 0.0 112.144 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.22 120.49 13.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.024 0.916 . . . . 0.0 109.576 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.47 122.72 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -67.82 115.84 7.82 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 166.17 54.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.45 128.09 7.51 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 122.426 -0.455 . . . . 0.0 111.046 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.57 -17.56 29.88 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.679 2.253 . . . . 0.0 113.021 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.01 60.47 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 0.0 112.654 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.45 65.11 1.42 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.423 1.089 . . . . 0.0 112.329 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.56 37.45 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 p -175.43 57.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.477 1.111 . . . . 0.0 111.391 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.43 150.17 21.94 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.294 1.045 . . . . 0.0 110.766 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.5 p -136.26 126.06 25.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -96.95 127.35 42.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.935 0.874 . . . . 0.0 108.879 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -101.17 116.71 33.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -72.94 170.76 14.11 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.137 0.494 . . . . 0.0 110.79 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.77 -55.34 6.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.119 0.967 . . . . 0.0 112.43 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.52 152.29 16.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 110.621 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.25 25.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.008 0.813 . . . . 0.0 112.805 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.25 128.68 2.07 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -133.8 136.96 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.991 0.901 . . . . 0.0 108.86 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.37 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.363 1.065 . . . . 0.0 108.252 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.33 111.05 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.1 m -102.81 122.45 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 126.18 14.49 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.042 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -70.34 150.45 64.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.542 1.494 . . . . 0.0 110.688 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -141.11 77.37 1.59 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.026 1.393 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 p -87.51 156.24 19.63 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.933 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -126.43 130.82 51.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.343 0.657 . . . . 0.0 110.034 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.96 39.86 2.75 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.075 1.321 . . . . 0.0 111.849 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.02 -89.98 0.93 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 78.3 p -134.98 38.49 3.0 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.772 1.272 . . . . 0.0 111.399 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.03 -148.91 5.97 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.317 1.437 . . . . 0.0 111.055 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -163.02 33.55 0.1 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.17 0.988 . . . . 0.0 111.523 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -91.1 147.97 22.7 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 120.531 -1.356 . . . . 0.0 109.972 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' ND2' ' CE2' ' A' ' 114' ' ' PHE . 13.1 t30 -121.93 133.8 54.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.921 0.888 . . . . 0.0 109.846 175.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.49 78.21 0.24 Allowed Glycine 0 CA--C 1.526 0.78 0 C-N-CA 126.127 1.822 . . . . 0.0 110.888 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CE2' ' ND2' ' A' ' 112' ' ' ASN . 42.5 m-85 -53.61 142.91 21.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.799 1.299 . . . . 0.0 112.099 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.2 p -128.83 104.82 7.83 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.06 0.944 . . . . 0.0 109.314 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 mt -108.07 93.12 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -67.9 138.25 55.87 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 172.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -135.6 127.66 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -136.34 104.2 5.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.356 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.43 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.824 1.249 . . . . 0.0 111.962 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 22.6 m -53.5 107.06 0.75 Allowed Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.23 1.812 . . . . 0.0 107.881 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -74.85 -169.47 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.851 1.034 . . . . 0.0 110.768 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -19.14 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.41 -0.806 . . . . 0.0 113.112 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 t -77.95 -46.29 21.59 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.097 -1.627 . . . . 0.0 111.076 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.24 -28.48 62.18 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.12 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -52.92 -28.84 25.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.817 1.644 . . . . 0.0 111.329 176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.4 -55.68 6.03 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 C-N-CA 125.972 1.709 . . . . 0.0 110.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 m -60.31 -44.1 95.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.226 -1.546 . . . . 0.0 113.2 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.7 mm -56.57 -42.79 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.737 1.615 . . . . 0.0 109.772 171.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 p -65.32 -45.35 84.65 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 119.187 0.903 . . . . 0.0 112.42 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.9 m -60.55 -30.02 69.52 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.873 1.269 . . . . 0.0 110.904 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.91 -32.85 13.5 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 123.567 0.603 . . . . 0.0 113.493 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.5 tpp -74.39 -24.77 59.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.997 1.398 . . . . 0.0 111.304 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 p -66.46 -24.18 66.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.805 1.642 . . . . 0.0 111.494 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -70.47 -4.92 25.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.793 1.237 . . . . 0.0 113.491 171.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.61 48.44 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.548 1.139 . . . . 0.0 111.103 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -40.53 -51.63 3.79 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.743 1.163 . . . . 0.0 114.711 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.75 73.53 0.48 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.791 1.186 . . . . 0.0 112.307 169.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.468 ' HG1' HD13 ' A' ' 142' ' ' ILE . 3.3 m -69.55 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.629 0.772 . . . . 0.0 110.452 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t 172.86 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.256 1.422 . . . . 0.0 111.794 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.78 73.74 0.07 OUTLIER Glycine 0 C--N 1.341 0.848 0 O-C-N 121.78 -0.575 . . . . 0.0 113.667 -177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.468 HD13 ' HG1' ' A' ' 139' ' ' THR . 13.2 mt -94.64 99.68 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.996 0.919 . . . . 0.0 111.708 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -91.95 94.81 9.47 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.874 -0.516 . . . . 0.0 110.691 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.5 mt -68.85 153.12 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.24 1.016 . . . . 0.0 110.489 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -52.68 116.92 2.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.931 -1.106 . . . . 0.0 110.498 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.86 -43.96 0.99 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.412 1.006 . . . . 0.0 113.835 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.59 34.34 0.53 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.869 2.068 . . . . 0.0 111.682 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -46.32 93.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.837 1.655 . . . . 0.0 111.886 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -113.94 -168.22 1.32 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.104 1.361 . . . . 0.0 109.565 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.4 p -138.7 -49.71 0.53 Allowed 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.818 -0.551 . . . . 0.0 110.856 -175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 20.25 2.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.541 1.537 . . . . 0.0 112.25 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -45.23 126.12 5.98 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-O 121.559 0.695 . . . . 0.0 111.061 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -117.91 70.62 0.8 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 122.33 1.062 . . . . 0.0 108.391 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -91.68 130.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.93 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.44 176.1 7.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.91 1.284 . . . . 0.0 110.412 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.33 58.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.653 0.66 . . . . 0.0 112.078 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -61.51 -32.53 72.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.703 0.801 . . . . 0.0 112.551 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.35 -50.69 29.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.458 1.027 . . . . 0.0 111.476 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 p -69.39 -32.0 70.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.299 0.64 . . . . 0.0 111.87 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.7 t -92.4 -50.94 5.38 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.31 1.044 . . . . 0.0 112.18 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -55.56 -51.53 66.77 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 127.265 2.226 . . . . 0.0 111.867 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 78.2 m -80.31 72.78 7.17 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.186 0.993 . . . . 0.0 110.211 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.77 160.84 24.97 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.771 1.228 . . . . 0.0 110.406 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 65.08 -174.91 0.18 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.093 1.357 . . . . 0.0 112.473 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -124.72 72.89 1.23 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.404 1.482 . . . . 0.0 109.964 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -76.28 131.66 39.37 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.703 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -63.17 -40.01 98.62 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 112.134 -0.386 . . . . 0.0 112.134 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -174.39 59.5 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.032 1.733 . . . . 0.0 111.742 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.23 125.32 24.67 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.365 -0.834 . . . . 0.0 112.094 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 35.06 -135.51 0.39 Allowed Glycine 0 C--N 1.339 0.734 0 O-C-N 124.394 1.059 . . . . 0.0 111.57 -174.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.1 p -149.03 123.84 9.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.83 136.23 38.92 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.118 -0.988 . . . . 0.0 110.749 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 m -109.47 112.46 24.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.22 109.86 10.72 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -81.98 135.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE1' ' CE1' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -100.67 120.26 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -97.94 144.36 27.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.105 0.562 . . . . 0.0 111.586 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 43' ' ' ALA . 16.2 t80 -142.67 105.71 4.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.336 0.654 . . . . 0.0 111.594 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.19 140.13 37.76 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.392 0.677 . . . . 0.0 110.386 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.046 -1.419 . . . . 0.0 111.896 178.24 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.532 0.682 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -160.73 149.28 16.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.145 0.978 . . . . 0.0 109.619 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.1 171.2 28.18 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.51 0.576 . . . . 0.0 111.98 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.92 -64.92 0.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 O-C-N 122.088 -0.654 . . . . 0.0 112.095 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -57.89 165.59 1.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.049 0.94 . . . . 0.0 110.275 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -94.12 -39.74 10.42 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 111.688 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.1 -45.13 8.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.684 1.194 . . . . 0.0 110.71 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.31 -27.8 1.92 Allowed Glycine 0 C--O 1.212 -1.251 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.596 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 p -38.3 -43.43 0.8 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.641 1.576 . . . . 0.0 114.756 168.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.12 -35.52 31.48 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.065 0.848 . . . . 0.0 112.493 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.09 -50.11 67.39 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.038 0.935 . . . . 0.0 110.704 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.5 p -60.08 -38.29 82.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.093 1.357 . . . . 0.0 110.632 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.96 -47.24 81.21 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.017 0.826 . . . . 0.0 112.496 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.58 ' CD1' ' CZ ' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -49.05 -59.04 3.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 109.235 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -66.04 -24.92 66.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.45 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -47.74 73.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 110.184 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -41.05 98.7 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 119.733 1.152 . . . . 0.0 109.051 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.26 96.35 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.767 0.712 . . . . 0.0 112.395 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.12 -31.6 58.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.704 1.202 . . . . 0.0 112.941 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -75.57 -63.61 1.25 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -17.7 7.13 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.401 1.081 . . . . 0.0 113.063 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -44.42 -35.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.989 1.316 . . . . 0.0 112.194 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.0 26.84 0.14 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.698 1.142 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.1 tpp -86.04 -69.89 0.64 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.042 0.937 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.5 mtt -154.74 60.42 0.67 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.821 1.296 . . . . 0.0 111.002 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -104.1 -29.8 10.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.41 36.13 0.04 OUTLIER Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.615 1.102 . . . . 0.0 111.715 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.56 -29.09 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.528 0.731 . . . . 0.0 110.602 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -46.52 76.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.616 0.766 . . . . 0.0 111.678 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.86 82.99 0.44 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-O 118.891 -0.95 . . . . 0.0 111.541 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 59.78 165.95 0.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.874 1.27 . . . . 0.0 113.302 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.45 175.21 14.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.668 0.787 . . . . 0.0 111.353 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.43 -65.34 0.7 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.531 0.733 . . . . 0.0 111.705 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -102.38 56.59 0.79 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.293 1.037 . . . . 0.0 108.612 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.3 m -56.64 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.885 1.674 . . . . 0.0 111.703 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.12 -61.31 0.29 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.803 1.192 . . . . 0.0 113.576 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.98 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.407 -1.055 . . . . 0.0 111.897 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -25.98 68.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.533 0.733 . . . . 0.0 112.364 171.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.427 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 14.2 ttm -58.36 -49.09 78.45 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.499 0.72 . . . . 0.0 110.21 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -72.8 -41.5 64.88 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.551 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -52.65 -53.43 47.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.006 1.276 . . . . 0.0 111.505 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.3 m -68.0 -43.21 79.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.054 1.342 . . . . 0.0 110.984 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.55 -47.1 80.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.662 0.785 . . . . 0.0 111.294 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.38 -50.22 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.405 175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.86 -20.25 55.96 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.158 -0.964 . . . . 0.0 112.448 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.54 9.93 6.72 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.48 1.512 . . . . 0.0 113.73 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.93 48.07 84.83 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.422 1.487 . . . . 0.0 112.589 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.34 -83.86 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.464 0.706 . . . . 0.0 111.275 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -47.15 72.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.796 0.438 . . . . 0.0 111.654 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -156.2 172.7 17.99 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.063 1.345 . . . . 0.0 109.902 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.78 34.77 3.63 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.796 1.189 . . . . 0.0 112.165 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.71 178.81 4.25 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.649 1.18 . . . . 0.0 112.004 -177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.42 136.99 54.15 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.438 175.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.57 109.78 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.7 t -57.81 137.06 56.97 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.54 169.24 47.82 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.871 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.74 113.66 46.67 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.755 0.822 . . . . 0.0 111.182 174.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -79.51 -64.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.03 1.82 . . . . 0.0 111.557 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.37 -40.37 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.886 0.874 . . . . 0.0 112.174 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.36 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.023 2.529 . . . . 0.0 112.998 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.69 95.85 0.14 Allowed Glycine 0 N--CA 1.466 0.666 0 C-N-CA 123.47 0.557 . . . . 0.0 111.759 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.8 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.02 2.128 . . . . 0.0 109.149 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.84 159.14 17.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 110.918 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -141.88 144.91 34.06 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.743 -1.223 . . . . 0.0 109.518 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.13 124.46 43.12 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 122.538 1.161 . . . . 0.0 109.675 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -88.07 129.5 35.27 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 123.978 0.911 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.6 113.87 18.08 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.538 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.4 t -54.31 -58.45 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.435 0.694 . . . . 0.0 112.0 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -56.35 -55.57 31.8 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 110.011 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.4 141.43 3.19 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 123.671 0.653 . . . . 0.0 111.963 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.79 -178.86 16.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.202 0.906 . . . . 0.0 112.631 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.87 143.78 36.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.551 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mt -130.55 151.76 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.339 1.456 . . . . 0.0 109.178 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.2 t -135.29 110.32 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.0 m -101.26 105.94 18.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.864 1.266 . . . . 0.0 108.466 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.31 146.58 58.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 120.043 -1.661 . . . . 0.0 110.355 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -73.22 151.46 49.04 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.557 1.505 . . . . 0.0 110.587 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -144.79 80.9 1.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.929 1.347 . . . . 0.0 110.435 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -92.29 118.8 31.26 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.151 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.48 144.68 28.57 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.561 -0.712 . . . . 0.0 110.292 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -122.01 41.94 1.75 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.736 1.16 . . . . 0.0 111.551 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.37 -144.91 7.49 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.78 1.181 . . . . 0.0 112.558 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -49.71 -48.85 49.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.238 1.015 . . . . 0.0 112.459 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.49 -146.23 3.7 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.49 29.09 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.804 0.811 . . . . 0.0 111.753 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -82.33 162.05 22.37 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.062 -1.024 . . . . 0.0 110.772 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -114.31 133.97 55.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.649 174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.62 -179.3 19.21 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 122.149 0.861 . . . . 0.0 111.481 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.13 150.94 51.93 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.071 0.948 . . . . 0.0 111.1 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -133.92 115.05 13.95 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.839 0.828 . . . . 0.0 110.344 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.0 mt -120.1 99.81 8.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.6 OUTLIER -70.53 141.59 51.9 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.007 172.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.4 p -134.35 123.76 24.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -134.94 122.46 21.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 109.727 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt 160.38 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.179 2.192 . . . . 0.0 110.325 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.9 m -45.87 103.64 0.36 Allowed Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 125.064 1.478 . . . . 0.0 110.483 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -74.23 -172.81 1.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.831 1.688 . . . . 0.0 109.996 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -27.08 34.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.698 -1.252 . . . . 0.0 113.003 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -72.22 -50.17 29.59 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.202 -0.936 . . . . 0.0 111.472 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.49 -13.56 61.07 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 121.902 -0.499 . . . . 0.0 111.197 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -30.58 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 119.513 -1.992 . . . . 0.0 110.069 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.18 -47.02 14.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 124.68 1.192 . . . . 0.0 109.531 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 m -61.26 -39.21 89.51 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.466 1.03 . . . . 0.0 112.708 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.8 mm -70.55 -49.07 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.046 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.9 m -57.83 -44.86 86.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 119.71 1.141 . . . . 0.0 112.563 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 m -59.44 -43.47 93.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.903 1.281 . . . . 0.0 111.476 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.51 -24.68 69.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.306 0.479 . . . . 0.0 113.517 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.2 25.75 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.963 -1.316 . . . . 0.0 111.338 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -26.01 63.67 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.963 1.705 . . . . 0.0 111.972 175.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -27.32 60.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.872 0.869 . . . . 0.0 112.391 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.3 t -154.97 48.64 0.56 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.853 1.661 . . . . 0.0 110.494 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.38 -80.86 0.81 Allowed Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 38.14 43.41 1.38 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 125.934 1.731 . . . . 0.0 114.915 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 m 61.57 144.63 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.711 1.604 . . . . 0.0 112.696 -170.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 t -166.47 -40.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.535 -1.353 . . . . 0.0 110.81 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 143.18 50.78 0.04 OUTLIER Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.975 1.274 . . . . 0.0 112.236 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.0 100.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.77 95.7 10.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.656 0.382 . . . . 0.0 110.571 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.8 mt -69.39 154.66 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.692 1.197 . . . . 0.0 109.911 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.33 115.75 2.45 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.89 -1.131 . . . . 0.0 111.448 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.98 -40.86 0.7 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.269 0.938 . . . . 0.0 114.538 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -86.28 41.12 0.91 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.324 1.85 . . . . 0.0 110.689 168.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -55.8 93.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.586 1.154 . . . . 0.0 111.05 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -116.96 -168.28 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.445 1.498 . . . . 0.0 109.094 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -136.25 -41.96 0.64 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 110.989 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.5 p30 -89.79 20.95 3.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.89 2.076 . . . . 0.0 113.547 170.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.98 83.91 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 111.076 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 76.9 2.04 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.184 1.394 . . . . 0.0 109.443 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.3 m -75.96 154.75 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.009 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.94 164.54 16.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.784 1.233 . . . . 0.0 111.021 -172.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.07 -53.34 20.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.881 1.272 . . . . 0.0 112.178 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.78 -34.1 73.97 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.005 0.922 . . . . 0.0 112.143 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -51.27 63.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 O-C-N 121.721 -0.612 . . . . 0.0 109.653 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.36 -21.3 66.58 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.934 0.788 . . . . 0.0 111.312 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.39 65.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 113.211 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.73 -51.24 3.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.187 1.395 . . . . 0.0 112.607 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -54.48 -58.31 7.95 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.967 2.107 . . . . 0.0 110.843 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 5.7 m -78.55 115.38 18.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.19 146.4 6.66 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.419 1.488 . . . . 0.0 111.275 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.89 116.23 19.08 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.847 0.459 . . . . 0.0 110.183 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.35 137.5 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.148 1.379 . . . . 0.0 112.455 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.71 -44.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.602 -1.311 . . . . 0.0 111.553 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.33 -47.3 1.06 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.618 1.58 . . . . 0.0 111.504 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.16 76.09 0.69 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.292 1.837 . . . . 0.0 109.943 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.0 p -56.4 135.93 53.87 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.245 173.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -46.18 139.36 6.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.5 p -47.61 120.41 3.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.096 1.358 . . . . 0.0 110.899 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.39 127.44 32.19 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 120.934 -1.104 . . . . 0.0 109.232 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 14.6 m -102.2 111.91 24.37 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.84 109.81 11.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -80.22 132.07 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.58 ' CZ ' ' CD1' ' A' ' 39' ' ' TYR . 2.6 t80 -97.83 115.16 27.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -101.27 107.33 18.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.234 0.614 . . . . 0.0 110.002 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -77.35 109.21 11.07 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.951 0.901 . . . . 0.0 110.92 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -108.15 106.13 16.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.787 0.835 . . . . 0.0 109.907 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 CA-C-O 117.935 -1.481 . . . . 0.0 112.734 178.06 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.51 159.86 1.55 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.63 1.572 . . . . 0.0 110.266 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.46 118.47 4.4 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 -94.05 0.48 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.239 1.016 . . . . 0.0 109.638 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -110.75 169.14 8.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.965 1.306 . . . . 0.0 110.454 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.69 -45.04 84.32 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.262 0.625 . . . . 0.0 111.168 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -92.7 -28.65 16.51 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.493 1.117 . . . . 0.0 110.968 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -19.51 14.22 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 113.569 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t -44.89 -52.44 8.63 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.858 1.329 . . . . 0.0 113.612 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -78.33 -33.9 48.91 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.674 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -56.47 -51.58 67.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.771 0.714 . . . . 0.0 110.909 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.5 p -65.95 -34.14 77.43 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.602 1.161 . . . . 0.0 111.079 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.85 -47.55 82.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.159 0.984 . . . . 0.0 112.32 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -57.29 -52.94 63.33 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 120.873 -1.142 . . . . 0.0 111.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -65.14 -24.13 67.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.204 172.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -47.46 81.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.289 0.95 . . . . 0.0 109.465 174.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tt -65.0 -41.64 95.21 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.918 0.781 . . . . 0.0 109.317 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' CD2' ' A' ' 179' ' ' TYR . . . -64.05 -43.24 96.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.39 0.431 . . . . 0.0 111.587 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -35.64 63.17 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.533 1.133 . . . . 0.0 112.132 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.15 -62.42 1.44 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -54.82 -25.92 31.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.936 0.894 . . . . 0.0 111.835 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -31.61 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.244 1.018 . . . . 0.0 112.774 171.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.5 51.67 0.25 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.329 1.442 . . . . 0.0 113.396 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.1 tpt -126.52 -77.02 0.58 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.382 1.073 . . . . 0.0 110.563 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.3 mtt -154.89 58.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.681 1.229 . . . . 0.0 111.235 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -106.38 -5.87 18.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.14 39.37 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.529 1.062 . . . . 0.0 112.579 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.9 -28.73 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 122.181 -0.599 . . . . 0.0 110.838 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.31 105.44 5.01 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.678 1.591 . . . . 0.0 109.767 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.76 64.89 2.06 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -69.68 143.68 53.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.766 0.793 . . . . 0.0 110.505 174.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.21 93.79 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -44.15 159.56 0.04 OUTLIER 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 111.962 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m 74.62 170.43 0.29 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.887 0.742 . . . . 0.0 109.117 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.56 -68.12 0.14 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.984 1.714 . . . . 0.0 111.776 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.3 21.14 32.02 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.46 1.505 . . . . 0.0 113.137 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.07 -56.0 4.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.801 0.84 . . . . 0.0 109.81 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -25.46 66.84 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.931 171.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -52.01 67.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.631 1.105 . . . . 0.0 111.298 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -68.63 -39.45 80.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.051 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -60.04 -48.81 80.17 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 111.026 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.5 m -68.35 -41.45 80.69 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 125.342 1.457 . . . . 0.0 110.286 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.22 -54.09 50.67 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.085 1.311 . . . . 0.0 111.203 172.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.96 -51.28 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.805 -1.184 . . . . 0.0 110.964 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -60.0 -26.13 65.81 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.711 -1.243 . . . . 0.0 112.592 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.7 -14.12 59.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.21 1.004 . . . . 0.0 113.088 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.74 34.13 9.41 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.167 1.365 . . . . 0.0 112.697 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.91 -73.46 0.56 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.065 0.546 . . . . 0.0 111.81 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -63.6 1.21 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.011 0.434 . . . . 0.0 110.22 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -134.24 -164.36 1.49 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.135 1.374 . . . . 0.0 109.698 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.42 23.49 1.37 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.659 1.123 . . . . 0.0 112.732 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.7 mmt -93.19 174.76 7.05 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.104 1.361 . . . . 0.0 112.029 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.01 138.75 58.66 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.35 0.595 . . . . 0.0 110.351 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.74 132.2 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 t -92.99 150.64 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.66 142.11 12.36 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.05 99.42 46.63 Favored Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 124.545 1.138 . . . . 0.0 108.005 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -74.22 -29.36 9.75 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.523 2.149 . . . . 0.0 112.26 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.81 68.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.452 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.29 -65.23 1.2 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.113 . . . . 0.0 111.818 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.93 52.81 0.24 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.051 1.31 . . . . 0.0 112.382 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.3 m -144.16 105.31 4.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.186 0.995 . . . . 0.0 109.828 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.55 145.61 45.39 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 122.111 0.958 . . . . 0.0 110.517 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -126.16 127.46 45.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -101.12 135.17 43.02 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.746 0.784 . . . . 0.0 109.261 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -96.21 119.71 35.19 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -171.84 0.9 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.768 0.427 . . . . 0.0 111.339 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -57.92 4.11 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.959 0.904 . . . . 0.0 112.254 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.99 132.99 3.8 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.145 0.978 . . . . 0.0 110.617 173.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.66 -57.61 4.5 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.657 1.123 . . . . 0.0 112.563 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -46.38 139.13 7.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 123.872 0.748 . . . . 0.0 112.611 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -132.64 152.67 51.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.479 1.133 . . . . 0.0 109.601 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -132.97 146.76 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.164 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.15 113.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 m -95.16 123.72 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.34 40.02 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.546 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -71.52 152.77 60.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.98 1.787 . . . . 0.0 110.784 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -149.66 84.99 1.42 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 123.749 1.738 . . . . 0.0 108.953 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.4 p -89.79 144.33 26.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.143 -1.844 . . . . 0.0 108.907 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 143.56 47.28 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.34 -41.68 3.9 Favored Glycine 0 N--CA 1.469 0.884 0 C-N-CA 123.093 0.378 . . . . 0.0 113.066 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.94 -158.23 0.51 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.691 1.138 . . . . 0.0 113.196 172.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -34.8 7.64 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.97 -1.014 . . . . 0.0 112.958 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -32.62 94.17 0.01 OUTLIER Glycine 0 C--N 1.344 1.003 0 C-N-CA 126.47 1.986 . . . . 0.0 112.56 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.35 18.11 4.0 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.135 0.974 . . . . 0.0 110.883 -176.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -107.08 147.31 30.16 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.621 1.568 . . . . 0.0 110.025 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -116.86 125.87 52.18 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.941 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.92 -176.35 19.14 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 122.181 0.879 . . . . 0.0 111.215 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -129.46 150.26 50.88 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.973 0.909 . . . . 0.0 110.883 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.01 119.16 8.85 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.077 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mt -119.01 115.91 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.351 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.7 OUTLIER -78.45 140.82 38.61 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.908 174.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 123.58 25.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -131.82 123.62 27.95 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.455 0.702 . . . . 0.0 110.041 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HE3' HG22 ' A' ' 121' ' ' VAL . 0.0 OUTLIER 161.57 -31.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.615 1.966 . . . . 0.0 113.268 -175.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.42 HG22 ' HE3' ' A' ' 120' ' ' LYS . 18.3 t -50.02 111.28 2.01 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.056 176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.16 -173.72 1.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.946 2.431 . . . . 0.0 110.743 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.75 -24.17 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.876 -1.14 . . . . 0.0 113.076 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -52.68 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.952 0.796 . . . . 0.0 111.211 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.46 -17.05 61.81 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.548 173.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 14.2 t -62.55 -45.57 92.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 120.902 1.683 . . . . 0.0 109.248 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.35 -45.6 40.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-O 118.216 -0.897 . . . . 0.0 108.998 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.412 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -57.74 -43.12 85.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.691 1.587 . . . . 0.0 113.768 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.7 mm -74.32 -44.7 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.073 1.749 . . . . 0.0 110.279 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.1 m -63.84 -26.73 68.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.0 m -82.35 -44.18 16.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.721 2.008 . . . . 0.0 110.258 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.78 -42.65 78.44 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.07 -27.21 67.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.825 1.312 . . . . 0.0 112.774 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.78 -21.77 63.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.206 0.602 . . . . 0.0 111.932 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.55 -25.81 39.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.585 1.154 . . . . 0.0 112.775 174.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -151.81 49.66 0.8 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.393 1.477 . . . . 0.0 110.212 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -36.56 -63.63 0.68 Allowed Glycine 0 C--N 1.344 1.024 0 C-N-CA 125.628 1.585 . . . . 0.0 113.18 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 25.21 78.22 0.01 OUTLIER Glycine 0 C--N 1.346 1.085 0 C-N-CA 126.971 2.224 . . . . 0.0 113.273 167.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.2 p -51.67 171.31 0.04 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.78 1.632 . . . . 0.0 112.937 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 p 178.92 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.647 0.779 . . . . 0.0 111.811 -170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.55 42.68 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.496 0.57 . . . . 0.0 113.949 176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.6 mt -80.12 117.07 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 123.321 0.648 . . . . 0.0 109.574 -175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.56 104.36 9.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.589 1.155 . . . . 0.0 108.036 -176.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.3 mm -78.6 168.09 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -50.06 116.22 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.29 1.436 . . . . 0.0 112.439 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.59 28.61 6.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 123.52 0.581 . . . . 0.0 114.11 -173.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.95 38.52 3.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.378 2.271 . . . . 0.0 108.398 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.63 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.668 1.987 . . . . 0.0 112.129 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -138.2 -173.43 3.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.624 1.57 . . . . 0.0 109.347 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.9 p -146.8 -52.14 0.22 Allowed 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.084 -1.01 . . . . 0.0 109.461 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -80.03 31.39 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.221 2.209 . . . . 0.0 113.521 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 105.43 13.45 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.839 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.88 128.36 35.35 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.13 134.43 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 178.5 7.22 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.959 0.904 . . . . 0.0 110.644 -170.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.54 -54.51 42.22 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 172.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.53 -32.46 72.52 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.899 0.88 . . . . 0.0 111.986 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.31 -54.35 17.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.62 -18.57 64.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.424 1.011 . . . . 0.0 111.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.07 -38.76 92.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.926 0.89 . . . . 0.0 111.945 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.4 m -111.25 -51.6 2.85 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.095 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -55.0 -49.46 71.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.287 1.835 . . . . 0.0 113.513 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.16 -38.05 75.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.426 0.632 . . . . 0.0 111.009 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.4 m -76.92 152.65 35.24 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.553 1.541 . . . . 0.0 110.305 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -165.99 -68.89 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 119.523 -1.986 . . . . 0.0 110.06 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -153.44 30.83 0.47 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.715 1.206 . . . . 0.0 112.452 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -154.03 106.71 2.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.397 1.079 . . . . 0.0 109.504 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.84 115.6 8.17 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.9 mtm105 53.81 68.65 0.81 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.301 1.041 . . . . 0.0 112.226 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p -46.28 152.26 0.44 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.059 0.944 . . . . 0.0 111.863 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.19 5.68 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 123.72 0.676 . . . . 0.0 113.077 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 46.4 m -152.05 99.52 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.152 1.381 . . . . 0.0 109.171 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -134.16 116.58 15.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.356 1.062 . . . . 0.0 110.123 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.9 m -115.92 107.14 14.62 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.2 123.15 40.82 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.578 0.751 . . . . 0.0 109.103 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -94.79 122.8 46.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -98.93 122.57 42.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.402 0.681 . . . . 0.0 110.046 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.09 138.94 41.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.587 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -145.05 136.4 25.12 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.888 177.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -48.41 149.64 1.54 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.022 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.914 -179.54 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.228 0.537 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 19.9 t90 -165.46 157.02 14.53 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.196 0.998 . . . . 0.0 109.712 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.97 152.46 18.57 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.941 0.781 . . . . 0.0 111.537 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -127.76 -69.55 0.73 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.17 0.988 . . . . 0.0 110.518 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -130.0 175.39 8.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.229 1.412 . . . . 0.0 110.246 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -90.26 -43.4 10.41 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.248 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.07 -34.13 19.26 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.01 -25.76 2.62 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 120.879 -1.138 . . . . 0.0 114.088 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 p -48.31 -41.6 28.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.822 1.649 . . . . 0.0 114.316 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.43 -34.99 47.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.9 mt -57.79 -53.28 59.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.141 0.882 . . . . 0.0 112.356 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.9 p -60.76 -36.83 79.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.711 176.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -50.84 72.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.859 1.263 . . . . 0.0 112.42 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.426 ' CZ ' HG23 ' A' ' 118' ' ' THR . 12.2 m-30 -57.98 -46.49 85.07 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.892 -1.13 . . . . 0.0 111.649 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -62.96 -31.96 73.17 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.008 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -45.74 89.22 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 123.663 0.785 . . . . 0.0 109.713 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tp -59.47 -49.57 77.29 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 120.374 1.443 . . . . 0.0 110.071 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.53 95.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.98 -33.37 59.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.615 1.166 . . . . 0.0 112.524 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -71.45 -61.12 1.89 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 t -56.51 -19.75 17.04 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.17 0.988 . . . . 0.0 112.332 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -32.22 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.735 0.814 . . . . 0.0 112.248 171.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.83 45.94 0.17 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.648 1.118 . . . . 0.0 113.009 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -113.64 -66.4 1.09 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.995 0.918 . . . . 0.0 110.128 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.02 31.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.693 1.197 . . . . 0.0 112.564 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.446 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.36 -21.91 48.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 176.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.07 47.1 0.13 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.302 0.953 . . . . 0.0 112.332 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.22 -32.7 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.384 0.674 . . . . 0.0 111.418 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -115.99 116.71 28.4 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.58 -163.28 0.11 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.594 0.616 . . . . 0.0 112.021 170.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 58.32 77.25 0.3 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.145 0.974 . . . . 0.0 112.615 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.19 156.33 32.44 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.724 -0.61 . . . . 0.0 111.399 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 -59.02 1.77 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.864 0.866 . . . . 0.0 111.245 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.8 m -121.61 144.99 48.43 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.827 1.251 . . . . 0.0 108.94 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 t -128.22 65.99 1.38 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.612 1.165 . . . . 0.0 109.727 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.56 -46.6 0.1 OUTLIER Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.181 0.895 . . . . 0.0 112.354 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . . . -85.07 -70.0 0.61 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -23.74 50.07 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 123.436 0.695 . . . . 0.0 112.302 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 51' ' ' LYS . 7.4 tpt -53.5 -71.61 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.512 0.725 . . . . 0.0 110.36 172.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -65.95 -32.98 74.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.494 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.68 -53.05 62.15 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.094 0.861 . . . . 0.0 111.02 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.1 m -68.18 -41.05 82.04 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.42 1.088 . . . . 0.0 110.891 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.072 0.851 . . . . 0.0 111.754 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.18 -52.06 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.067 -1.02 . . . . 0.0 110.48 176.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.06 -20.44 53.28 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.364 -1.46 . . . . 0.0 113.094 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.54 13.65 3.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.509 1.524 . . . . 0.0 113.615 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 53.18 40.8 60.27 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.865 1.698 . . . . 0.0 112.8 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.83 -70.29 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 -54.27 5.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -149.25 178.13 9.03 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.089 1.356 . . . . 0.0 109.538 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.69 31.46 3.38 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 124.787 1.184 . . . . 0.0 112.105 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.38 171.28 8.06 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.353 1.061 . . . . 0.0 111.639 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -61.88 131.44 49.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.446 0.641 . . . . 0.0 110.497 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.13 136.94 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.799 1.24 . . . . 0.0 108.464 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 t -88.02 126.94 35.35 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.75 103.42 2.91 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -50.14 105.39 0.51 Allowed Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.481 1.112 . . . . 0.0 111.373 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.16 -17.25 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.504 2.136 . . . . 0.0 112.388 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.31 -7.09 58.76 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.99 1.316 . . . . 0.0 112.594 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m 60.04 68.45 0.78 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.436 1.494 . . . . 0.0 112.05 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.03 -52.89 0.1 OUTLIER Glycine 0 N--CA 1.467 0.747 0 C-N-CA 124.006 0.812 . . . . 0.0 112.215 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -177.25 124.29 0.14 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.832 1.253 . . . . 0.0 110.965 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -64.81 164.58 12.06 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 122.355 1.074 . . . . 0.0 112.029 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.6 t -133.86 142.21 47.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.65 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -109.23 123.84 49.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.059 0.944 . . . . 0.0 109.099 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -82.04 119.56 24.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.802 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -70.27 176.6 3.81 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.282 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.68 -53.65 4.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.036 1.334 . . . . 0.0 113.01 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -149.6 -51.36 0.15 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 0.0 111.779 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.46 98.83 0.86 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.82 132.99 1.57 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 124.012 0.815 . . . . 0.0 111.535 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.03 127.41 50.21 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.81 136.82 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 108.684 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.26 109.49 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 m -87.32 122.98 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.97 136.94 18.74 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.337 -0.852 . . . . 0.0 109.209 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -76.08 152.38 35.79 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.734 1.623 . . . . 0.0 110.554 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -143.75 69.04 1.28 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 111.667 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.3 p -97.61 104.53 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.281 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.05 95.2 5.61 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.24 84.07 1.23 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.76 59.15 4.73 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.869 1.224 . . . . 0.0 112.633 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 p -92.42 -49.22 6.25 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.288 1.435 . . . . 0.0 111.9 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.36 43.2 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.304 0.954 . . . . 0.0 112.675 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.22 175.83 5.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.989 1.316 . . . . 0.0 111.176 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -63.7 137.92 58.28 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.139 0.495 . . . . 0.0 111.088 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -64.37 143.46 57.88 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.892 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -103.8 116.13 5.3 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -108.18 135.56 49.3 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.507 0.723 . . . . 0.0 110.333 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 p -124.03 102.44 7.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.748 1.261 . . . . 0.0 110.9 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.44 110.25 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.425 ' CB ' HG22 ' A' ' 176' ' ' VAL . 0.6 OUTLIER -76.84 141.95 40.44 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.285 173.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 39' ' ' TYR . 5.8 p -133.91 130.32 37.59 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.43 -173.88 3.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.352 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 89.84 -31.11 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.576 2.75 . . . . 0.0 110.418 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.7 t -47.61 104.39 0.41 Allowed Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 127.19 2.196 . . . . 0.0 108.405 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -73.66 -170.09 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.991 1.794 . . . . 0.0 110.431 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.401 ' HB3' ' HG1' ' A' ' 170' ' ' THR . 4.9 pp0? -59.54 -31.14 69.14 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.873 -1.142 . . . . 0.0 112.277 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.0 p -73.72 -50.54 20.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.501 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.97 -17.83 62.04 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.91 172.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.45 -45.91 92.29 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 120.878 1.672 . . . . 0.0 108.385 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.98 -42.04 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.629 0.649 . . . . 0.0 111.467 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.47 -45.1 92.35 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.4 mm -63.25 -52.99 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 C-N-CA 124.957 1.303 . . . . 0.0 109.52 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.7 m -56.26 -42.44 77.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 119.121 0.873 . . . . 0.0 112.226 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -56.8 -52.44 65.04 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.127 1.371 . . . . 0.0 110.969 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.6 -29.01 72.8 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 122.867 0.27 . . . . 0.0 112.682 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.429 ' HE1' ' HA ' ' A' ' 133' ' ' MET . 0.0 OUTLIER -76.57 -35.3 58.26 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.245 1.018 . . . . 0.0 111.201 176.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -25.06 65.67 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.929 0.892 . . . . 0.0 112.126 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -60.91 -30.15 70.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.247 0.619 . . . . 0.0 112.605 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 t -153.76 50.75 0.68 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.285 1.034 . . . . 0.0 111.428 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.55 -85.51 1.65 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 44.03 49.91 7.69 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.471 1.034 . . . . 0.0 113.618 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.2 m 66.22 147.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.529 1.532 . . . . 0.0 112.326 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.1 p -179.7 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.142 -0.974 . . . . 0.0 110.961 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.85 48.62 0.07 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.575 1.083 . . . . 0.0 112.216 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.5 mt -88.91 99.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.038 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -90.56 97.08 10.97 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.816 0.446 . . . . 0.0 110.016 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.4 mt -73.87 146.82 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 124.4 1.062 . . . . 0.0 109.516 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -48.36 114.58 0.98 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.467 1.507 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.88 -39.64 0.96 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.302 0.953 . . . . 0.0 113.983 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.57 35.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.265 1.826 . . . . 0.0 111.428 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -51.85 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.378 1.471 . . . . 0.0 110.473 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -123.05 -169.24 1.89 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.976 1.31 . . . . 0.0 109.204 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 p -139.68 -41.69 0.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.784 0.834 . . . . 0.0 110.852 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -90.89 24.44 2.76 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.574 1.949 . . . . 0.0 113.412 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.59 125.76 24.37 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.509 0.671 . . . . 0.0 110.079 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -113.39 74.73 0.88 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 122.479 1.133 . . . . 0.0 108.315 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.66 135.18 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.494 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.7 p -136.56 -179.04 5.44 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.072 0.949 . . . . 0.0 111.449 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.29 81.88 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.605 -0.684 . . . . 0.0 112.386 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.56 -35.54 78.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.584 0.754 . . . . 0.0 111.421 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -46.08 36.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.786 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.47 66.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.1 0.864 . . . . 0.0 111.124 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -39.26 87.74 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 170.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.36 -31.59 24.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.694 1.597 . . . . 0.0 113.792 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -84.01 -56.47 3.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.899 1.68 . . . . 0.0 110.462 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 78.8 m -94.56 62.34 2.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.919 1.688 . . . . 0.0 109.588 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.1 m -77.79 155.89 30.85 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.736 1.214 . . . . 0.0 110.313 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 55.43 175.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.765 1.226 . . . . 0.0 113.095 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -130.76 70.62 1.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.651 0.78 . . . . 0.0 110.251 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -21.74 65.42 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.424 -0.797 . . . . 0.0 112.417 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.25 -48.33 3.4 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.674 1.607 . . . . 0.0 112.378 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.56 50.46 1.25 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.034 1.734 . . . . 0.0 111.952 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.401 ' HG1' ' HB3' ' A' ' 123' ' ' GLN . 67.5 p -64.17 165.74 8.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.103 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.59 136.05 2.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.746 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 95.3 m -50.81 135.12 24.49 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.26 110.26 20.4 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.0 m -110.77 112.09 23.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.06 109.55 11.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.425 HG22 ' CB ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -85.93 137.75 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -111.18 113.01 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.309 0.644 . . . . 0.0 109.726 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -101.46 118.32 36.71 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 109.689 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.46 122.71 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.093 0.957 . . . . 0.0 110.209 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -113.23 95.35 5.33 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.363 1.065 . . . . 0.0 108.91 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.204 0 CA-C-O 118.513 -1.159 . . . . 0.0 112.349 -174.484 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.834 0.826 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -171.62 147.16 2.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.061 1.745 . . . . 0.0 108.669 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.02 91.99 0.18 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -0.27 50.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.335 0.654 . . . . 0.0 112.328 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -109.22 141.3 41.68 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.892 1.677 . . . . 0.0 108.719 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.8 -27.61 44.46 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.522 0.729 . . . . 0.0 112.253 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.72 -36.18 13.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.398 1.079 . . . . 0.0 111.249 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.92 -26.07 32.64 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.201 -0.777 . . . . 0.0 112.827 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -46.14 -43.34 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.003 1.321 . . . . 0.0 113.196 172.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.19 -34.31 49.58 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.739 -0.601 . . . . 0.0 111.805 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.6 mt -63.28 -50.82 68.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 110.341 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.6 p -63.48 -38.1 89.83 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.308 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -58.56 -53.12 61.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.896 1.225 . . . . 0.0 112.416 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -51.25 -52.16 47.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.036 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -67.14 -23.66 65.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.38 69.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.052 1.341 . . . . 0.0 108.685 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.57 -41.46 98.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.269 0.94 . . . . 0.0 109.498 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.31 -44.5 92.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 117.978 0.354 . . . . 0.0 111.075 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -78.53 -39.03 39.15 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.241 0.616 . . . . 0.0 112.618 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -60.68 -57.92 10.67 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -41.36 62.33 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.606 1.162 . . . . 0.0 111.089 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -42.89 -31.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.771 1.629 . . . . 0.0 112.996 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -150.62 50.62 0.54 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.307 1.432 . . . . 0.0 112.678 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.7 tpp -137.26 -60.27 0.67 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.026 0.93 . . . . 0.0 110.569 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.1 tpt -162.12 39.67 0.12 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.72 5.66 38.78 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.2 38.02 0.51 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.9 1.238 . . . . 0.0 112.801 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.0 t -69.54 109.89 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 0.0 109.157 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.47 -54.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.181 1.392 . . . . 0.0 110.557 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.2 -43.32 0.78 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.328 1.442 . . . . 0.0 112.725 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -138.75 55.95 1.72 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.618 1.567 . . . . 0.0 110.838 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.86 159.07 1.8 Allowed 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.844 -1.16 . . . . 0.0 112.432 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.76 -64.45 1.06 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.504 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -148.06 -61.39 0.26 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 117.692 -1.147 . . . . 0.0 109.437 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 76.1 p 38.91 71.71 0.16 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.842 1.339 . . . . 0.0 111.135 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.94 -1.69 30.23 Favored Glycine 0 N--CA 1.468 0.793 0 O-C-N 121.436 -0.79 . . . . 0.0 113.597 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 -61.49 1.54 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.234 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -61.92 -28.57 69.62 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 123.757 0.823 . . . . 0.0 112.481 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.458 ' HE2' ' CZ ' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -56.54 -49.71 74.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.788 0.722 . . . . 0.0 110.322 173.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.611 ' HG1' HG13 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -72.26 -41.13 67.1 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.285 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -55.84 -52.58 63.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.923 0.868 . . . . 0.0 110.62 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.4 m -68.99 -43.1 75.55 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.933 1.293 . . . . 0.0 110.715 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.88 -43.49 90.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.706 1.593 . . . . 0.0 111.989 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.75 -53.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.282 0.633 . . . . 0.0 111.027 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -64.57 -17.2 63.74 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.168 -0.958 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.07 -19.44 30.23 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 112.35 174.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.1 76.17 1.21 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.998 1.285 . . . . 0.0 112.544 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.25 -97.9 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.001 0.52 . . . . 0.0 112.166 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.74 -40.69 60.68 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.005 0.922 . . . . 0.0 111.368 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -165.71 -178.77 4.99 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.017 1.727 . . . . 0.0 110.185 173.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.37 18.02 7.83 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.315 1.436 . . . . 0.0 112.783 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.0 ttt -92.45 171.38 9.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.611 1.165 . . . . 0.0 111.553 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.94 145.98 44.05 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.27 -0.894 . . . . 0.0 111.097 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.3 t -120.67 129.37 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.76 132.68 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.44 136.61 14.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -42.51 113.52 1.29 Allowed Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.907 1.283 . . . . 0.0 112.78 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -76.51 -68.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.943 1.762 . . . . 0.0 111.375 -173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.73 13.18 20.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.762 1.225 . . . . 0.0 112.138 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.24 56.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.225 1.41 . . . . 0.0 111.632 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.02 -56.94 0.78 Allowed Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p 169.79 137.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.676 1.59 . . . . 0.0 110.47 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 87.63 0.19 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.447 0.699 . . . . 0.0 111.049 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 t -63.08 139.22 58.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 110.431 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -114.34 131.57 56.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.401 1.48 . . . . 0.0 108.909 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -91.93 115.54 28.15 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.365 1.066 . . . . 0.0 110.101 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.36 -179.63 2.54 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.61 0.719 . . . . 0.0 112.058 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 -51.51 6.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -45.7 87.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.38 0.672 . . . . 0.0 111.462 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.8 41.68 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.679 1.133 . . . . 0.0 112.705 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -104.97 170.16 17.54 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.155 0.883 . . . . 0.0 111.748 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -123.48 138.97 54.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.753 0.787 . . . . 0.0 109.262 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.13 119.4 56.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.54 115.22 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.611 HG13 ' HG1' ' A' ' 65' ' ' THR . 1.7 m -100.22 132.11 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.34 137.21 9.2 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.987 -0.446 . . . . 0.0 110.899 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.3 154.23 61.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.215 1.943 . . . . 0.0 111.608 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.9 65.42 1.11 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.575 1.655 . . . . 0.0 111.099 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -86.48 172.04 10.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.443 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.24 147.01 35.79 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.341 0.656 . . . . 0.0 111.111 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.22 39.72 92.83 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.893 -0.948 . . . . 0.0 113.413 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 48.92 -103.72 0.08 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.189 1.376 . . . . 0.0 113.105 -173.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.6 p -108.91 175.74 5.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.31 1.844 . . . . 0.0 111.961 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 115.66 -50.86 0.75 Allowed Glycine 0 N--CA 1.47 0.9 0 O-C-N 120.802 -1.186 . . . . 0.0 111.869 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.46 -177.96 3.66 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.394 1.077 . . . . 0.0 111.775 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -66.55 163.09 19.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.736 0.779 . . . . 0.0 111.277 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -91.77 144.68 25.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.775 172.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.56 104.05 1.44 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.458 ' CZ ' ' HE2' ' A' ' 64' ' ' MET . 2.0 m-85 -87.47 155.68 19.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.708 -0.878 . . . . 0.0 111.18 175.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.86 118.21 9.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 122.023 0.916 . . . . 0.0 110.822 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mt -113.57 108.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -71.17 131.34 43.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.125 0.97 . . . . 0.0 108.807 172.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -130.38 124.72 32.83 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -131.15 128.18 39.55 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt 164.74 -38.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.771 2.029 . . . . 0.0 110.872 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -45.19 103.35 0.34 Allowed Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.711 1.604 . . . . 0.0 110.492 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -74.82 -172.1 1.14 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 110.363 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -22.54 53.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.545 -1.347 . . . . 0.0 114.324 173.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.8 t -79.34 -52.01 8.66 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.964 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.32 -23.9 60.32 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 121.866 -0.521 . . . . 0.0 110.86 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.26 -27.54 62.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.791 1.178 . . . . 0.0 110.164 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.59 -50.87 11.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 CA-C-O 117.871 -1.062 . . . . 0.0 110.609 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -45.22 68.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.943 1.247 . . . . 0.0 113.38 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.09 -38.61 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.206 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -67.2 -43.78 81.23 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.463 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.4 m -65.15 -27.89 69.03 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.243 1.383 . . . . 0.0 111.957 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.02 20.68 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.227 0.917 . . . . 0.0 113.75 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 1.9 ttp -84.71 -24.78 28.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.289 1.435 . . . . 0.0 112.43 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.6 p -69.59 -21.36 63.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.917 1.287 . . . . 0.0 111.888 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.0 mtt-85 -60.57 -17.91 49.35 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 113.133 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 t -154.04 53.44 0.7 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.255 1.022 . . . . 0.0 110.593 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -38.09 -65.39 0.7 Allowed Glycine 0 C--N 1.345 1.075 0 C-N-CA 125.34 1.448 . . . . 0.0 112.961 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 22.39 72.29 0.01 OUTLIER Glycine 0 C--N 1.347 1.187 0 C-N-CA 126.991 2.234 . . . . 0.0 113.217 167.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.9 p -53.28 171.16 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.531 1.532 . . . . 0.0 112.668 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.39 -33.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.67 -0.644 . . . . 0.0 111.315 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.12 43.5 0.03 OUTLIER Glycine 0 C--N 1.338 0.643 0 CA-C-O 119.58 -0.567 . . . . 0.0 113.399 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.0 mt -77.2 116.3 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.166 0.586 . . . . 0.0 110.812 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.79 96.45 5.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.574 1.15 . . . . 0.0 108.897 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.7 mt -74.96 167.14 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -49.53 115.83 1.51 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.35 1.46 . . . . 0.0 111.981 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.65 27.19 8.6 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 123.444 0.545 . . . . 0.0 114.138 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.34 39.94 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.06 2.544 . . . . 0.0 107.615 -176.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -42.53 95.91 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.657 1.183 . . . . 0.0 111.593 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -142.8 -173.52 3.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.221 1.408 . . . . 0.0 108.784 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.3 p -146.29 -47.57 0.2 Allowed 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.548 -0.72 . . . . 0.0 110.193 -174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.57 18.53 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.259 1.824 . . . . 0.0 112.142 172.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.97 97.71 0.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.304 -0.873 . . . . 0.0 111.146 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.62 125.1 29.58 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.07 170.06 16.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.151 0.98 . . . . 0.0 110.809 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.05 -37.67 72.12 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.5 -42.3 43.93 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.185 0.994 . . . . 0.0 110.891 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -45.51 94.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 173.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.84 -17.95 61.5 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.761 -0.587 . . . . 0.0 111.972 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -40.6 76.67 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.243 -0.91 . . . . 0.0 111.531 172.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 70.1 m -107.96 -58.01 2.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.805 0.842 . . . . 0.0 112.12 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -82.76 63.32 6.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.365 1.866 . . . . 0.0 113.037 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 2.5 t 176.47 -45.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 110.624 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 m -95.94 156.24 16.41 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.305 1.042 . . . . 0.0 109.527 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 62.48 154.89 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.314 1.446 . . . . 0.0 112.336 -169.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.7 t70 81.1 7.04 1.25 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.39 1.476 . . . . 0.0 112.576 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.49 -45.04 0.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.336 1.454 . . . . 0.0 111.187 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.18 -43.13 1.88 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.472 1.51 . . . . 0.0 112.366 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -162.78 67.79 0.22 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.492 1.117 . . . . 0.0 111.737 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.7 p -47.86 128.69 13.63 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.507 0.67 . . . . 0.0 111.158 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.07 0.65 Allowed Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 67.4 p -89.28 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.348 1.459 . . . . 0.0 109.7 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.32 84.28 2.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.974 1.71 . . . . 0.0 109.792 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.0 m -77.16 123.87 27.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.199 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.26 112.68 11.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -82.67 131.52 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 171.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -108.88 111.34 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -85.79 141.82 29.39 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.022 0.439 . . . . 0.0 111.498 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -142.22 118.71 10.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.824 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.66 142.39 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.677 0.391 . . . . 0.0 110.489 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 C-N-CA 124.276 0.941 . . . . 0.0 113.961 175.262 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.244 0.545 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.69 168.49 2.59 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.405 1.482 . . . . 0.0 110.408 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 110.96 0.22 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -105.85 -78.29 0.58 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.717 0.807 . . . . 0.0 110.063 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -137.67 172.15 13.39 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.271 1.428 . . . . 0.0 110.893 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -65.32 -46.07 81.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.218 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.11 -38.39 20.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.341 1.056 . . . . 0.0 111.24 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.73 -28.85 1.19 Allowed Glycine 0 C--O 1.216 -1.0 0 CA-C-O 117.868 -1.518 . . . . 0.0 113.142 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 t -40.3 -46.15 2.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.293 1.546 . . . . 0.0 113.649 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -73.62 -39.23 64.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.17 0.896 . . . . 0.0 111.517 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mt -66.44 -51.85 52.62 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.848 0.859 . . . . 0.0 112.017 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 p -62.69 -35.76 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.35 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -58.62 -54.44 47.07 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.117 1.326 . . . . 0.0 111.588 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -56.7 -45.63 81.71 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.206 -0.934 . . . . 0.0 111.638 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -65.01 -28.56 69.59 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 112.222 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -43.23 81.61 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 109.688 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.89 -44.09 97.04 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.083 -1.011 . . . . 0.0 109.994 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.75 86.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.455 0.57 . . . . 0.0 112.264 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.34 -30.94 63.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.39 1.076 . . . . 0.0 112.656 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.85 -60.83 2.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 t -55.27 -21.15 13.35 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.948 0.899 . . . . 0.0 112.587 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -47.39 -33.84 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.545 1.138 . . . . 0.0 113.087 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.93 37.31 0.42 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.611 1.101 . . . . 0.0 112.283 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.9 tpt -109.47 -70.41 0.81 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.518 0.727 . . . . 0.0 110.583 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.76 64.03 0.73 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.8 1.286 . . . . 0.0 111.297 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.49 -9.52 15.37 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.68 37.77 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.236 1.398 . . . . 0.0 111.924 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.75 125.96 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.2 t70 74.23 -46.1 0.61 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.397 1.879 . . . . 0.0 112.712 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -44.93 140.23 4.54 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.913 1.72 . . . . 0.0 112.934 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.19 120.81 43.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.296 1.038 . . . . 0.0 110.358 -172.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 49.87 -163.82 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.762 0.825 . . . . 0.0 111.393 -172.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 48.02 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.983 1.313 . . . . 0.0 113.19 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.6 t -52.36 154.23 2.56 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.122 0.963 . . . . 0.0 111.854 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.0 m -71.08 -52.96 16.45 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.413 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.24 -89.97 0.91 Allowed Glycine 0 N--CA 1.469 0.863 0 O-C-N 120.915 -1.116 . . . . 0.0 112.651 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . . . -83.07 -49.85 9.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.38 -22.91 34.32 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 123.679 0.791 . . . . 0.0 112.106 169.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -60.46 -51.48 69.28 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.071 0.85 . . . . 0.0 110.076 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.649 ' HG1' HG23 ' A' ' 100' ' ' VAL . 11.4 m -74.85 -40.75 60.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.049 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -56.04 -52.5 64.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.194 0.906 . . . . 0.0 110.738 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.4 m -68.57 -39.64 80.91 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 110.928 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.58 -51.29 70.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.626 1.557 . . . . 0.0 111.557 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -51.93 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 120.694 -1.253 . . . . 0.0 110.863 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -61.88 -18.34 59.8 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.484 -1.385 . . . . 0.0 112.711 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.08 12.11 5.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.493 1.517 . . . . 0.0 113.295 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.62 40.83 80.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.977 1.275 . . . . 0.0 112.743 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.19 -77.73 0.54 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.01 0.524 . . . . 0.0 110.861 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.39 -59.57 2.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -140.04 179.66 6.49 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.178 1.391 . . . . 0.0 109.9 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.16 35.37 2.45 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.104 1.335 . . . . 0.0 112.161 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.2 mtt -103.72 179.77 4.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.801 1.24 . . . . 0.0 111.982 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -69.77 133.74 47.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.587 0.708 . . . . 0.0 110.473 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.26 134.36 59.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.53 1.132 . . . . 0.0 108.515 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.26 152.15 36.59 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.184 0.516 . . . . 0.0 110.803 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.95 158.05 14.54 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -145.36 127.85 8.08 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 122.766 0.426 . . . . 0.0 110.552 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.29 -17.02 27.82 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.639 2.226 . . . . 0.0 112.514 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.1 61.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.508 0.723 . . . . 0.0 112.842 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 t 66.56 63.69 0.51 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 112.296 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.76 41.16 0.02 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.727 -0.608 . . . . 0.0 114.127 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.35 25.39 0.3 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.942 0.897 . . . . 0.0 111.761 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -60.26 126.97 29.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.215 1.007 . . . . 0.0 109.914 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 t -117.58 140.44 49.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.19 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -106.62 127.11 53.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -87.37 113.83 23.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.764 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -74.48 170.55 15.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.769 0.795 . . . . 0.0 111.643 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -87.75 -36.0 17.58 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.078 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -87.73 46.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 112.162 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 46.94 61.25 4.49 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.023 1.297 . . . . 0.0 112.832 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -130.15 160.31 22.92 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 123.774 0.702 . . . . 0.0 112.329 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.43 133.93 48.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.796 1.284 . . . . 0.0 108.95 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.08 135.81 59.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.911 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.32 110.37 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.649 HG23 ' HG1' ' A' ' 65' ' ' THR . 3.0 m -90.32 125.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.33 125.55 13.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.538 -0.726 . . . . 0.0 109.248 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.86 153.96 58.55 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.488 1.459 . . . . 0.0 111.203 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -147.56 73.14 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.935 1.694 . . . . 0.0 110.852 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.7 p -104.55 82.46 1.91 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.775 1.274 . . . . 0.0 109.807 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.14 95.07 2.66 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.627 -1.295 . . . . 0.0 111.124 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.65 88.14 2.02 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.5 143.29 14.81 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.218 0.913 . . . . 0.0 111.452 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -101.36 -48.15 4.46 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.881 1.272 . . . . 0.0 111.326 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.25 -92.66 2.27 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.186 1.374 . . . . 0.0 110.576 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.75 29.44 0.83 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.977 0.894 . . . . 0.0 112.871 -176.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -86.27 114.65 23.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.219 1.008 . . . . 0.0 109.803 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -95.4 153.47 17.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.397 170.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.99 119.26 6.14 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.47 133.05 56.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.085 0.942 . . . . 0.0 109.674 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.0 p -116.55 124.01 48.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 122.135 0.969 . . . . 0.0 108.968 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.3 mp -120.8 98.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -69.38 135.68 50.66 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.56 172.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.6 p -125.28 121.86 35.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -120.58 175.42 6.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.545 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 84.19 -18.42 0.41 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.959 2.104 . . . . 0.0 111.897 -175.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -49.38 107.68 0.83 Allowed Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.283 1.833 . . . . 0.0 109.011 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -73.71 -174.47 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.352 2.035 . . . . 0.0 110.026 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -59.47 -28.13 66.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.383 -0.823 . . . . 0.0 111.863 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.4 t -70.24 -43.59 70.26 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.497 -1.377 . . . . 0.0 111.524 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 119.425 -0.322 . . . . 0.0 111.387 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -26.94 63.03 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.937 -1.102 . . . . 0.0 111.614 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.02 -53.58 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 124.49 1.116 . . . . 0.0 110.674 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 p -57.08 -44.72 83.4 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.681 1.128 . . . . 0.0 113.249 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.53 -38.4 56.5 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 C-N-CA 124.851 1.26 . . . . 0.0 109.338 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.9 m -73.38 -46.6 48.01 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.963 0.801 . . . . 0.0 112.469 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 m -56.99 -32.36 66.01 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.468 1.485 . . . . 0.0 111.727 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.45 -37.36 9.75 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.105 0.86 . . . . 0.0 113.394 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.3 ttm -74.34 -15.5 60.95 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.003 -1.292 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.2 t -84.84 -21.64 29.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.323 -1.486 . . . . 0.0 111.193 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -62.64 -41.95 99.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.095 0.558 . . . . 0.0 112.086 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.2 t -161.75 55.53 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.178 0.991 . . . . 0.0 110.688 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.25 -83.55 0.19 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.81 149.13 0.01 OUTLIER Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.759 1.2 . . . . 0.0 111.827 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.0 m -49.84 143.03 8.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.986 -1.302 . . . . 0.0 111.555 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.97 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.267 0.627 . . . . 0.0 111.717 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 153.98 54.49 0.01 OUTLIER Glycine 0 C--N 1.337 0.615 0 C-N-CA 123.902 0.763 . . . . 0.0 112.488 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.62 98.38 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.358 0.599 . . . . 0.0 109.941 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -91.42 93.91 9.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.0 tt -77.32 148.87 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 111.027 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -54.29 122.43 10.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.669 -0.644 . . . . 0.0 112.23 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.56 -52.73 3.53 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.403 1.001 . . . . 0.0 113.327 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -79.7 31.03 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.983 1.313 . . . . 0.0 111.968 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -48.81 98.18 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.253 1.421 . . . . 0.0 110.676 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -126.22 -165.86 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.915 1.286 . . . . 0.0 109.089 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.6 p -132.2 -37.63 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.009 0.924 . . . . 0.0 110.921 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.95 12.14 18.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.371 1.868 . . . . 0.0 113.646 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.58 137.42 19.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.768 0.794 . . . . 0.0 109.881 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 120.15 25.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.25 133.9 63.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 171.15 12.62 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.333 1.053 . . . . 0.0 110.245 -169.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.16 -52.19 63.41 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 111.784 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.43 -37.65 78.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.879 0.871 . . . . 0.0 111.982 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.74 42.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.322 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.34 67.47 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.581 1.082 . . . . 0.0 111.985 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -34.93 78.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.497 1.119 . . . . 0.0 112.194 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -43.06 8.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.293 1.037 . . . . 0.0 112.299 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.11 -50.86 72.45 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.702 2.001 . . . . 0.0 111.113 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 59.2 m -84.13 90.38 7.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.346 1.07 . . . . 0.0 109.306 173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.2 p -72.34 141.92 48.8 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.203 1.401 . . . . 0.0 111.382 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 43.83 -157.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.241 1.019 . . . . 0.0 112.341 -173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.26 68.47 1.04 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -51.28 -25.16 5.32 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.583 -0.698 . . . . 0.0 111.901 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.75 104.47 1.43 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.97 51.85 3.56 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.849 0.833 . . . . 0.0 111.116 -173.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.7 p -49.96 159.57 0.4 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.201 1.001 . . . . 0.0 111.322 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.19 130.73 2.77 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.022 0.82 . . . . 0.0 112.589 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.2 p -45.73 108.24 0.12 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.789 1.636 . . . . 0.0 110.804 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.5 125.94 30.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 m -96.5 108.24 20.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.76 102.17 7.19 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.578 1.151 . . . . 0.0 108.576 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -81.69 131.32 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 173.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -111.39 101.08 9.57 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.777 0.831 . . . . 0.0 109.224 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -87.01 144.16 27.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.41 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -138.59 111.52 7.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.812 1.245 . . . . 0.0 109.912 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.93 129.01 38.99 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.346 0.658 . . . . 0.0 109.408 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.589 0 CA-C-O 116.81 -2.106 . . . . 0.0 115.661 173.534 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.72 170.66 1.95 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.032 1.733 . . . . 0.0 110.375 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.92 90.17 0.61 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 123.616 0.627 . . . . 0.0 111.59 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 -64.4 1.32 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.392 0.677 . . . . 0.0 110.879 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -133.97 175.78 9.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.647 1.579 . . . . 0.0 110.545 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.84 -43.0 5.67 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.45 0.7 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.9 -42.31 8.37 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.206 1.402 . . . . 0.0 112.07 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.58 -29.25 5.53 Favored Glycine 0 C--O 1.212 -1.27 0 CA-C-O 117.065 -1.964 . . . . 0.0 111.838 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.1 p -40.43 -34.92 0.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.172 2.189 . . . . 0.0 114.743 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -88.08 -38.03 15.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.25 . . . . 0.0 110.785 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.7 -47.63 30.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.399 1.08 . . . . 0.0 111.032 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -56.87 -40.3 75.9 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 109.763 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -59.13 -51.84 68.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.468 1.486 . . . . 0.0 111.692 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -50.74 -52.04 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.022 -0.424 . . . . 0.0 111.478 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -67.4 -23.91 65.61 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.1 81.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.368 1.467 . . . . 0.0 109.062 176.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 tt -67.24 -43.25 82.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.792 0.724 . . . . 0.0 109.7 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 179' ' ' TYR . . . -62.59 -43.3 99.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.082 0.239 . . . . 0.0 111.309 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.18 -33.68 59.32 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.065 1.346 . . . . 0.0 112.634 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -67.07 -62.91 1.19 Allowed 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -29.92 59.75 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.79 0.836 . . . . 0.0 111.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.61 -34.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.814 1.246 . . . . 0.0 112.389 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 44.49 0.63 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.178 1.37 . . . . 0.0 112.373 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -134.0 -70.3 0.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.951 0.9 . . . . 0.0 111.46 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.67 71.57 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.75 1.262 . . . . 0.0 111.784 -173.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -116.5 14.08 15.49 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.962 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.66 2.52 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.596 1.093 . . . . 0.0 113.032 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.92 -36.29 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.103 0.951 . . . . 0.0 111.012 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.47 101.76 11.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.572 1.549 . . . . 0.0 109.717 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 117.89 -48.35 0.95 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.57 1.081 . . . . 0.0 112.497 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.9 t80 50.37 38.57 18.28 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.826 1.25 . . . . 0.0 113.38 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.58 69.05 0.13 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 120.983 -1.073 . . . . 0.0 112.096 -171.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -165.06 164.43 20.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.337 1.055 . . . . 0.0 111.167 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.7 m -118.75 -33.13 4.33 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.61 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.9 m -47.49 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.594 1.557 . . . . 0.0 111.765 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.74 19.9 17.98 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 123.848 0.737 . . . . 0.0 112.283 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . . . -84.77 -55.44 4.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.47 0.708 . . . . 0.0 111.927 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.56 -27.92 68.97 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.166 170.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -53.8 52.43 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.714 0.688 . . . . 0.0 110.311 175.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.573 ' HG1' HG13 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -70.85 -37.76 73.14 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 118.595 -0.717 . . . . 0.0 112.232 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -57.83 -56.42 22.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.82 0.736 . . . . 0.0 110.834 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.0 m -68.3 -35.21 77.48 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.019 1.327 . . . . 0.0 110.389 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -62.29 -50.82 70.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.37 1.441 . . . . 0.0 111.324 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.36 -52.86 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 O-C-N 120.825 -1.172 . . . . 0.0 110.994 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.72 -18.32 62.31 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.701 -1.249 . . . . 0.0 112.38 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.84 10.22 6.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.711 1.604 . . . . 0.0 112.908 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.18 51.25 60.27 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.98 1.276 . . . . 0.0 112.307 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.08 -85.07 0.63 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.512 0.725 . . . . 0.0 111.017 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.49 -52.15 35.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 122.638 0.375 . . . . 0.0 111.646 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -149.98 -179.94 7.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.09 25.22 5.25 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.992 1.282 . . . . 0.0 112.489 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.58 168.6 10.93 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.226 1.01 . . . . 0.0 111.567 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -60.92 136.21 58.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.326 0.584 . . . . 0.0 110.403 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.94 136.34 53.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.421 1.088 . . . . 0.0 108.347 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.58 128.97 50.76 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.18 154.55 33.04 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -44.69 110.42 1.04 Allowed Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.502 0.721 . . . . 0.0 112.852 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.17 -31.75 4.58 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.508 1.472 . . . . 0.0 111.694 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.73 11.85 21.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.269 1.427 . . . . 0.0 112.606 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m 62.07 98.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 112.996 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.57 38.16 1.49 Allowed Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.914 0.769 . . . . 0.0 114.037 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 p -175.52 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.809 1.244 . . . . 0.0 111.69 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -75.62 100.41 4.6 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.007 -1.058 . . . . 0.0 111.174 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -69.87 134.92 48.99 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.762 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.07 126.3 50.43 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.58 1.552 . . . . 0.0 108.81 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -81.16 111.64 17.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.286 1.035 . . . . 0.0 110.065 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.26 179.09 4.08 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.78 0.8 . . . . 0.0 111.724 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -82.76 -55.23 4.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.115 0.566 . . . . 0.0 111.946 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -83.17 50.77 1.81 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.092 0.957 . . . . 0.0 112.14 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.1 69.7 0.84 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.269 1.414 . . . . 0.0 112.928 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -129.54 163.8 22.56 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 123.28 0.467 . . . . 0.0 112.373 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.48 131.91 42.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.49 120.41 56.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.325 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.23 113.99 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.573 HG13 ' HG1' ' A' ' 65' ' ' THR . 2.1 m -97.63 139.99 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.23 135.57 9.22 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.515 0.726 . . . . 0.0 109.058 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -76.19 150.54 33.34 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 121.809 1.672 . . . . 0.0 111.057 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.23 76.0 1.52 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.224 1.488 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.33 114.53 28.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.764 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.81 138.75 19.03 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.476 -0.765 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.56 96.28 0.54 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -44.05 -73.6 0.25 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.576 1.084 . . . . 0.0 113.988 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -80.16 49.49 1.11 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.033 1.733 . . . . 0.0 112.302 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.69 95.9 0.13 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.614 1.102 . . . . 0.0 112.038 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -68.48 26.63 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.55 1.54 . . . . 0.0 114.319 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -88.35 130.0 35.26 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.318 1.447 . . . . 0.0 109.551 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -99.59 132.25 45.05 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.927 0.891 . . . . 0.0 108.648 172.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -107.8 89.28 0.57 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.459 1.028 . . . . 0.0 111.395 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -70.74 120.41 16.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.385 -1.656 . . . . 0.0 111.607 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.6 p -108.63 110.71 22.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.67 1.224 . . . . 0.0 111.428 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.8 mt -117.36 105.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 O-C-N 120.94 -1.1 . . . . 0.0 108.25 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -74.85 139.94 43.53 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.976 171.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -131.38 122.5 26.44 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -136.29 110.13 8.16 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.796 -0.565 . . . . 0.0 110.61 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.03 -31.47 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.551 1.54 . . . . 0.0 113.058 -173.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.2 m -50.89 109.47 1.36 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.138 1.375 . . . . 0.0 109.878 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.62 -169.55 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.044 2.496 . . . . 0.0 110.692 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -33.93 69.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.646 -1.284 . . . . 0.0 113.413 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.4 p -65.99 -48.13 72.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.528 1.058 . . . . 0.0 111.222 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.45 -34.05 63.06 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.507 0.723 . . . . 0.0 111.144 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.3 t -49.62 -31.46 10.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.445 -1.409 . . . . 0.0 111.099 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.36 -54.98 6.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 124.434 1.093 . . . . 0.0 112.239 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -46.61 72.4 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.007 1.276 . . . . 0.0 113.96 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.1 mm -56.37 -38.81 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.638 1.575 . . . . 0.0 110.701 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -74.12 -39.67 63.19 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.362 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.4 m -58.45 -35.76 72.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.56 1.527 . . . . 0.0 111.768 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.44 -32.14 28.79 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.833 -0.542 . . . . 0.0 112.122 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 40.9 tpp -78.65 -19.93 51.46 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 118.213 1.007 . . . . 0.0 111.41 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.413 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 17.9 p -77.54 -20.5 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.408 -1.432 . . . . 0.0 111.695 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -41.44 93.61 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.069 0.948 . . . . 0.0 112.037 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.3 t -162.1 62.36 0.23 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.34 -77.78 0.15 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.3 143.83 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.408 1.004 . . . . 0.0 111.455 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.3 p -41.92 111.2 0.21 Allowed 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.632 -1.511 . . . . 0.0 112.804 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 p -145.02 28.49 1.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.228 1.811 . . . . 0.0 110.529 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.05 45.76 94.86 Favored Glycine 0 CA--C 1.523 0.542 0 O-C-N 121.276 -0.89 . . . . 0.0 113.102 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.5 mt -83.48 112.52 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.66 0.784 . . . . 0.0 109.947 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -115.63 97.36 6.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.044 0.938 . . . . 0.0 109.108 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 88.1 mt -73.95 164.66 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.203 0.601 . . . . 0.0 109.53 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -47.15 116.34 1.36 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.71 25.33 6.73 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 123.632 0.634 . . . . 0.0 114.156 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -131.61 37.35 3.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.617 2.767 . . . . 0.0 107.818 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -36.98 90.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.086 1.755 . . . . 0.0 112.924 167.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -142.03 -174.6 4.14 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.36 1.464 . . . . 0.0 109.065 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.6 p -146.68 -41.8 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -85.87 8.98 18.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.944 2.097 . . . . 0.0 113.864 168.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.08 136.67 8.45 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.173 0.987 . . . . 0.0 110.448 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 100.31 4.71 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.643 1.211 . . . . 0.0 108.443 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.8 t -117.79 119.77 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.512 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 134' ' ' SER . 0.6 OUTLIER -108.24 179.92 4.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.346 -174.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.9 62.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.824 -0.548 . . . . 0.0 111.599 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.07 -35.65 80.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.339 0.655 . . . . 0.0 112.287 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.87 -52.52 22.19 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.47 67.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.5 1.046 . . . . 0.0 111.934 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.7 m -63.92 -43.98 94.28 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.531 -0.731 . . . . 0.0 111.648 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.5 t -105.54 -56.81 2.12 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.79 67.7 2.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.412 1.885 . . . . 0.0 112.354 172.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 175.96 -56.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.671 1.988 . . . . 0.0 109.398 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.8 m -90.94 157.24 17.42 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.196 0.998 . . . . 0.0 109.159 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 71.59 -47.44 0.66 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.043 1.737 . . . . 0.0 113.422 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -76.26 42.64 0.27 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.622 1.969 . . . . 0.0 112.937 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.14 -39.16 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.293 1.437 . . . . 0.0 110.584 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.05 113.86 0.02 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.467 1.508 . . . . 0.0 112.122 -174.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 48.7 63.8 1.96 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.211 1.004 . . . . 0.0 112.013 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.9 p -54.68 125.15 18.72 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.279 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.44 -80.56 0.55 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 72.4 p -135.98 116.97 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.11 129.45 34.5 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 109.85 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.3 m -89.8 116.85 28.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.81 122.87 21.48 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.583 0.753 . . . . 0.0 109.266 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -94.06 143.75 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.05 0.54 . . . . 0.0 109.663 174.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.72 114.0 18.72 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.838 0.855 . . . . 0.0 109.642 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -99.61 118.73 36.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.039 0.936 . . . . 0.0 110.966 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 36.7 t80 -102.11 103.54 14.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.442 0.697 . . . . 0.0 110.955 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -71.94 136.25 46.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.957 0.503 . . . . 0.0 110.838 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.275 0 CA-C-O 117.581 -1.677 . . . . 0.0 113.095 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -170.68 155.89 5.02 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.534 1.134 . . . . 0.0 109.19 172.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.91 -169.57 45.41 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 121.536 0.52 . . . . 0.0 112.001 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.36 -82.14 0.54 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.098 0.959 . . . . 0.0 110.133 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -141.45 -178.49 5.65 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.925 1.69 . . . . 0.0 110.935 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -34.44 75.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.161 0.985 . . . . 0.0 112.916 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -103.02 -29.55 11.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.292 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.48 -32.2 5.33 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.918 0.77 . . . . 0.0 112.833 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -42.2 21.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.114 1.766 . . . . 0.0 113.852 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -68.2 -36.17 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.654 -1.279 . . . . 0.0 113.114 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.85 -48.2 66.8 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.551 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.0 p -64.78 -38.61 91.58 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.943 0.897 . . . . 0.0 110.828 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -58.51 -51.85 68.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.639 1.176 . . . . 0.0 111.17 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 177' ' ' PHE . 10.9 t80 -56.47 -48.26 77.47 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.171 -0.955 . . . . 0.0 112.075 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -26.54 68.58 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -42.12 88.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.459 1.104 . . . . 0.0 109.971 173.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.56 -44.99 92.5 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 117.582 -1.199 . . . . 0.0 108.918 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.75 92.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.159 0.891 . . . . 0.0 111.368 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -38.17 69.27 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.195 -0.94 . . . . 0.0 112.837 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -69.22 -57.0 5.94 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -51.98 -30.9 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.57 1.548 . . . . 0.0 112.008 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.17 -25.46 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.157 1.383 . . . . 0.0 113.373 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.41 25.5 1.85 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.67 1.605 . . . . 0.0 113.617 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -157.8 0.63 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.319 1.048 . . . . 0.0 110.489 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.08 52.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.307 1.843 . . . . 0.0 113.577 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -115.25 -60.69 1.85 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.91 1.284 . . . . 0.0 111.255 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.06 0.66 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.572 1.082 . . . . 0.0 111.03 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.96 52.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.665 1.586 . . . . 0.0 108.64 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.24 -56.83 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.249 -0.907 . . . . 0.0 111.096 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.58 -57.83 0.5 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.926 1.25 . . . . 0.0 111.77 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -156.85 41.16 0.34 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.395 1.078 . . . . 0.0 112.284 -172.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.26 157.09 3.77 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.192 -0.942 . . . . 0.0 112.603 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.94 111.03 15.88 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.848 0.859 . . . . 0.0 110.543 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.7 m 62.93 134.94 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.178 1.466 . . . . 0.0 112.012 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.5 p -133.91 76.03 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 O-C-N 120.579 -1.326 . . . . 0.0 108.783 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -159.47 -61.41 0.01 OUTLIER Glycine 0 N--CA 1.47 0.911 0 CA-C-O 119.103 -0.831 . . . . 0.0 113.828 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.49 -75.87 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.415 1.108 . . . . 0.0 112.334 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -32.69 70.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.81 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.1 ttp -57.37 -40.57 78.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.903 1.281 . . . . 0.0 111.789 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -72.0 -47.36 52.5 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.843 174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -50.09 -49.42 51.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.666 1.121 . . . . 0.0 111.314 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -68.32 -46.63 69.73 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.646 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.43 -42.02 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.199 0.909 . . . . 0.0 110.512 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 121.188 -0.945 . . . . 0.0 110.573 175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -61.39 -23.55 65.87 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.698 -0.626 . . . . 0.0 111.97 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.8 -3.47 28.75 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.374 1.47 . . . . 0.0 113.439 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.5 50.38 9.8 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.943 1.735 . . . . 0.0 112.487 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.32 -88.75 0.61 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.424 0.689 . . . . 0.0 112.271 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.56 83.43 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 122.94 0.496 . . . . 0.0 111.716 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -160.61 146.89 15.19 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 125.169 1.387 . . . . 0.0 109.586 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.11 55.4 1.13 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.655 1.121 . . . . 0.0 112.824 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 -179.87 5.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.632 1.173 . . . . 0.0 112.349 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.14 141.9 41.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.32 0.581 . . . . 0.0 110.579 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.44 152.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.491 1.116 . . . . 0.0 109.058 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.57 122.04 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.256 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.73 101.05 2.7 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -56.25 109.78 1.9 Allowed Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.825 0.85 . . . . 0.0 110.992 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.22 -25.0 14.01 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.77 -13.39 59.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.484 1.114 . . . . 0.0 112.661 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.08 75.39 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.344 1.458 . . . . 0.0 111.755 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.03 -53.57 0.07 OUTLIER Glycine 0 N--CA 1.465 0.609 0 C-N-CA 124.135 0.874 . . . . 0.0 111.574 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.7 t -172.16 122.95 0.48 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.122 0.969 . . . . 0.0 111.51 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.56 126.03 28.05 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.498 1.142 . . . . 0.0 110.551 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 p -95.83 138.45 33.46 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.027 -1.045 . . . . 0.0 108.747 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.76 121.19 42.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.54 124.63 29.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.697 0.799 . . . . 0.0 110.815 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.02 109.2 22.01 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -54.84 -53.27 57.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.43 0.692 . . . . 0.0 112.358 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -107.26 47.26 0.89 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 110.634 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.22 -142.16 3.32 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.261 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -114.4 -121.3 3.57 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 124.318 0.961 . . . . 0.0 111.516 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -131.15 148.66 52.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.763 0.792 . . . . 0.0 110.397 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.13 149.93 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.229 1.411 . . . . 0.0 108.561 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.98 113.03 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.51 114.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 122.368 1.08 . . . . 0.0 108.869 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.68 138.34 31.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 O-C-N 120.473 -1.392 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.98 154.05 47.54 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.078 1.185 . . . . 0.0 110.731 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.34 68.42 1.14 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 123.432 1.586 . . . . 0.0 110.021 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 p -86.78 169.54 12.52 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.117 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.8 145.95 33.74 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 110.451 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.26 38.0 3.27 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.542 1.068 . . . . 0.0 111.9 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.37 -132.23 0.06 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.371 1.462 . . . . 0.0 112.372 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.2 t -136.37 33.95 2.77 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 123.195 1.474 . . . . 0.0 111.962 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.1 -158.25 10.04 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.614 1.102 . . . . 0.0 111.404 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -154.37 26.01 0.46 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.056 1.342 . . . . 0.0 111.871 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -97.61 111.37 23.67 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -56.78 131.09 48.29 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.01 115.31 4.44 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -117.5 144.85 44.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.882 0.873 . . . . 0.0 110.333 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -134.98 113.32 11.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.444 1.116 . . . . 0.0 111.0 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.0 mt -115.58 108.89 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.409 ' CB ' HG22 ' A' ' 176' ' ' VAL . 0.7 OUTLIER -78.2 142.09 38.18 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.246 173.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -134.81 125.92 27.84 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.35 98.34 4.85 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -38.87 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.465 1.106 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.5 m -52.62 104.33 0.43 Allowed Pre-proline 0 C--N 1.342 0.256 0 O-C-N 125.304 1.627 . . . . 0.0 108.249 -173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -74.35 -168.08 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.604 1.536 . . . . 0.0 110.097 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.04 -29.42 65.33 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.118 -0.989 . . . . 0.0 112.502 174.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.2 p -71.73 -40.96 69.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.783 1.174 . . . . 0.0 112.429 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.75 49.97 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.5 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.5 -30.85 13.84 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.037 1.289 . . . . 0.0 109.995 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.1 t -78.39 -57.87 4.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 123.642 0.777 . . . . 0.0 111.536 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.8 m -55.91 -25.09 41.31 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.63 -47.84 16.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 C-N-CA 126.215 1.806 . . . . 0.0 110.228 170.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.7 m -58.44 -30.4 66.89 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 121.191 1.814 . . . . 0.0 111.846 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.1 t -86.5 -49.03 7.88 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.098 -1.001 . . . . 0.0 112.044 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.94 91.85 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -33.51 76.1 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 118.555 1.177 . . . . 0.0 110.736 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.34 -20.47 19.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -26.85 65.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.262 1.025 . . . . 0.0 113.296 172.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.5 t -159.03 46.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.451 1.9 . . . . 0.0 110.856 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.3 -86.59 1.72 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.58 49.41 1.81 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 125.67 1.605 . . . . 0.0 114.785 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.5 m 63.96 142.86 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.657 1.583 . . . . 0.0 112.224 -172.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.95 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.841 -1.162 . . . . 0.0 111.257 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.37 48.52 0.04 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 124.531 1.063 . . . . 0.0 112.269 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.1 mt -89.42 102.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -91.87 98.99 11.93 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 122.957 0.503 . . . . 0.0 109.713 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -73.26 141.23 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 123.584 0.753 . . . . 0.0 109.8 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -47.61 119.99 3.07 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.383 -0.823 . . . . 0.0 111.612 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.06 -45.87 1.45 Allowed Glycine 0 CA--C 1.541 1.697 0 O-C-N 120.056 -1.653 . . . . 0.0 114.882 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.48 38.84 0.8 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.347 1.859 . . . . 0.0 111.242 170.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -51.35 95.76 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.968 1.307 . . . . 0.0 110.655 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -118.36 -168.77 1.58 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.099 1.359 . . . . 0.0 108.96 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -139.84 -40.11 0.45 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.723 0.809 . . . . 0.0 110.783 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.52 17.45 6.32 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.1 1.76 . . . . 0.0 114.026 169.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -46.01 126.1 7.07 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.587 0.708 . . . . 0.0 110.326 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -113.64 85.49 2.21 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.594 1.187 . . . . 0.0 107.865 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.23 121.47 63.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.399 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.1 p -131.41 -179.79 5.57 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.809 1.644 . . . . 0.0 110.914 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.35 85.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.57 1.532 . . . . 0.0 114.136 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -58.54 -41.64 86.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.241 0.616 . . . . 0.0 110.765 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.84 19.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 122.817 0.447 . . . . 0.0 111.039 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.79 -55.29 17.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 p -69.53 -29.33 66.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -66.8 -61.07 2.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.871 0.868 . . . . 0.0 111.065 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 167.06 92.57 0.0 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 129.381 3.072 . . . . 0.0 108.421 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 32.0 p -41.8 143.37 0.53 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.0 m -48.9 152.9 0.94 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.428 0.691 . . . . 0.0 109.793 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 63.57 131.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.33 1.452 . . . . 0.0 113.673 -168.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.68 145.08 50.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.206 1.002 . . . . 0.0 110.776 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -160.63 39.99 0.16 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.892 0.877 . . . . 0.0 111.407 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 52.34 -91.69 0.01 OUTLIER Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.141 1.353 . . . . 0.0 113.081 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -104.06 81.79 1.89 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.559 1.544 . . . . 0.0 111.503 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.8 p -70.05 126.84 30.85 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.749 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -98.68 -46.43 2.12 Favored Glycine 0 N--CA 1.469 0.886 0 O-C-N 121.628 -0.67 . . . . 0.0 111.758 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.0 m -128.83 89.45 2.88 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.33 1.052 . . . . 0.0 108.967 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -79.59 102.49 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.87 0.868 . . . . 0.0 109.057 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.8 m -68.94 105.26 2.33 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.62 1.168 . . . . 0.0 109.879 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.97 112.41 16.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.409 HG22 ' CB ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -85.6 137.05 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.422 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 13.0 m-85 -111.86 117.98 34.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -107.9 145.14 34.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 109.727 173.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -142.65 109.01 5.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.696 1.198 . . . . 0.0 109.154 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -100.09 98.19 8.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.539 1.136 . . . . 0.0 109.549 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 124.849 1.214 . . . . 0.0 113.633 178.276 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 175.73 166.02 0.37 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.558 1.943 . . . . 0.0 110.351 177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.4 108.48 0.44 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -146.86 109.19 4.49 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.594 1.157 . . . . 0.0 109.636 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm 62.31 166.91 0.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.896 1.679 . . . . 0.0 112.088 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.57 -48.33 14.0 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.422 -0.799 . . . . 0.0 111.121 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -75.72 -39.98 56.39 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.643 0.777 . . . . 0.0 110.96 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.61 -27.06 0.8 Allowed Glycine 0 C--O 1.216 -0.984 0 CA-C-O 116.326 -2.375 . . . . 0.0 113.311 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -38.55 -48.26 1.4 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.485 2.142 . . . . 0.0 114.341 166.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -30.35 60.51 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.782 -1.199 . . . . 0.0 112.207 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.6 -50.23 18.66 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.046 0.939 . . . . 0.0 111.065 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 t -58.55 -45.16 89.52 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.48 1.112 . . . . 0.0 110.468 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -60.96 -49.68 76.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.309 0.958 . . . . 0.0 112.094 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -59.74 3.68 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.467 0.707 . . . . 0.0 111.348 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -59.6 -27.37 66.24 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 118.805 -0.616 . . . . 0.0 110.795 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -46.56 67.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.745 1.218 . . . . 0.0 111.393 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 tp -54.65 -44.66 73.44 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 179' ' ' TYR . . . -69.54 -43.48 72.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.6 -15.04 63.4 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.981 1.712 . . . . 0.0 112.709 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -95.47 -52.03 4.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -22.41 2.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.974 0.909 . . . . 0.0 111.84 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.1 pt -41.8 -41.99 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.634 1.174 . . . . 0.0 113.012 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.8 21.46 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.279 0.943 . . . . 0.0 114.375 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.09 -55.38 5.79 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.22 1.008 . . . . 0.0 109.422 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.71 21.16 0.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HZ2' ' ND2' ' A' ' 112' ' ' ASN . 2.1 ttpp -96.52 80.83 3.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.254 -1.529 . . . . 0.0 110.038 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 44.64 49.47 8.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.595 1.184 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.21 -73.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.718 0.807 . . . . 0.0 110.384 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.06 98.7 2.14 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.528 1.131 . . . . 0.0 109.915 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.26 144.26 9.29 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.573 1.082 . . . . 0.0 111.632 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -52.18 111.78 0.68 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.013 0.925 . . . . 0.0 112.069 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.94 100.09 7.92 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.209 0.603 . . . . 0.0 109.41 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -65.55 178.68 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 122.418 1.104 . . . . 0.0 112.258 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -52.68 177.89 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.481 1.512 . . . . 0.0 112.12 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m 60.88 60.17 1.92 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.465 -0.772 . . . . 0.0 109.667 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.97 46.42 0.22 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.064 1.792 . . . . 0.0 114.063 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.43 -63.26 1.33 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.351 1.86 . . . . 0.0 110.276 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -38.35 66.0 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.269 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -59.77 -51.38 69.99 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 112.342 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -36.8 84.5 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.414 -0.327 . . . . 0.0 111.625 175.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -51.52 69.72 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.919 0.887 . . . . 0.0 110.441 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 p -68.18 -35.35 77.88 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 111.384 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -50.08 68.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.791 1.178 . . . . 0.0 110.708 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.4 mt -63.14 -50.58 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.893 -1.129 . . . . 0.0 110.061 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -60.78 -32.67 72.0 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.096 -1.002 . . . . 0.0 112.321 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.42 65.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.82 0.848 . . . . 0.0 112.848 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.79 4.81 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 124.998 1.285 . . . . 0.0 112.397 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.07 -64.01 1.08 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.59 -63.18 1.38 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.917 0.389 . . . . 0.0 110.247 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -132.61 -170.66 2.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.02 1.328 . . . . 0.0 109.062 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -140.59 16.71 2.87 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.26 0.933 . . . . 0.0 112.831 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.9 ttt -92.58 171.36 9.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.384 1.074 . . . . 0.0 111.329 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.41 141.81 53.75 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.346 0.593 . . . . 0.0 110.603 174.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.89 148.18 21.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 108.583 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.32 130.48 53.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.053 0.541 . . . . 0.0 110.08 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.03 130.71 9.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -114.34 101.61 54.27 Favored Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 124.365 1.066 . . . . 0.0 108.541 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -74.33 -35.82 3.6 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.766 2.31 . . . . 0.0 112.197 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.01 66.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.996 0.918 . . . . 0.0 112.125 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -59.86 1.76 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.916 0.886 . . . . 0.0 111.838 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.27 24.52 7.49 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.819 1.676 . . . . 0.0 113.582 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -135.06 88.33 2.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.647 1.579 . . . . 0.0 108.462 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.94 151.43 11.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.833 0.825 . . . . 0.0 111.686 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.0 p -129.06 147.17 50.9 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.719 0.808 . . . . 0.0 108.959 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -127.37 122.22 33.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.716 0.77 . . . . 0.0 109.265 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -80.84 120.82 25.18 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.491 0.716 . . . . 0.0 110.309 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -76.28 132.33 39.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.559 . . . . 0.0 109.861 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t -54.38 -47.64 72.43 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.9 0.48 . . . . 0.0 111.723 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -140.24 76.1 1.54 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 110.591 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.8 -103.23 0.16 Allowed Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.232 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.81 -119.77 0.91 Allowed Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.77 154.81 48.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 122.649 1.214 . . . . 0.0 110.744 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.4 mt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 125.473 1.509 . . . . 0.0 107.789 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.33 116.13 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 125.08 1.352 . . . . 0.0 107.371 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.6 124.84 52.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.98 145.52 22.65 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.513 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -77.31 154.56 32.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 121.912 1.742 . . . . 0.0 111.213 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.58 74.79 1.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.03 1.732 . . . . 0.0 110.641 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -111.94 140.84 46.28 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.829 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.26 107.46 3.6 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.223 0.609 . . . . 0.0 110.052 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.52 66.87 1.81 Allowed Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.81 138.62 14.34 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.739 0.685 . . . . 0.0 111.893 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 p -145.99 -71.04 0.25 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.203 1.001 . . . . 0.0 111.327 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.8 46.77 0.64 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.128 1.346 . . . . 0.0 111.879 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.87 170.91 15.01 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.425 1.49 . . . . 0.0 111.603 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.82 162.74 3.84 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.003 0.906 . . . . 0.0 111.843 170.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.436 ' ND2' ' HZ2' ' A' ' 51' ' ' LYS . 12.3 p30 -91.02 169.08 11.17 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.152 173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.48 113.1 4.16 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.83 145.39 27.02 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 174.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.5 p -131.57 107.08 8.61 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.838 1.304 . . . . 0.0 110.929 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.21 106.98 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.3 OUTLIER -71.73 135.23 46.7 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.61 0.764 . . . . 0.0 109.545 171.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.6 p -134.39 120.04 19.35 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.67 119.24 26.5 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.72 -0.612 . . . . 0.0 109.697 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.55 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.857 1.663 . . . . 0.0 112.731 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.18 103.03 0.33 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.396 1.878 . . . . 0.0 109.844 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -75.17 -167.83 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.384 2.056 . . . . 0.0 110.776 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -22.08 65.31 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.745 -1.222 . . . . 0.0 113.549 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.8 p -78.16 -52.0 9.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.917 0.887 . . . . 0.0 110.321 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.61 -21.62 61.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.668 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -52.6 -32.37 41.05 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.697 -1.252 . . . . 0.0 110.187 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.91 -41.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.135 1.374 . . . . 0.0 111.872 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.454 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 19.3 m -59.75 -34.8 73.44 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 119.903 -1.748 . . . . 0.0 113.152 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.72 -34.5 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.6 p -63.85 -41.98 97.68 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 120.753 1.615 . . . . 0.0 112.431 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.4 t -77.07 -39.51 49.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.753 0.821 . . . . 0.0 111.34 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.24 -38.29 71.77 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 5.3 ttm -83.03 -32.21 27.01 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 110.282 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.8 t -62.9 -26.65 68.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.659 1.572 . . . . 0.0 112.413 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -62.74 -26.87 68.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -154.75 46.77 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.68 -83.0 1.71 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 40.5 58.84 2.43 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.76 1.171 . . . . 0.0 113.222 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 151' ' ' ASP . 3.7 m 70.17 135.06 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.4 1.48 . . . . 0.0 111.727 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 p 179.77 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.061 -1.024 . . . . 0.0 111.696 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.01 49.49 23.58 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.42 1.01 . . . . 0.0 113.499 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 2.7 mt -92.07 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.397 0.617 . . . . 0.0 109.999 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -89.3 94.13 9.79 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.037 -0.414 . . . . 0.0 110.449 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.0 mt -70.62 144.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.373 1.069 . . . . 0.0 110.467 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -48.33 118.55 2.5 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.01 -48.32 1.69 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.935 0.778 . . . . 0.0 113.466 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.43 36.83 0.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.438 1.895 . . . . 0.0 112.141 172.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -54.22 96.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.565 1.146 . . . . 0.0 110.019 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -119.64 -169.13 1.71 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.378 1.471 . . . . 0.0 109.772 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -134.67 -40.59 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.581 0.753 . . . . 0.0 110.866 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.415 ' HA ' HG22 ' A' ' 139' ' ' THR . 5.8 p-10 -91.63 17.81 8.32 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.304 1.842 . . . . 0.0 113.863 170.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 142' ' ' ILE . . . -42.77 130.22 4.18 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.628 0.728 . . . . 0.0 111.574 174.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 77.8 1.81 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.328 1.061 . . . . 0.0 109.044 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.1 t -98.68 135.84 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.522 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.2 167.03 22.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.813 1.245 . . . . 0.0 110.673 -172.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.83 -34.98 63.45 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.963 -0.461 . . . . 0.0 111.977 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.31 -44.11 22.27 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.073 1.349 . . . . 0.0 110.586 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -52.55 59.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.579 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.6 71.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.016 0.825 . . . . 0.0 111.228 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -45.68 71.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.263 0.625 . . . . 0.0 111.619 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.0 t -85.25 -55.9 3.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.515 0.726 . . . . 0.0 111.937 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -52.18 -57.8 8.52 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.531 2.332 . . . . 0.0 112.756 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 52.9 m -79.06 77.29 5.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.193 0.997 . . . . 0.0 109.386 170.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.3 m -62.59 157.15 21.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.706 1.202 . . . . 0.0 110.44 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.99 -29.93 69.97 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.71 155.1 1.2 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.286 1.035 . . . . 0.0 111.228 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.5 m120 55.07 79.73 0.14 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.403 0.681 . . . . 0.0 110.455 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -41.7 -39.09 2.49 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 124.374 0.988 . . . . 0.0 114.019 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.49 87.56 2.74 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.201 1.8 . . . . 0.0 109.351 167.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.1 p -50.59 152.99 1.77 Allowed 'General case' 0 C--O 1.24 0.574 0 O-C-N 121.118 -0.989 . . . . 0.0 110.431 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -48.21 160.41 0.57 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.379 0.433 . . . . 0.0 112.085 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 60.3 p -43.07 126.72 4.04 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.493 1.117 . . . . 0.0 110.982 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.43 87.4 3.39 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.725 -1.235 . . . . 0.0 108.812 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.5 m -83.53 125.13 31.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.12 102.32 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.831 1.252 . . . . 0.0 108.146 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -76.5 131.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -107.59 111.87 24.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.063 0.545 . . . . 0.0 109.907 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.28 106.35 18.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.018 0.913 . . . . 0.0 110.335 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.432 ' CG ' ' HB3' ' A' ' 43' ' ' ALA . 90.5 t80 -86.49 110.33 19.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 110.362 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -123.72 145.51 48.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.76 1.224 . . . . 0.0 109.893 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.217 0 C-N-CA 124.438 1.018 . . . . 0.0 113.122 176.377 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.51 ' HB1' ' CD1' ' A' ' 129' ' ' ILE . . . -95.51 -35.74 11.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.366 1.066 . . . . 0.0 110.932 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -30.25 10.35 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 124.271 0.938 . . . . 0.0 113.205 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -39.89 -47.1 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.012 1.325 . . . . 0.0 113.891 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.32 -39.0 59.97 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.239 0.927 . . . . 0.0 112.449 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 129' ' ' ILE . 10.9 mt -58.4 -47.78 82.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.361 0.6 . . . . 0.0 110.394 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 p -66.48 -37.69 85.66 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 117.669 -1.158 . . . . 0.0 110.725 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -59.06 -54.55 45.81 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.274 1.397 . . . . 0.0 112.203 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' A' ' 118' ' ' THR . 15.5 m-30 -57.13 -46.22 82.87 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.011 -1.055 . . . . 0.0 111.339 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.4 -27.48 68.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.516 0.726 . . . . 0.0 112.619 173.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -49.34 71.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.671 1.188 . . . . 0.0 108.861 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 116' ' ' ILE . 3.2 tt -61.99 -40.55 96.04 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 118.933 0.788 . . . . 0.0 109.669 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -62.4 -42.85 99.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.726 0.694 . . . . 0.0 111.895 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -33.12 47.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.126 0.97 . . . . 0.0 113.121 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -70.31 -64.04 0.97 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.224 -0.922 . . . . 0.0 108.523 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.87 -21.18 27.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.801 1.24 . . . . 0.0 112.64 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -44.93 -33.26 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.196 0.999 . . . . 0.0 111.98 171.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.04 50.93 0.2 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.68 1.134 . . . . 0.0 112.868 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.5 tpt -113.71 -63.82 1.4 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.694 0.798 . . . . 0.0 111.121 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.44 34.32 0.46 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.693 1.197 . . . . 0.0 112.357 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 31.48 0.27 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.637 1.175 . . . . 0.0 113.165 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.16 49.14 2.29 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.245 0.926 . . . . 0.0 112.108 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.482 1.13 0 C-N-CA 125.737 1.615 . . . . 0.0 110.456 176.918 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.713 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -107.17 -62.75 1.37 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.052 0.941 . . . . 0.0 113.018 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -25.58 60.05 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.372 172.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mtp -53.47 -57.14 11.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.908 0.883 . . . . 0.0 111.867 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.512 HG23 HD12 ' A' ' 69' ' ' ILE . 1.1 m -69.73 -40.12 76.39 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.37 176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.42 ' HA ' HG21 ' A' ' 79' ' ' VAL . 19.2 t70 -50.73 -47.24 59.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -70.16 -42.33 72.65 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.0 111.14 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tp -59.27 -51.44 69.95 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.889 1.222 . . . . 0.0 112.014 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.563 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -61.12 -52.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 120.766 -1.209 . . . . 0.0 110.015 177.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -62.27 -23.58 66.78 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.907 -1.121 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -2.9 23.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 113.796 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.65 78.88 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.089 1.804 . . . . 0.0 112.886 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.11 -76.9 0.24 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 117.73 0.765 . . . . 0.0 111.289 -177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.39 -50.66 36.33 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 111.8 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.45 132.42 8.78 Favored 'General case' 0 C--O 1.211 -0.926 0 C-N-CA 124.703 1.201 . . . . 0.0 109.85 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.63 59.37 4.6 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 119.419 1.008 . . . . 0.0 113.251 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.06 176.73 7.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.102 0.961 . . . . 0.0 112.475 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.16 147.64 38.34 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.705 -0.622 . . . . 0.0 110.685 172.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.563 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.3 t -121.23 157.51 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 109.007 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.9 OUTLIER -107.38 101.93 11.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.74 112.91 4.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -35.92 115.79 0.6 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.603 1.161 . . . . 0.0 113.341 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -71.49 -18.14 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.301 1.334 . . . . 0.0 112.026 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.33 -4.79 41.42 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.86 1.264 . . . . 0.0 113.262 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 86.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.133 1.373 . . . . 0.0 113.057 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.77 -40.57 0.02 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.182 -0.949 . . . . 0.0 114.136 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 p -158.37 114.31 2.71 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.307 1.443 . . . . 0.0 111.638 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.713 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -60.66 161.38 7.86 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 122.743 1.258 . . . . 0.0 111.811 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 80' ' ' SER . 3.7 t -135.85 127.46 28.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.528 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.465 HD23 HD13 ' A' ' 69' ' ' ILE . 2.0 tm? -99.41 136.75 38.89 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.304 1.05 . . . . 0.0 109.403 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -93.26 104.64 16.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.574 1.15 . . . . 0.0 110.651 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.31 112.09 23.54 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.319 0.648 . . . . 0.0 110.168 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -57.86 5.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.641 -0.662 . . . . 0.0 111.815 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -68.03 -46.21 71.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.128 0.571 . . . . 0.0 112.002 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.84 -123.08 0.11 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.337 0.97 . . . . 0.0 111.923 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -143.65 -98.09 0.26 Allowed Glycine 0 N--CA 1.465 0.596 0 O-C-N 122.093 -0.651 . . . . 0.0 112.266 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.53 149.29 52.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.062 0.934 . . . . 0.0 110.261 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 mt -130.63 145.24 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.362 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.633 ' HB ' HG22 ' A' ' 117' ' ' THR . 21.9 t -132.27 109.59 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.512 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 1.9 m -94.93 122.0 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.54 131.74 11.95 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.054 -1.029 . . . . 0.0 109.446 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.5 152.4 43.37 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.179 1.253 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -145.82 66.85 1.21 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.476 1.911 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.9 p -100.14 97.96 8.72 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.319 1.057 . . . . 0.0 109.251 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.329 0 O-C-N 120.849 -1.157 . . . . 0.0 110.84 -177.866 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.626 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.33 135.81 48.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.258 1.529 . . . . 0.0 109.033 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.7 p -122.06 116.77 24.86 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.463 ' CD1' HD22 ' A' ' 42' ' ' LEU . 16.2 mt -124.41 104.5 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.633 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.8 OUTLIER -75.84 142.55 42.18 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.248 173.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 39' ' ' TYR . 2.6 p -140.66 128.28 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.87 0.843 . . . . 0.0 108.989 -177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.72 99.6 4.67 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -172.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.514 1.126 . . . . 0.0 112.393 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.2 t -48.61 101.95 0.29 Allowed Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 127.001 2.12 . . . . 0.0 109.09 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 28.8 Cg_endo -73.13 -171.21 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.773 1.649 . . . . 0.0 110.758 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.4 tm0? -59.81 -44.25 94.08 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.944 -1.097 . . . . 0.0 112.544 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 p -56.54 -42.4 78.45 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.051 -1.03 . . . . 0.0 112.002 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -78.97 -29.37 43.84 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.057 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -30.41 14.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.895 1.68 . . . . 0.0 110.496 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.42 -55.78 6.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 125.451 1.5 . . . . 0.0 111.335 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 31.2 m -57.64 -48.73 78.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.778 1.172 . . . . 0.0 113.327 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.613 HG23 HD21 ' A' ' 36' ' ' LEU . 36.6 mm -56.13 -47.2 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 C-N-CA 125.615 1.566 . . . . 0.0 110.981 171.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -62.92 -45.69 91.31 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.167 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 m -51.01 -42.47 60.44 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 111.365 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.06 -39.23 33.07 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 121.933 -0.479 . . . . 0.0 113.137 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 11.4 ttm -67.85 -20.5 65.15 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.467 -1.608 . . . . 0.0 112.466 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 -28.17 57.44 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.753 1.221 . . . . 0.0 111.888 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -16.14 63.34 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 112.836 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.08 46.94 0.92 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.386 1.474 . . . . 0.0 110.716 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -35.58 -64.88 0.49 Allowed Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.571 1.558 . . . . 0.0 113.293 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 17.78 75.59 0.01 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 127.308 2.385 . . . . 0.0 113.355 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 151' ' ' ASP . 20.4 p -51.54 167.2 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.897 1.679 . . . . 0.0 112.466 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -33.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.502 -0.749 . . . . 0.0 111.812 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 170.79 51.0 0.04 OUTLIER Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.636 0.636 . . . . 0.0 112.891 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.4 mt -86.84 113.42 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -119.46 103.15 9.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 108.362 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.87 166.95 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -51.9 119.18 4.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.008 1.323 . . . . 0.0 112.675 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.28 27.44 5.53 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.484 0.564 . . . . 0.0 113.909 -173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.72 32.85 4.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.877 2.071 . . . . 0.0 109.024 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -36.62 98.96 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.114 1.366 . . . . 0.0 111.129 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -142.42 -174.07 4.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.456 1.502 . . . . 0.0 108.691 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.409 HG22 ' HA2' ' A' ' 141' ' ' GLY . 4.7 p -147.98 -46.48 0.16 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.212 -0.93 . . . . 0.0 109.107 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.433 ' HA ' HG21 ' A' ' 139' ' ' THR . 28.1 m-20 -83.52 18.56 1.82 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.591 1.556 . . . . 0.0 112.881 172.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.06 111.6 2.26 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.417 -0.802 . . . . 0.0 110.717 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 105.75 17.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.487 ' HA ' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -111.91 129.26 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.763 1.225 . . . . 0.0 110.027 -176.148 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 175.2 9.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.794 1.238 . . . . 0.0 110.945 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.96 39.76 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.785 -0.572 . . . . 0.0 112.473 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -61.27 -33.15 73.07 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.654 0.782 . . . . 0.0 111.969 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.487 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -70.19 -51.39 39.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.588 176.34 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.98 66.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 119.192 0.905 . . . . 0.0 112.138 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -28.96 68.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.751 0.821 . . . . 0.0 112.648 171.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.94 -48.95 3.49 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.135 1.374 . . . . 0.0 112.838 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--O 1.233 0.22 0 C-N-CA 126.449 1.9 . . . . 0.0 111.307 177.287 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.7 p . . . . . 0 C--O 1.24 0.57 0 CA-C-O 120.445 0.164 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -45.53 146.7 2.32 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 122.98 0.324 . . . . 0.0 112.295 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 20.1 p -46.59 118.62 2.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.019 1.328 . . . . 0.0 111.567 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.17 85.2 6.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 122.405 1.097 . . . . 0.0 109.182 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 m -75.13 116.04 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.316 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.1 119.0 23.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.634 0.774 . . . . 0.0 109.204 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -93.74 128.81 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.065 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -103.11 127.63 50.31 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.04 139.45 46.39 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.287 0.635 . . . . 0.0 110.283 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.465 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -130.57 111.82 12.59 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.274 1.029 . . . . 0.0 110.234 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.64 142.39 27.67 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.137 0.575 . . . . 0.0 110.896 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 C-N-CA 124.462 1.03 . . . . 0.0 112.697 -177.377 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.39 -35.91 9.04 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.693 1.197 . . . . 0.0 112.05 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.03 -29.87 9.05 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 117.863 -1.521 . . . . 0.0 111.908 170.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -49.54 -38.59 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.197 1.399 . . . . 0.0 112.779 171.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -79.82 -38.17 33.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.145 -0.972 . . . . 0.0 111.282 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 129' ' ' ILE . 2.1 mt -71.35 -47.29 57.32 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.411 0.624 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -60.61 -41.21 94.35 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.916 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -59.86 -46.27 89.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.764 1.62 . . . . 0.0 111.796 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -48.91 -62.68 1.39 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.933 0.893 . . . . 0.0 109.738 174.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -21.14 66.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.758 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.44 68.45 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.308 1.443 . . . . 0.0 109.483 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.54 -38.7 87.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.885 1.221 . . . . 0.0 110.011 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB1' ' CZ ' ' A' ' 179' ' ' TYR . . . -65.56 -45.95 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.36 0.664 . . . . 0.0 111.893 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -76.57 -38.84 54.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.266 1.027 . . . . 0.0 112.034 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 8.9 m120 -64.4 -56.76 12.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 t -58.35 -26.81 63.57 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.689 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.06 -26.73 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.65 53.81 0.28 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.903 1.24 . . . . 0.0 113.03 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.64 -71.49 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.184 0.994 . . . . 0.0 111.079 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.6 mmt -139.73 53.25 1.69 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.77 1.228 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -109.85 2.66 20.04 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.695 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.17 -30.3 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.213 0.911 . . . . 0.0 113.534 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.473 0.68 0 CA-C-N 118.293 1.047 . . . . 0.0 109.707 171.813 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.954 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.3 -67.57 0.38 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.67 0.735 . . . . 0.0 110.501 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -59.3 -33.52 71.19 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.402 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -46.28 90.95 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.668 0.667 . . . . 0.0 111.357 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.549 HG21 HG11 ' A' ' 100' ' ' VAL . 1.1 m -64.3 -42.32 96.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.371 -0.824 . . . . 0.0 110.081 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.418 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -58.33 -50.02 75.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.278 0.944 . . . . 0.0 110.68 177.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -66.88 -40.87 87.91 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 124.563 1.145 . . . . 0.0 111.12 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 8.7 tp -61.47 -52.83 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.355 1.462 . . . . 0.0 110.83 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 65' ' ' THR . 9.1 mt -59.13 -51.32 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.095 -1.003 . . . . 0.0 111.251 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -63.29 -25.8 68.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.593 -0.692 . . . . 0.0 112.737 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.72 21.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.023 1.329 . . . . 0.0 112.743 171.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.59 58.39 5.42 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.787 1.184 . . . . 0.0 111.628 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -123.21 -81.16 0.64 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.46 -59.82 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -136.26 -163.06 1.35 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.755 1.622 . . . . 0.0 110.242 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.58 21.1 1.04 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.756 1.169 . . . . 0.0 112.937 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.7 mmt -90.68 173.72 7.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.594 1.158 . . . . 0.0 112.144 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.22 120.49 13.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.024 0.916 . . . . 0.0 109.576 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 90' ' ' LEU . 2.5 t -98.47 122.72 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -67.82 115.84 7.82 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 166.17 54.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.45 128.09 7.51 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 122.426 -0.455 . . . . 0.0 111.046 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.57 -17.56 29.88 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.679 2.253 . . . . 0.0 113.021 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.01 60.47 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 0.0 112.654 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.45 65.11 1.42 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.423 1.089 . . . . 0.0 112.329 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.56 37.45 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 p -175.43 57.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.477 1.111 . . . . 0.0 111.391 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -90.43 150.17 21.94 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.294 1.045 . . . . 0.0 110.766 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.5 p -136.26 126.06 25.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.451 HD23 HD13 ' A' ' 69' ' ' ILE . 1.8 tm? -96.95 127.35 42.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.935 0.874 . . . . 0.0 108.879 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -101.17 116.71 33.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -72.94 170.76 14.11 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.137 0.494 . . . . 0.0 110.79 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.77 -55.34 6.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.119 0.967 . . . . 0.0 112.43 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.52 152.29 16.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 110.621 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.25 25.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.008 0.813 . . . . 0.0 112.805 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.25 128.68 2.07 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -133.8 136.96 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.991 0.901 . . . . 0.0 108.86 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.37 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.363 1.065 . . . . 0.0 108.252 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 117' ' ' THR . 40.4 t -136.33 111.05 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 65' ' ' THR . 1.1 m -102.81 122.45 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 126.18 14.49 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.042 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -70.34 150.45 64.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.542 1.494 . . . . 0.0 110.688 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -141.11 77.37 1.59 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.026 1.393 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 p -87.51 156.24 19.63 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.933 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.33 0 C-N-CA 123.343 0.657 . . . . 0.0 110.034 176.723 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.78 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -53.61 142.91 21.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.799 1.299 . . . . 0.0 112.099 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.2 p -128.83 104.82 7.83 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.06 0.944 . . . . 0.0 109.314 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 mt -108.07 93.12 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.495 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -67.9 138.25 55.87 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 172.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -135.6 127.66 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -136.34 104.2 5.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.356 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.43 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.824 1.249 . . . . 0.0 111.962 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 173' ' ' ASN . 22.6 m -53.5 107.06 0.75 Allowed Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.23 1.812 . . . . 0.0 107.881 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 20.3 Cg_endo -74.85 -169.47 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.851 1.034 . . . . 0.0 110.768 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -19.14 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.41 -0.806 . . . . 0.0 113.112 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 t -77.95 -46.29 21.59 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.097 -1.627 . . . . 0.0 111.076 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.24 -28.48 62.18 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.12 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -52.92 -28.84 25.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.817 1.644 . . . . 0.0 111.329 176.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.4 -55.68 6.03 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 C-N-CA 125.972 1.709 . . . . 0.0 110.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 m -60.31 -44.1 95.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.226 -1.546 . . . . 0.0 113.2 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 36' ' ' LEU . 35.7 mm -56.57 -42.79 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.737 1.615 . . . . 0.0 109.772 171.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.504 ' HB2' HG12 ' A' ' 154' ' ' VAL . 3.7 p -65.32 -45.35 84.65 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 119.187 0.903 . . . . 0.0 112.42 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.9 m -60.55 -30.02 69.52 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.873 1.269 . . . . 0.0 110.904 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.91 -32.85 13.5 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 123.567 0.603 . . . . 0.0 113.493 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.5 tpp -74.39 -24.77 59.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.997 1.398 . . . . 0.0 111.304 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 p -66.46 -24.18 66.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.805 1.642 . . . . 0.0 111.494 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -70.47 -4.92 25.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.793 1.237 . . . . 0.0 113.491 171.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.61 48.44 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.548 1.139 . . . . 0.0 111.103 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -40.53 -51.63 3.79 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.743 1.163 . . . . 0.0 114.711 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.75 73.53 0.48 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.791 1.186 . . . . 0.0 112.307 169.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.455 HG21 HG12 ' A' ' 142' ' ' ILE . 3.3 m -69.55 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.629 0.772 . . . . 0.0 110.452 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t 172.86 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.256 1.422 . . . . 0.0 111.794 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 150' ' ' THR . . . -177.78 73.74 0.07 OUTLIER Glycine 0 C--N 1.341 0.848 0 O-C-N 121.78 -0.575 . . . . 0.0 113.667 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 13.2 mt -94.64 99.68 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.996 0.919 . . . . 0.0 111.708 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -91.95 94.81 9.47 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.874 -0.516 . . . . 0.0 110.691 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.5 mt -68.85 153.12 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.24 1.016 . . . . 0.0 110.489 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -52.68 116.92 2.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.931 -1.106 . . . . 0.0 110.498 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.86 -43.96 0.99 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.412 1.006 . . . . 0.0 113.835 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.59 34.34 0.53 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.869 2.068 . . . . 0.0 111.682 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -46.32 93.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.837 1.655 . . . . 0.0 111.886 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -113.94 -168.22 1.32 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.104 1.361 . . . . 0.0 109.565 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.435 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.4 p -138.7 -49.71 0.53 Allowed 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.818 -0.551 . . . . 0.0 110.856 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 20.25 2.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.541 1.537 . . . . 0.0 112.25 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -45.23 126.12 5.98 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-O 121.559 0.695 . . . . 0.0 111.061 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -117.91 70.62 0.8 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 122.33 1.062 . . . . 0.0 108.391 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 130' ' ' SER . 13.0 t -91.68 130.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.93 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.44 176.1 7.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.91 1.284 . . . . 0.0 110.412 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.33 58.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.653 0.66 . . . . 0.0 112.078 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -61.51 -32.53 72.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.703 0.801 . . . . 0.0 112.551 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.469 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -73.35 -50.69 29.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.458 1.027 . . . . 0.0 111.476 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 p -69.39 -32.0 70.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.299 0.64 . . . . 0.0 111.87 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.7 t -92.4 -50.94 5.38 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.31 1.044 . . . . 0.0 112.18 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 . . . . . 0 C--O 1.234 0.241 0 C-N-CA 127.265 2.226 . . . . 0.0 111.867 179.95 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 35.06 -135.51 0.39 Allowed Glycine 0 C--N 1.339 0.734 0 O-C-N 124.394 1.059 . . . . 0.0 111.57 -174.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.1 p -149.03 123.84 9.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.434 ' HB3' HG23 ' A' ' 121' ' ' VAL . 4.9 t-20 -76.83 136.23 38.92 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.118 -0.988 . . . . 0.0 110.749 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 m -109.47 112.46 24.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.22 109.86 10.72 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -81.98 135.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.108 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 179' ' ' TYR . 0.6 OUTLIER -100.67 120.26 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -97.94 144.36 27.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.105 0.562 . . . . 0.0 111.586 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.2 t80 -142.67 105.71 4.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.336 0.654 . . . . 0.0 111.594 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.19 140.13 37.76 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.392 0.677 . . . . 0.0 110.386 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.046 -1.419 . . . . 0.0 111.896 178.24 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.1 -45.13 8.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.684 1.194 . . . . 0.0 110.71 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.31 -27.8 1.92 Allowed Glycine 0 C--O 1.212 -1.251 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.596 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 p -38.3 -43.43 0.8 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.641 1.576 . . . . 0.0 114.756 168.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.12 -35.52 31.48 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.065 0.848 . . . . 0.0 112.493 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 129' ' ' ILE . 16.0 mt -65.09 -50.11 67.39 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.038 0.935 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.5 p -60.08 -38.29 82.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.093 1.357 . . . . 0.0 110.632 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.96 -47.24 81.21 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.017 0.826 . . . . 0.0 112.496 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.58 ' CD1' ' CZ ' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -49.05 -59.04 3.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 109.235 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -66.04 -24.92 66.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.45 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -47.74 73.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 110.184 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -41.05 98.7 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 119.733 1.152 . . . . 0.0 109.051 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.26 96.35 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.767 0.712 . . . . 0.0 112.395 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.12 -31.6 58.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.704 1.202 . . . . 0.0 112.941 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.446 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 8.4 m-80 -75.57 -63.61 1.25 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -17.7 7.13 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.401 1.081 . . . . 0.0 113.063 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -44.42 -35.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.989 1.316 . . . . 0.0 112.194 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.0 26.84 0.14 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.698 1.142 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.1 tpp -86.04 -69.89 0.64 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.042 0.937 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' HB2' ' A' ' 71' ' ' ALA . 3.5 mtt -154.74 60.42 0.67 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.821 1.296 . . . . 0.0 111.002 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -104.1 -29.8 10.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.41 36.13 0.04 OUTLIER Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.615 1.102 . . . . 0.0 111.715 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 N--CA 1.473 0.722 0 C-N-CA 123.528 0.731 . . . . 0.0 110.602 176.823 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.922 0 N-CA-C 113.576 0.19 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.98 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.407 -1.055 . . . . 0.0 111.897 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -25.98 68.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.533 0.733 . . . . 0.0 112.364 171.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.429 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 14.2 ttm -58.36 -49.09 78.45 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.499 0.72 . . . . 0.0 110.21 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.693 HG21 HG21 ' A' ' 100' ' ' VAL . 1.4 m -72.8 -41.5 64.88 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.551 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HA ' HG21 ' A' ' 79' ' ' VAL . 11.9 t0 -52.65 -53.43 47.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.006 1.276 . . . . 0.0 111.505 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.403 HG22 ' SD ' ' A' ' 50' ' ' MET . 94.3 m -68.0 -43.21 79.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.054 1.342 . . . . 0.0 110.984 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.55 -47.1 80.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.662 0.785 . . . . 0.0 111.294 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.508 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -60.38 -50.22 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.405 175.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.86 -20.25 55.96 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.158 -0.964 . . . . 0.0 112.448 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 50' ' ' MET . . . -81.54 9.93 6.72 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.48 1.512 . . . . 0.0 113.73 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.93 48.07 84.83 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.422 1.487 . . . . 0.0 112.589 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' ' CB ' ' A' ' 45' ' ' ASN . . . -110.34 -83.86 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.464 0.706 . . . . 0.0 111.275 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -47.15 72.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.796 0.438 . . . . 0.0 111.654 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -156.2 172.7 17.99 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.063 1.345 . . . . 0.0 109.902 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.78 34.77 3.63 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.796 1.189 . . . . 0.0 112.165 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.71 178.81 4.25 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.649 1.18 . . . . 0.0 112.004 -177.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.42 136.99 54.15 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.438 175.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.508 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.4 t -114.57 109.78 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.7 t -57.81 137.06 56.97 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.54 169.24 47.82 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.871 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.74 113.66 46.67 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.755 0.822 . . . . 0.0 111.182 174.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -79.51 -64.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.03 1.82 . . . . 0.0 111.557 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.37 -40.37 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.886 0.874 . . . . 0.0 112.174 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.36 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.023 2.529 . . . . 0.0 112.998 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.69 95.85 0.14 Allowed Glycine 0 N--CA 1.466 0.666 0 C-N-CA 123.47 0.557 . . . . 0.0 111.759 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.8 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.02 2.128 . . . . 0.0 109.149 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.526 ' HB3' HG23 ' A' ' 100' ' ' VAL . . . -62.84 159.14 17.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 110.918 174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -141.88 144.91 34.06 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.743 -1.223 . . . . 0.0 109.518 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.13 124.46 43.12 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 122.538 1.161 . . . . 0.0 109.675 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -88.07 129.5 35.27 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 123.978 0.911 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.6 113.87 18.08 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.538 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.4 t -54.31 -58.45 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.435 0.694 . . . . 0.0 112.0 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -56.35 -55.57 31.8 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 110.011 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.4 141.43 3.19 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 123.671 0.653 . . . . 0.0 111.963 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.79 -178.86 16.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.202 0.906 . . . . 0.0 112.631 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.87 143.78 36.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.551 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mt -130.55 151.76 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.339 1.456 . . . . 0.0 109.178 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 117' ' ' THR . 35.2 t -135.29 110.32 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 65' ' ' THR . 8.0 m -101.26 105.94 18.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.864 1.266 . . . . 0.0 108.466 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.31 146.58 58.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 120.043 -1.661 . . . . 0.0 110.355 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -73.22 151.46 49.04 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.557 1.505 . . . . 0.0 110.587 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -144.79 80.9 1.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.929 1.347 . . . . 0.0 110.435 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -92.29 118.8 31.26 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.151 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.56 0 O-C-N 121.561 -0.712 . . . . 0.0 110.292 176.642 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 CA-C-O 122.149 0.861 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.13 150.94 51.93 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.071 0.948 . . . . 0.0 111.1 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -133.92 115.05 13.95 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.839 0.828 . . . . 0.0 110.344 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.0 mt -120.1 99.81 8.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.6 OUTLIER -70.53 141.59 51.9 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.007 172.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.4 p -134.35 123.76 24.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -134.94 122.46 21.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 109.727 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt 160.38 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.179 2.192 . . . . 0.0 110.325 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.9 m -45.87 103.64 0.36 Allowed Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 125.064 1.478 . . . . 0.0 110.483 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 27.4 Cg_endo -74.23 -172.81 1.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.831 1.688 . . . . 0.0 109.996 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -27.08 34.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.698 -1.252 . . . . 0.0 113.003 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -72.22 -50.17 29.59 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.202 -0.936 . . . . 0.0 111.472 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.49 -13.56 61.07 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 121.902 -0.499 . . . . 0.0 111.197 173.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -30.58 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 119.513 -1.992 . . . . 0.0 110.069 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.411 ' HA ' ' CB ' ' A' ' 159' ' ' ALA . 2.7 t -90.18 -47.02 14.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 124.68 1.192 . . . . 0.0 109.531 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 m -61.26 -39.21 89.51 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.466 1.03 . . . . 0.0 112.708 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.463 HG23 HD21 ' A' ' 36' ' ' LEU . 45.8 mm -70.55 -49.07 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.046 172.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.9 m -57.83 -44.86 86.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 119.71 1.141 . . . . 0.0 112.563 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 m -59.44 -43.47 93.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.903 1.281 . . . . 0.0 111.476 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.51 -24.68 69.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.306 0.479 . . . . 0.0 113.517 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.2 25.75 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.963 -1.316 . . . . 0.0 111.338 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 155' ' ' THR . 0.3 OUTLIER -70.22 -26.01 63.67 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.963 1.705 . . . . 0.0 111.972 175.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -27.32 60.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.872 0.869 . . . . 0.0 112.391 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.3 t -154.97 48.64 0.56 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.853 1.661 . . . . 0.0 110.494 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.38 -80.86 0.81 Allowed Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 38.14 43.41 1.38 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 125.934 1.731 . . . . 0.0 114.915 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 151' ' ' ASP . 41.0 m 61.57 144.63 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.711 1.604 . . . . 0.0 112.696 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 t -166.47 -40.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.535 -1.353 . . . . 0.0 110.81 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 178' ' ' ASN . . . 143.18 50.78 0.04 OUTLIER Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.975 1.274 . . . . 0.0 112.236 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.421 ' CG2' HD23 ' A' ' 175' ' ' LEU . 3.1 mt -89.0 100.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.77 95.7 10.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.656 0.382 . . . . 0.0 110.571 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 152' ' ' ALA . 36.8 mt -69.39 154.66 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.692 1.197 . . . . 0.0 109.911 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.33 115.75 2.45 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.89 -1.131 . . . . 0.0 111.448 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.98 -40.86 0.7 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.269 0.938 . . . . 0.0 114.538 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -86.28 41.12 0.91 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.324 1.85 . . . . 0.0 110.689 168.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -55.8 93.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.586 1.154 . . . . 0.0 111.05 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -116.96 -168.28 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.445 1.498 . . . . 0.0 109.094 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -136.25 -41.96 0.64 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 110.989 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HA ' HG23 ' A' ' 139' ' ' THR . 32.5 p30 -89.79 20.95 3.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.89 2.076 . . . . 0.0 113.547 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 144' ' ' ILE . . . -62.98 83.91 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 111.076 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 76.9 2.04 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.184 1.394 . . . . 0.0 109.443 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.406 ' HA ' HG21 ' A' ' 158' ' ' ILE . 3.3 m -75.96 154.75 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.009 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 134' ' ' SER . 0.1 OUTLIER -166.94 164.54 16.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.784 1.233 . . . . 0.0 111.021 -172.048 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.07 -53.34 20.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.881 1.272 . . . . 0.0 112.178 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.78 -34.1 73.97 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.005 0.922 . . . . 0.0 112.143 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -65.83 -51.27 63.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 O-C-N 121.721 -0.612 . . . . 0.0 109.653 175.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -64.36 -21.3 66.58 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.934 0.788 . . . . 0.0 111.312 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.39 65.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 113.211 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.73 -51.24 3.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.187 1.395 . . . . 0.0 112.607 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 . . . . . 0 C--O 1.233 0.226 0 C-N-CA 126.967 2.107 . . . . 0.0 110.843 175.798 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 C--O 1.239 0.539 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -46.18 139.36 6.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.5 p -47.61 120.41 3.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.096 1.358 . . . . 0.0 110.899 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.39 127.44 32.19 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 120.934 -1.104 . . . . 0.0 109.232 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 14.6 m -102.2 111.91 24.37 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 142' ' ' ILE . 0.9 OUTLIER -127.84 109.81 11.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -80.22 132.07 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.58 ' CZ ' ' CD1' ' A' ' 39' ' ' TYR . 2.6 t80 -97.83 115.16 27.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.443 ' HB3' ' HA3' ' A' ' 141' ' ' GLY . 12.9 t-20 -101.27 107.33 18.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.234 0.614 . . . . 0.0 110.002 174.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.8 t80 -77.35 109.21 11.07 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.951 0.901 . . . . 0.0 110.92 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -108.15 106.13 16.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.787 0.835 . . . . 0.0 109.907 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 CA-C-O 117.935 -1.481 . . . . 0.0 112.734 178.06 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.846 0.355 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -92.7 -28.65 16.51 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.493 1.117 . . . . 0.0 110.968 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -19.51 14.22 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 113.569 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t -44.89 -52.44 8.63 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.858 1.329 . . . . 0.0 113.612 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -78.33 -33.9 48.91 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.674 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.515 HD21 HG23 ' A' ' 129' ' ' ILE . 72.0 mt -56.47 -51.58 67.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.771 0.714 . . . . 0.0 110.909 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.5 p -65.95 -34.14 77.43 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.602 1.161 . . . . 0.0 111.079 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.85 -47.55 82.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.159 0.984 . . . . 0.0 112.32 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -57.29 -52.94 63.33 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 120.873 -1.142 . . . . 0.0 111.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -65.14 -24.13 67.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.204 172.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -47.46 81.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.289 0.95 . . . . 0.0 109.465 174.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tt -65.0 -41.64 95.21 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.918 0.781 . . . . 0.0 109.317 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -64.05 -43.24 96.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.39 0.431 . . . . 0.0 111.587 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -35.64 63.17 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.533 1.133 . . . . 0.0 112.132 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.615 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 19.1 m-80 -67.15 -62.42 1.44 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -54.82 -25.92 31.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.936 0.894 . . . . 0.0 111.835 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -31.61 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.244 1.018 . . . . 0.0 112.774 171.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.5 51.67 0.25 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.329 1.442 . . . . 0.0 113.396 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.1 tpt -126.52 -77.02 0.58 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.382 1.073 . . . . 0.0 110.563 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.3 mtt -154.89 58.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.681 1.229 . . . . 0.0 111.235 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -106.38 -5.87 18.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.14 39.37 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.529 1.062 . . . . 0.0 112.579 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.476 0.872 0 O-C-N 122.181 -0.599 . . . . 0.0 110.838 178.101 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.921 0 CA-C-O 120.796 0.109 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.07 -56.0 4.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.801 0.84 . . . . 0.0 109.81 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -25.46 66.84 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.931 171.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -52.01 67.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.631 1.105 . . . . 0.0 111.298 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.623 HG21 HG11 ' A' ' 100' ' ' VAL . 1.1 m -68.63 -39.45 80.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.051 176.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.4 ' HA ' HG21 ' A' ' 79' ' ' VAL . 44.5 t0 -60.04 -48.81 80.17 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 111.026 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.5 m -68.35 -41.45 80.69 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 125.342 1.457 . . . . 0.0 110.286 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.625 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -57.22 -54.09 50.67 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.085 1.311 . . . . 0.0 111.203 172.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.96 -51.28 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.805 -1.184 . . . . 0.0 110.964 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -60.0 -26.13 65.81 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.711 -1.243 . . . . 0.0 112.592 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.7 -14.12 59.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.21 1.004 . . . . 0.0 113.088 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.74 34.13 9.41 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.167 1.365 . . . . 0.0 112.697 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.625 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -92.91 -73.46 0.56 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.065 0.546 . . . . 0.0 111.81 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -63.6 1.21 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.011 0.434 . . . . 0.0 110.22 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -134.24 -164.36 1.49 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.135 1.374 . . . . 0.0 109.698 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.42 23.49 1.37 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.659 1.123 . . . . 0.0 112.732 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.7 mmt -93.19 174.76 7.05 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.104 1.361 . . . . 0.0 112.029 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.01 138.75 58.66 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.35 0.595 . . . . 0.0 110.351 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 66' ' ' ASP . 2.9 t -120.74 132.2 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 t -92.99 150.64 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.66 142.11 12.36 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.05 99.42 46.63 Favored Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 124.545 1.138 . . . . 0.0 108.005 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -74.22 -29.36 9.75 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.523 2.149 . . . . 0.0 112.26 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.81 68.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.452 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.29 -65.23 1.2 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.113 . . . . 0.0 111.818 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.93 52.81 0.24 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.051 1.31 . . . . 0.0 112.382 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.3 m -144.16 105.31 4.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.186 0.995 . . . . 0.0 109.828 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -73.55 145.61 45.39 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 122.111 0.958 . . . . 0.0 110.517 174.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -126.16 127.46 45.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -101.12 135.17 43.02 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.746 0.784 . . . . 0.0 109.261 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -96.21 119.71 35.19 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -171.84 0.9 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.768 0.427 . . . . 0.0 111.339 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -57.92 4.11 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.959 0.904 . . . . 0.0 112.254 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.99 132.99 3.8 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.145 0.978 . . . . 0.0 110.617 173.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.66 -57.61 4.5 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.657 1.123 . . . . 0.0 112.563 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -46.38 139.13 7.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 123.872 0.748 . . . . 0.0 112.611 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -132.64 152.67 51.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.479 1.133 . . . . 0.0 109.601 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -132.97 146.76 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.164 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 117' ' ' THR . 61.4 t -133.15 113.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.623 HG11 HG21 ' A' ' 65' ' ' THR . 1.2 m -95.16 123.72 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.34 40.02 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.546 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -71.52 152.77 60.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.98 1.787 . . . . 0.0 110.784 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -149.66 84.99 1.42 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 123.749 1.738 . . . . 0.0 108.953 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.4 p -89.79 144.33 26.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.143 -1.844 . . . . 0.0 108.907 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 177.109 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 CA-C-O 122.181 0.879 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -129.46 150.26 50.88 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.973 0.909 . . . . 0.0 110.883 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 176' ' ' VAL . 0.2 OUTLIER -146.01 119.16 8.85 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.077 -174.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mt -119.01 115.91 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.351 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.53 ' CB ' HG23 ' A' ' 176' ' ' VAL . 0.7 OUTLIER -78.45 140.82 38.61 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.908 174.073 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 123.58 25.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -131.82 123.62 27.95 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.455 0.702 . . . . 0.0 110.041 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.434 ' HE3' HG23 ' A' ' 121' ' ' VAL . 0.0 OUTLIER 161.57 -31.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.615 1.966 . . . . 0.0 113.268 -175.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.434 HG23 ' HE3' ' A' ' 120' ' ' LYS . 18.3 t -50.02 111.28 2.01 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.056 176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 36.8 Cg_endo -73.16 -173.72 1.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.946 2.431 . . . . 0.0 110.743 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.75 -24.17 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.876 -1.14 . . . . 0.0 113.076 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -52.68 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.952 0.796 . . . . 0.0 111.211 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.557 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -72.46 -17.05 61.81 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.548 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 14.2 t -62.55 -45.57 92.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 120.902 1.683 . . . . 0.0 109.248 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.35 -45.6 40.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-O 118.216 -0.897 . . . . 0.0 108.998 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -57.74 -43.12 85.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.691 1.587 . . . . 0.0 113.768 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.515 HG23 HD21 ' A' ' 36' ' ' LEU . 46.7 mm -74.32 -44.7 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.073 1.749 . . . . 0.0 110.279 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.1 m -63.84 -26.73 68.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.0 m -82.35 -44.18 16.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.721 2.008 . . . . 0.0 110.258 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.78 -42.65 78.44 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.07 -27.21 67.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.825 1.312 . . . . 0.0 112.774 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.78 -21.77 63.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.206 0.602 . . . . 0.0 111.932 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.55 -25.81 39.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.585 1.154 . . . . 0.0 112.775 174.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -151.81 49.66 0.8 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.393 1.477 . . . . 0.0 110.212 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -36.56 -63.63 0.68 Allowed Glycine 0 C--N 1.344 1.024 0 C-N-CA 125.628 1.585 . . . . 0.0 113.18 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 25.21 78.22 0.01 OUTLIER Glycine 0 C--N 1.346 1.085 0 C-N-CA 126.971 2.224 . . . . 0.0 113.273 167.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 151' ' ' ASP . 23.2 p -51.67 171.31 0.04 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.78 1.632 . . . . 0.0 112.937 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 p 178.92 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.647 0.779 . . . . 0.0 111.811 -170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 171.55 42.68 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.496 0.57 . . . . 0.0 113.949 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 139' ' ' THR . 41.6 mt -80.12 117.07 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 123.321 0.648 . . . . 0.0 109.574 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.472 ' CD ' HG11 ' A' ' 176' ' ' VAL . 0.9 OUTLIER -121.56 104.36 9.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.589 1.155 . . . . 0.0 108.036 -176.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 147' ' ' ASN . 4.3 mm -78.6 168.09 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -50.06 116.22 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.29 1.436 . . . . 0.0 112.439 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.59 28.61 6.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 123.52 0.581 . . . . 0.0 114.11 -173.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.2 t-20 -129.95 38.52 3.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.378 2.271 . . . . 0.0 108.398 -174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.63 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.668 1.987 . . . . 0.0 112.129 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -138.2 -173.43 3.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.624 1.57 . . . . 0.0 109.347 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 141' ' ' GLY . 7.9 p -146.8 -52.14 0.22 Allowed 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.084 -1.01 . . . . 0.0 109.461 -175.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.464 ' HA ' HG21 ' A' ' 139' ' ' THR . 14.7 p-10 -80.03 31.39 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.221 2.209 . . . . 0.0 113.521 171.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 105.43 13.45 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.839 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.88 128.36 35.35 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.13 134.43 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 178.5 7.22 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.959 0.904 . . . . 0.0 110.644 -170.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.54 -54.51 42.22 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 172.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.53 -32.46 72.52 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.899 0.88 . . . . 0.0 111.986 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.31 -54.35 17.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.62 -18.57 64.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.424 1.011 . . . . 0.0 111.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.07 -38.76 92.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.926 0.89 . . . . 0.0 111.945 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.4 m -111.25 -51.6 2.85 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.095 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.468 0.44 0 C-N-CA 126.287 1.835 . . . . 0.0 113.513 178.263 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.573 0.702 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.19 5.68 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 123.72 0.676 . . . . 0.0 113.077 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 46.4 m -152.05 99.52 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.152 1.381 . . . . 0.0 109.171 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -134.16 116.58 15.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.356 1.062 . . . . 0.0 110.123 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.9 m -115.92 107.14 14.62 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.41 ' HG ' HD13 ' A' ' 144' ' ' ILE . 1.1 mp -122.2 123.15 40.82 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.578 0.751 . . . . 0.0 109.103 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 115' ' ' THR . 0.8 OUTLIER -94.79 122.8 46.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -98.93 122.57 42.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.402 0.681 . . . . 0.0 110.046 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.09 138.94 41.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.587 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.462 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -145.05 136.4 25.12 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.888 177.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -48.41 149.64 1.54 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.022 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.914 -179.54 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 t0 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.647 0.26 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 128' ' ' SER . . . -87.07 -34.13 19.26 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.01 -25.76 2.62 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 120.879 -1.138 . . . . 0.0 114.088 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 p -48.31 -41.6 28.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.822 1.649 . . . . 0.0 114.316 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.497 ' CG ' HD11 ' A' ' 129' ' ' ILE . 3.8 pt-20 -78.43 -34.99 47.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 129' ' ' ILE . 16.9 mt -57.79 -53.28 59.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.141 0.882 . . . . 0.0 112.356 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.9 p -60.76 -36.83 79.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.711 176.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -50.84 72.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.859 1.263 . . . . 0.0 112.42 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' A' ' 118' ' ' THR . 12.2 m-30 -57.98 -46.49 85.07 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.892 -1.13 . . . . 0.0 111.649 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -62.96 -31.96 73.17 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.008 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -45.74 89.22 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 123.663 0.785 . . . . 0.0 109.713 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.504 HD13 ' CD2' ' A' ' 68' ' ' LEU . 1.9 tp -59.47 -49.57 77.29 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 120.374 1.443 . . . . 0.0 110.071 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.53 95.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.98 -33.37 59.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.615 1.166 . . . . 0.0 112.524 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.553 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 9.0 m120 -71.45 -61.12 1.89 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.44 ' HB ' HD13 ' A' ' 68' ' ' LEU . 2.1 t -56.51 -19.75 17.04 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.17 0.988 . . . . 0.0 112.332 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -32.22 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.735 0.814 . . . . 0.0 112.248 171.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.83 45.94 0.17 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.648 1.118 . . . . 0.0 113.009 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -113.64 -66.4 1.09 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.995 0.918 . . . . 0.0 110.128 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.478 ' HG2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -146.02 31.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.693 1.197 . . . . 0.0 112.564 -176.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.36 -21.91 48.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 176.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.07 47.1 0.13 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.302 0.953 . . . . 0.0 112.332 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 123.384 0.674 . . . . 0.0 111.418 178.379 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.937 0 CA-C-O 119.938 -0.368 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.743 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -85.07 -70.0 0.61 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -23.74 50.07 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 123.436 0.695 . . . . 0.0 112.302 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.44 ' SD ' ' HA ' ' A' ' 51' ' ' LYS . 7.4 tpt -53.5 -71.61 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.512 0.725 . . . . 0.0 110.36 172.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.496 HG21 HG11 ' A' ' 100' ' ' VAL . 1.2 m -65.95 -32.98 74.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.494 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.68 -53.05 62.15 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.094 0.861 . . . . 0.0 111.02 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.478 HG22 ' HG2' ' A' ' 50' ' ' MET . 90.1 m -68.18 -41.05 82.04 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.42 1.088 . . . . 0.0 110.891 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.072 0.851 . . . . 0.0 111.754 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -61.18 -52.06 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.067 -1.02 . . . . 0.0 110.48 176.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.06 -20.44 53.28 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.364 -1.46 . . . . 0.0 113.094 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.54 13.65 3.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.509 1.524 . . . . 0.0 113.615 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 53.18 40.8 60.27 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.865 1.698 . . . . 0.0 112.8 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 45' ' ' ASN . . . -100.83 -70.29 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 -54.27 5.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -149.25 178.13 9.03 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.089 1.356 . . . . 0.0 109.538 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.69 31.46 3.38 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 124.787 1.184 . . . . 0.0 112.105 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.38 171.28 8.06 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.353 1.061 . . . . 0.0 111.639 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -61.88 131.44 49.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.446 0.641 . . . . 0.0 110.497 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.6 t -114.13 136.94 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.799 1.24 . . . . 0.0 108.464 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 t -88.02 126.94 35.35 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.75 103.42 2.91 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -50.14 105.39 0.51 Allowed Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.481 1.112 . . . . 0.0 111.373 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.16 -17.25 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.504 2.136 . . . . 0.0 112.388 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.31 -7.09 58.76 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.99 1.316 . . . . 0.0 112.594 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m 60.04 68.45 0.78 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.436 1.494 . . . . 0.0 112.05 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.03 -52.89 0.1 OUTLIER Glycine 0 N--CA 1.467 0.747 0 C-N-CA 124.006 0.812 . . . . 0.0 112.215 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -177.25 124.29 0.14 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.832 1.253 . . . . 0.0 110.965 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.743 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -64.81 164.58 12.06 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 122.355 1.074 . . . . 0.0 112.029 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.6 t -133.86 142.21 47.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.65 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 90' ' ' LEU . 1.6 tm? -109.23 123.84 49.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.059 0.944 . . . . 0.0 109.099 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -82.04 119.56 24.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.802 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -70.27 176.6 3.81 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.282 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.68 -53.65 4.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.036 1.334 . . . . 0.0 113.01 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -149.6 -51.36 0.15 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 0.0 111.779 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.46 98.83 0.86 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.82 132.99 1.57 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 124.012 0.815 . . . . 0.0 111.535 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.03 127.41 50.21 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.81 136.82 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 108.684 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 117' ' ' THR . 21.0 t -124.26 109.49 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 65' ' ' THR . 1.4 m -87.32 122.98 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.97 136.94 18.74 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.337 -0.852 . . . . 0.0 109.209 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -76.08 152.38 35.79 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.734 1.623 . . . . 0.0 110.554 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -143.75 69.04 1.28 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 111.667 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.3 p -97.61 104.53 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.281 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.428 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.184 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -108.18 135.56 49.3 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.507 0.723 . . . . 0.0 110.333 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 p -124.03 102.44 7.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.748 1.261 . . . . 0.0 110.9 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.44 110.25 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.634 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -76.84 141.95 40.44 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.285 173.093 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 39' ' ' TYR . 5.8 p -133.91 130.32 37.59 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.43 -173.88 3.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.352 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 89.84 -31.11 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.576 2.75 . . . . 0.0 110.418 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.7 t -47.61 104.39 0.41 Allowed Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 127.19 2.196 . . . . 0.0 108.405 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 21.6 Cg_endo -73.66 -170.09 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.991 1.794 . . . . 0.0 110.431 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -59.54 -31.14 69.14 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.873 -1.142 . . . . 0.0 112.277 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.0 p -73.72 -50.54 20.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.501 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.591 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -71.97 -17.83 62.04 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.91 172.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.45 -45.91 92.29 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 120.878 1.672 . . . . 0.0 108.385 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.434 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 3.2 t -72.98 -42.04 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.629 0.649 . . . . 0.0 111.467 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -63.47 -45.1 92.35 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 177.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.497 HD11 ' CG ' ' A' ' 35' ' ' GLU . 11.4 mm -63.25 -52.99 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 C-N-CA 124.957 1.303 . . . . 0.0 109.52 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.7 m -56.26 -42.44 77.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 119.121 0.873 . . . . 0.0 112.226 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -56.8 -52.44 65.04 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.127 1.371 . . . . 0.0 110.969 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.6 -29.01 72.8 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 122.867 0.27 . . . . 0.0 112.682 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -35.3 58.26 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.245 1.018 . . . . 0.0 111.201 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -25.06 65.67 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.929 0.892 . . . . 0.0 112.126 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -60.91 -30.15 70.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.247 0.619 . . . . 0.0 112.605 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 t -153.76 50.75 0.68 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.285 1.034 . . . . 0.0 111.428 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.55 -85.51 1.65 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 44.03 49.91 7.69 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.471 1.034 . . . . 0.0 113.618 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 151' ' ' ASP . 26.2 m 66.22 147.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.529 1.532 . . . . 0.0 112.326 -173.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.1 p -179.7 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.142 -0.974 . . . . 0.0 110.961 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.85 48.62 0.07 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.575 1.083 . . . . 0.0 112.216 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 5.5 mt -88.91 99.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.038 -172.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -90.56 97.08 10.97 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.816 0.446 . . . . 0.0 110.016 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.4 mt -73.87 146.82 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 124.4 1.062 . . . . 0.0 109.516 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -48.36 114.58 0.98 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.467 1.507 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.88 -39.64 0.96 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.302 0.953 . . . . 0.0 113.983 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.57 35.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.265 1.826 . . . . 0.0 111.428 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -51.85 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.378 1.471 . . . . 0.0 110.473 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -123.05 -169.24 1.89 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.976 1.31 . . . . 0.0 109.204 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 p -139.68 -41.69 0.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.784 0.834 . . . . 0.0 110.852 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.432 ' HA ' HG23 ' A' ' 139' ' ' THR . 3.7 p-10 -90.89 24.44 2.76 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.574 1.949 . . . . 0.0 113.412 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.41 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -57.59 125.76 24.37 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.509 0.671 . . . . 0.0 110.079 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -113.39 74.73 0.88 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 122.479 1.133 . . . . 0.0 108.315 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.66 135.18 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.494 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.7 p -136.56 -179.04 5.44 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.072 0.949 . . . . 0.0 111.449 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.29 81.88 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.605 -0.684 . . . . 0.0 112.386 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.56 -35.54 78.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.584 0.754 . . . . 0.0 111.421 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -46.08 36.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.786 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 127' ' ' VAL . . . -60.18 -26.47 66.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.1 0.864 . . . . 0.0 111.124 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -39.26 87.74 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 170.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.36 -31.59 24.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.694 1.597 . . . . 0.0 113.792 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 CA--C 1.539 0.52 0 C-N-CA 125.899 1.68 . . . . 0.0 110.462 178.75 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.238 0.455 0 CA-C-O 120.627 0.251 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.59 136.05 2.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.746 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 95.3 m -50.81 135.12 24.49 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.26 110.26 20.4 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.0 m -110.77 112.09 23.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.06 109.55 11.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -85.93 137.75 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -111.18 113.01 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.309 0.644 . . . . 0.0 109.726 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -101.46 118.32 36.71 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 109.689 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.46 122.71 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.093 0.957 . . . . 0.0 110.209 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -113.23 95.35 5.33 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.363 1.065 . . . . 0.0 108.91 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.204 0 CA-C-O 118.513 -1.159 . . . . 0.0 112.349 -174.484 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -91.72 -36.18 13.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.398 1.079 . . . . 0.0 111.249 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.92 -26.07 32.64 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.201 -0.777 . . . . 0.0 112.827 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -46.14 -43.34 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.003 1.321 . . . . 0.0 113.196 172.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.19 -34.31 49.58 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.739 -0.601 . . . . 0.0 111.805 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 129' ' ' ILE . 19.6 mt -63.28 -50.82 68.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 110.341 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.6 p -63.48 -38.1 89.83 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.308 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -58.56 -53.12 61.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.896 1.225 . . . . 0.0 112.416 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 177' ' ' PHE . 7.9 t80 -51.25 -52.16 47.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.036 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -67.14 -23.66 65.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.38 69.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.052 1.341 . . . . 0.0 108.685 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 74' ' ' ALA . 1.8 tt -63.57 -41.46 98.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.269 0.94 . . . . 0.0 109.498 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 179' ' ' TYR . . . -59.31 -44.5 92.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 117.978 0.354 . . . . 0.0 111.075 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -78.53 -39.03 39.15 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.241 0.616 . . . . 0.0 112.618 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -60.68 -57.92 10.67 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -41.36 62.33 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.606 1.162 . . . . 0.0 111.089 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -42.89 -31.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.771 1.629 . . . . 0.0 112.996 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -150.62 50.62 0.54 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.307 1.432 . . . . 0.0 112.678 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.7 tpp -137.26 -60.27 0.67 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.026 0.93 . . . . 0.0 110.569 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.1 tpt -162.12 39.67 0.12 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.72 5.66 38.78 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.2 38.02 0.51 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.9 1.238 . . . . 0.0 112.801 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.0 t . . . . . 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 0.0 109.157 -179.624 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.793 0 CA-C-O 119.593 -0.559 . . . . 0.0 113.597 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 -61.49 1.54 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.234 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -61.92 -28.57 69.62 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 123.757 0.823 . . . . 0.0 112.481 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -49.71 74.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.788 0.722 . . . . 0.0 110.322 173.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.26 -41.13 67.1 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.285 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.538 ' HA ' HG21 ' A' ' 79' ' ' VAL . 10.8 t0 -55.84 -52.58 63.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.923 0.868 . . . . 0.0 110.62 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.4 m -68.99 -43.1 75.55 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.933 1.293 . . . . 0.0 110.715 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.88 -43.49 90.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.706 1.593 . . . . 0.0 111.989 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.402 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -63.75 -53.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.282 0.633 . . . . 0.0 111.027 173.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -64.57 -17.2 63.74 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.168 -0.958 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.07 -19.44 30.23 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 112.35 174.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.1 76.17 1.21 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.998 1.285 . . . . 0.0 112.544 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.25 -97.9 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.001 0.52 . . . . 0.0 112.166 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -51.74 -40.69 60.68 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.005 0.922 . . . . 0.0 111.368 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -165.71 -178.77 4.99 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.017 1.727 . . . . 0.0 110.185 173.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.37 18.02 7.83 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.315 1.436 . . . . 0.0 112.783 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.0 ttt -92.45 171.38 9.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.611 1.165 . . . . 0.0 111.553 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.94 145.98 44.05 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.27 -0.894 . . . . 0.0 111.097 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 66' ' ' ASP . 10.3 t -120.67 129.37 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.76 132.68 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.44 136.61 14.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -42.51 113.52 1.29 Allowed Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.907 1.283 . . . . 0.0 112.78 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -76.51 -68.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.943 1.762 . . . . 0.0 111.375 -173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.73 13.18 20.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.762 1.225 . . . . 0.0 112.138 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.24 56.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.225 1.41 . . . . 0.0 111.632 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.02 -56.94 0.78 Allowed Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p 169.79 137.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.676 1.59 . . . . 0.0 110.47 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 87.63 0.19 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.447 0.699 . . . . 0.0 111.049 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 t -63.08 139.22 58.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 110.431 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.414 HD23 HG13 ' A' ' 79' ' ' VAL . 2.5 tm? -114.34 131.57 56.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.401 1.48 . . . . 0.0 108.909 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -91.93 115.54 28.15 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.365 1.066 . . . . 0.0 110.101 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.36 -179.63 2.54 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.61 0.719 . . . . 0.0 112.058 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 -51.51 6.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -45.7 87.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.38 0.672 . . . . 0.0 111.462 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.8 41.68 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.679 1.133 . . . . 0.0 112.705 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -104.97 170.16 17.54 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.155 0.883 . . . . 0.0 111.748 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -123.48 138.97 54.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.753 0.787 . . . . 0.0 109.262 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.13 119.4 56.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.54 115.22 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 132.11 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.34 137.21 9.2 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.987 -0.446 . . . . 0.0 110.899 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.3 154.23 61.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.215 1.943 . . . . 0.0 111.608 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.9 65.42 1.11 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.575 1.655 . . . . 0.0 111.099 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -86.48 172.04 10.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.443 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.382 0 C-N-CA 123.341 0.656 . . . . 0.0 111.111 177.425 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -87.47 155.68 19.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.708 -0.878 . . . . 0.0 111.18 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.456 HG22 HG13 ' A' ' 176' ' ' VAL . 0.1 OUTLIER -143.86 118.21 9.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 122.023 0.916 . . . . 0.0 110.822 -176.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.405 HD13 HD13 ' A' ' 42' ' ' LEU . 5.6 mt -113.57 108.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -71.17 131.34 43.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.125 0.97 . . . . 0.0 108.807 172.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -130.38 124.72 32.83 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -131.15 128.18 39.55 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt 164.74 -38.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.771 2.029 . . . . 0.0 110.872 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -45.19 103.35 0.34 Allowed Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.711 1.604 . . . . 0.0 110.492 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 30.1 Cg_endo -74.82 -172.1 1.14 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 110.363 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -22.54 53.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.545 -1.347 . . . . 0.0 114.324 173.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.8 t -79.34 -52.01 8.66 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.964 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.578 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.32 -23.9 60.32 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 121.866 -0.521 . . . . 0.0 110.86 175.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.26 -27.54 62.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.791 1.178 . . . . 0.0 110.164 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.59 -50.87 11.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 CA-C-O 117.871 -1.062 . . . . 0.0 110.609 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.411 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -53.31 -45.22 68.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.943 1.247 . . . . 0.0 113.38 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.59 HG23 HD21 ' A' ' 36' ' ' LEU . 21.6 mm -62.09 -38.61 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.206 172.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -67.2 -43.78 81.23 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.463 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.4 m -65.15 -27.89 69.03 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.243 1.383 . . . . 0.0 111.957 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.02 20.68 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.227 0.917 . . . . 0.0 113.75 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 1.9 ttp -84.71 -24.78 28.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.289 1.435 . . . . 0.0 112.43 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.6 p -69.59 -21.36 63.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.917 1.287 . . . . 0.0 111.888 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.0 mtt-85 -60.57 -17.91 49.35 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 113.133 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 t -154.04 53.44 0.7 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.255 1.022 . . . . 0.0 110.593 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -38.09 -65.39 0.7 Allowed Glycine 0 C--N 1.345 1.075 0 C-N-CA 125.34 1.448 . . . . 0.0 112.961 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 22.39 72.29 0.01 OUTLIER Glycine 0 C--N 1.347 1.187 0 C-N-CA 126.991 2.234 . . . . 0.0 113.217 167.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.527 HG22 ' CD1' ' A' ' 142' ' ' ILE . 3.9 p -53.28 171.16 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.531 1.532 . . . . 0.0 112.668 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.39 -33.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.67 -0.644 . . . . 0.0 111.315 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 171.12 43.5 0.03 OUTLIER Glycine 0 C--N 1.338 0.643 0 CA-C-O 119.58 -0.567 . . . . 0.0 113.399 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.527 ' CD1' HG22 ' A' ' 139' ' ' THR . 3.0 mt -77.2 116.3 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.166 0.586 . . . . 0.0 110.812 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.79 96.45 5.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.574 1.15 . . . . 0.0 108.897 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 147' ' ' ASN . 10.7 mt -74.96 167.14 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -49.53 115.83 1.51 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.35 1.46 . . . . 0.0 111.981 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.65 27.19 8.6 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 123.444 0.545 . . . . 0.0 114.138 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 0.7 OUTLIER -129.34 39.94 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.06 2.544 . . . . 0.0 107.615 -176.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -42.53 95.91 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.657 1.183 . . . . 0.0 111.593 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -142.8 -173.52 3.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.221 1.408 . . . . 0.0 108.784 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.499 HG22 ' HA2' ' A' ' 141' ' ' GLY . 12.3 p -146.29 -47.57 0.2 Allowed 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.548 -0.72 . . . . 0.0 110.193 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.439 ' C ' HG21 ' A' ' 139' ' ' THR . 1.0 OUTLIER -85.57 18.53 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.259 1.824 . . . . 0.0 112.142 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.97 97.71 0.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.304 -0.873 . . . . 0.0 111.146 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.62 125.1 29.58 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' A' ' 158' ' ' ILE . 2.1 t -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.07 170.06 16.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.151 0.98 . . . . 0.0 110.809 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.05 -37.67 72.12 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.5 -42.3 43.93 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.185 0.994 . . . . 0.0 110.891 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -59.89 -45.51 94.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 173.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.84 -17.95 61.5 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.761 -0.587 . . . . 0.0 111.972 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -40.6 76.67 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.243 -0.91 . . . . 0.0 111.531 172.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 70.1 m -107.96 -58.01 2.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.805 0.842 . . . . 0.0 112.12 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 126.365 1.866 . . . . 0.0 113.037 176.585 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.7 p . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 121.507 0.67 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.07 0.65 Allowed Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 67.4 p -89.28 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.348 1.459 . . . . 0.0 109.7 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.32 84.28 2.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.974 1.71 . . . . 0.0 109.792 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.0 m -77.16 123.87 27.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.199 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.26 112.68 11.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -82.67 131.52 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 171.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.464 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 13.6 m-85 -108.88 111.34 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -85.79 141.82 29.39 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.022 0.439 . . . . 0.0 111.498 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 43' ' ' ALA . 15.2 t80 -142.22 118.71 10.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.824 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.66 142.39 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.677 0.391 . . . . 0.0 110.489 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 C-N-CA 124.276 0.941 . . . . 0.0 113.961 175.262 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 t0 . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.114 0.483 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 128' ' ' SER . . . -84.11 -38.39 20.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.341 1.056 . . . . 0.0 111.24 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.73 -28.85 1.19 Allowed Glycine 0 C--O 1.216 -1.0 0 CA-C-O 117.868 -1.518 . . . . 0.0 113.142 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 t -40.3 -46.15 2.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.293 1.546 . . . . 0.0 113.649 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -73.62 -39.23 64.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.17 0.896 . . . . 0.0 111.517 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mt -66.44 -51.85 52.62 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.848 0.859 . . . . 0.0 112.017 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 p -62.69 -35.76 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.35 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -58.62 -54.44 47.07 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.117 1.326 . . . . 0.0 111.588 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -56.7 -45.63 81.71 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.206 -0.934 . . . . 0.0 111.638 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -65.01 -28.56 69.59 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 112.222 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -43.23 81.61 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 109.688 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.451 ' CD2' HD11 ' A' ' 116' ' ' ILE . 2.3 tt -62.89 -44.09 97.04 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.083 -1.011 . . . . 0.0 109.994 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.75 86.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.455 0.57 . . . . 0.0 112.264 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.34 -30.94 63.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.39 1.076 . . . . 0.0 112.656 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.85 -60.83 2.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 t -55.27 -21.15 13.35 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.948 0.899 . . . . 0.0 112.587 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -47.39 -33.84 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.545 1.138 . . . . 0.0 113.087 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.93 37.31 0.42 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.611 1.101 . . . . 0.0 112.283 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.9 tpt -109.47 -70.41 0.81 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.518 0.727 . . . . 0.0 110.583 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.76 64.03 0.73 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.8 1.286 . . . . 0.0 111.297 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.49 -9.52 15.37 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.68 37.77 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.236 1.398 . . . . 0.0 111.924 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.611 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 CA-C-O 120.134 -0.259 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.617 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -83.07 -49.85 9.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.38 -22.91 34.32 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 123.679 0.791 . . . . 0.0 112.106 169.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -60.46 -51.48 69.28 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.071 0.85 . . . . 0.0 110.076 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.508 ' OG1' HG21 ' A' ' 100' ' ' VAL . 11.4 m -74.85 -40.75 60.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.049 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -56.04 -52.5 64.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.194 0.906 . . . . 0.0 110.738 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.4 m -68.57 -39.64 80.91 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 110.928 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD21 ' HG ' ' A' ' 42' ' ' LEU . 9.4 tp -60.58 -51.29 70.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.626 1.557 . . . . 0.0 111.557 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 65' ' ' THR . 0.9 OUTLIER -62.37 -51.93 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 120.694 -1.253 . . . . 0.0 110.863 176.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -61.88 -18.34 59.8 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.484 -1.385 . . . . 0.0 112.711 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.08 12.11 5.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.493 1.517 . . . . 0.0 113.295 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.62 40.83 80.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.977 1.275 . . . . 0.0 112.743 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.19 -77.73 0.54 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.01 0.524 . . . . 0.0 110.861 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.39 -59.57 2.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -140.04 179.66 6.49 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.178 1.391 . . . . 0.0 109.9 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.16 35.37 2.45 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.104 1.335 . . . . 0.0 112.161 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.2 mtt -103.72 179.77 4.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.801 1.24 . . . . 0.0 111.982 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -69.77 133.74 47.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.587 0.708 . . . . 0.0 110.473 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.26 134.36 59.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.53 1.132 . . . . 0.0 108.515 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.26 152.15 36.59 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.184 0.516 . . . . 0.0 110.803 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.95 158.05 14.54 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -145.36 127.85 8.08 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 122.766 0.426 . . . . 0.0 110.552 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.29 -17.02 27.82 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.639 2.226 . . . . 0.0 112.514 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.1 61.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.508 0.723 . . . . 0.0 112.842 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 t 66.56 63.69 0.51 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 112.296 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.76 41.16 0.02 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.727 -0.608 . . . . 0.0 114.127 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.35 25.39 0.3 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.942 0.897 . . . . 0.0 111.761 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -60.26 126.97 29.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.215 1.007 . . . . 0.0 109.914 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 t -117.58 140.44 49.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.19 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -106.62 127.11 53.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -87.37 113.83 23.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.764 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -74.48 170.55 15.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.769 0.795 . . . . 0.0 111.643 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -87.75 -36.0 17.58 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.078 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -87.73 46.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 112.162 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 46.94 61.25 4.49 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.023 1.297 . . . . 0.0 112.832 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -130.15 160.31 22.92 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 123.774 0.702 . . . . 0.0 112.329 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.43 133.93 48.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.796 1.284 . . . . 0.0 108.95 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.08 135.81 59.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.911 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.48 ' HB ' HG22 ' A' ' 117' ' ' THR . 77.2 t -119.32 110.37 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.508 HG21 ' OG1' ' A' ' 65' ' ' THR . 3.0 m -90.32 125.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.33 125.55 13.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.538 -0.726 . . . . 0.0 109.248 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.86 153.96 58.55 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.488 1.459 . . . . 0.0 111.203 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -147.56 73.14 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.935 1.694 . . . . 0.0 110.852 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.7 p -104.55 82.46 1.91 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.775 1.274 . . . . 0.0 109.807 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.376 0 O-C-N 120.627 -1.295 . . . . 0.0 111.124 -175.21 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.477 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.47 133.05 56.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.085 0.942 . . . . 0.0 109.674 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.0 p -116.55 124.01 48.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 122.135 0.969 . . . . 0.0 108.968 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 42' ' ' LEU . 3.3 mp -120.8 98.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -69.38 135.68 50.66 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.56 172.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.6 p -125.28 121.86 35.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -120.58 175.42 6.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.545 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 84.19 -18.42 0.41 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.959 2.104 . . . . 0.0 111.897 -175.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -49.38 107.68 0.83 Allowed Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.283 1.833 . . . . 0.0 109.011 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -73.71 -174.47 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.352 2.035 . . . . 0.0 110.026 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -59.47 -28.13 66.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.383 -0.823 . . . . 0.0 111.863 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.4 t -70.24 -43.59 70.26 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.497 -1.377 . . . . 0.0 111.524 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 119.425 -0.322 . . . . 0.0 111.387 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -26.94 63.03 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.937 -1.102 . . . . 0.0 111.614 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.02 -53.58 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 124.49 1.116 . . . . 0.0 110.674 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 32' ' ' ALA . 60.4 p -57.08 -44.72 83.4 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.681 1.128 . . . . 0.0 113.249 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.53 -38.4 56.5 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 C-N-CA 124.851 1.26 . . . . 0.0 109.338 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.9 m -73.38 -46.6 48.01 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.963 0.801 . . . . 0.0 112.469 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 m -56.99 -32.36 66.01 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.468 1.485 . . . . 0.0 111.727 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.45 -37.36 9.75 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.105 0.86 . . . . 0.0 113.394 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.3 ttm -74.34 -15.5 60.95 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.003 -1.292 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.2 t -84.84 -21.64 29.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.323 -1.486 . . . . 0.0 111.193 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -62.64 -41.95 99.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.095 0.558 . . . . 0.0 112.086 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.2 t -161.75 55.53 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.178 0.991 . . . . 0.0 110.688 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.25 -83.55 0.19 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.81 149.13 0.01 OUTLIER Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.759 1.2 . . . . 0.0 111.827 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.0 m -49.84 143.03 8.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.986 -1.302 . . . . 0.0 111.555 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.97 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.267 0.627 . . . . 0.0 111.717 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 153.98 54.49 0.01 OUTLIER Glycine 0 C--N 1.337 0.615 0 C-N-CA 123.902 0.763 . . . . 0.0 112.488 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.62 98.38 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.358 0.599 . . . . 0.0 109.941 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -91.42 93.91 9.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.0 tt -77.32 148.87 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 111.027 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.415 ' HB2' ' H ' ' A' ' 174' ' ' THR . 24.6 t30 -54.29 122.43 10.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.669 -0.644 . . . . 0.0 112.23 -174.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.56 -52.73 3.53 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.403 1.001 . . . . 0.0 113.327 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -79.7 31.03 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.983 1.313 . . . . 0.0 111.968 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -48.81 98.18 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.253 1.421 . . . . 0.0 110.676 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -126.22 -165.86 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.915 1.286 . . . . 0.0 109.089 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.6 p -132.2 -37.63 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.009 0.924 . . . . 0.0 110.921 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.95 12.14 18.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.371 1.868 . . . . 0.0 113.646 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.58 137.42 19.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.768 0.794 . . . . 0.0 109.881 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 120.15 25.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.25 133.9 63.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 171.15 12.62 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.333 1.053 . . . . 0.0 110.245 -169.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.16 -52.19 63.41 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 111.784 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.43 -37.65 78.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.879 0.871 . . . . 0.0 111.982 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.74 42.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.322 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.34 67.47 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.581 1.082 . . . . 0.0 111.985 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -34.93 78.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.497 1.119 . . . . 0.0 112.194 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -43.06 8.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.293 1.037 . . . . 0.0 112.299 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--O 1.234 0.277 0 C-N-CA 126.702 2.001 . . . . 0.0 111.113 -179.902 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.7 p . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.439 0.161 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.19 130.73 2.77 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.022 0.82 . . . . 0.0 112.589 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.2 p -45.73 108.24 0.12 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.789 1.636 . . . . 0.0 110.804 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.5 125.94 30.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 145' ' ' ASN . 2.5 m -96.5 108.24 20.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.76 102.17 7.19 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.578 1.151 . . . . 0.0 108.576 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -81.69 131.32 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 173.529 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -111.39 101.08 9.57 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.777 0.831 . . . . 0.0 109.224 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -87.01 144.16 27.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.41 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -138.59 111.52 7.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.812 1.245 . . . . 0.0 109.912 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.93 129.01 38.99 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.346 0.658 . . . . 0.0 109.408 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.589 0 CA-C-O 116.81 -2.106 . . . . 0.0 115.661 173.534 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.612 0.244 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.9 -42.31 8.37 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.206 1.402 . . . . 0.0 112.07 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.58 -29.25 5.53 Favored Glycine 0 C--O 1.212 -1.27 0 CA-C-O 117.065 -1.964 . . . . 0.0 111.838 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.1 p -40.43 -34.92 0.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.172 2.189 . . . . 0.0 114.743 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.437 ' HG3' HD11 ' A' ' 129' ' ' ILE . 2.3 mm-40 -88.08 -38.03 15.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.25 . . . . 0.0 110.785 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.7 -47.63 30.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.399 1.08 . . . . 0.0 111.032 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -56.87 -40.3 75.9 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 109.763 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -59.13 -51.84 68.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.468 1.486 . . . . 0.0 111.692 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -50.74 -52.04 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.022 -0.424 . . . . 0.0 111.478 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -67.4 -23.91 65.61 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.1 81.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.368 1.467 . . . . 0.0 109.062 176.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.471 HD22 HD13 ' A' ' 116' ' ' ILE . 2.5 tt -67.24 -43.25 82.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.792 0.724 . . . . 0.0 109.7 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -62.59 -43.3 99.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.082 0.239 . . . . 0.0 111.309 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.18 -33.68 59.32 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.065 1.346 . . . . 0.0 112.634 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -67.07 -62.91 1.19 Allowed 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -29.92 59.75 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.79 0.836 . . . . 0.0 111.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.61 -34.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.814 1.246 . . . . 0.0 112.389 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 44.49 0.63 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.178 1.37 . . . . 0.0 112.373 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -134.0 -70.3 0.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.951 0.9 . . . . 0.0 111.46 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.439 ' HG3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -145.67 71.57 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.75 1.262 . . . . 0.0 111.784 -173.324 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -116.5 14.08 15.49 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.962 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.66 2.52 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.596 1.093 . . . . 0.0 113.032 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.478 0.96 0 CA-C-N 118.103 0.951 . . . . 0.0 111.012 178.312 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.583 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -84.77 -55.44 4.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.47 0.708 . . . . 0.0 111.927 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.56 -27.92 68.97 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.166 170.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -53.8 52.43 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.714 0.688 . . . . 0.0 110.311 175.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.442 ' CB ' HG21 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -70.85 -37.76 73.14 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 118.595 -0.717 . . . . 0.0 112.232 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HA ' HG21 ' A' ' 79' ' ' VAL . 11.0 t0 -57.83 -56.42 22.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.82 0.736 . . . . 0.0 110.834 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.439 HG22 ' HG3' ' A' ' 50' ' ' MET . 9.0 m -68.3 -35.21 77.48 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.019 1.327 . . . . 0.0 110.389 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.425 HD21 ' HG ' ' A' ' 42' ' ' LEU . 15.0 tp -62.29 -50.82 70.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.37 1.441 . . . . 0.0 111.324 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.36 -52.86 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 O-C-N 120.825 -1.172 . . . . 0.0 110.994 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.72 -18.32 62.31 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.701 -1.249 . . . . 0.0 112.38 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.84 10.22 6.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.711 1.604 . . . . 0.0 112.908 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.18 51.25 60.27 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.98 1.276 . . . . 0.0 112.307 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.08 -85.07 0.63 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.512 0.725 . . . . 0.0 111.017 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.49 -52.15 35.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 122.638 0.375 . . . . 0.0 111.646 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -149.98 -179.94 7.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.09 25.22 5.25 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.992 1.282 . . . . 0.0 112.489 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.58 168.6 10.93 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.226 1.01 . . . . 0.0 111.567 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -60.92 136.21 58.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.326 0.584 . . . . 0.0 110.403 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 66' ' ' ASP . 4.0 t -115.94 136.34 53.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.421 1.088 . . . . 0.0 108.347 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.58 128.97 50.76 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.18 154.55 33.04 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -44.69 110.42 1.04 Allowed Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.502 0.721 . . . . 0.0 112.852 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.17 -31.75 4.58 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.508 1.472 . . . . 0.0 111.694 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.73 11.85 21.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.269 1.427 . . . . 0.0 112.606 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m 62.07 98.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 112.996 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.57 38.16 1.49 Allowed Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.914 0.769 . . . . 0.0 114.037 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 p -175.52 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.809 1.244 . . . . 0.0 111.69 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -75.62 100.41 4.6 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.007 -1.058 . . . . 0.0 111.174 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -69.87 134.92 48.99 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.762 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.07 126.3 50.43 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.58 1.552 . . . . 0.0 108.81 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -81.16 111.64 17.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.286 1.035 . . . . 0.0 110.065 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.26 179.09 4.08 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.78 0.8 . . . . 0.0 111.724 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -82.76 -55.23 4.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.115 0.566 . . . . 0.0 111.946 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -83.17 50.77 1.81 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.092 0.957 . . . . 0.0 112.14 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.1 69.7 0.84 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.269 1.414 . . . . 0.0 112.928 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -129.54 163.8 22.56 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 123.28 0.467 . . . . 0.0 112.373 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.48 131.91 42.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.49 120.41 56.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.325 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 117' ' ' THR . 2.6 t -107.23 113.99 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 88' ' ' ALA . 2.1 m -97.63 139.99 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.23 135.57 9.22 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.515 0.726 . . . . 0.0 109.058 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -76.19 150.54 33.34 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 121.809 1.672 . . . . 0.0 111.057 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.23 76.0 1.52 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.224 1.488 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.33 114.53 28.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.764 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 O-C-N 121.476 -0.765 . . . . 0.0 110.87 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.061 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -70.74 120.41 16.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.385 -1.656 . . . . 0.0 111.607 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.6 p -108.63 110.71 22.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.67 1.224 . . . . 0.0 111.428 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.471 HD13 HD22 ' A' ' 42' ' ' LEU . 5.8 mt -117.36 105.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 O-C-N 120.94 -1.1 . . . . 0.0 108.25 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.583 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -74.85 139.94 43.53 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.976 171.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -131.38 122.5 26.44 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -136.29 110.13 8.16 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.796 -0.565 . . . . 0.0 110.61 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.03 -31.47 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.551 1.54 . . . . 0.0 113.058 -173.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.2 m -50.89 109.47 1.36 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.138 1.375 . . . . 0.0 109.878 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.62 -169.55 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.044 2.496 . . . . 0.0 110.692 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -33.93 69.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.646 -1.284 . . . . 0.0 113.413 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.4 p -65.99 -48.13 72.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.528 1.058 . . . . 0.0 111.222 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.45 -34.05 63.06 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.507 0.723 . . . . 0.0 111.144 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.3 t -49.62 -31.46 10.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.445 -1.409 . . . . 0.0 111.099 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.36 -54.98 6.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 124.434 1.093 . . . . 0.0 112.239 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -46.61 72.4 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.007 1.276 . . . . 0.0 113.96 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.437 HD11 ' HG3' ' A' ' 35' ' ' GLU . 51.1 mm -56.37 -38.81 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.638 1.575 . . . . 0.0 110.701 173.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -74.12 -39.67 63.19 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.362 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.4 m -58.45 -35.76 72.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.56 1.527 . . . . 0.0 111.768 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.44 -32.14 28.79 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.833 -0.542 . . . . 0.0 112.122 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 40.9 tpp -78.65 -19.93 51.46 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 118.213 1.007 . . . . 0.0 111.41 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 17.9 p -77.54 -20.5 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.408 -1.432 . . . . 0.0 111.695 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -41.44 93.61 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.069 0.948 . . . . 0.0 112.037 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.3 t -162.1 62.36 0.23 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.34 -77.78 0.15 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.3 143.83 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.408 1.004 . . . . 0.0 111.455 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 151' ' ' ASP . 2.3 p -41.92 111.2 0.21 Allowed 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.632 -1.511 . . . . 0.0 112.804 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 p -145.02 28.49 1.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.228 1.811 . . . . 0.0 110.529 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 63.05 45.76 94.86 Favored Glycine 0 CA--C 1.523 0.542 0 O-C-N 121.276 -0.89 . . . . 0.0 113.102 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.5 mt -83.48 112.52 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.66 0.784 . . . . 0.0 109.947 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -115.63 97.36 6.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.044 0.938 . . . . 0.0 109.108 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 154' ' ' VAL . 88.1 mt -73.95 164.66 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.203 0.601 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -47.15 116.34 1.36 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.71 25.33 6.73 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 123.632 0.634 . . . . 0.0 114.156 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -131.61 37.35 3.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.617 2.767 . . . . 0.0 107.818 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -36.98 90.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.086 1.755 . . . . 0.0 112.924 167.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -142.03 -174.6 4.14 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.36 1.464 . . . . 0.0 109.065 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.472 HG22 ' HA2' ' A' ' 141' ' ' GLY . 11.6 p -146.68 -41.8 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -172.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 139' ' ' THR . 10.4 p-10 -85.87 8.98 18.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.944 2.097 . . . . 0.0 113.864 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.08 136.67 8.45 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.173 0.987 . . . . 0.0 110.448 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 100.31 4.71 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.643 1.211 . . . . 0.0 108.443 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 144' ' ' ILE . 45.8 t -117.79 119.77 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.512 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.457 ' HA ' ' HB3' ' A' ' 134' ' ' SER . 0.6 OUTLIER -108.24 179.92 4.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.346 -174.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.9 62.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.824 -0.548 . . . . 0.0 111.599 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.07 -35.65 80.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.339 0.655 . . . . 0.0 112.287 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.458 HG22 HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -72.87 -52.52 22.19 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.06 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.47 67.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.5 1.046 . . . . 0.0 111.934 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.7 m -63.92 -43.98 94.28 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.531 -0.731 . . . . 0.0 111.648 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.5 t -105.54 -56.81 2.12 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.628 0 C-N-CA 126.412 1.885 . . . . 0.0 112.354 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.236 0.386 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.44 -80.56 0.55 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 72.4 p -135.98 116.97 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.11 129.45 34.5 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 109.85 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.3 m -89.8 116.85 28.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.81 122.87 21.48 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.583 0.753 . . . . 0.0 109.266 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -94.06 143.75 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.05 0.54 . . . . 0.0 109.663 174.013 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.72 114.0 18.72 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.838 0.855 . . . . 0.0 109.642 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -99.61 118.73 36.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.039 0.936 . . . . 0.0 110.966 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.466 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 36.7 t80 -102.11 103.54 14.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.442 0.697 . . . . 0.0 110.955 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -71.94 136.25 46.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.957 0.503 . . . . 0.0 110.838 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.275 0 CA-C-O 117.581 -1.677 . . . . 0.0 113.095 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 129' ' ' ILE . . . -103.02 -29.55 11.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.292 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.48 -32.2 5.33 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.918 0.77 . . . . 0.0 112.833 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -42.2 21.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.114 1.766 . . . . 0.0 113.852 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -68.2 -36.17 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.654 -1.279 . . . . 0.0 113.114 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.85 -48.2 66.8 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.551 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.0 p -64.78 -38.61 91.58 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.943 0.897 . . . . 0.0 110.828 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -58.51 -51.85 68.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.639 1.176 . . . . 0.0 111.17 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 177' ' ' PHE . 10.9 t80 -56.47 -48.26 77.47 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.171 -0.955 . . . . 0.0 112.075 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -26.54 68.58 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -42.12 88.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.459 1.104 . . . . 0.0 109.971 173.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.56 -44.99 92.5 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 117.582 -1.199 . . . . 0.0 108.918 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.75 92.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.159 0.891 . . . . 0.0 111.368 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -38.17 69.27 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.195 -0.94 . . . . 0.0 112.837 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -69.22 -57.0 5.94 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -51.98 -30.9 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.57 1.548 . . . . 0.0 112.008 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.17 -25.46 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.157 1.383 . . . . 0.0 113.373 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.41 25.5 1.85 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.67 1.605 . . . . 0.0 113.617 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -157.8 0.63 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.319 1.048 . . . . 0.0 110.489 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.08 52.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.307 1.843 . . . . 0.0 113.577 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -115.25 -60.69 1.85 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.91 1.284 . . . . 0.0 111.255 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.06 0.66 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.572 1.082 . . . . 0.0 111.03 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 125.665 1.586 . . . . 0.0 108.64 -177.507 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 CA-C-O 119.103 -0.831 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.49 -75.87 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.415 1.108 . . . . 0.0 112.334 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -32.69 70.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.81 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.1 ttp -57.37 -40.57 78.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.903 1.281 . . . . 0.0 111.789 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 69' ' ' ILE . 1.1 m -72.0 -47.36 52.5 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.843 174.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.522 ' HA ' HG21 ' A' ' 79' ' ' VAL . 2.9 t0 -50.09 -49.42 51.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.666 1.121 . . . . 0.0 111.314 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -68.32 -46.63 69.73 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.646 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.43 -42.02 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.199 0.909 . . . . 0.0 110.512 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.628 HD12 HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -63.89 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 121.188 -0.945 . . . . 0.0 110.573 175.008 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -61.39 -23.55 65.87 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.698 -0.626 . . . . 0.0 111.97 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.8 -3.47 28.75 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.374 1.47 . . . . 0.0 113.439 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.5 50.38 9.8 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.943 1.735 . . . . 0.0 112.487 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.32 -88.75 0.61 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.424 0.689 . . . . 0.0 112.271 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.56 83.43 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 122.94 0.496 . . . . 0.0 111.716 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -160.61 146.89 15.19 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 125.169 1.387 . . . . 0.0 109.586 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.11 55.4 1.13 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.655 1.121 . . . . 0.0 112.824 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 -179.87 5.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.632 1.173 . . . . 0.0 112.349 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.14 141.9 41.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.32 0.581 . . . . 0.0 110.579 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.576 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.5 t -115.44 152.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.491 1.116 . . . . 0.0 109.058 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.57 122.04 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.256 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.73 101.05 2.7 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -56.25 109.78 1.9 Allowed Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.825 0.85 . . . . 0.0 110.992 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.22 -25.0 14.01 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.77 -13.39 59.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.484 1.114 . . . . 0.0 112.661 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.08 75.39 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.344 1.458 . . . . 0.0 111.755 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.03 -53.57 0.07 OUTLIER Glycine 0 N--CA 1.465 0.609 0 C-N-CA 124.135 0.874 . . . . 0.0 111.574 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.7 t -172.16 122.95 0.48 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.122 0.969 . . . . 0.0 111.51 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.56 126.03 28.05 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.498 1.142 . . . . 0.0 110.551 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 p -95.83 138.45 33.46 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.027 -1.045 . . . . 0.0 108.747 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.76 121.19 42.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.54 124.63 29.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.697 0.799 . . . . 0.0 110.815 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.02 109.2 22.01 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -54.84 -53.27 57.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.43 0.692 . . . . 0.0 112.358 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -107.26 47.26 0.89 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 110.634 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.22 -142.16 3.32 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.261 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -114.4 -121.3 3.57 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 124.318 0.961 . . . . 0.0 111.516 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -131.15 148.66 52.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.763 0.792 . . . . 0.0 110.397 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.13 149.93 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.229 1.411 . . . . 0.0 108.561 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.723 ' HB ' HG22 ' A' ' 117' ' ' THR . 24.3 t -133.98 113.03 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 65' ' ' THR . 1.4 m -95.51 114.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 122.368 1.08 . . . . 0.0 108.869 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.68 138.34 31.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 O-C-N 120.473 -1.392 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.98 154.05 47.54 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.078 1.185 . . . . 0.0 110.731 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.34 68.42 1.14 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 123.432 1.586 . . . . 0.0 110.021 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 p -86.78 169.54 12.52 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.117 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 110.451 175.995 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -117.5 144.85 44.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.882 0.873 . . . . 0.0 110.333 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -134.98 113.32 11.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.444 1.116 . . . . 0.0 111.0 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.0 mt -115.58 108.89 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.7 OUTLIER -78.2 142.09 38.18 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.246 173.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -134.81 125.92 27.84 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.35 98.34 4.85 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -38.87 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.465 1.106 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.5 m -52.62 104.33 0.43 Allowed Pre-proline 0 C--N 1.342 0.256 0 O-C-N 125.304 1.627 . . . . 0.0 108.249 -173.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -74.35 -168.08 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.604 1.536 . . . . 0.0 110.097 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.04 -29.42 65.33 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.118 -0.989 . . . . 0.0 112.502 174.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.2 p -71.73 -40.96 69.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.783 1.174 . . . . 0.0 112.429 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.75 49.97 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.5 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.5 -30.85 13.84 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.037 1.289 . . . . 0.0 109.995 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 159' ' ' ALA . 64.1 t -78.39 -57.87 4.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 123.642 0.777 . . . . 0.0 111.536 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 37.8 m -55.91 -25.09 41.31 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.516 ' CD1' ' HB1' ' A' ' 32' ' ' ALA . 1.3 mp -85.63 -47.84 16.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 C-N-CA 126.215 1.806 . . . . 0.0 110.228 170.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.7 m -58.44 -30.4 66.89 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 121.191 1.814 . . . . 0.0 111.846 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.1 t -86.5 -49.03 7.88 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.098 -1.001 . . . . 0.0 112.044 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.94 91.85 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -33.51 76.1 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 118.555 1.177 . . . . 0.0 110.736 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.34 -20.47 19.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -26.85 65.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.262 1.025 . . . . 0.0 113.296 172.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.5 t -159.03 46.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.451 1.9 . . . . 0.0 110.856 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.3 -86.59 1.72 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.58 49.41 1.81 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 125.67 1.605 . . . . 0.0 114.785 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 151' ' ' ASP . 17.5 m 63.96 142.86 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.657 1.583 . . . . 0.0 112.224 -172.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.95 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.841 -1.162 . . . . 0.0 111.257 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.37 48.52 0.04 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 124.531 1.063 . . . . 0.0 112.269 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 7.1 mt -89.42 102.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -91.87 98.99 11.93 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 122.957 0.503 . . . . 0.0 109.713 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -73.26 141.23 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 123.584 0.753 . . . . 0.0 109.8 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -47.61 119.99 3.07 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.383 -0.823 . . . . 0.0 111.612 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.06 -45.87 1.45 Allowed Glycine 0 CA--C 1.541 1.697 0 O-C-N 120.056 -1.653 . . . . 0.0 114.882 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.48 38.84 0.8 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.347 1.859 . . . . 0.0 111.242 170.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -51.35 95.76 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.968 1.307 . . . . 0.0 110.655 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -118.36 -168.77 1.58 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.099 1.359 . . . . 0.0 108.96 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -139.84 -40.11 0.45 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.723 0.809 . . . . 0.0 110.783 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.472 ' HA ' HG23 ' A' ' 139' ' ' THR . 4.3 p-10 -89.52 17.45 6.32 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.1 1.76 . . . . 0.0 114.026 169.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.528 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -46.01 126.1 7.07 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.587 0.708 . . . . 0.0 110.326 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -113.64 85.49 2.21 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.594 1.187 . . . . 0.0 107.865 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.404 ' HA ' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -110.23 121.47 63.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.399 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 158' ' ' ILE . 2.1 p -131.41 -179.79 5.57 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.809 1.644 . . . . 0.0 110.914 -173.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.35 85.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.57 1.532 . . . . 0.0 114.136 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -58.54 -41.64 86.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.241 0.616 . . . . 0.0 110.765 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 155' ' ' THR . 0.4 OUTLIER -78.98 -36.84 19.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 122.817 0.447 . . . . 0.0 111.039 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 127' ' ' VAL . . . -50.79 -55.29 17.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 p -69.53 -29.33 66.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -66.8 -61.07 2.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.871 0.868 . . . . 0.0 111.065 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.236 0.374 0 C-N-CA 129.381 3.072 . . . . 0.0 108.421 -177.291 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.222 0.534 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -98.68 -46.43 2.12 Favored Glycine 0 N--CA 1.469 0.886 0 O-C-N 121.628 -0.67 . . . . 0.0 111.758 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.0 m -128.83 89.45 2.88 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.33 1.052 . . . . 0.0 108.967 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -79.59 102.49 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.87 0.868 . . . . 0.0 109.057 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.8 m -68.94 105.26 2.33 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.62 1.168 . . . . 0.0 109.879 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.97 112.41 16.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -85.6 137.05 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.467 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 13.0 m-85 -111.86 117.98 34.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -107.9 145.14 34.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 109.727 173.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -142.65 109.01 5.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.696 1.198 . . . . 0.0 109.154 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -100.09 98.19 8.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.539 1.136 . . . . 0.0 109.549 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 124.849 1.214 . . . . 0.0 113.633 178.276 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 111.121 0.045 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.507 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -75.72 -39.98 56.39 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.643 0.777 . . . . 0.0 110.96 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.61 -27.06 0.8 Allowed Glycine 0 C--O 1.216 -0.984 0 CA-C-O 116.326 -2.375 . . . . 0.0 113.311 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -38.55 -48.26 1.4 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.485 2.142 . . . . 0.0 114.341 166.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -30.35 60.51 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.782 -1.199 . . . . 0.0 112.207 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.6 -50.23 18.66 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.046 0.939 . . . . 0.0 111.065 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 t -58.55 -45.16 89.52 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.48 1.112 . . . . 0.0 110.468 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -60.96 -49.68 76.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.309 0.958 . . . . 0.0 112.094 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 177' ' ' PHE . 0.6 OUTLIER -50.35 -59.74 3.68 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.467 0.707 . . . . 0.0 111.348 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -59.6 -27.37 66.24 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 118.805 -0.616 . . . . 0.0 110.795 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 44' ' ' THR . 0.3 OUTLIER -69.05 -46.56 67.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.745 1.218 . . . . 0.0 111.393 177.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 68' ' ' LEU . 3.8 tp -54.65 -44.66 73.44 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 47' ' ' ILE . . . -69.54 -43.48 72.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -68.6 -15.04 63.4 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.981 1.712 . . . . 0.0 112.709 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.577 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 20.9 m-20 -95.47 -52.03 4.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -22.41 2.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.974 0.909 . . . . 0.0 111.84 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 43' ' ' ALA . 14.1 pt -41.8 -41.99 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.634 1.174 . . . . 0.0 113.012 171.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.8 21.46 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.279 0.943 . . . . 0.0 114.375 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.453 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -75.09 -55.38 5.79 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.22 1.008 . . . . 0.0 109.422 177.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.71 21.16 0.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -96.52 80.83 3.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.254 -1.529 . . . . 0.0 110.038 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 44.64 49.47 8.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.595 1.184 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.3 t . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 123.718 0.807 . . . . 0.0 110.384 -172.847 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 N-CA-C 114.063 0.385 . . . . 0.0 114.063 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 88' ' ' ALA . . . -87.43 -63.26 1.33 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.351 1.86 . . . . 0.0 110.276 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -38.35 66.0 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.269 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -59.77 -51.38 69.99 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 112.342 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.426 HG23 HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -65.83 -36.8 84.5 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.414 -0.327 . . . . 0.0 111.625 175.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -51.52 69.72 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.919 0.887 . . . . 0.0 110.441 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 p -68.18 -35.35 77.88 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 111.384 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.665 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -64.67 -50.08 68.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.791 1.178 . . . . 0.0 110.708 174.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.426 HD12 HG23 ' A' ' 65' ' ' THR . 3.4 mt -63.14 -50.58 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.893 -1.129 . . . . 0.0 110.061 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -60.78 -32.67 72.0 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.096 -1.002 . . . . 0.0 112.321 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.42 65.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.82 0.848 . . . . 0.0 112.848 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.79 4.81 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 124.998 1.285 . . . . 0.0 112.397 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.665 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -100.07 -64.01 1.08 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.59 -63.18 1.38 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.917 0.389 . . . . 0.0 110.247 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -132.61 -170.66 2.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.02 1.328 . . . . 0.0 109.062 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -140.59 16.71 2.87 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.26 0.933 . . . . 0.0 112.831 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.9 ttt -92.58 171.36 9.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.384 1.074 . . . . 0.0 111.329 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.41 141.81 53.75 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.346 0.593 . . . . 0.0 110.603 174.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.481 HG13 HD23 ' A' ' 90' ' ' LEU . 2.8 t -118.89 148.18 21.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 108.583 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.32 130.48 53.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.053 0.541 . . . . 0.0 110.08 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.03 130.71 9.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -114.34 101.61 54.27 Favored Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 124.365 1.066 . . . . 0.0 108.541 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -74.33 -35.82 3.6 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.766 2.31 . . . . 0.0 112.197 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.01 66.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.996 0.918 . . . . 0.0 112.125 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -59.86 1.76 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.916 0.886 . . . . 0.0 111.838 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.27 24.52 7.49 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.819 1.676 . . . . 0.0 113.582 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -135.06 88.33 2.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.647 1.579 . . . . 0.0 108.462 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -55.94 151.43 11.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.833 0.825 . . . . 0.0 111.686 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.0 p -129.06 147.17 50.9 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.719 0.808 . . . . 0.0 108.959 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.481 HD23 HG13 ' A' ' 79' ' ' VAL . 1.5 tm? -127.37 122.22 33.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.716 0.77 . . . . 0.0 109.265 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -80.84 120.82 25.18 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.491 0.716 . . . . 0.0 110.309 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -76.28 132.33 39.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.559 . . . . 0.0 109.861 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t -54.38 -47.64 72.43 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.9 0.48 . . . . 0.0 111.723 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -140.24 76.1 1.54 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 110.591 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.8 -103.23 0.16 Allowed Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.232 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.81 -119.77 0.91 Allowed Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.77 154.81 48.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 122.649 1.214 . . . . 0.0 110.744 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.4 mt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 125.473 1.509 . . . . 0.0 107.789 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.33 116.13 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 125.08 1.352 . . . . 0.0 107.371 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.595 HG22 ' HB3' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -98.6 124.84 52.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.98 145.52 22.65 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.513 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -77.31 154.56 32.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 121.912 1.742 . . . . 0.0 111.213 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.58 74.79 1.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.03 1.732 . . . . 0.0 110.641 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -111.94 140.84 46.28 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.829 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 C-N-CA 123.223 0.609 . . . . 0.0 110.052 -178.767 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.82 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.83 145.39 27.02 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 174.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.5 p -131.57 107.08 8.61 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.838 1.304 . . . . 0.0 110.929 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.21 106.98 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.3 OUTLIER -71.73 135.23 46.7 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.61 0.764 . . . . 0.0 109.545 171.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.6 p -134.39 120.04 19.35 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.67 119.24 26.5 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.72 -0.612 . . . . 0.0 109.697 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.55 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.857 1.663 . . . . 0.0 112.731 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.18 103.03 0.33 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.396 1.878 . . . . 0.0 109.844 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 21.2 Cg_endo -75.17 -167.83 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.384 2.056 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -22.08 65.31 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.745 -1.222 . . . . 0.0 113.549 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.8 p -78.16 -52.0 9.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.917 0.887 . . . . 0.0 110.321 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.581 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -72.61 -21.62 61.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.668 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -52.6 -32.37 41.05 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.697 -1.252 . . . . 0.0 110.187 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.91 -41.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.135 1.374 . . . . 0.0 111.872 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.507 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 19.3 m -59.75 -34.8 73.44 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 119.903 -1.748 . . . . 0.0 113.152 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.72 -34.5 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.551 ' HB2' HG12 ' A' ' 154' ' ' VAL . 26.6 p -63.85 -41.98 97.68 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 120.753 1.615 . . . . 0.0 112.431 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 156' ' ' ALA . 12.4 t -77.07 -39.51 49.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.753 0.821 . . . . 0.0 111.34 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.24 -38.29 71.77 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 5.3 ttm -83.03 -32.21 27.01 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 110.282 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.8 t -62.9 -26.65 68.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.659 1.572 . . . . 0.0 112.413 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -62.74 -26.87 68.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -154.75 46.77 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.68 -83.0 1.71 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 40.5 58.84 2.43 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.76 1.171 . . . . 0.0 113.222 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 151' ' ' ASP . 3.7 m 70.17 135.06 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.4 1.48 . . . . 0.0 111.727 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 p 179.77 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.061 -1.024 . . . . 0.0 111.696 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.01 49.49 23.58 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.42 1.01 . . . . 0.0 113.499 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 2.7 mt -92.07 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.397 0.617 . . . . 0.0 109.999 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -89.3 94.13 9.79 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.037 -0.414 . . . . 0.0 110.449 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.417 HD11 ' HB1' ' A' ' 152' ' ' ALA . 10.0 mt -70.62 144.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.373 1.069 . . . . 0.0 110.467 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -48.33 118.55 2.5 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.01 -48.32 1.69 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.935 0.778 . . . . 0.0 113.466 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.43 36.83 0.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.438 1.895 . . . . 0.0 112.141 172.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -54.22 96.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.565 1.146 . . . . 0.0 110.019 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -119.64 -169.13 1.71 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.378 1.471 . . . . 0.0 109.772 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -134.67 -40.59 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.581 0.753 . . . . 0.0 110.866 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 139' ' ' THR . 5.8 p-10 -91.63 17.81 8.32 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.304 1.842 . . . . 0.0 113.863 170.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -42.77 130.22 4.18 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.628 0.728 . . . . 0.0 111.574 174.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 77.8 1.81 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.328 1.061 . . . . 0.0 109.044 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 130' ' ' SER . 6.1 t -98.68 135.84 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.522 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.2 167.03 22.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.813 1.245 . . . . 0.0 110.673 -172.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 131' ' ' THR . . . -54.83 -34.98 63.45 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.963 -0.461 . . . . 0.0 111.977 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.31 -44.11 22.27 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.073 1.349 . . . . 0.0 110.586 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -52.55 59.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.579 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.6 71.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.016 0.825 . . . . 0.0 111.228 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -45.68 71.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.263 0.625 . . . . 0.0 111.619 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.0 t -85.25 -55.9 3.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.515 0.726 . . . . 0.0 111.937 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 127.531 2.332 . . . . 0.0 112.756 -178.934 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 C--O 1.24 0.574 0 CA-C-O 120.711 0.291 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -48.21 160.41 0.57 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.379 0.433 . . . . 0.0 112.085 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 60.3 p -43.07 126.72 4.04 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.493 1.117 . . . . 0.0 110.982 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.43 87.4 3.39 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.725 -1.235 . . . . 0.0 108.812 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.5 m -83.53 125.13 31.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.12 102.32 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.831 1.252 . . . . 0.0 108.146 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -76.5 131.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 38.8 m-85 -107.59 111.87 24.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.063 0.545 . . . . 0.0 109.907 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.28 106.35 18.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.018 0.913 . . . . 0.0 110.335 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.494 ' CG ' ' HB1' ' A' ' 43' ' ' ALA . 90.5 t80 -86.49 110.33 19.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 110.362 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -123.72 145.51 48.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.76 1.224 . . . . 0.0 109.893 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.217 0 C-N-CA 124.438 1.018 . . . . 0.0 113.122 176.377 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.51 0.671 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -128.96 -66.13 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 43.61 -140.97 2.83 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 69.11 -62.1 0.41 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.072 2.149 . . . . 0.0 111.835 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -134.97 137.89 43.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 128.405 2.682 . . . . 0.0 109.833 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.59 -9.75 58.71 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.743 1.217 . . . . 0.0 112.849 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.51 ' HB1' ' CD1' ' A' ' 129' ' ' ILE . . . -95.51 -35.74 11.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.366 1.066 . . . . 0.0 110.932 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -30.25 10.35 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 124.271 0.938 . . . . 0.0 113.205 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -39.89 -47.1 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.012 1.325 . . . . 0.0 113.891 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.32 -39.0 59.97 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.239 0.927 . . . . 0.0 112.449 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 129' ' ' ILE . 10.9 mt -58.4 -47.78 82.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.361 0.6 . . . . 0.0 110.394 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 p -66.48 -37.69 85.66 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 117.669 -1.158 . . . . 0.0 110.725 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -59.06 -54.55 45.81 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.274 1.397 . . . . 0.0 112.203 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' A' ' 118' ' ' THR . 15.5 m-30 -57.13 -46.22 82.87 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.011 -1.055 . . . . 0.0 111.339 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.4 -27.48 68.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.516 0.726 . . . . 0.0 112.619 173.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -49.34 71.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.671 1.188 . . . . 0.0 108.861 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 116' ' ' ILE . 3.2 tt -61.99 -40.55 96.04 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 118.933 0.788 . . . . 0.0 109.669 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -62.4 -42.85 99.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.726 0.694 . . . . 0.0 111.895 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -33.12 47.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.126 0.97 . . . . 0.0 113.121 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -70.31 -64.04 0.97 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.224 -0.922 . . . . 0.0 108.523 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.87 -21.18 27.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.801 1.24 . . . . 0.0 112.64 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -44.93 -33.26 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.196 0.999 . . . . 0.0 111.98 171.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.04 50.93 0.2 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.68 1.134 . . . . 0.0 112.868 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.5 tpt -113.71 -63.82 1.4 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.694 0.798 . . . . 0.0 111.121 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.44 34.32 0.46 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.693 1.197 . . . . 0.0 112.357 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 31.48 0.27 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.637 1.175 . . . . 0.0 113.165 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.16 49.14 2.29 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.245 0.926 . . . . 0.0 112.108 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.69 57.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.737 1.615 . . . . 0.0 110.456 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.96 -50.02 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.939 1.296 . . . . 0.0 110.841 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.79 73.03 1.27 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.804 0.716 . . . . 0.0 111.571 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -104.52 168.58 8.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.81 1.244 . . . . 0.0 111.927 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.27 166.8 5.82 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.842 0.457 . . . . 0.0 111.171 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 58.66 166.25 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 122.736 1.255 . . . . 0.0 113.214 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.9 m -80.61 -35.02 34.64 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.629 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m 49.51 53.78 12.11 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.102 0.961 . . . . 0.0 112.188 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.34 4.5 6.41 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.082 0.849 . . . . 0.0 114.195 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.713 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -107.17 -62.75 1.37 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.052 0.941 . . . . 0.0 113.018 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -25.58 60.05 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.372 172.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mtp -53.47 -57.14 11.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.908 0.883 . . . . 0.0 111.867 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.512 HG23 HD12 ' A' ' 69' ' ' ILE . 1.1 m -69.73 -40.12 76.39 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.37 176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' HA ' HG21 ' A' ' 79' ' ' VAL . 19.2 t70 -50.73 -47.24 59.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -70.16 -42.33 72.65 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.0 111.14 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tp -59.27 -51.44 69.95 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.889 1.222 . . . . 0.0 112.014 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.563 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -61.12 -52.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 120.766 -1.209 . . . . 0.0 110.015 177.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -62.27 -23.58 66.78 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.907 -1.121 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -2.9 23.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 113.796 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.65 78.88 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.089 1.804 . . . . 0.0 112.886 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.11 -76.9 0.24 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 117.73 0.765 . . . . 0.0 111.289 -177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.39 -50.66 36.33 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 111.8 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.45 132.42 8.78 Favored 'General case' 0 C--O 1.211 -0.926 0 C-N-CA 124.703 1.201 . . . . 0.0 109.85 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.63 59.37 4.6 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 119.419 1.008 . . . . 0.0 113.251 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.06 176.73 7.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.102 0.961 . . . . 0.0 112.475 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.16 147.64 38.34 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.705 -0.622 . . . . 0.0 110.685 172.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.563 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.3 t -121.23 157.51 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 109.007 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.9 OUTLIER -107.38 101.93 11.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.74 112.91 4.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -35.92 115.79 0.6 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.603 1.161 . . . . 0.0 113.341 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -71.49 -18.14 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.301 1.334 . . . . 0.0 112.026 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.33 -4.79 41.42 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.86 1.264 . . . . 0.0 113.262 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 86.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.133 1.373 . . . . 0.0 113.057 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.77 -40.57 0.02 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.182 -0.949 . . . . 0.0 114.136 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 p -158.37 114.31 2.71 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.307 1.443 . . . . 0.0 111.638 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.713 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -60.66 161.38 7.86 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 122.743 1.258 . . . . 0.0 111.811 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 80' ' ' SER . 3.7 t -135.85 127.46 28.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.528 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.465 HD23 HD13 ' A' ' 69' ' ' ILE . 2.0 tm? -99.41 136.75 38.89 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.304 1.05 . . . . 0.0 109.403 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -93.26 104.64 16.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.574 1.15 . . . . 0.0 110.651 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.31 112.09 23.54 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.319 0.648 . . . . 0.0 110.168 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -57.86 5.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.641 -0.662 . . . . 0.0 111.815 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -68.03 -46.21 71.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.128 0.571 . . . . 0.0 112.002 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.84 -123.08 0.11 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.337 0.97 . . . . 0.0 111.923 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -143.65 -98.09 0.26 Allowed Glycine 0 N--CA 1.465 0.596 0 O-C-N 122.093 -0.651 . . . . 0.0 112.266 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.53 149.29 52.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.062 0.934 . . . . 0.0 110.261 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 mt -130.63 145.24 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.362 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.633 ' HB ' HG22 ' A' ' 117' ' ' THR . 21.9 t -132.27 109.59 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.512 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 1.9 m -94.93 122.0 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.54 131.74 11.95 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.054 -1.029 . . . . 0.0 109.446 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.5 152.4 43.37 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.179 1.253 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -145.82 66.85 1.21 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.476 1.911 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.9 p -100.14 97.96 8.72 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.319 1.057 . . . . 0.0 109.251 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.57 113.91 4.89 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.849 -1.157 . . . . 0.0 110.84 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.03 73.8 1.23 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -110.59 165.85 12.29 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.324 0.964 . . . . 0.0 112.057 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.8 p -142.1 -43.95 0.34 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.945 0.898 . . . . 0.0 111.772 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.13 58.05 0.71 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 125.685 1.612 . . . . 0.0 111.38 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 53.68 43.12 31.54 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.992 0.901 . . . . 0.0 112.632 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -92.68 115.98 28.6 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.642 -0.661 . . . . 0.0 109.765 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -102.72 138.82 39.11 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.344 0.658 . . . . 0.0 109.792 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.57 112.46 3.97 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.33 135.81 48.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.258 1.529 . . . . 0.0 109.033 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.7 p -122.06 116.77 24.86 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.463 ' CD1' HD22 ' A' ' 42' ' ' LEU . 16.2 mt -124.41 104.5 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.633 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.8 OUTLIER -75.84 142.55 42.18 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.248 173.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 39' ' ' TYR . 2.6 p -140.66 128.28 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.87 0.843 . . . . 0.0 108.989 -177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.72 99.6 4.67 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -172.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.514 1.126 . . . . 0.0 112.393 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.2 t -48.61 101.95 0.29 Allowed Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 127.001 2.12 . . . . 0.0 109.09 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 28.8 Cg_endo -73.13 -171.21 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.773 1.649 . . . . 0.0 110.758 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.4 tm0? -59.81 -44.25 94.08 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.944 -1.097 . . . . 0.0 112.544 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 p -56.54 -42.4 78.45 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.051 -1.03 . . . . 0.0 112.002 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -78.97 -29.37 43.84 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.057 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -30.41 14.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.895 1.68 . . . . 0.0 110.496 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.42 -55.78 6.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 125.451 1.5 . . . . 0.0 111.335 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 31.2 m -57.64 -48.73 78.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.778 1.172 . . . . 0.0 113.327 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.613 HG23 HD21 ' A' ' 36' ' ' LEU . 36.6 mm -56.13 -47.2 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 C-N-CA 125.615 1.566 . . . . 0.0 110.981 171.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -62.92 -45.69 91.31 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.167 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 m -51.01 -42.47 60.44 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 111.365 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.06 -39.23 33.07 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 121.933 -0.479 . . . . 0.0 113.137 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 11.4 ttm -67.85 -20.5 65.15 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.467 -1.608 . . . . 0.0 112.466 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 -28.17 57.44 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.753 1.221 . . . . 0.0 111.888 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -16.14 63.34 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 112.836 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.08 46.94 0.92 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.386 1.474 . . . . 0.0 110.716 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -35.58 -64.88 0.49 Allowed Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.571 1.558 . . . . 0.0 113.293 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 17.78 75.59 0.01 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 127.308 2.385 . . . . 0.0 113.355 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 151' ' ' ASP . 20.4 p -51.54 167.2 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.897 1.679 . . . . 0.0 112.466 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -33.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.502 -0.749 . . . . 0.0 111.812 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 170.79 51.0 0.04 OUTLIER Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.636 0.636 . . . . 0.0 112.891 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.4 mt -86.84 113.42 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -119.46 103.15 9.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 108.362 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.87 166.95 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -51.9 119.18 4.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.008 1.323 . . . . 0.0 112.675 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.28 27.44 5.53 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.484 0.564 . . . . 0.0 113.909 -173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.72 32.85 4.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.877 2.071 . . . . 0.0 109.024 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -36.62 98.96 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.114 1.366 . . . . 0.0 111.129 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -142.42 -174.07 4.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.456 1.502 . . . . 0.0 108.691 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.409 HG22 ' HA2' ' A' ' 141' ' ' GLY . 4.7 p -147.98 -46.48 0.16 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.212 -0.93 . . . . 0.0 109.107 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.433 ' HA ' HG21 ' A' ' 139' ' ' THR . 28.1 m-20 -83.52 18.56 1.82 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.591 1.556 . . . . 0.0 112.881 172.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.06 111.6 2.26 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.417 -0.802 . . . . 0.0 110.717 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 105.75 17.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.487 ' HA ' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -111.91 129.26 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.763 1.225 . . . . 0.0 110.027 -176.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 175.2 9.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.794 1.238 . . . . 0.0 110.945 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.96 39.76 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.785 -0.572 . . . . 0.0 112.473 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -61.27 -33.15 73.07 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.654 0.782 . . . . 0.0 111.969 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.487 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -70.19 -51.39 39.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.588 176.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.98 66.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 119.192 0.905 . . . . 0.0 112.138 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -28.96 68.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.751 0.821 . . . . 0.0 112.648 171.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.94 -48.95 3.49 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.135 1.374 . . . . 0.0 112.838 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -51.77 -47.07 64.31 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.449 1.9 . . . . 0.0 111.307 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 35.5 m -81.98 133.73 35.32 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.4 m -54.55 155.22 4.19 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.786 1.234 . . . . 0.0 110.516 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -39.7 -56.75 1.65 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.791 1.236 . . . . 0.0 112.499 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -177.21 117.05 0.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.158 1.783 . . . . 0.0 109.512 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 170' ' ' THR . 55.3 m-20 -125.24 38.09 4.25 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.381 1.072 . . . . 0.0 110.743 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 53.79 -99.22 0.05 OUTLIER Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.302 1.429 . . . . 0.0 112.281 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -100.68 79.89 2.13 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.037 1.335 . . . . 0.0 110.415 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 167' ' ' ASN . 35.7 p -56.8 156.94 5.96 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.869 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -45.53 146.7 2.32 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 122.98 0.324 . . . . 0.0 112.295 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 20.1 p -46.59 118.62 2.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.019 1.328 . . . . 0.0 111.567 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.17 85.2 6.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 122.405 1.097 . . . . 0.0 109.182 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 m -75.13 116.04 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.316 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.1 119.0 23.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.634 0.774 . . . . 0.0 109.204 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -93.74 128.81 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -103.11 127.63 50.31 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.04 139.45 46.39 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.287 0.635 . . . . 0.0 110.283 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.465 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -130.57 111.82 12.59 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.274 1.029 . . . . 0.0 110.234 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.64 142.39 27.67 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.137 0.575 . . . . 0.0 110.896 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 C-N-CA 124.462 1.03 . . . . 0.0 112.697 -177.377 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.328 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -168.59 161.89 11.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.421 1.088 . . . . 0.0 110.601 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.35 153.77 15.46 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.375 0.512 . . . . 0.0 111.978 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -135.74 -66.96 0.54 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.265 1.026 . . . . 0.0 110.664 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -148.68 179.77 7.58 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.698 1.599 . . . . 0.0 111.468 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.43 -40.61 73.71 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.318 1.047 . . . . 0.0 111.944 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.39 -35.91 9.04 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.693 1.197 . . . . 0.0 112.05 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.03 -29.87 9.05 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 117.863 -1.521 . . . . 0.0 111.908 170.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -49.54 -38.59 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.197 1.399 . . . . 0.0 112.779 171.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -79.82 -38.17 33.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.145 -0.972 . . . . 0.0 111.282 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 129' ' ' ILE . 2.1 mt -71.35 -47.29 57.32 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.411 0.624 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -60.61 -41.21 94.35 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.916 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -59.86 -46.27 89.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.764 1.62 . . . . 0.0 111.796 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -48.91 -62.68 1.39 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.933 0.893 . . . . 0.0 109.738 174.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -21.14 66.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.758 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.44 68.45 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.308 1.443 . . . . 0.0 109.483 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.54 -38.7 87.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.885 1.221 . . . . 0.0 110.011 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB1' ' CZ ' ' A' ' 179' ' ' TYR . . . -65.56 -45.95 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.36 0.664 . . . . 0.0 111.893 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -76.57 -38.84 54.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.266 1.027 . . . . 0.0 112.034 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 8.9 m120 -64.4 -56.76 12.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 t -58.35 -26.81 63.57 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.689 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.06 -26.73 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.65 53.81 0.28 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.903 1.24 . . . . 0.0 113.03 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.64 -71.49 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.184 0.994 . . . . 0.0 111.079 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.6 mmt -139.73 53.25 1.69 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.77 1.228 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -109.85 2.66 20.04 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.695 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.17 -30.3 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.213 0.911 . . . . 0.0 113.534 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -48.15 120.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.293 1.047 . . . . 0.0 109.707 171.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 t70 65.0 110.74 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.163 1.385 . . . . 0.0 113.18 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.8 158.35 34.57 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.332 -0.855 . . . . 0.0 112.764 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -154.27 100.41 2.3 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.282 1.033 . . . . 0.0 109.878 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.95 166.69 25.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.162 0.985 . . . . 0.0 111.113 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.59 162.79 28.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.322 1.049 . . . . 0.0 110.556 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.4 m 57.17 86.16 0.07 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 122.544 1.164 . . . . 0.0 111.488 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.06 81.12 1.65 Allowed 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.89 -55.59 0.06 OUTLIER Glycine 0 N--CA 1.47 0.931 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.954 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.3 -67.57 0.38 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.67 0.735 . . . . 0.0 110.501 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -59.3 -33.52 71.19 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.402 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -46.28 90.95 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.668 0.667 . . . . 0.0 111.357 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.549 HG21 HG11 ' A' ' 100' ' ' VAL . 1.1 m -64.3 -42.32 96.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.371 -0.824 . . . . 0.0 110.081 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.418 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -58.33 -50.02 75.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.278 0.944 . . . . 0.0 110.68 177.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -66.88 -40.87 87.91 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 124.563 1.145 . . . . 0.0 111.12 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 8.7 tp -61.47 -52.83 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.355 1.462 . . . . 0.0 110.83 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 65' ' ' THR . 9.1 mt -59.13 -51.32 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.095 -1.003 . . . . 0.0 111.251 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -63.29 -25.8 68.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.593 -0.692 . . . . 0.0 112.737 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.72 21.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.023 1.329 . . . . 0.0 112.743 171.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.59 58.39 5.42 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.787 1.184 . . . . 0.0 111.628 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -123.21 -81.16 0.64 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.46 -59.82 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -136.26 -163.06 1.35 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.755 1.622 . . . . 0.0 110.242 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.58 21.1 1.04 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.756 1.169 . . . . 0.0 112.937 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.7 mmt -90.68 173.72 7.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.594 1.158 . . . . 0.0 112.144 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.22 120.49 13.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.024 0.916 . . . . 0.0 109.576 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 90' ' ' LEU . 2.5 t -98.47 122.72 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -67.82 115.84 7.82 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 166.17 54.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.45 128.09 7.51 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 122.426 -0.455 . . . . 0.0 111.046 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.57 -17.56 29.88 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.679 2.253 . . . . 0.0 113.021 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.01 60.47 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 0.0 112.654 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.45 65.11 1.42 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.423 1.089 . . . . 0.0 112.329 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.56 37.45 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 p -175.43 57.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.477 1.111 . . . . 0.0 111.391 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -90.43 150.17 21.94 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.294 1.045 . . . . 0.0 110.766 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.5 p -136.26 126.06 25.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.451 HD23 HD13 ' A' ' 69' ' ' ILE . 1.8 tm? -96.95 127.35 42.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.935 0.874 . . . . 0.0 108.879 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -101.17 116.71 33.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -72.94 170.76 14.11 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.137 0.494 . . . . 0.0 110.79 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.77 -55.34 6.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.119 0.967 . . . . 0.0 112.43 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.52 152.29 16.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 110.621 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.25 25.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.008 0.813 . . . . 0.0 112.805 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.25 128.68 2.07 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -133.8 136.96 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.991 0.901 . . . . 0.0 108.86 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.37 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.363 1.065 . . . . 0.0 108.252 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 117' ' ' THR . 40.4 t -136.33 111.05 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 65' ' ' THR . 1.1 m -102.81 122.45 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 126.18 14.49 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.042 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -70.34 150.45 64.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.542 1.494 . . . . 0.0 110.688 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -141.11 77.37 1.59 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.026 1.393 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 p -87.51 156.24 19.63 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.933 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -126.43 130.82 51.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.343 0.657 . . . . 0.0 110.034 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.96 39.86 2.75 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.075 1.321 . . . . 0.0 111.849 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.02 -89.98 0.93 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 78.3 p -134.98 38.49 3.0 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.772 1.272 . . . . 0.0 111.399 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.03 -148.91 5.97 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.317 1.437 . . . . 0.0 111.055 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -163.02 33.55 0.1 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.17 0.988 . . . . 0.0 111.523 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -91.1 147.97 22.7 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 120.531 -1.356 . . . . 0.0 109.972 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' ND2' ' CE2' ' A' ' 114' ' ' PHE . 13.1 t30 -121.93 133.8 54.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.921 0.888 . . . . 0.0 109.846 175.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.49 78.21 0.24 Allowed Glycine 0 CA--C 1.526 0.78 0 C-N-CA 126.127 1.822 . . . . 0.0 110.888 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CE2' ' ND2' ' A' ' 112' ' ' ASN . 42.5 m-85 -53.61 142.91 21.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.799 1.299 . . . . 0.0 112.099 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.2 p -128.83 104.82 7.83 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.06 0.944 . . . . 0.0 109.314 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 mt -108.07 93.12 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.495 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -67.9 138.25 55.87 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 172.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -135.6 127.66 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -136.34 104.2 5.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.356 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.43 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.824 1.249 . . . . 0.0 111.962 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 173' ' ' ASN . 22.6 m -53.5 107.06 0.75 Allowed Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.23 1.812 . . . . 0.0 107.881 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 20.3 Cg_endo -74.85 -169.47 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.851 1.034 . . . . 0.0 110.768 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -19.14 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.41 -0.806 . . . . 0.0 113.112 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 t -77.95 -46.29 21.59 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.097 -1.627 . . . . 0.0 111.076 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.24 -28.48 62.18 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.12 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -52.92 -28.84 25.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.817 1.644 . . . . 0.0 111.329 176.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.4 -55.68 6.03 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 C-N-CA 125.972 1.709 . . . . 0.0 110.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 m -60.31 -44.1 95.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.226 -1.546 . . . . 0.0 113.2 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 36' ' ' LEU . 35.7 mm -56.57 -42.79 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.737 1.615 . . . . 0.0 109.772 171.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.504 ' HB2' HG12 ' A' ' 154' ' ' VAL . 3.7 p -65.32 -45.35 84.65 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 119.187 0.903 . . . . 0.0 112.42 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.9 m -60.55 -30.02 69.52 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.873 1.269 . . . . 0.0 110.904 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.91 -32.85 13.5 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 123.567 0.603 . . . . 0.0 113.493 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.5 tpp -74.39 -24.77 59.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.997 1.398 . . . . 0.0 111.304 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 p -66.46 -24.18 66.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.805 1.642 . . . . 0.0 111.494 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -70.47 -4.92 25.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.793 1.237 . . . . 0.0 113.491 171.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.61 48.44 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.548 1.139 . . . . 0.0 111.103 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -40.53 -51.63 3.79 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.743 1.163 . . . . 0.0 114.711 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.75 73.53 0.48 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.791 1.186 . . . . 0.0 112.307 169.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.455 HG21 HG12 ' A' ' 142' ' ' ILE . 3.3 m -69.55 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.629 0.772 . . . . 0.0 110.452 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t 172.86 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.256 1.422 . . . . 0.0 111.794 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 150' ' ' THR . . . -177.78 73.74 0.07 OUTLIER Glycine 0 C--N 1.341 0.848 0 O-C-N 121.78 -0.575 . . . . 0.0 113.667 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 13.2 mt -94.64 99.68 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.996 0.919 . . . . 0.0 111.708 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -91.95 94.81 9.47 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.874 -0.516 . . . . 0.0 110.691 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.5 mt -68.85 153.12 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.24 1.016 . . . . 0.0 110.489 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -52.68 116.92 2.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.931 -1.106 . . . . 0.0 110.498 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.86 -43.96 0.99 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.412 1.006 . . . . 0.0 113.835 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.59 34.34 0.53 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.869 2.068 . . . . 0.0 111.682 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -46.32 93.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.837 1.655 . . . . 0.0 111.886 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -113.94 -168.22 1.32 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.104 1.361 . . . . 0.0 109.565 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.435 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.4 p -138.7 -49.71 0.53 Allowed 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.818 -0.551 . . . . 0.0 110.856 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 20.25 2.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.541 1.537 . . . . 0.0 112.25 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -45.23 126.12 5.98 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-O 121.559 0.695 . . . . 0.0 111.061 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -117.91 70.62 0.8 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 122.33 1.062 . . . . 0.0 108.391 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 130' ' ' SER . 13.0 t -91.68 130.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.93 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.44 176.1 7.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.91 1.284 . . . . 0.0 110.412 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.33 58.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.653 0.66 . . . . 0.0 112.078 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -61.51 -32.53 72.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.703 0.801 . . . . 0.0 112.551 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.469 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -73.35 -50.69 29.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.458 1.027 . . . . 0.0 111.476 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 p -69.39 -32.0 70.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.299 0.64 . . . . 0.0 111.87 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.7 t -92.4 -50.94 5.38 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.31 1.044 . . . . 0.0 112.18 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -55.56 -51.53 66.77 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 127.265 2.226 . . . . 0.0 111.867 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 78.2 m -80.31 72.78 7.17 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.186 0.993 . . . . 0.0 110.211 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.77 160.84 24.97 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.771 1.228 . . . . 0.0 110.406 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 65.08 -174.91 0.18 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.093 1.357 . . . . 0.0 112.473 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -124.72 72.89 1.23 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.404 1.482 . . . . 0.0 109.964 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -76.28 131.66 39.37 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.703 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -63.17 -40.01 98.62 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 112.134 -0.386 . . . . 0.0 112.134 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -174.39 59.5 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.032 1.733 . . . . 0.0 111.742 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.23 125.32 24.67 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.365 -0.834 . . . . 0.0 112.094 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 35.06 -135.51 0.39 Allowed Glycine 0 C--N 1.339 0.734 0 O-C-N 124.394 1.059 . . . . 0.0 111.57 -174.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.1 p -149.03 123.84 9.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.434 ' HB3' HG23 ' A' ' 121' ' ' VAL . 4.9 t-20 -76.83 136.23 38.92 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.118 -0.988 . . . . 0.0 110.749 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 m -109.47 112.46 24.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.22 109.86 10.72 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -81.98 135.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.108 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 179' ' ' TYR . 0.6 OUTLIER -100.67 120.26 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -97.94 144.36 27.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.105 0.562 . . . . 0.0 111.586 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.2 t80 -142.67 105.71 4.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.336 0.654 . . . . 0.0 111.594 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.19 140.13 37.76 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.392 0.677 . . . . 0.0 110.386 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.046 -1.419 . . . . 0.0 111.896 178.24 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.532 0.682 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -160.73 149.28 16.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.145 0.978 . . . . 0.0 109.619 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.1 171.2 28.18 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.51 0.576 . . . . 0.0 111.98 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.92 -64.92 0.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 O-C-N 122.088 -0.654 . . . . 0.0 112.095 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -57.89 165.59 1.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.049 0.94 . . . . 0.0 110.275 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -94.12 -39.74 10.42 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 111.688 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.1 -45.13 8.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.684 1.194 . . . . 0.0 110.71 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.31 -27.8 1.92 Allowed Glycine 0 C--O 1.212 -1.251 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.596 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 p -38.3 -43.43 0.8 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.641 1.576 . . . . 0.0 114.756 168.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.12 -35.52 31.48 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.065 0.848 . . . . 0.0 112.493 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 129' ' ' ILE . 16.0 mt -65.09 -50.11 67.39 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.038 0.935 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.5 p -60.08 -38.29 82.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.093 1.357 . . . . 0.0 110.632 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.96 -47.24 81.21 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.017 0.826 . . . . 0.0 112.496 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.58 ' CD1' ' CZ ' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -49.05 -59.04 3.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 109.235 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -66.04 -24.92 66.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.45 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -47.74 73.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 110.184 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -41.05 98.7 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 119.733 1.152 . . . . 0.0 109.051 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.26 96.35 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.767 0.712 . . . . 0.0 112.395 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.12 -31.6 58.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.704 1.202 . . . . 0.0 112.941 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.446 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 8.4 m-80 -75.57 -63.61 1.25 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -17.7 7.13 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.401 1.081 . . . . 0.0 113.063 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -44.42 -35.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.989 1.316 . . . . 0.0 112.194 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.0 26.84 0.14 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.698 1.142 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.1 tpp -86.04 -69.89 0.64 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.042 0.937 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' HB2' ' A' ' 71' ' ' ALA . 3.5 mtt -154.74 60.42 0.67 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.821 1.296 . . . . 0.0 111.002 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -104.1 -29.8 10.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.41 36.13 0.04 OUTLIER Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.615 1.102 . . . . 0.0 111.715 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.56 -29.09 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.528 0.731 . . . . 0.0 110.602 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -46.52 76.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.616 0.766 . . . . 0.0 111.678 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.86 82.99 0.44 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-O 118.891 -0.95 . . . . 0.0 111.541 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 59.78 165.95 0.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.874 1.27 . . . . 0.0 113.302 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.45 175.21 14.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.668 0.787 . . . . 0.0 111.353 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.43 -65.34 0.7 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.531 0.733 . . . . 0.0 111.705 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -102.38 56.59 0.79 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.293 1.037 . . . . 0.0 108.612 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.3 m -56.64 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.885 1.674 . . . . 0.0 111.703 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.12 -61.31 0.29 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.803 1.192 . . . . 0.0 113.576 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.98 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.407 -1.055 . . . . 0.0 111.897 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -25.98 68.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.533 0.733 . . . . 0.0 112.364 171.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.429 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 14.2 ttm -58.36 -49.09 78.45 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.499 0.72 . . . . 0.0 110.21 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.693 HG21 HG21 ' A' ' 100' ' ' VAL . 1.4 m -72.8 -41.5 64.88 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.551 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HA ' HG21 ' A' ' 79' ' ' VAL . 11.9 t0 -52.65 -53.43 47.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.006 1.276 . . . . 0.0 111.505 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.403 HG22 ' SD ' ' A' ' 50' ' ' MET . 94.3 m -68.0 -43.21 79.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.054 1.342 . . . . 0.0 110.984 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.55 -47.1 80.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.662 0.785 . . . . 0.0 111.294 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.508 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -60.38 -50.22 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.405 175.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.86 -20.25 55.96 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.158 -0.964 . . . . 0.0 112.448 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 50' ' ' MET . . . -81.54 9.93 6.72 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.48 1.512 . . . . 0.0 113.73 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.93 48.07 84.83 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.422 1.487 . . . . 0.0 112.589 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' ' CB ' ' A' ' 45' ' ' ASN . . . -110.34 -83.86 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.464 0.706 . . . . 0.0 111.275 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -47.15 72.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.796 0.438 . . . . 0.0 111.654 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -156.2 172.7 17.99 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.063 1.345 . . . . 0.0 109.902 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.78 34.77 3.63 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.796 1.189 . . . . 0.0 112.165 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.71 178.81 4.25 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.649 1.18 . . . . 0.0 112.004 -177.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.42 136.99 54.15 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.438 175.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.508 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.4 t -114.57 109.78 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.7 t -57.81 137.06 56.97 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.54 169.24 47.82 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.871 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.74 113.66 46.67 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.755 0.822 . . . . 0.0 111.182 174.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -79.51 -64.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.03 1.82 . . . . 0.0 111.557 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.37 -40.37 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.886 0.874 . . . . 0.0 112.174 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.36 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.023 2.529 . . . . 0.0 112.998 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.69 95.85 0.14 Allowed Glycine 0 N--CA 1.466 0.666 0 C-N-CA 123.47 0.557 . . . . 0.0 111.759 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.8 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.02 2.128 . . . . 0.0 109.149 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.526 ' HB3' HG23 ' A' ' 100' ' ' VAL . . . -62.84 159.14 17.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 110.918 174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -141.88 144.91 34.06 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.743 -1.223 . . . . 0.0 109.518 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.13 124.46 43.12 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 122.538 1.161 . . . . 0.0 109.675 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -88.07 129.5 35.27 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 123.978 0.911 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.6 113.87 18.08 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.538 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.4 t -54.31 -58.45 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.435 0.694 . . . . 0.0 112.0 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -56.35 -55.57 31.8 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 110.011 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.4 141.43 3.19 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 123.671 0.653 . . . . 0.0 111.963 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.79 -178.86 16.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.202 0.906 . . . . 0.0 112.631 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.87 143.78 36.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.551 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mt -130.55 151.76 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.339 1.456 . . . . 0.0 109.178 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 117' ' ' THR . 35.2 t -135.29 110.32 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 65' ' ' THR . 8.0 m -101.26 105.94 18.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.864 1.266 . . . . 0.0 108.466 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.31 146.58 58.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 120.043 -1.661 . . . . 0.0 110.355 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -73.22 151.46 49.04 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.557 1.505 . . . . 0.0 110.587 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -144.79 80.9 1.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.929 1.347 . . . . 0.0 110.435 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 112' ' ' ASN . 4.0 p -92.29 118.8 31.26 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.151 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.48 144.68 28.57 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.561 -0.712 . . . . 0.0 110.292 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -122.01 41.94 1.75 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.736 1.16 . . . . 0.0 111.551 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.37 -144.91 7.49 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.78 1.181 . . . . 0.0 112.558 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -49.71 -48.85 49.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.238 1.015 . . . . 0.0 112.459 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.49 -146.23 3.7 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.49 29.09 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.804 0.811 . . . . 0.0 111.753 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -82.33 162.05 22.37 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.062 -1.024 . . . . 0.0 110.772 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.541 ' HB2' HG22 ' A' ' 104' ' ' THR . 10.2 p30 -114.31 133.97 55.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.649 174.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.62 -179.3 19.21 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 122.149 0.861 . . . . 0.0 111.481 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.13 150.94 51.93 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.071 0.948 . . . . 0.0 111.1 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -133.92 115.05 13.95 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.839 0.828 . . . . 0.0 110.344 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.0 mt -120.1 99.81 8.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.6 OUTLIER -70.53 141.59 51.9 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.007 172.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.4 p -134.35 123.76 24.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -134.94 122.46 21.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 109.727 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt 160.38 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.179 2.192 . . . . 0.0 110.325 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.9 m -45.87 103.64 0.36 Allowed Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 125.064 1.478 . . . . 0.0 110.483 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 27.4 Cg_endo -74.23 -172.81 1.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.831 1.688 . . . . 0.0 109.996 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -27.08 34.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.698 -1.252 . . . . 0.0 113.003 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -72.22 -50.17 29.59 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.202 -0.936 . . . . 0.0 111.472 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.49 -13.56 61.07 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 121.902 -0.499 . . . . 0.0 111.197 173.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -30.58 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 119.513 -1.992 . . . . 0.0 110.069 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.411 ' HA ' ' CB ' ' A' ' 159' ' ' ALA . 2.7 t -90.18 -47.02 14.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 124.68 1.192 . . . . 0.0 109.531 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 m -61.26 -39.21 89.51 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.466 1.03 . . . . 0.0 112.708 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.463 HG23 HD21 ' A' ' 36' ' ' LEU . 45.8 mm -70.55 -49.07 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.046 172.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.9 m -57.83 -44.86 86.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 119.71 1.141 . . . . 0.0 112.563 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 m -59.44 -43.47 93.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.903 1.281 . . . . 0.0 111.476 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.51 -24.68 69.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.306 0.479 . . . . 0.0 113.517 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.2 25.75 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.963 -1.316 . . . . 0.0 111.338 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 155' ' ' THR . 0.3 OUTLIER -70.22 -26.01 63.67 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.963 1.705 . . . . 0.0 111.972 175.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -27.32 60.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.872 0.869 . . . . 0.0 112.391 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.3 t -154.97 48.64 0.56 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.853 1.661 . . . . 0.0 110.494 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.38 -80.86 0.81 Allowed Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 38.14 43.41 1.38 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 125.934 1.731 . . . . 0.0 114.915 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 151' ' ' ASP . 41.0 m 61.57 144.63 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.711 1.604 . . . . 0.0 112.696 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 t -166.47 -40.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.535 -1.353 . . . . 0.0 110.81 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 178' ' ' ASN . . . 143.18 50.78 0.04 OUTLIER Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.975 1.274 . . . . 0.0 112.236 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.421 ' CG2' HD23 ' A' ' 175' ' ' LEU . 3.1 mt -89.0 100.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.77 95.7 10.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.656 0.382 . . . . 0.0 110.571 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 152' ' ' ALA . 36.8 mt -69.39 154.66 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.692 1.197 . . . . 0.0 109.911 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.33 115.75 2.45 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.89 -1.131 . . . . 0.0 111.448 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.98 -40.86 0.7 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.269 0.938 . . . . 0.0 114.538 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -86.28 41.12 0.91 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.324 1.85 . . . . 0.0 110.689 168.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -55.8 93.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.586 1.154 . . . . 0.0 111.05 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -116.96 -168.28 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.445 1.498 . . . . 0.0 109.094 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -136.25 -41.96 0.64 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 110.989 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HA ' HG23 ' A' ' 139' ' ' THR . 32.5 p30 -89.79 20.95 3.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.89 2.076 . . . . 0.0 113.547 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 144' ' ' ILE . . . -62.98 83.91 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 111.076 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 76.9 2.04 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.184 1.394 . . . . 0.0 109.443 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.406 ' HA ' HG21 ' A' ' 158' ' ' ILE . 3.3 m -75.96 154.75 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.009 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 134' ' ' SER . 0.1 OUTLIER -166.94 164.54 16.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.784 1.233 . . . . 0.0 111.021 -172.048 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.07 -53.34 20.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.881 1.272 . . . . 0.0 112.178 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.78 -34.1 73.97 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.005 0.922 . . . . 0.0 112.143 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -65.83 -51.27 63.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 O-C-N 121.721 -0.612 . . . . 0.0 109.653 175.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -64.36 -21.3 66.58 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.934 0.788 . . . . 0.0 111.312 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.39 65.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 113.211 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.73 -51.24 3.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.187 1.395 . . . . 0.0 112.607 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -54.48 -58.31 7.95 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.967 2.107 . . . . 0.0 110.843 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 5.7 m -78.55 115.38 18.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.19 146.4 6.66 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.419 1.488 . . . . 0.0 111.275 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.89 116.23 19.08 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.847 0.459 . . . . 0.0 110.183 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.35 137.5 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.148 1.379 . . . . 0.0 112.455 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.71 -44.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.602 -1.311 . . . . 0.0 111.553 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.33 -47.3 1.06 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.618 1.58 . . . . 0.0 111.504 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.16 76.09 0.69 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.292 1.837 . . . . 0.0 109.943 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.0 p -56.4 135.93 53.87 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.245 173.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -46.18 139.36 6.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.5 p -47.61 120.41 3.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.096 1.358 . . . . 0.0 110.899 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.39 127.44 32.19 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 120.934 -1.104 . . . . 0.0 109.232 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 14.6 m -102.2 111.91 24.37 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 142' ' ' ILE . 0.9 OUTLIER -127.84 109.81 11.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -80.22 132.07 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.58 ' CZ ' ' CD1' ' A' ' 39' ' ' TYR . 2.6 t80 -97.83 115.16 27.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.443 ' HB3' ' HA3' ' A' ' 141' ' ' GLY . 12.9 t-20 -101.27 107.33 18.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.234 0.614 . . . . 0.0 110.002 174.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.8 t80 -77.35 109.21 11.07 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.951 0.901 . . . . 0.0 110.92 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -108.15 106.13 16.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.787 0.835 . . . . 0.0 109.907 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 CA-C-O 117.935 -1.481 . . . . 0.0 112.734 178.06 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.51 159.86 1.55 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.63 1.572 . . . . 0.0 110.266 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.46 118.47 4.4 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 -94.05 0.48 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.239 1.016 . . . . 0.0 109.638 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -110.75 169.14 8.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.965 1.306 . . . . 0.0 110.454 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.69 -45.04 84.32 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.262 0.625 . . . . 0.0 111.168 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -92.7 -28.65 16.51 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.493 1.117 . . . . 0.0 110.968 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -19.51 14.22 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 113.569 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t -44.89 -52.44 8.63 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.858 1.329 . . . . 0.0 113.612 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -78.33 -33.9 48.91 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.674 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.515 HD21 HG23 ' A' ' 129' ' ' ILE . 72.0 mt -56.47 -51.58 67.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.771 0.714 . . . . 0.0 110.909 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.5 p -65.95 -34.14 77.43 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.602 1.161 . . . . 0.0 111.079 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.85 -47.55 82.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.159 0.984 . . . . 0.0 112.32 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -57.29 -52.94 63.33 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 120.873 -1.142 . . . . 0.0 111.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -65.14 -24.13 67.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.204 172.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -47.46 81.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.289 0.95 . . . . 0.0 109.465 174.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tt -65.0 -41.64 95.21 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.918 0.781 . . . . 0.0 109.317 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -64.05 -43.24 96.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.39 0.431 . . . . 0.0 111.587 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -35.64 63.17 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.533 1.133 . . . . 0.0 112.132 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.615 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 19.1 m-80 -67.15 -62.42 1.44 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -54.82 -25.92 31.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.936 0.894 . . . . 0.0 111.835 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -31.61 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.244 1.018 . . . . 0.0 112.774 171.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.5 51.67 0.25 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.329 1.442 . . . . 0.0 113.396 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.1 tpt -126.52 -77.02 0.58 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.382 1.073 . . . . 0.0 110.563 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.3 mtt -154.89 58.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.681 1.229 . . . . 0.0 111.235 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -106.38 -5.87 18.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.14 39.37 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.529 1.062 . . . . 0.0 112.579 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.9 -28.73 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 122.181 -0.599 . . . . 0.0 110.838 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.31 105.44 5.01 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.678 1.591 . . . . 0.0 109.767 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.76 64.89 2.06 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -69.68 143.68 53.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.766 0.793 . . . . 0.0 110.505 174.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.21 93.79 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -44.15 159.56 0.04 OUTLIER 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 111.962 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m 74.62 170.43 0.29 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.887 0.742 . . . . 0.0 109.117 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.56 -68.12 0.14 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.984 1.714 . . . . 0.0 111.776 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.3 21.14 32.02 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.46 1.505 . . . . 0.0 113.137 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.07 -56.0 4.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.801 0.84 . . . . 0.0 109.81 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -25.46 66.84 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.931 171.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -52.01 67.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.631 1.105 . . . . 0.0 111.298 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.623 HG21 HG11 ' A' ' 100' ' ' VAL . 1.1 m -68.63 -39.45 80.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.051 176.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.4 ' HA ' HG21 ' A' ' 79' ' ' VAL . 44.5 t0 -60.04 -48.81 80.17 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 111.026 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.5 m -68.35 -41.45 80.69 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 125.342 1.457 . . . . 0.0 110.286 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.625 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -57.22 -54.09 50.67 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.085 1.311 . . . . 0.0 111.203 172.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.96 -51.28 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.805 -1.184 . . . . 0.0 110.964 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -60.0 -26.13 65.81 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.711 -1.243 . . . . 0.0 112.592 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.7 -14.12 59.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.21 1.004 . . . . 0.0 113.088 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.74 34.13 9.41 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.167 1.365 . . . . 0.0 112.697 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.625 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -92.91 -73.46 0.56 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.065 0.546 . . . . 0.0 111.81 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -63.6 1.21 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.011 0.434 . . . . 0.0 110.22 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -134.24 -164.36 1.49 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.135 1.374 . . . . 0.0 109.698 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.42 23.49 1.37 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.659 1.123 . . . . 0.0 112.732 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.7 mmt -93.19 174.76 7.05 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.104 1.361 . . . . 0.0 112.029 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.01 138.75 58.66 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.35 0.595 . . . . 0.0 110.351 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 66' ' ' ASP . 2.9 t -120.74 132.2 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 t -92.99 150.64 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.66 142.11 12.36 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.05 99.42 46.63 Favored Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 124.545 1.138 . . . . 0.0 108.005 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -74.22 -29.36 9.75 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.523 2.149 . . . . 0.0 112.26 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.81 68.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.452 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.29 -65.23 1.2 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.113 . . . . 0.0 111.818 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.93 52.81 0.24 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.051 1.31 . . . . 0.0 112.382 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.3 m -144.16 105.31 4.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.186 0.995 . . . . 0.0 109.828 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -73.55 145.61 45.39 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 122.111 0.958 . . . . 0.0 110.517 174.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -126.16 127.46 45.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -101.12 135.17 43.02 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.746 0.784 . . . . 0.0 109.261 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -96.21 119.71 35.19 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -171.84 0.9 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.768 0.427 . . . . 0.0 111.339 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -57.92 4.11 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.959 0.904 . . . . 0.0 112.254 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.99 132.99 3.8 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.145 0.978 . . . . 0.0 110.617 173.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.66 -57.61 4.5 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.657 1.123 . . . . 0.0 112.563 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -46.38 139.13 7.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 123.872 0.748 . . . . 0.0 112.611 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -132.64 152.67 51.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.479 1.133 . . . . 0.0 109.601 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -132.97 146.76 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.164 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 117' ' ' THR . 61.4 t -133.15 113.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.623 HG11 HG21 ' A' ' 65' ' ' THR . 1.2 m -95.16 123.72 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.34 40.02 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.546 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -71.52 152.77 60.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.98 1.787 . . . . 0.0 110.784 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -149.66 84.99 1.42 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 123.749 1.738 . . . . 0.0 108.953 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.528 HG22 ' HB2' ' A' ' 112' ' ' ASN . 3.4 p -89.79 144.33 26.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.143 -1.844 . . . . 0.0 108.907 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 143.56 47.28 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.34 -41.68 3.9 Favored Glycine 0 N--CA 1.469 0.884 0 C-N-CA 123.093 0.378 . . . . 0.0 113.066 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.94 -158.23 0.51 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.691 1.138 . . . . 0.0 113.196 172.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -34.8 7.64 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.97 -1.014 . . . . 0.0 112.958 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -32.62 94.17 0.01 OUTLIER Glycine 0 C--N 1.344 1.003 0 C-N-CA 126.47 1.986 . . . . 0.0 112.56 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.35 18.11 4.0 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.135 0.974 . . . . 0.0 110.883 -176.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -107.08 147.31 30.16 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.621 1.568 . . . . 0.0 110.025 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.528 ' HB2' HG22 ' A' ' 104' ' ' THR . 7.8 p30 -116.86 125.87 52.18 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.941 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.92 -176.35 19.14 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 122.181 0.879 . . . . 0.0 111.215 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -129.46 150.26 50.88 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.973 0.909 . . . . 0.0 110.883 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 176' ' ' VAL . 0.2 OUTLIER -146.01 119.16 8.85 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.077 -174.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mt -119.01 115.91 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.351 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.53 ' CB ' HG23 ' A' ' 176' ' ' VAL . 0.7 OUTLIER -78.45 140.82 38.61 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.908 174.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 123.58 25.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -131.82 123.62 27.95 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.455 0.702 . . . . 0.0 110.041 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.434 ' HE3' HG23 ' A' ' 121' ' ' VAL . 0.0 OUTLIER 161.57 -31.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.615 1.966 . . . . 0.0 113.268 -175.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.434 HG23 ' HE3' ' A' ' 120' ' ' LYS . 18.3 t -50.02 111.28 2.01 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.056 176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 36.8 Cg_endo -73.16 -173.72 1.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.946 2.431 . . . . 0.0 110.743 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.75 -24.17 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.876 -1.14 . . . . 0.0 113.076 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -52.68 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.952 0.796 . . . . 0.0 111.211 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.557 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -72.46 -17.05 61.81 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.548 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 14.2 t -62.55 -45.57 92.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 120.902 1.683 . . . . 0.0 109.248 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.35 -45.6 40.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-O 118.216 -0.897 . . . . 0.0 108.998 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -57.74 -43.12 85.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.691 1.587 . . . . 0.0 113.768 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.515 HG23 HD21 ' A' ' 36' ' ' LEU . 46.7 mm -74.32 -44.7 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.073 1.749 . . . . 0.0 110.279 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.1 m -63.84 -26.73 68.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.0 m -82.35 -44.18 16.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.721 2.008 . . . . 0.0 110.258 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.78 -42.65 78.44 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.07 -27.21 67.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.825 1.312 . . . . 0.0 112.774 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.78 -21.77 63.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.206 0.602 . . . . 0.0 111.932 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.55 -25.81 39.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.585 1.154 . . . . 0.0 112.775 174.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -151.81 49.66 0.8 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.393 1.477 . . . . 0.0 110.212 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -36.56 -63.63 0.68 Allowed Glycine 0 C--N 1.344 1.024 0 C-N-CA 125.628 1.585 . . . . 0.0 113.18 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 25.21 78.22 0.01 OUTLIER Glycine 0 C--N 1.346 1.085 0 C-N-CA 126.971 2.224 . . . . 0.0 113.273 167.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 151' ' ' ASP . 23.2 p -51.67 171.31 0.04 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.78 1.632 . . . . 0.0 112.937 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 p 178.92 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.647 0.779 . . . . 0.0 111.811 -170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 171.55 42.68 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.496 0.57 . . . . 0.0 113.949 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 139' ' ' THR . 41.6 mt -80.12 117.07 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 123.321 0.648 . . . . 0.0 109.574 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.472 ' CD ' HG11 ' A' ' 176' ' ' VAL . 0.9 OUTLIER -121.56 104.36 9.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.589 1.155 . . . . 0.0 108.036 -176.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 147' ' ' ASN . 4.3 mm -78.6 168.09 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -50.06 116.22 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.29 1.436 . . . . 0.0 112.439 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.59 28.61 6.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 123.52 0.581 . . . . 0.0 114.11 -173.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.2 t-20 -129.95 38.52 3.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.378 2.271 . . . . 0.0 108.398 -174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.63 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.668 1.987 . . . . 0.0 112.129 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -138.2 -173.43 3.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.624 1.57 . . . . 0.0 109.347 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 141' ' ' GLY . 7.9 p -146.8 -52.14 0.22 Allowed 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.084 -1.01 . . . . 0.0 109.461 -175.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.464 ' HA ' HG21 ' A' ' 139' ' ' THR . 14.7 p-10 -80.03 31.39 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.221 2.209 . . . . 0.0 113.521 171.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 105.43 13.45 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.839 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.88 128.36 35.35 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.13 134.43 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 178.5 7.22 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.959 0.904 . . . . 0.0 110.644 -170.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.54 -54.51 42.22 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 172.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.53 -32.46 72.52 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.899 0.88 . . . . 0.0 111.986 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.31 -54.35 17.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.62 -18.57 64.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.424 1.011 . . . . 0.0 111.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.07 -38.76 92.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.926 0.89 . . . . 0.0 111.945 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.4 m -111.25 -51.6 2.85 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.095 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -55.0 -49.46 71.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.287 1.835 . . . . 0.0 113.513 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.16 -38.05 75.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.426 0.632 . . . . 0.0 111.009 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.4 m -76.92 152.65 35.24 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.553 1.541 . . . . 0.0 110.305 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -165.99 -68.89 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 119.523 -1.986 . . . . 0.0 110.06 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -153.44 30.83 0.47 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.715 1.206 . . . . 0.0 112.452 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -154.03 106.71 2.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.397 1.079 . . . . 0.0 109.504 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.84 115.6 8.17 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.9 mtm105 53.81 68.65 0.81 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.301 1.041 . . . . 0.0 112.226 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p -46.28 152.26 0.44 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.059 0.944 . . . . 0.0 111.863 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.19 5.68 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 123.72 0.676 . . . . 0.0 113.077 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 46.4 m -152.05 99.52 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.152 1.381 . . . . 0.0 109.171 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -134.16 116.58 15.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.356 1.062 . . . . 0.0 110.123 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.9 m -115.92 107.14 14.62 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.41 ' HG ' HD13 ' A' ' 144' ' ' ILE . 1.1 mp -122.2 123.15 40.82 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.578 0.751 . . . . 0.0 109.103 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 115' ' ' THR . 0.8 OUTLIER -94.79 122.8 46.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -98.93 122.57 42.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.402 0.681 . . . . 0.0 110.046 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.09 138.94 41.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.587 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.462 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -145.05 136.4 25.12 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.888 177.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -48.41 149.64 1.54 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.022 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.914 -179.54 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.228 0.537 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 19.9 t90 -165.46 157.02 14.53 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.196 0.998 . . . . 0.0 109.712 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.97 152.46 18.57 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.941 0.781 . . . . 0.0 111.537 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -127.76 -69.55 0.73 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.17 0.988 . . . . 0.0 110.518 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -130.0 175.39 8.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.229 1.412 . . . . 0.0 110.246 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -90.26 -43.4 10.41 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.248 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 128' ' ' SER . . . -87.07 -34.13 19.26 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.01 -25.76 2.62 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 120.879 -1.138 . . . . 0.0 114.088 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 p -48.31 -41.6 28.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.822 1.649 . . . . 0.0 114.316 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' CG ' HD11 ' A' ' 129' ' ' ILE . 3.8 pt-20 -78.43 -34.99 47.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 129' ' ' ILE . 16.9 mt -57.79 -53.28 59.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.141 0.882 . . . . 0.0 112.356 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.9 p -60.76 -36.83 79.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.711 176.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -50.84 72.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.859 1.263 . . . . 0.0 112.42 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' A' ' 118' ' ' THR . 12.2 m-30 -57.98 -46.49 85.07 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.892 -1.13 . . . . 0.0 111.649 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -62.96 -31.96 73.17 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.008 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -45.74 89.22 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 123.663 0.785 . . . . 0.0 109.713 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.504 HD13 ' CD2' ' A' ' 68' ' ' LEU . 1.9 tp -59.47 -49.57 77.29 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 120.374 1.443 . . . . 0.0 110.071 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.53 95.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.98 -33.37 59.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.615 1.166 . . . . 0.0 112.524 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.553 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 9.0 m120 -71.45 -61.12 1.89 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.44 ' HB ' HD13 ' A' ' 68' ' ' LEU . 2.1 t -56.51 -19.75 17.04 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.17 0.988 . . . . 0.0 112.332 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -32.22 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.735 0.814 . . . . 0.0 112.248 171.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.83 45.94 0.17 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.648 1.118 . . . . 0.0 113.009 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -113.64 -66.4 1.09 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.995 0.918 . . . . 0.0 110.128 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.478 ' HG2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -146.02 31.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.693 1.197 . . . . 0.0 112.564 -176.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.36 -21.91 48.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 176.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.07 47.1 0.13 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.302 0.953 . . . . 0.0 112.332 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.22 -32.7 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.384 0.674 . . . . 0.0 111.418 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -115.99 116.71 28.4 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.58 -163.28 0.11 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.594 0.616 . . . . 0.0 112.021 170.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 58.32 77.25 0.3 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.145 0.974 . . . . 0.0 112.615 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.19 156.33 32.44 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.724 -0.61 . . . . 0.0 111.399 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 -59.02 1.77 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.864 0.866 . . . . 0.0 111.245 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.8 m -121.61 144.99 48.43 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.827 1.251 . . . . 0.0 108.94 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 t -128.22 65.99 1.38 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.612 1.165 . . . . 0.0 109.727 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.56 -46.6 0.1 OUTLIER Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.181 0.895 . . . . 0.0 112.354 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.743 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -85.07 -70.0 0.61 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -23.74 50.07 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 123.436 0.695 . . . . 0.0 112.302 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.44 ' SD ' ' HA ' ' A' ' 51' ' ' LYS . 7.4 tpt -53.5 -71.61 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.512 0.725 . . . . 0.0 110.36 172.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.496 HG21 HG11 ' A' ' 100' ' ' VAL . 1.2 m -65.95 -32.98 74.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.494 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.68 -53.05 62.15 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.094 0.861 . . . . 0.0 111.02 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.478 HG22 ' HG2' ' A' ' 50' ' ' MET . 90.1 m -68.18 -41.05 82.04 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.42 1.088 . . . . 0.0 110.891 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.072 0.851 . . . . 0.0 111.754 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -61.18 -52.06 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.067 -1.02 . . . . 0.0 110.48 176.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.06 -20.44 53.28 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.364 -1.46 . . . . 0.0 113.094 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.54 13.65 3.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.509 1.524 . . . . 0.0 113.615 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 53.18 40.8 60.27 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.865 1.698 . . . . 0.0 112.8 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 45' ' ' ASN . . . -100.83 -70.29 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 -54.27 5.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -149.25 178.13 9.03 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.089 1.356 . . . . 0.0 109.538 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.69 31.46 3.38 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 124.787 1.184 . . . . 0.0 112.105 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.38 171.28 8.06 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.353 1.061 . . . . 0.0 111.639 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -61.88 131.44 49.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.446 0.641 . . . . 0.0 110.497 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.6 t -114.13 136.94 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.799 1.24 . . . . 0.0 108.464 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 t -88.02 126.94 35.35 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.75 103.42 2.91 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -50.14 105.39 0.51 Allowed Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.481 1.112 . . . . 0.0 111.373 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.16 -17.25 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.504 2.136 . . . . 0.0 112.388 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.31 -7.09 58.76 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.99 1.316 . . . . 0.0 112.594 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m 60.04 68.45 0.78 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.436 1.494 . . . . 0.0 112.05 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.03 -52.89 0.1 OUTLIER Glycine 0 N--CA 1.467 0.747 0 C-N-CA 124.006 0.812 . . . . 0.0 112.215 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -177.25 124.29 0.14 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.832 1.253 . . . . 0.0 110.965 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.743 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -64.81 164.58 12.06 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 122.355 1.074 . . . . 0.0 112.029 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.6 t -133.86 142.21 47.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.65 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 90' ' ' LEU . 1.6 tm? -109.23 123.84 49.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.059 0.944 . . . . 0.0 109.099 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -82.04 119.56 24.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.802 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -70.27 176.6 3.81 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.282 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.68 -53.65 4.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.036 1.334 . . . . 0.0 113.01 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -149.6 -51.36 0.15 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 0.0 111.779 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.46 98.83 0.86 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.82 132.99 1.57 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 124.012 0.815 . . . . 0.0 111.535 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.03 127.41 50.21 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.81 136.82 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 108.684 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 117' ' ' THR . 21.0 t -124.26 109.49 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 65' ' ' THR . 1.4 m -87.32 122.98 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.97 136.94 18.74 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.337 -0.852 . . . . 0.0 109.209 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -76.08 152.38 35.79 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.734 1.623 . . . . 0.0 110.554 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -143.75 69.04 1.28 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 111.667 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.3 p -97.61 104.53 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.281 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.05 95.2 5.61 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.24 84.07 1.23 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.76 59.15 4.73 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.869 1.224 . . . . 0.0 112.633 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 p -92.42 -49.22 6.25 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.288 1.435 . . . . 0.0 111.9 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.36 43.2 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.304 0.954 . . . . 0.0 112.675 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.22 175.83 5.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.989 1.316 . . . . 0.0 111.176 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -63.7 137.92 58.28 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.139 0.495 . . . . 0.0 111.088 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -64.37 143.46 57.88 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.892 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -103.8 116.13 5.3 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -108.18 135.56 49.3 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.507 0.723 . . . . 0.0 110.333 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 p -124.03 102.44 7.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.748 1.261 . . . . 0.0 110.9 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.44 110.25 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.634 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -76.84 141.95 40.44 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.285 173.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 39' ' ' TYR . 5.8 p -133.91 130.32 37.59 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.43 -173.88 3.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.352 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 89.84 -31.11 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.576 2.75 . . . . 0.0 110.418 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.7 t -47.61 104.39 0.41 Allowed Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 127.19 2.196 . . . . 0.0 108.405 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 21.6 Cg_endo -73.66 -170.09 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.991 1.794 . . . . 0.0 110.431 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -59.54 -31.14 69.14 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.873 -1.142 . . . . 0.0 112.277 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.0 p -73.72 -50.54 20.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.501 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.591 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -71.97 -17.83 62.04 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.91 172.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.45 -45.91 92.29 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 120.878 1.672 . . . . 0.0 108.385 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.434 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 3.2 t -72.98 -42.04 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.629 0.649 . . . . 0.0 111.467 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -63.47 -45.1 92.35 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 177.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.497 HD11 ' CG ' ' A' ' 35' ' ' GLU . 11.4 mm -63.25 -52.99 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 C-N-CA 124.957 1.303 . . . . 0.0 109.52 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.7 m -56.26 -42.44 77.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 119.121 0.873 . . . . 0.0 112.226 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -56.8 -52.44 65.04 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.127 1.371 . . . . 0.0 110.969 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.6 -29.01 72.8 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 122.867 0.27 . . . . 0.0 112.682 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -35.3 58.26 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.245 1.018 . . . . 0.0 111.201 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -25.06 65.67 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.929 0.892 . . . . 0.0 112.126 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -60.91 -30.15 70.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.247 0.619 . . . . 0.0 112.605 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 t -153.76 50.75 0.68 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.285 1.034 . . . . 0.0 111.428 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.55 -85.51 1.65 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 44.03 49.91 7.69 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.471 1.034 . . . . 0.0 113.618 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 151' ' ' ASP . 26.2 m 66.22 147.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.529 1.532 . . . . 0.0 112.326 -173.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.1 p -179.7 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.142 -0.974 . . . . 0.0 110.961 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.85 48.62 0.07 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.575 1.083 . . . . 0.0 112.216 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 5.5 mt -88.91 99.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.038 -172.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -90.56 97.08 10.97 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.816 0.446 . . . . 0.0 110.016 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.4 mt -73.87 146.82 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 124.4 1.062 . . . . 0.0 109.516 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -48.36 114.58 0.98 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.467 1.507 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.88 -39.64 0.96 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.302 0.953 . . . . 0.0 113.983 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.57 35.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.265 1.826 . . . . 0.0 111.428 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -51.85 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.378 1.471 . . . . 0.0 110.473 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -123.05 -169.24 1.89 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.976 1.31 . . . . 0.0 109.204 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 p -139.68 -41.69 0.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.784 0.834 . . . . 0.0 110.852 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.432 ' HA ' HG23 ' A' ' 139' ' ' THR . 3.7 p-10 -90.89 24.44 2.76 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.574 1.949 . . . . 0.0 113.412 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.41 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -57.59 125.76 24.37 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.509 0.671 . . . . 0.0 110.079 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -113.39 74.73 0.88 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 122.479 1.133 . . . . 0.0 108.315 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.66 135.18 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.494 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.7 p -136.56 -179.04 5.44 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.072 0.949 . . . . 0.0 111.449 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.29 81.88 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.605 -0.684 . . . . 0.0 112.386 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.56 -35.54 78.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.584 0.754 . . . . 0.0 111.421 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -46.08 36.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.786 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 127' ' ' VAL . . . -60.18 -26.47 66.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.1 0.864 . . . . 0.0 111.124 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -39.26 87.74 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 170.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.36 -31.59 24.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.694 1.597 . . . . 0.0 113.792 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -84.01 -56.47 3.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.899 1.68 . . . . 0.0 110.462 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 78.8 m -94.56 62.34 2.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.919 1.688 . . . . 0.0 109.588 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.1 m -77.79 155.89 30.85 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.736 1.214 . . . . 0.0 110.313 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 55.43 175.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.765 1.226 . . . . 0.0 113.095 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -130.76 70.62 1.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.651 0.78 . . . . 0.0 110.251 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -21.74 65.42 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.424 -0.797 . . . . 0.0 112.417 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.25 -48.33 3.4 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.674 1.607 . . . . 0.0 112.378 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.56 50.46 1.25 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.034 1.734 . . . . 0.0 111.952 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.5 p -64.17 165.74 8.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.103 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.59 136.05 2.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.746 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 95.3 m -50.81 135.12 24.49 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.26 110.26 20.4 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.0 m -110.77 112.09 23.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.06 109.55 11.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -85.93 137.75 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -111.18 113.01 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.309 0.644 . . . . 0.0 109.726 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -101.46 118.32 36.71 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 109.689 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.46 122.71 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.093 0.957 . . . . 0.0 110.209 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -113.23 95.35 5.33 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.363 1.065 . . . . 0.0 108.91 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.204 0 CA-C-O 118.513 -1.159 . . . . 0.0 112.349 -174.484 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.834 0.826 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -171.62 147.16 2.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.061 1.745 . . . . 0.0 108.669 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.02 91.99 0.18 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -0.27 50.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.335 0.654 . . . . 0.0 112.328 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -109.22 141.3 41.68 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.892 1.677 . . . . 0.0 108.719 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.8 -27.61 44.46 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.522 0.729 . . . . 0.0 112.253 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -91.72 -36.18 13.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.398 1.079 . . . . 0.0 111.249 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.92 -26.07 32.64 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.201 -0.777 . . . . 0.0 112.827 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -46.14 -43.34 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.003 1.321 . . . . 0.0 113.196 172.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.19 -34.31 49.58 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.739 -0.601 . . . . 0.0 111.805 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 129' ' ' ILE . 19.6 mt -63.28 -50.82 68.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 110.341 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.6 p -63.48 -38.1 89.83 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.308 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -58.56 -53.12 61.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.896 1.225 . . . . 0.0 112.416 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 177' ' ' PHE . 7.9 t80 -51.25 -52.16 47.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.036 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -67.14 -23.66 65.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.38 69.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.052 1.341 . . . . 0.0 108.685 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 74' ' ' ALA . 1.8 tt -63.57 -41.46 98.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.269 0.94 . . . . 0.0 109.498 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 179' ' ' TYR . . . -59.31 -44.5 92.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 117.978 0.354 . . . . 0.0 111.075 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -78.53 -39.03 39.15 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.241 0.616 . . . . 0.0 112.618 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -60.68 -57.92 10.67 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -41.36 62.33 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.606 1.162 . . . . 0.0 111.089 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -42.89 -31.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.771 1.629 . . . . 0.0 112.996 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -150.62 50.62 0.54 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.307 1.432 . . . . 0.0 112.678 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.7 tpp -137.26 -60.27 0.67 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.026 0.93 . . . . 0.0 110.569 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.1 tpt -162.12 39.67 0.12 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.72 5.66 38.78 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.2 38.02 0.51 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.9 1.238 . . . . 0.0 112.801 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.0 t -69.54 109.89 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 0.0 109.157 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.47 -54.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.181 1.392 . . . . 0.0 110.557 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.2 -43.32 0.78 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.328 1.442 . . . . 0.0 112.725 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -138.75 55.95 1.72 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.618 1.567 . . . . 0.0 110.838 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.86 159.07 1.8 Allowed 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.844 -1.16 . . . . 0.0 112.432 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.76 -64.45 1.06 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.504 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -148.06 -61.39 0.26 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 117.692 -1.147 . . . . 0.0 109.437 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 76.1 p 38.91 71.71 0.16 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.842 1.339 . . . . 0.0 111.135 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.94 -1.69 30.23 Favored Glycine 0 N--CA 1.468 0.793 0 O-C-N 121.436 -0.79 . . . . 0.0 113.597 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 -61.49 1.54 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.234 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -61.92 -28.57 69.62 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 123.757 0.823 . . . . 0.0 112.481 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -49.71 74.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.788 0.722 . . . . 0.0 110.322 173.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.26 -41.13 67.1 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.285 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.538 ' HA ' HG21 ' A' ' 79' ' ' VAL . 10.8 t0 -55.84 -52.58 63.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.923 0.868 . . . . 0.0 110.62 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.4 m -68.99 -43.1 75.55 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.933 1.293 . . . . 0.0 110.715 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.88 -43.49 90.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.706 1.593 . . . . 0.0 111.989 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.402 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -63.75 -53.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.282 0.633 . . . . 0.0 111.027 173.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -64.57 -17.2 63.74 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.168 -0.958 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.07 -19.44 30.23 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 112.35 174.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.1 76.17 1.21 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.998 1.285 . . . . 0.0 112.544 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.25 -97.9 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.001 0.52 . . . . 0.0 112.166 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -51.74 -40.69 60.68 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.005 0.922 . . . . 0.0 111.368 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -165.71 -178.77 4.99 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.017 1.727 . . . . 0.0 110.185 173.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.37 18.02 7.83 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.315 1.436 . . . . 0.0 112.783 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.0 ttt -92.45 171.38 9.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.611 1.165 . . . . 0.0 111.553 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.94 145.98 44.05 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.27 -0.894 . . . . 0.0 111.097 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 66' ' ' ASP . 10.3 t -120.67 129.37 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.76 132.68 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.44 136.61 14.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -42.51 113.52 1.29 Allowed Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.907 1.283 . . . . 0.0 112.78 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -76.51 -68.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.943 1.762 . . . . 0.0 111.375 -173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.73 13.18 20.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.762 1.225 . . . . 0.0 112.138 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.24 56.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.225 1.41 . . . . 0.0 111.632 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.02 -56.94 0.78 Allowed Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p 169.79 137.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.676 1.59 . . . . 0.0 110.47 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 87.63 0.19 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.447 0.699 . . . . 0.0 111.049 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 t -63.08 139.22 58.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 110.431 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.414 HD23 HG13 ' A' ' 79' ' ' VAL . 2.5 tm? -114.34 131.57 56.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.401 1.48 . . . . 0.0 108.909 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -91.93 115.54 28.15 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.365 1.066 . . . . 0.0 110.101 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.36 -179.63 2.54 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.61 0.719 . . . . 0.0 112.058 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 -51.51 6.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -45.7 87.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.38 0.672 . . . . 0.0 111.462 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.8 41.68 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.679 1.133 . . . . 0.0 112.705 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -104.97 170.16 17.54 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.155 0.883 . . . . 0.0 111.748 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -123.48 138.97 54.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.753 0.787 . . . . 0.0 109.262 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.13 119.4 56.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.54 115.22 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 132.11 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.34 137.21 9.2 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.987 -0.446 . . . . 0.0 110.899 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.3 154.23 61.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.215 1.943 . . . . 0.0 111.608 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.9 65.42 1.11 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.575 1.655 . . . . 0.0 111.099 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -86.48 172.04 10.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.443 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.24 147.01 35.79 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.341 0.656 . . . . 0.0 111.111 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.22 39.72 92.83 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.893 -0.948 . . . . 0.0 113.413 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 48.92 -103.72 0.08 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.189 1.376 . . . . 0.0 113.105 -173.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.6 p -108.91 175.74 5.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.31 1.844 . . . . 0.0 111.961 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 115.66 -50.86 0.75 Allowed Glycine 0 N--CA 1.47 0.9 0 O-C-N 120.802 -1.186 . . . . 0.0 111.869 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.46 -177.96 3.66 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.394 1.077 . . . . 0.0 111.775 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -66.55 163.09 19.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.736 0.779 . . . . 0.0 111.277 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -91.77 144.68 25.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.775 172.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.56 104.05 1.44 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -87.47 155.68 19.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.708 -0.878 . . . . 0.0 111.18 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.456 HG22 HG13 ' A' ' 176' ' ' VAL . 0.1 OUTLIER -143.86 118.21 9.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 122.023 0.916 . . . . 0.0 110.822 -176.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.405 HD13 HD13 ' A' ' 42' ' ' LEU . 5.6 mt -113.57 108.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -71.17 131.34 43.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.125 0.97 . . . . 0.0 108.807 172.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -130.38 124.72 32.83 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -131.15 128.18 39.55 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt 164.74 -38.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.771 2.029 . . . . 0.0 110.872 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -45.19 103.35 0.34 Allowed Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.711 1.604 . . . . 0.0 110.492 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 30.1 Cg_endo -74.82 -172.1 1.14 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 110.363 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -22.54 53.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.545 -1.347 . . . . 0.0 114.324 173.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.8 t -79.34 -52.01 8.66 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.964 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.578 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.32 -23.9 60.32 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 121.866 -0.521 . . . . 0.0 110.86 175.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.26 -27.54 62.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.791 1.178 . . . . 0.0 110.164 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.59 -50.87 11.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 CA-C-O 117.871 -1.062 . . . . 0.0 110.609 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.411 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -53.31 -45.22 68.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.943 1.247 . . . . 0.0 113.38 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.59 HG23 HD21 ' A' ' 36' ' ' LEU . 21.6 mm -62.09 -38.61 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.206 172.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -67.2 -43.78 81.23 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.463 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.4 m -65.15 -27.89 69.03 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.243 1.383 . . . . 0.0 111.957 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.02 20.68 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.227 0.917 . . . . 0.0 113.75 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 1.9 ttp -84.71 -24.78 28.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.289 1.435 . . . . 0.0 112.43 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.6 p -69.59 -21.36 63.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.917 1.287 . . . . 0.0 111.888 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.0 mtt-85 -60.57 -17.91 49.35 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 113.133 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 t -154.04 53.44 0.7 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.255 1.022 . . . . 0.0 110.593 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -38.09 -65.39 0.7 Allowed Glycine 0 C--N 1.345 1.075 0 C-N-CA 125.34 1.448 . . . . 0.0 112.961 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 22.39 72.29 0.01 OUTLIER Glycine 0 C--N 1.347 1.187 0 C-N-CA 126.991 2.234 . . . . 0.0 113.217 167.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.527 HG22 ' CD1' ' A' ' 142' ' ' ILE . 3.9 p -53.28 171.16 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.531 1.532 . . . . 0.0 112.668 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.39 -33.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.67 -0.644 . . . . 0.0 111.315 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 171.12 43.5 0.03 OUTLIER Glycine 0 C--N 1.338 0.643 0 CA-C-O 119.58 -0.567 . . . . 0.0 113.399 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.527 ' CD1' HG22 ' A' ' 139' ' ' THR . 3.0 mt -77.2 116.3 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.166 0.586 . . . . 0.0 110.812 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.79 96.45 5.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.574 1.15 . . . . 0.0 108.897 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 147' ' ' ASN . 10.7 mt -74.96 167.14 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -49.53 115.83 1.51 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.35 1.46 . . . . 0.0 111.981 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.65 27.19 8.6 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 123.444 0.545 . . . . 0.0 114.138 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 0.7 OUTLIER -129.34 39.94 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.06 2.544 . . . . 0.0 107.615 -176.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -42.53 95.91 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.657 1.183 . . . . 0.0 111.593 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -142.8 -173.52 3.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.221 1.408 . . . . 0.0 108.784 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.499 HG22 ' HA2' ' A' ' 141' ' ' GLY . 12.3 p -146.29 -47.57 0.2 Allowed 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.548 -0.72 . . . . 0.0 110.193 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.439 ' C ' HG21 ' A' ' 139' ' ' THR . 1.0 OUTLIER -85.57 18.53 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.259 1.824 . . . . 0.0 112.142 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.97 97.71 0.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.304 -0.873 . . . . 0.0 111.146 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.62 125.1 29.58 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' A' ' 158' ' ' ILE . 2.1 t -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.07 170.06 16.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.151 0.98 . . . . 0.0 110.809 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.05 -37.67 72.12 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.5 -42.3 43.93 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.185 0.994 . . . . 0.0 110.891 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -59.89 -45.51 94.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 173.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.84 -17.95 61.5 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.761 -0.587 . . . . 0.0 111.972 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -40.6 76.67 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.243 -0.91 . . . . 0.0 111.531 172.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 70.1 m -107.96 -58.01 2.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.805 0.842 . . . . 0.0 112.12 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -82.76 63.32 6.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.365 1.866 . . . . 0.0 113.037 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 2.5 t 176.47 -45.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 110.624 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 m -95.94 156.24 16.41 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.305 1.042 . . . . 0.0 109.527 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 62.48 154.89 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.314 1.446 . . . . 0.0 112.336 -169.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.7 t70 81.1 7.04 1.25 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.39 1.476 . . . . 0.0 112.576 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.49 -45.04 0.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.336 1.454 . . . . 0.0 111.187 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.18 -43.13 1.88 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.472 1.51 . . . . 0.0 112.366 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -162.78 67.79 0.22 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.492 1.117 . . . . 0.0 111.737 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.7 p -47.86 128.69 13.63 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.507 0.67 . . . . 0.0 111.158 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.07 0.65 Allowed Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 67.4 p -89.28 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.348 1.459 . . . . 0.0 109.7 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.32 84.28 2.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.974 1.71 . . . . 0.0 109.792 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.0 m -77.16 123.87 27.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.199 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.26 112.68 11.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -82.67 131.52 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 171.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.464 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 13.6 m-85 -108.88 111.34 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -85.79 141.82 29.39 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.022 0.439 . . . . 0.0 111.498 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 43' ' ' ALA . 15.2 t80 -142.22 118.71 10.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.824 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.66 142.39 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.677 0.391 . . . . 0.0 110.489 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 C-N-CA 124.276 0.941 . . . . 0.0 113.961 175.262 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.244 0.545 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.69 168.49 2.59 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.405 1.482 . . . . 0.0 110.408 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 110.96 0.22 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -105.85 -78.29 0.58 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.717 0.807 . . . . 0.0 110.063 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -137.67 172.15 13.39 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.271 1.428 . . . . 0.0 110.893 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -65.32 -46.07 81.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.218 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 128' ' ' SER . . . -84.11 -38.39 20.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.341 1.056 . . . . 0.0 111.24 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.73 -28.85 1.19 Allowed Glycine 0 C--O 1.216 -1.0 0 CA-C-O 117.868 -1.518 . . . . 0.0 113.142 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 t -40.3 -46.15 2.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.293 1.546 . . . . 0.0 113.649 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -73.62 -39.23 64.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.17 0.896 . . . . 0.0 111.517 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mt -66.44 -51.85 52.62 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.848 0.859 . . . . 0.0 112.017 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 p -62.69 -35.76 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.35 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -58.62 -54.44 47.07 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.117 1.326 . . . . 0.0 111.588 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -56.7 -45.63 81.71 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.206 -0.934 . . . . 0.0 111.638 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -65.01 -28.56 69.59 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 112.222 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -43.23 81.61 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 109.688 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.451 ' CD2' HD11 ' A' ' 116' ' ' ILE . 2.3 tt -62.89 -44.09 97.04 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.083 -1.011 . . . . 0.0 109.994 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.75 86.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.455 0.57 . . . . 0.0 112.264 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.34 -30.94 63.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.39 1.076 . . . . 0.0 112.656 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.85 -60.83 2.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 t -55.27 -21.15 13.35 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.948 0.899 . . . . 0.0 112.587 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -47.39 -33.84 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.545 1.138 . . . . 0.0 113.087 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.93 37.31 0.42 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.611 1.101 . . . . 0.0 112.283 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.9 tpt -109.47 -70.41 0.81 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.518 0.727 . . . . 0.0 110.583 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.76 64.03 0.73 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.8 1.286 . . . . 0.0 111.297 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.49 -9.52 15.37 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.68 37.77 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.236 1.398 . . . . 0.0 111.924 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.75 125.96 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.2 t70 74.23 -46.1 0.61 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.397 1.879 . . . . 0.0 112.712 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -44.93 140.23 4.54 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.913 1.72 . . . . 0.0 112.934 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.19 120.81 43.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.296 1.038 . . . . 0.0 110.358 -172.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 49.87 -163.82 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.762 0.825 . . . . 0.0 111.393 -172.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 48.02 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.983 1.313 . . . . 0.0 113.19 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.6 t -52.36 154.23 2.56 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.122 0.963 . . . . 0.0 111.854 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.0 m -71.08 -52.96 16.45 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.413 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.24 -89.97 0.91 Allowed Glycine 0 N--CA 1.469 0.863 0 O-C-N 120.915 -1.116 . . . . 0.0 112.651 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.617 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -83.07 -49.85 9.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.38 -22.91 34.32 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 123.679 0.791 . . . . 0.0 112.106 169.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -60.46 -51.48 69.28 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.071 0.85 . . . . 0.0 110.076 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.508 ' OG1' HG21 ' A' ' 100' ' ' VAL . 11.4 m -74.85 -40.75 60.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.049 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -56.04 -52.5 64.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.194 0.906 . . . . 0.0 110.738 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.4 m -68.57 -39.64 80.91 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 110.928 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD21 ' HG ' ' A' ' 42' ' ' LEU . 9.4 tp -60.58 -51.29 70.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.626 1.557 . . . . 0.0 111.557 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 65' ' ' THR . 0.9 OUTLIER -62.37 -51.93 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 120.694 -1.253 . . . . 0.0 110.863 176.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -61.88 -18.34 59.8 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.484 -1.385 . . . . 0.0 112.711 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.08 12.11 5.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.493 1.517 . . . . 0.0 113.295 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.62 40.83 80.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.977 1.275 . . . . 0.0 112.743 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.19 -77.73 0.54 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.01 0.524 . . . . 0.0 110.861 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.39 -59.57 2.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -140.04 179.66 6.49 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.178 1.391 . . . . 0.0 109.9 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.16 35.37 2.45 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.104 1.335 . . . . 0.0 112.161 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.2 mtt -103.72 179.77 4.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.801 1.24 . . . . 0.0 111.982 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -69.77 133.74 47.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.587 0.708 . . . . 0.0 110.473 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.26 134.36 59.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.53 1.132 . . . . 0.0 108.515 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.26 152.15 36.59 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.184 0.516 . . . . 0.0 110.803 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.95 158.05 14.54 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -145.36 127.85 8.08 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 122.766 0.426 . . . . 0.0 110.552 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.29 -17.02 27.82 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.639 2.226 . . . . 0.0 112.514 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.1 61.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.508 0.723 . . . . 0.0 112.842 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 t 66.56 63.69 0.51 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 112.296 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.76 41.16 0.02 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.727 -0.608 . . . . 0.0 114.127 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.35 25.39 0.3 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.942 0.897 . . . . 0.0 111.761 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -60.26 126.97 29.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.215 1.007 . . . . 0.0 109.914 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 t -117.58 140.44 49.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.19 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -106.62 127.11 53.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -87.37 113.83 23.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.764 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -74.48 170.55 15.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.769 0.795 . . . . 0.0 111.643 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -87.75 -36.0 17.58 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.078 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -87.73 46.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 112.162 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 46.94 61.25 4.49 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.023 1.297 . . . . 0.0 112.832 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -130.15 160.31 22.92 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 123.774 0.702 . . . . 0.0 112.329 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.43 133.93 48.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.796 1.284 . . . . 0.0 108.95 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.08 135.81 59.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.911 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.48 ' HB ' HG22 ' A' ' 117' ' ' THR . 77.2 t -119.32 110.37 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.508 HG21 ' OG1' ' A' ' 65' ' ' THR . 3.0 m -90.32 125.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.33 125.55 13.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.538 -0.726 . . . . 0.0 109.248 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.86 153.96 58.55 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.488 1.459 . . . . 0.0 111.203 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -147.56 73.14 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.935 1.694 . . . . 0.0 110.852 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.7 p -104.55 82.46 1.91 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.775 1.274 . . . . 0.0 109.807 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.14 95.07 2.66 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.627 -1.295 . . . . 0.0 111.124 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.65 88.14 2.02 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.5 143.29 14.81 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.218 0.913 . . . . 0.0 111.452 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -101.36 -48.15 4.46 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.881 1.272 . . . . 0.0 111.326 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.25 -92.66 2.27 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.186 1.374 . . . . 0.0 110.576 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.75 29.44 0.83 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.977 0.894 . . . . 0.0 112.871 -176.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -86.27 114.65 23.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.219 1.008 . . . . 0.0 109.803 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -95.4 153.47 17.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.397 170.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.99 119.26 6.14 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.47 133.05 56.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.085 0.942 . . . . 0.0 109.674 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.0 p -116.55 124.01 48.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 122.135 0.969 . . . . 0.0 108.968 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 42' ' ' LEU . 3.3 mp -120.8 98.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -69.38 135.68 50.66 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.56 172.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.6 p -125.28 121.86 35.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -120.58 175.42 6.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.545 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 84.19 -18.42 0.41 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.959 2.104 . . . . 0.0 111.897 -175.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -49.38 107.68 0.83 Allowed Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.283 1.833 . . . . 0.0 109.011 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -73.71 -174.47 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.352 2.035 . . . . 0.0 110.026 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -59.47 -28.13 66.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.383 -0.823 . . . . 0.0 111.863 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.4 t -70.24 -43.59 70.26 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.497 -1.377 . . . . 0.0 111.524 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 119.425 -0.322 . . . . 0.0 111.387 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -26.94 63.03 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.937 -1.102 . . . . 0.0 111.614 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.02 -53.58 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 124.49 1.116 . . . . 0.0 110.674 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 32' ' ' ALA . 60.4 p -57.08 -44.72 83.4 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.681 1.128 . . . . 0.0 113.249 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.53 -38.4 56.5 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 C-N-CA 124.851 1.26 . . . . 0.0 109.338 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.9 m -73.38 -46.6 48.01 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.963 0.801 . . . . 0.0 112.469 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 m -56.99 -32.36 66.01 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.468 1.485 . . . . 0.0 111.727 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.45 -37.36 9.75 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.105 0.86 . . . . 0.0 113.394 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.3 ttm -74.34 -15.5 60.95 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.003 -1.292 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.2 t -84.84 -21.64 29.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.323 -1.486 . . . . 0.0 111.193 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -62.64 -41.95 99.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.095 0.558 . . . . 0.0 112.086 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.2 t -161.75 55.53 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.178 0.991 . . . . 0.0 110.688 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.25 -83.55 0.19 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.81 149.13 0.01 OUTLIER Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.759 1.2 . . . . 0.0 111.827 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.0 m -49.84 143.03 8.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.986 -1.302 . . . . 0.0 111.555 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.97 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.267 0.627 . . . . 0.0 111.717 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 153.98 54.49 0.01 OUTLIER Glycine 0 C--N 1.337 0.615 0 C-N-CA 123.902 0.763 . . . . 0.0 112.488 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.62 98.38 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.358 0.599 . . . . 0.0 109.941 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -91.42 93.91 9.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.0 tt -77.32 148.87 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 111.027 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.415 ' HB2' ' H ' ' A' ' 174' ' ' THR . 24.6 t30 -54.29 122.43 10.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.669 -0.644 . . . . 0.0 112.23 -174.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.56 -52.73 3.53 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.403 1.001 . . . . 0.0 113.327 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -79.7 31.03 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.983 1.313 . . . . 0.0 111.968 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -48.81 98.18 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.253 1.421 . . . . 0.0 110.676 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -126.22 -165.86 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.915 1.286 . . . . 0.0 109.089 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.6 p -132.2 -37.63 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.009 0.924 . . . . 0.0 110.921 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.95 12.14 18.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.371 1.868 . . . . 0.0 113.646 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.58 137.42 19.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.768 0.794 . . . . 0.0 109.881 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 120.15 25.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.25 133.9 63.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 171.15 12.62 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.333 1.053 . . . . 0.0 110.245 -169.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.16 -52.19 63.41 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 111.784 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.43 -37.65 78.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.879 0.871 . . . . 0.0 111.982 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.74 42.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.322 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.34 67.47 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.581 1.082 . . . . 0.0 111.985 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -34.93 78.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.497 1.119 . . . . 0.0 112.194 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -43.06 8.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.293 1.037 . . . . 0.0 112.299 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.11 -50.86 72.45 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.702 2.001 . . . . 0.0 111.113 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 59.2 m -84.13 90.38 7.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.346 1.07 . . . . 0.0 109.306 173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.2 p -72.34 141.92 48.8 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.203 1.401 . . . . 0.0 111.382 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 43.83 -157.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.241 1.019 . . . . 0.0 112.341 -173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.26 68.47 1.04 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -51.28 -25.16 5.32 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.583 -0.698 . . . . 0.0 111.901 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.75 104.47 1.43 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.97 51.85 3.56 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.849 0.833 . . . . 0.0 111.116 -173.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.7 p -49.96 159.57 0.4 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.201 1.001 . . . . 0.0 111.322 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.19 130.73 2.77 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.022 0.82 . . . . 0.0 112.589 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.2 p -45.73 108.24 0.12 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.789 1.636 . . . . 0.0 110.804 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.5 125.94 30.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 145' ' ' ASN . 2.5 m -96.5 108.24 20.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.76 102.17 7.19 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.578 1.151 . . . . 0.0 108.576 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -81.69 131.32 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 173.529 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -111.39 101.08 9.57 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.777 0.831 . . . . 0.0 109.224 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -87.01 144.16 27.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.41 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -138.59 111.52 7.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.812 1.245 . . . . 0.0 109.912 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.93 129.01 38.99 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.346 0.658 . . . . 0.0 109.408 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.589 0 CA-C-O 116.81 -2.106 . . . . 0.0 115.661 173.534 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.72 170.66 1.95 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.032 1.733 . . . . 0.0 110.375 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.92 90.17 0.61 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 123.616 0.627 . . . . 0.0 111.59 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 -64.4 1.32 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.392 0.677 . . . . 0.0 110.879 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -133.97 175.78 9.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.647 1.579 . . . . 0.0 110.545 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.84 -43.0 5.67 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.45 0.7 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.9 -42.31 8.37 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.206 1.402 . . . . 0.0 112.07 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.58 -29.25 5.53 Favored Glycine 0 C--O 1.212 -1.27 0 CA-C-O 117.065 -1.964 . . . . 0.0 111.838 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.1 p -40.43 -34.92 0.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.172 2.189 . . . . 0.0 114.743 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.437 ' HG3' HD11 ' A' ' 129' ' ' ILE . 2.3 mm-40 -88.08 -38.03 15.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.25 . . . . 0.0 110.785 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.7 -47.63 30.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.399 1.08 . . . . 0.0 111.032 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -56.87 -40.3 75.9 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 109.763 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -59.13 -51.84 68.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.468 1.486 . . . . 0.0 111.692 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -50.74 -52.04 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.022 -0.424 . . . . 0.0 111.478 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -67.4 -23.91 65.61 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.1 81.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.368 1.467 . . . . 0.0 109.062 176.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.471 HD22 HD13 ' A' ' 116' ' ' ILE . 2.5 tt -67.24 -43.25 82.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.792 0.724 . . . . 0.0 109.7 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -62.59 -43.3 99.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.082 0.239 . . . . 0.0 111.309 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.18 -33.68 59.32 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.065 1.346 . . . . 0.0 112.634 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -67.07 -62.91 1.19 Allowed 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -29.92 59.75 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.79 0.836 . . . . 0.0 111.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.61 -34.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.814 1.246 . . . . 0.0 112.389 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 44.49 0.63 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.178 1.37 . . . . 0.0 112.373 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -134.0 -70.3 0.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.951 0.9 . . . . 0.0 111.46 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.439 ' HG3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -145.67 71.57 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.75 1.262 . . . . 0.0 111.784 -173.324 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -116.5 14.08 15.49 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.962 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.66 2.52 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.596 1.093 . . . . 0.0 113.032 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.92 -36.29 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.103 0.951 . . . . 0.0 111.012 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.47 101.76 11.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.572 1.549 . . . . 0.0 109.717 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 117.89 -48.35 0.95 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.57 1.081 . . . . 0.0 112.497 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.9 t80 50.37 38.57 18.28 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.826 1.25 . . . . 0.0 113.38 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.58 69.05 0.13 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 120.983 -1.073 . . . . 0.0 112.096 -171.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -165.06 164.43 20.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.337 1.055 . . . . 0.0 111.167 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.7 m -118.75 -33.13 4.33 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.61 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.9 m -47.49 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.594 1.557 . . . . 0.0 111.765 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.74 19.9 17.98 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 123.848 0.737 . . . . 0.0 112.283 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.583 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -84.77 -55.44 4.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.47 0.708 . . . . 0.0 111.927 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.56 -27.92 68.97 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.166 170.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -53.8 52.43 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.714 0.688 . . . . 0.0 110.311 175.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.442 ' CB ' HG21 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -70.85 -37.76 73.14 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 118.595 -0.717 . . . . 0.0 112.232 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HA ' HG21 ' A' ' 79' ' ' VAL . 11.0 t0 -57.83 -56.42 22.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.82 0.736 . . . . 0.0 110.834 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.439 HG22 ' HG3' ' A' ' 50' ' ' MET . 9.0 m -68.3 -35.21 77.48 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.019 1.327 . . . . 0.0 110.389 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.425 HD21 ' HG ' ' A' ' 42' ' ' LEU . 15.0 tp -62.29 -50.82 70.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.37 1.441 . . . . 0.0 111.324 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.36 -52.86 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 O-C-N 120.825 -1.172 . . . . 0.0 110.994 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.72 -18.32 62.31 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.701 -1.249 . . . . 0.0 112.38 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.84 10.22 6.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.711 1.604 . . . . 0.0 112.908 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.18 51.25 60.27 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.98 1.276 . . . . 0.0 112.307 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.08 -85.07 0.63 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.512 0.725 . . . . 0.0 111.017 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.49 -52.15 35.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 122.638 0.375 . . . . 0.0 111.646 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -149.98 -179.94 7.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.09 25.22 5.25 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.992 1.282 . . . . 0.0 112.489 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.58 168.6 10.93 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.226 1.01 . . . . 0.0 111.567 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -60.92 136.21 58.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.326 0.584 . . . . 0.0 110.403 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 66' ' ' ASP . 4.0 t -115.94 136.34 53.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.421 1.088 . . . . 0.0 108.347 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.58 128.97 50.76 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.18 154.55 33.04 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -44.69 110.42 1.04 Allowed Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.502 0.721 . . . . 0.0 112.852 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.17 -31.75 4.58 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.508 1.472 . . . . 0.0 111.694 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.73 11.85 21.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.269 1.427 . . . . 0.0 112.606 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m 62.07 98.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 112.996 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.57 38.16 1.49 Allowed Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.914 0.769 . . . . 0.0 114.037 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 p -175.52 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.809 1.244 . . . . 0.0 111.69 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -75.62 100.41 4.6 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.007 -1.058 . . . . 0.0 111.174 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -69.87 134.92 48.99 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.762 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.07 126.3 50.43 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.58 1.552 . . . . 0.0 108.81 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -81.16 111.64 17.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.286 1.035 . . . . 0.0 110.065 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.26 179.09 4.08 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.78 0.8 . . . . 0.0 111.724 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -82.76 -55.23 4.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.115 0.566 . . . . 0.0 111.946 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -83.17 50.77 1.81 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.092 0.957 . . . . 0.0 112.14 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.1 69.7 0.84 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.269 1.414 . . . . 0.0 112.928 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -129.54 163.8 22.56 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 123.28 0.467 . . . . 0.0 112.373 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.48 131.91 42.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.49 120.41 56.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.325 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 117' ' ' THR . 2.6 t -107.23 113.99 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 88' ' ' ALA . 2.1 m -97.63 139.99 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.23 135.57 9.22 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.515 0.726 . . . . 0.0 109.058 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -76.19 150.54 33.34 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 121.809 1.672 . . . . 0.0 111.057 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.23 76.0 1.52 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.224 1.488 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.33 114.53 28.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.764 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.81 138.75 19.03 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.476 -0.765 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.56 96.28 0.54 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -44.05 -73.6 0.25 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.576 1.084 . . . . 0.0 113.988 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -80.16 49.49 1.11 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.033 1.733 . . . . 0.0 112.302 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.69 95.9 0.13 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.614 1.102 . . . . 0.0 112.038 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -68.48 26.63 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.55 1.54 . . . . 0.0 114.319 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -88.35 130.0 35.26 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.318 1.447 . . . . 0.0 109.551 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -99.59 132.25 45.05 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.927 0.891 . . . . 0.0 108.648 172.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -107.8 89.28 0.57 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.459 1.028 . . . . 0.0 111.395 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -70.74 120.41 16.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.385 -1.656 . . . . 0.0 111.607 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.6 p -108.63 110.71 22.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.67 1.224 . . . . 0.0 111.428 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.471 HD13 HD22 ' A' ' 42' ' ' LEU . 5.8 mt -117.36 105.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 O-C-N 120.94 -1.1 . . . . 0.0 108.25 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.583 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -74.85 139.94 43.53 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.976 171.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -131.38 122.5 26.44 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -136.29 110.13 8.16 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.796 -0.565 . . . . 0.0 110.61 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.03 -31.47 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.551 1.54 . . . . 0.0 113.058 -173.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.2 m -50.89 109.47 1.36 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.138 1.375 . . . . 0.0 109.878 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.62 -169.55 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.044 2.496 . . . . 0.0 110.692 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -33.93 69.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.646 -1.284 . . . . 0.0 113.413 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.4 p -65.99 -48.13 72.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.528 1.058 . . . . 0.0 111.222 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.45 -34.05 63.06 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.507 0.723 . . . . 0.0 111.144 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.3 t -49.62 -31.46 10.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.445 -1.409 . . . . 0.0 111.099 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.36 -54.98 6.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 124.434 1.093 . . . . 0.0 112.239 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -46.61 72.4 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.007 1.276 . . . . 0.0 113.96 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.437 HD11 ' HG3' ' A' ' 35' ' ' GLU . 51.1 mm -56.37 -38.81 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.638 1.575 . . . . 0.0 110.701 173.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -74.12 -39.67 63.19 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.362 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.4 m -58.45 -35.76 72.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.56 1.527 . . . . 0.0 111.768 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.44 -32.14 28.79 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.833 -0.542 . . . . 0.0 112.122 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 40.9 tpp -78.65 -19.93 51.46 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 118.213 1.007 . . . . 0.0 111.41 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 17.9 p -77.54 -20.5 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.408 -1.432 . . . . 0.0 111.695 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -41.44 93.61 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.069 0.948 . . . . 0.0 112.037 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.3 t -162.1 62.36 0.23 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.34 -77.78 0.15 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.3 143.83 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.408 1.004 . . . . 0.0 111.455 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 151' ' ' ASP . 2.3 p -41.92 111.2 0.21 Allowed 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.632 -1.511 . . . . 0.0 112.804 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 p -145.02 28.49 1.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.228 1.811 . . . . 0.0 110.529 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 63.05 45.76 94.86 Favored Glycine 0 CA--C 1.523 0.542 0 O-C-N 121.276 -0.89 . . . . 0.0 113.102 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.5 mt -83.48 112.52 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.66 0.784 . . . . 0.0 109.947 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -115.63 97.36 6.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.044 0.938 . . . . 0.0 109.108 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 154' ' ' VAL . 88.1 mt -73.95 164.66 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.203 0.601 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -47.15 116.34 1.36 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.71 25.33 6.73 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 123.632 0.634 . . . . 0.0 114.156 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -131.61 37.35 3.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.617 2.767 . . . . 0.0 107.818 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -36.98 90.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.086 1.755 . . . . 0.0 112.924 167.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -142.03 -174.6 4.14 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.36 1.464 . . . . 0.0 109.065 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.472 HG22 ' HA2' ' A' ' 141' ' ' GLY . 11.6 p -146.68 -41.8 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -172.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 139' ' ' THR . 10.4 p-10 -85.87 8.98 18.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.944 2.097 . . . . 0.0 113.864 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.08 136.67 8.45 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.173 0.987 . . . . 0.0 110.448 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 100.31 4.71 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.643 1.211 . . . . 0.0 108.443 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 144' ' ' ILE . 45.8 t -117.79 119.77 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.512 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.457 ' HA ' ' HB3' ' A' ' 134' ' ' SER . 0.6 OUTLIER -108.24 179.92 4.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.346 -174.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.9 62.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.824 -0.548 . . . . 0.0 111.599 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.07 -35.65 80.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.339 0.655 . . . . 0.0 112.287 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.458 HG22 HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -72.87 -52.52 22.19 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.06 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.47 67.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.5 1.046 . . . . 0.0 111.934 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.7 m -63.92 -43.98 94.28 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.531 -0.731 . . . . 0.0 111.648 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.5 t -105.54 -56.81 2.12 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.79 67.7 2.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.412 1.885 . . . . 0.0 112.354 172.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 175.96 -56.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.671 1.988 . . . . 0.0 109.398 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.8 m -90.94 157.24 17.42 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.196 0.998 . . . . 0.0 109.159 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 71.59 -47.44 0.66 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.043 1.737 . . . . 0.0 113.422 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -76.26 42.64 0.27 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.622 1.969 . . . . 0.0 112.937 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.483 ' HB3' HG22 ' A' ' 170' ' ' THR . 0.6 OUTLIER -172.14 -39.16 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.293 1.437 . . . . 0.0 110.584 -178.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.05 113.86 0.02 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.467 1.508 . . . . 0.0 112.122 -174.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 48.7 63.8 1.96 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.211 1.004 . . . . 0.0 112.013 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 167' ' ' ASN . 12.9 p -54.68 125.15 18.72 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.279 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.44 -80.56 0.55 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 72.4 p -135.98 116.97 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.11 129.45 34.5 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 109.85 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.3 m -89.8 116.85 28.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.81 122.87 21.48 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.583 0.753 . . . . 0.0 109.266 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -94.06 143.75 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.05 0.54 . . . . 0.0 109.663 174.013 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.72 114.0 18.72 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.838 0.855 . . . . 0.0 109.642 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -99.61 118.73 36.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.039 0.936 . . . . 0.0 110.966 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.466 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 36.7 t80 -102.11 103.54 14.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.442 0.697 . . . . 0.0 110.955 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -71.94 136.25 46.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.957 0.503 . . . . 0.0 110.838 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.275 0 CA-C-O 117.581 -1.677 . . . . 0.0 113.095 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -170.68 155.89 5.02 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.534 1.134 . . . . 0.0 109.19 172.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.91 -169.57 45.41 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 121.536 0.52 . . . . 0.0 112.001 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.36 -82.14 0.54 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.098 0.959 . . . . 0.0 110.133 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -141.45 -178.49 5.65 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.925 1.69 . . . . 0.0 110.935 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -34.44 75.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.161 0.985 . . . . 0.0 112.916 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 129' ' ' ILE . . . -103.02 -29.55 11.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.292 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.48 -32.2 5.33 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.918 0.77 . . . . 0.0 112.833 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -42.2 21.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.114 1.766 . . . . 0.0 113.852 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -68.2 -36.17 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.654 -1.279 . . . . 0.0 113.114 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.85 -48.2 66.8 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.551 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.0 p -64.78 -38.61 91.58 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.943 0.897 . . . . 0.0 110.828 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -58.51 -51.85 68.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.639 1.176 . . . . 0.0 111.17 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 177' ' ' PHE . 10.9 t80 -56.47 -48.26 77.47 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.171 -0.955 . . . . 0.0 112.075 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -26.54 68.58 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -42.12 88.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.459 1.104 . . . . 0.0 109.971 173.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.56 -44.99 92.5 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 117.582 -1.199 . . . . 0.0 108.918 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.75 92.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.159 0.891 . . . . 0.0 111.368 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -38.17 69.27 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.195 -0.94 . . . . 0.0 112.837 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -69.22 -57.0 5.94 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -51.98 -30.9 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.57 1.548 . . . . 0.0 112.008 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.17 -25.46 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.157 1.383 . . . . 0.0 113.373 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.41 25.5 1.85 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.67 1.605 . . . . 0.0 113.617 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -157.8 0.63 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.319 1.048 . . . . 0.0 110.489 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.08 52.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.307 1.843 . . . . 0.0 113.577 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -115.25 -60.69 1.85 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.91 1.284 . . . . 0.0 111.255 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.06 0.66 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.572 1.082 . . . . 0.0 111.03 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.96 52.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.665 1.586 . . . . 0.0 108.64 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.24 -56.83 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.249 -0.907 . . . . 0.0 111.096 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.58 -57.83 0.5 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.926 1.25 . . . . 0.0 111.77 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -156.85 41.16 0.34 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.395 1.078 . . . . 0.0 112.284 -172.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.26 157.09 3.77 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.192 -0.942 . . . . 0.0 112.603 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.94 111.03 15.88 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.848 0.859 . . . . 0.0 110.543 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.7 m 62.93 134.94 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.178 1.466 . . . . 0.0 112.012 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.5 p -133.91 76.03 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 O-C-N 120.579 -1.326 . . . . 0.0 108.783 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -159.47 -61.41 0.01 OUTLIER Glycine 0 N--CA 1.47 0.911 0 CA-C-O 119.103 -0.831 . . . . 0.0 113.828 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.49 -75.87 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.415 1.108 . . . . 0.0 112.334 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -32.69 70.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.81 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.1 ttp -57.37 -40.57 78.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.903 1.281 . . . . 0.0 111.789 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 69' ' ' ILE . 1.1 m -72.0 -47.36 52.5 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.843 174.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.522 ' HA ' HG21 ' A' ' 79' ' ' VAL . 2.9 t0 -50.09 -49.42 51.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.666 1.121 . . . . 0.0 111.314 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -68.32 -46.63 69.73 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.646 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.43 -42.02 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.199 0.909 . . . . 0.0 110.512 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.628 HD12 HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -63.89 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 121.188 -0.945 . . . . 0.0 110.573 175.008 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -61.39 -23.55 65.87 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.698 -0.626 . . . . 0.0 111.97 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.8 -3.47 28.75 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.374 1.47 . . . . 0.0 113.439 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.5 50.38 9.8 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.943 1.735 . . . . 0.0 112.487 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.32 -88.75 0.61 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.424 0.689 . . . . 0.0 112.271 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.56 83.43 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 122.94 0.496 . . . . 0.0 111.716 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -160.61 146.89 15.19 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 125.169 1.387 . . . . 0.0 109.586 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.11 55.4 1.13 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.655 1.121 . . . . 0.0 112.824 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 -179.87 5.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.632 1.173 . . . . 0.0 112.349 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.14 141.9 41.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.32 0.581 . . . . 0.0 110.579 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.576 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.5 t -115.44 152.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.491 1.116 . . . . 0.0 109.058 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.57 122.04 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.256 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.73 101.05 2.7 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -56.25 109.78 1.9 Allowed Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.825 0.85 . . . . 0.0 110.992 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.22 -25.0 14.01 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.77 -13.39 59.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.484 1.114 . . . . 0.0 112.661 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.08 75.39 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.344 1.458 . . . . 0.0 111.755 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.03 -53.57 0.07 OUTLIER Glycine 0 N--CA 1.465 0.609 0 C-N-CA 124.135 0.874 . . . . 0.0 111.574 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.7 t -172.16 122.95 0.48 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.122 0.969 . . . . 0.0 111.51 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.56 126.03 28.05 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.498 1.142 . . . . 0.0 110.551 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 p -95.83 138.45 33.46 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.027 -1.045 . . . . 0.0 108.747 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.76 121.19 42.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.54 124.63 29.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.697 0.799 . . . . 0.0 110.815 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.02 109.2 22.01 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -54.84 -53.27 57.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.43 0.692 . . . . 0.0 112.358 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -107.26 47.26 0.89 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 110.634 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.22 -142.16 3.32 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.261 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -114.4 -121.3 3.57 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 124.318 0.961 . . . . 0.0 111.516 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -131.15 148.66 52.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.763 0.792 . . . . 0.0 110.397 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.13 149.93 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.229 1.411 . . . . 0.0 108.561 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.723 ' HB ' HG22 ' A' ' 117' ' ' THR . 24.3 t -133.98 113.03 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 65' ' ' THR . 1.4 m -95.51 114.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 122.368 1.08 . . . . 0.0 108.869 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.68 138.34 31.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 O-C-N 120.473 -1.392 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.98 154.05 47.54 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.078 1.185 . . . . 0.0 110.731 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.34 68.42 1.14 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 123.432 1.586 . . . . 0.0 110.021 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 p -86.78 169.54 12.52 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.117 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.8 145.95 33.74 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 110.451 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.26 38.0 3.27 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.542 1.068 . . . . 0.0 111.9 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.37 -132.23 0.06 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.371 1.462 . . . . 0.0 112.372 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.2 t -136.37 33.95 2.77 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 123.195 1.474 . . . . 0.0 111.962 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.1 -158.25 10.04 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.614 1.102 . . . . 0.0 111.404 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -154.37 26.01 0.46 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.056 1.342 . . . . 0.0 111.871 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -97.61 111.37 23.67 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -56.78 131.09 48.29 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.01 115.31 4.44 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -117.5 144.85 44.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.882 0.873 . . . . 0.0 110.333 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -134.98 113.32 11.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.444 1.116 . . . . 0.0 111.0 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.0 mt -115.58 108.89 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.7 OUTLIER -78.2 142.09 38.18 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.246 173.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -134.81 125.92 27.84 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.35 98.34 4.85 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -38.87 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.465 1.106 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.5 m -52.62 104.33 0.43 Allowed Pre-proline 0 C--N 1.342 0.256 0 O-C-N 125.304 1.627 . . . . 0.0 108.249 -173.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -74.35 -168.08 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.604 1.536 . . . . 0.0 110.097 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.04 -29.42 65.33 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.118 -0.989 . . . . 0.0 112.502 174.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.2 p -71.73 -40.96 69.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.783 1.174 . . . . 0.0 112.429 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.75 49.97 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.5 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.5 -30.85 13.84 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.037 1.289 . . . . 0.0 109.995 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 159' ' ' ALA . 64.1 t -78.39 -57.87 4.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 123.642 0.777 . . . . 0.0 111.536 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 37.8 m -55.91 -25.09 41.31 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.516 ' CD1' ' HB1' ' A' ' 32' ' ' ALA . 1.3 mp -85.63 -47.84 16.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 C-N-CA 126.215 1.806 . . . . 0.0 110.228 170.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.7 m -58.44 -30.4 66.89 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 121.191 1.814 . . . . 0.0 111.846 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.1 t -86.5 -49.03 7.88 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.098 -1.001 . . . . 0.0 112.044 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.94 91.85 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -33.51 76.1 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 118.555 1.177 . . . . 0.0 110.736 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.34 -20.47 19.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -26.85 65.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.262 1.025 . . . . 0.0 113.296 172.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.5 t -159.03 46.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.451 1.9 . . . . 0.0 110.856 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.3 -86.59 1.72 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.58 49.41 1.81 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 125.67 1.605 . . . . 0.0 114.785 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 151' ' ' ASP . 17.5 m 63.96 142.86 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.657 1.583 . . . . 0.0 112.224 -172.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.95 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.841 -1.162 . . . . 0.0 111.257 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.37 48.52 0.04 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 124.531 1.063 . . . . 0.0 112.269 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 7.1 mt -89.42 102.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -91.87 98.99 11.93 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 122.957 0.503 . . . . 0.0 109.713 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.417 HG21 ' HB ' ' A' ' 164' ' ' THR . 30.5 mm -73.26 141.23 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 123.584 0.753 . . . . 0.0 109.8 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -47.61 119.99 3.07 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.383 -0.823 . . . . 0.0 111.612 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.06 -45.87 1.45 Allowed Glycine 0 CA--C 1.541 1.697 0 O-C-N 120.056 -1.653 . . . . 0.0 114.882 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.48 38.84 0.8 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.347 1.859 . . . . 0.0 111.242 170.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -51.35 95.76 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.968 1.307 . . . . 0.0 110.655 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -118.36 -168.77 1.58 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.099 1.359 . . . . 0.0 108.96 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -139.84 -40.11 0.45 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.723 0.809 . . . . 0.0 110.783 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.472 ' HA ' HG23 ' A' ' 139' ' ' THR . 4.3 p-10 -89.52 17.45 6.32 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.1 1.76 . . . . 0.0 114.026 169.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.528 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -46.01 126.1 7.07 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.587 0.708 . . . . 0.0 110.326 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -113.64 85.49 2.21 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.594 1.187 . . . . 0.0 107.865 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.404 ' HA ' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -110.23 121.47 63.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.399 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 158' ' ' ILE . 2.1 p -131.41 -179.79 5.57 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.809 1.644 . . . . 0.0 110.914 -173.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.35 85.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.57 1.532 . . . . 0.0 114.136 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -58.54 -41.64 86.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.241 0.616 . . . . 0.0 110.765 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 155' ' ' THR . 0.4 OUTLIER -78.98 -36.84 19.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 122.817 0.447 . . . . 0.0 111.039 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 127' ' ' VAL . . . -50.79 -55.29 17.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 p -69.53 -29.33 66.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -66.8 -61.07 2.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.871 0.868 . . . . 0.0 111.065 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 167.06 92.57 0.0 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 129.381 3.072 . . . . 0.0 108.421 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 32.0 p -41.8 143.37 0.53 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.417 ' HB ' HG21 ' A' ' 144' ' ' ILE . 2.0 m -48.9 152.9 0.94 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.428 0.691 . . . . 0.0 109.793 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 63.57 131.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.33 1.452 . . . . 0.0 113.673 -168.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.68 145.08 50.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.206 1.002 . . . . 0.0 110.776 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.554 ' HB2' HG22 ' A' ' 170' ' ' THR . 5.7 m120 -160.63 39.99 0.16 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.892 0.877 . . . . 0.0 111.407 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 52.34 -91.69 0.01 OUTLIER Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.141 1.353 . . . . 0.0 113.081 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -104.06 81.79 1.89 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.559 1.544 . . . . 0.0 111.503 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 167' ' ' ASN . 5.8 p -70.05 126.84 30.85 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.749 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -98.68 -46.43 2.12 Favored Glycine 0 N--CA 1.469 0.886 0 O-C-N 121.628 -0.67 . . . . 0.0 111.758 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.0 m -128.83 89.45 2.88 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.33 1.052 . . . . 0.0 108.967 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -79.59 102.49 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.87 0.868 . . . . 0.0 109.057 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.8 m -68.94 105.26 2.33 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.62 1.168 . . . . 0.0 109.879 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.97 112.41 16.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -85.6 137.05 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.467 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 13.0 m-85 -111.86 117.98 34.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -107.9 145.14 34.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 109.727 173.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -142.65 109.01 5.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.696 1.198 . . . . 0.0 109.154 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -100.09 98.19 8.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.539 1.136 . . . . 0.0 109.549 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 124.849 1.214 . . . . 0.0 113.633 178.276 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 175.73 166.02 0.37 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.558 1.943 . . . . 0.0 110.351 177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.4 108.48 0.44 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -146.86 109.19 4.49 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.594 1.157 . . . . 0.0 109.636 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm 62.31 166.91 0.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.896 1.679 . . . . 0.0 112.088 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.57 -48.33 14.0 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.422 -0.799 . . . . 0.0 111.121 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.507 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -75.72 -39.98 56.39 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.643 0.777 . . . . 0.0 110.96 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.61 -27.06 0.8 Allowed Glycine 0 C--O 1.216 -0.984 0 CA-C-O 116.326 -2.375 . . . . 0.0 113.311 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -38.55 -48.26 1.4 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.485 2.142 . . . . 0.0 114.341 166.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -30.35 60.51 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.782 -1.199 . . . . 0.0 112.207 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.6 -50.23 18.66 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.046 0.939 . . . . 0.0 111.065 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 t -58.55 -45.16 89.52 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.48 1.112 . . . . 0.0 110.468 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -60.96 -49.68 76.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.309 0.958 . . . . 0.0 112.094 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 177' ' ' PHE . 0.6 OUTLIER -50.35 -59.74 3.68 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.467 0.707 . . . . 0.0 111.348 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -59.6 -27.37 66.24 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 118.805 -0.616 . . . . 0.0 110.795 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 44' ' ' THR . 0.3 OUTLIER -69.05 -46.56 67.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.745 1.218 . . . . 0.0 111.393 177.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 68' ' ' LEU . 3.8 tp -54.65 -44.66 73.44 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 47' ' ' ILE . . . -69.54 -43.48 72.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -68.6 -15.04 63.4 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.981 1.712 . . . . 0.0 112.709 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.577 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 20.9 m-20 -95.47 -52.03 4.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -22.41 2.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.974 0.909 . . . . 0.0 111.84 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 43' ' ' ALA . 14.1 pt -41.8 -41.99 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.634 1.174 . . . . 0.0 113.012 171.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.8 21.46 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.279 0.943 . . . . 0.0 114.375 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.453 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -75.09 -55.38 5.79 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.22 1.008 . . . . 0.0 109.422 177.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.71 21.16 0.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -96.52 80.83 3.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.254 -1.529 . . . . 0.0 110.038 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 44.64 49.47 8.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.595 1.184 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.21 -73.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.718 0.807 . . . . 0.0 110.384 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.06 98.7 2.14 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.528 1.131 . . . . 0.0 109.915 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.26 144.26 9.29 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.573 1.082 . . . . 0.0 111.632 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -52.18 111.78 0.68 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.013 0.925 . . . . 0.0 112.069 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.94 100.09 7.92 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.209 0.603 . . . . 0.0 109.41 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -65.55 178.68 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 122.418 1.104 . . . . 0.0 112.258 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -52.68 177.89 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.481 1.512 . . . . 0.0 112.12 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m 60.88 60.17 1.92 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.465 -0.772 . . . . 0.0 109.667 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.97 46.42 0.22 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.064 1.792 . . . . 0.0 114.063 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 88' ' ' ALA . . . -87.43 -63.26 1.33 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.351 1.86 . . . . 0.0 110.276 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -38.35 66.0 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.269 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -59.77 -51.38 69.99 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 112.342 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.426 HG23 HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -65.83 -36.8 84.5 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.414 -0.327 . . . . 0.0 111.625 175.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -51.52 69.72 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.919 0.887 . . . . 0.0 110.441 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 p -68.18 -35.35 77.88 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 111.384 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.665 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -64.67 -50.08 68.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.791 1.178 . . . . 0.0 110.708 174.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.426 HD12 HG23 ' A' ' 65' ' ' THR . 3.4 mt -63.14 -50.58 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.893 -1.129 . . . . 0.0 110.061 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -60.78 -32.67 72.0 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.096 -1.002 . . . . 0.0 112.321 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.42 65.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.82 0.848 . . . . 0.0 112.848 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.79 4.81 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 124.998 1.285 . . . . 0.0 112.397 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.665 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -100.07 -64.01 1.08 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.59 -63.18 1.38 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.917 0.389 . . . . 0.0 110.247 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -132.61 -170.66 2.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.02 1.328 . . . . 0.0 109.062 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -140.59 16.71 2.87 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.26 0.933 . . . . 0.0 112.831 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.9 ttt -92.58 171.36 9.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.384 1.074 . . . . 0.0 111.329 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.41 141.81 53.75 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.346 0.593 . . . . 0.0 110.603 174.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.481 HG13 HD23 ' A' ' 90' ' ' LEU . 2.8 t -118.89 148.18 21.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 108.583 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.32 130.48 53.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.053 0.541 . . . . 0.0 110.08 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.03 130.71 9.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -114.34 101.61 54.27 Favored Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 124.365 1.066 . . . . 0.0 108.541 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -74.33 -35.82 3.6 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.766 2.31 . . . . 0.0 112.197 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.01 66.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.996 0.918 . . . . 0.0 112.125 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -59.86 1.76 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.916 0.886 . . . . 0.0 111.838 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.27 24.52 7.49 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.819 1.676 . . . . 0.0 113.582 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -135.06 88.33 2.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.647 1.579 . . . . 0.0 108.462 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -55.94 151.43 11.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.833 0.825 . . . . 0.0 111.686 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.0 p -129.06 147.17 50.9 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.719 0.808 . . . . 0.0 108.959 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.481 HD23 HG13 ' A' ' 79' ' ' VAL . 1.5 tm? -127.37 122.22 33.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.716 0.77 . . . . 0.0 109.265 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -80.84 120.82 25.18 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.491 0.716 . . . . 0.0 110.309 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -76.28 132.33 39.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.559 . . . . 0.0 109.861 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t -54.38 -47.64 72.43 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.9 0.48 . . . . 0.0 111.723 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -140.24 76.1 1.54 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 110.591 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.8 -103.23 0.16 Allowed Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.232 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.81 -119.77 0.91 Allowed Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.77 154.81 48.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 122.649 1.214 . . . . 0.0 110.744 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.4 mt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 125.473 1.509 . . . . 0.0 107.789 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.33 116.13 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 125.08 1.352 . . . . 0.0 107.371 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.595 HG22 ' HB3' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -98.6 124.84 52.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.98 145.52 22.65 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.513 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -77.31 154.56 32.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 121.912 1.742 . . . . 0.0 111.213 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.58 74.79 1.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.03 1.732 . . . . 0.0 110.641 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -111.94 140.84 46.28 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.829 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.26 107.46 3.6 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.223 0.609 . . . . 0.0 110.052 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.52 66.87 1.81 Allowed Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.81 138.62 14.34 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.739 0.685 . . . . 0.0 111.893 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 p -145.99 -71.04 0.25 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.203 1.001 . . . . 0.0 111.327 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.8 46.77 0.64 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.128 1.346 . . . . 0.0 111.879 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.87 170.91 15.01 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.425 1.49 . . . . 0.0 111.603 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.82 162.74 3.84 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.003 0.906 . . . . 0.0 111.843 170.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -91.02 169.08 11.17 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.152 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.48 113.1 4.16 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.83 145.39 27.02 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 174.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.5 p -131.57 107.08 8.61 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.838 1.304 . . . . 0.0 110.929 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.21 106.98 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.3 OUTLIER -71.73 135.23 46.7 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.61 0.764 . . . . 0.0 109.545 171.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.6 p -134.39 120.04 19.35 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.67 119.24 26.5 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.72 -0.612 . . . . 0.0 109.697 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.55 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.857 1.663 . . . . 0.0 112.731 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.18 103.03 0.33 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.396 1.878 . . . . 0.0 109.844 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 21.2 Cg_endo -75.17 -167.83 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.384 2.056 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -22.08 65.31 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.745 -1.222 . . . . 0.0 113.549 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.8 p -78.16 -52.0 9.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.917 0.887 . . . . 0.0 110.321 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.581 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -72.61 -21.62 61.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.668 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -52.6 -32.37 41.05 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.697 -1.252 . . . . 0.0 110.187 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.91 -41.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.135 1.374 . . . . 0.0 111.872 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.507 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 19.3 m -59.75 -34.8 73.44 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 119.903 -1.748 . . . . 0.0 113.152 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.72 -34.5 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.551 ' HB2' HG12 ' A' ' 154' ' ' VAL . 26.6 p -63.85 -41.98 97.68 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 120.753 1.615 . . . . 0.0 112.431 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 156' ' ' ALA . 12.4 t -77.07 -39.51 49.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.753 0.821 . . . . 0.0 111.34 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.24 -38.29 71.77 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 5.3 ttm -83.03 -32.21 27.01 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 110.282 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.8 t -62.9 -26.65 68.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.659 1.572 . . . . 0.0 112.413 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -62.74 -26.87 68.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -154.75 46.77 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.68 -83.0 1.71 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 40.5 58.84 2.43 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.76 1.171 . . . . 0.0 113.222 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 151' ' ' ASP . 3.7 m 70.17 135.06 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.4 1.48 . . . . 0.0 111.727 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 p 179.77 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.061 -1.024 . . . . 0.0 111.696 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.01 49.49 23.58 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.42 1.01 . . . . 0.0 113.499 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 2.7 mt -92.07 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.397 0.617 . . . . 0.0 109.999 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -89.3 94.13 9.79 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.037 -0.414 . . . . 0.0 110.449 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.417 HD11 ' HB1' ' A' ' 152' ' ' ALA . 10.0 mt -70.62 144.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.373 1.069 . . . . 0.0 110.467 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -48.33 118.55 2.5 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.01 -48.32 1.69 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.935 0.778 . . . . 0.0 113.466 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.43 36.83 0.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.438 1.895 . . . . 0.0 112.141 172.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -54.22 96.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.565 1.146 . . . . 0.0 110.019 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -119.64 -169.13 1.71 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.378 1.471 . . . . 0.0 109.772 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -134.67 -40.59 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.581 0.753 . . . . 0.0 110.866 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 139' ' ' THR . 5.8 p-10 -91.63 17.81 8.32 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.304 1.842 . . . . 0.0 113.863 170.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -42.77 130.22 4.18 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.628 0.728 . . . . 0.0 111.574 174.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 77.8 1.81 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.328 1.061 . . . . 0.0 109.044 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 130' ' ' SER . 6.1 t -98.68 135.84 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.522 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.2 167.03 22.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.813 1.245 . . . . 0.0 110.673 -172.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 131' ' ' THR . . . -54.83 -34.98 63.45 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.963 -0.461 . . . . 0.0 111.977 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.31 -44.11 22.27 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.073 1.349 . . . . 0.0 110.586 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -52.55 59.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.579 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.6 71.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.016 0.825 . . . . 0.0 111.228 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -45.68 71.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.263 0.625 . . . . 0.0 111.619 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.0 t -85.25 -55.9 3.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.515 0.726 . . . . 0.0 111.937 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -52.18 -57.8 8.52 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.531 2.332 . . . . 0.0 112.756 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 52.9 m -79.06 77.29 5.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.193 0.997 . . . . 0.0 109.386 170.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.3 m -62.59 157.15 21.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.706 1.202 . . . . 0.0 110.44 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.99 -29.93 69.97 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.71 155.1 1.2 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.286 1.035 . . . . 0.0 111.228 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.5 m120 55.07 79.73 0.14 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.403 0.681 . . . . 0.0 110.455 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -41.7 -39.09 2.49 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 124.374 0.988 . . . . 0.0 114.019 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.49 87.56 2.74 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.201 1.8 . . . . 0.0 109.351 167.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.1 p -50.59 152.99 1.77 Allowed 'General case' 0 C--O 1.24 0.574 0 O-C-N 121.118 -0.989 . . . . 0.0 110.431 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -48.21 160.41 0.57 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.379 0.433 . . . . 0.0 112.085 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 60.3 p -43.07 126.72 4.04 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.493 1.117 . . . . 0.0 110.982 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.43 87.4 3.39 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.725 -1.235 . . . . 0.0 108.812 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.5 m -83.53 125.13 31.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.12 102.32 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.831 1.252 . . . . 0.0 108.146 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -76.5 131.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 38.8 m-85 -107.59 111.87 24.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.063 0.545 . . . . 0.0 109.907 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.28 106.35 18.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.018 0.913 . . . . 0.0 110.335 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.494 ' CG ' ' HB1' ' A' ' 43' ' ' ALA . 90.5 t80 -86.49 110.33 19.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 110.362 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -123.72 145.51 48.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.76 1.224 . . . . 0.0 109.893 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.217 0 C-N-CA 124.438 1.018 . . . . 0.0 113.122 176.377 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.51 ' HB1' ' CD1' ' A' ' 129' ' ' ILE . . . -95.51 -35.74 11.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.366 1.066 . . . . 0.0 110.932 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -30.25 10.35 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 124.271 0.938 . . . . 0.0 113.205 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -39.89 -47.1 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.012 1.325 . . . . 0.0 113.891 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.32 -39.0 59.97 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.239 0.927 . . . . 0.0 112.449 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 129' ' ' ILE . 10.9 mt -58.4 -47.78 82.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.361 0.6 . . . . 0.0 110.394 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 p -66.48 -37.69 85.66 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 117.669 -1.158 . . . . 0.0 110.725 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -59.06 -54.55 45.81 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.274 1.397 . . . . 0.0 112.203 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' A' ' 118' ' ' THR . 15.5 m-30 -57.13 -46.22 82.87 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.011 -1.055 . . . . 0.0 111.339 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.4 -27.48 68.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.516 0.726 . . . . 0.0 112.619 173.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -49.34 71.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.671 1.188 . . . . 0.0 108.861 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 116' ' ' ILE . 3.2 tt -61.99 -40.55 96.04 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 118.933 0.788 . . . . 0.0 109.669 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -62.4 -42.85 99.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.726 0.694 . . . . 0.0 111.895 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -33.12 47.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.126 0.97 . . . . 0.0 113.121 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -70.31 -64.04 0.97 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.224 -0.922 . . . . 0.0 108.523 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.87 -21.18 27.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.801 1.24 . . . . 0.0 112.64 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -44.93 -33.26 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.196 0.999 . . . . 0.0 111.98 171.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.04 50.93 0.2 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.68 1.134 . . . . 0.0 112.868 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.5 tpt -113.71 -63.82 1.4 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.694 0.798 . . . . 0.0 111.121 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.44 34.32 0.46 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.693 1.197 . . . . 0.0 112.357 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 31.48 0.27 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.637 1.175 . . . . 0.0 113.165 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.16 49.14 2.29 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.245 0.926 . . . . 0.0 112.108 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.482 1.13 0 C-N-CA 125.737 1.615 . . . . 0.0 110.456 176.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.713 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -107.17 -62.75 1.37 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.052 0.941 . . . . 0.0 113.018 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -25.58 60.05 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.372 172.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mtp -53.47 -57.14 11.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.908 0.883 . . . . 0.0 111.867 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.512 HG23 HD12 ' A' ' 69' ' ' ILE . 1.1 m -69.73 -40.12 76.39 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.37 176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.42 ' HA ' HG21 ' A' ' 79' ' ' VAL . 19.2 t70 -50.73 -47.24 59.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -70.16 -42.33 72.65 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.0 111.14 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tp -59.27 -51.44 69.95 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.889 1.222 . . . . 0.0 112.014 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.563 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -61.12 -52.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 120.766 -1.209 . . . . 0.0 110.015 177.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -62.27 -23.58 66.78 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.907 -1.121 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -2.9 23.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 113.796 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.65 78.88 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.089 1.804 . . . . 0.0 112.886 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.11 -76.9 0.24 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 117.73 0.765 . . . . 0.0 111.289 -177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.39 -50.66 36.33 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 111.8 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.45 132.42 8.78 Favored 'General case' 0 C--O 1.211 -0.926 0 C-N-CA 124.703 1.201 . . . . 0.0 109.85 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.63 59.37 4.6 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 119.419 1.008 . . . . 0.0 113.251 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.06 176.73 7.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.102 0.961 . . . . 0.0 112.475 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.16 147.64 38.34 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.705 -0.622 . . . . 0.0 110.685 172.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.563 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.3 t -121.23 157.51 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 109.007 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.9 OUTLIER -107.38 101.93 11.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.74 112.91 4.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -35.92 115.79 0.6 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.603 1.161 . . . . 0.0 113.341 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -71.49 -18.14 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.301 1.334 . . . . 0.0 112.026 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.33 -4.79 41.42 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.86 1.264 . . . . 0.0 113.262 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 86.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.133 1.373 . . . . 0.0 113.057 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.77 -40.57 0.02 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.182 -0.949 . . . . 0.0 114.136 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 p -158.37 114.31 2.71 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.307 1.443 . . . . 0.0 111.638 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.713 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -60.66 161.38 7.86 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 122.743 1.258 . . . . 0.0 111.811 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 80' ' ' SER . 3.7 t -135.85 127.46 28.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.528 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.465 HD23 HD13 ' A' ' 69' ' ' ILE . 2.0 tm? -99.41 136.75 38.89 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.304 1.05 . . . . 0.0 109.403 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -93.26 104.64 16.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.574 1.15 . . . . 0.0 110.651 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.31 112.09 23.54 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.319 0.648 . . . . 0.0 110.168 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -57.86 5.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.641 -0.662 . . . . 0.0 111.815 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -68.03 -46.21 71.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.128 0.571 . . . . 0.0 112.002 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.84 -123.08 0.11 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.337 0.97 . . . . 0.0 111.923 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -143.65 -98.09 0.26 Allowed Glycine 0 N--CA 1.465 0.596 0 O-C-N 122.093 -0.651 . . . . 0.0 112.266 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.53 149.29 52.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.062 0.934 . . . . 0.0 110.261 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 mt -130.63 145.24 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.362 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.633 ' HB ' HG22 ' A' ' 117' ' ' THR . 21.9 t -132.27 109.59 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.512 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 1.9 m -94.93 122.0 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.54 131.74 11.95 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.054 -1.029 . . . . 0.0 109.446 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.5 152.4 43.37 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.179 1.253 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -145.82 66.85 1.21 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.476 1.911 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.9 p -100.14 97.96 8.72 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.319 1.057 . . . . 0.0 109.251 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.329 0 O-C-N 120.849 -1.157 . . . . 0.0 110.84 -177.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.626 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.33 135.81 48.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.258 1.529 . . . . 0.0 109.033 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.7 p -122.06 116.77 24.86 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.463 ' CD1' HD22 ' A' ' 42' ' ' LEU . 16.2 mt -124.41 104.5 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.633 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.8 OUTLIER -75.84 142.55 42.18 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.248 173.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 39' ' ' TYR . 2.6 p -140.66 128.28 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.87 0.843 . . . . 0.0 108.989 -177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.72 99.6 4.67 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -172.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.514 1.126 . . . . 0.0 112.393 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.2 t -48.61 101.95 0.29 Allowed Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 127.001 2.12 . . . . 0.0 109.09 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 28.8 Cg_endo -73.13 -171.21 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.773 1.649 . . . . 0.0 110.758 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.4 tm0? -59.81 -44.25 94.08 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.944 -1.097 . . . . 0.0 112.544 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 p -56.54 -42.4 78.45 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.051 -1.03 . . . . 0.0 112.002 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -78.97 -29.37 43.84 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.057 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -30.41 14.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.895 1.68 . . . . 0.0 110.496 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.42 -55.78 6.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 125.451 1.5 . . . . 0.0 111.335 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 31.2 m -57.64 -48.73 78.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.778 1.172 . . . . 0.0 113.327 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.613 HG23 HD21 ' A' ' 36' ' ' LEU . 36.6 mm -56.13 -47.2 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 C-N-CA 125.615 1.566 . . . . 0.0 110.981 171.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -62.92 -45.69 91.31 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.167 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 m -51.01 -42.47 60.44 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 111.365 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.06 -39.23 33.07 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 121.933 -0.479 . . . . 0.0 113.137 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 11.4 ttm -67.85 -20.5 65.15 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.467 -1.608 . . . . 0.0 112.466 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 -28.17 57.44 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.753 1.221 . . . . 0.0 111.888 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -16.14 63.34 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 112.836 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.08 46.94 0.92 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.386 1.474 . . . . 0.0 110.716 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -35.58 -64.88 0.49 Allowed Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.571 1.558 . . . . 0.0 113.293 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 17.78 75.59 0.01 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 127.308 2.385 . . . . 0.0 113.355 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 151' ' ' ASP . 20.4 p -51.54 167.2 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.897 1.679 . . . . 0.0 112.466 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -33.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.502 -0.749 . . . . 0.0 111.812 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 170.79 51.0 0.04 OUTLIER Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.636 0.636 . . . . 0.0 112.891 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.4 mt -86.84 113.42 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -119.46 103.15 9.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 108.362 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.87 166.95 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -51.9 119.18 4.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.008 1.323 . . . . 0.0 112.675 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.28 27.44 5.53 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.484 0.564 . . . . 0.0 113.909 -173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.72 32.85 4.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.877 2.071 . . . . 0.0 109.024 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -36.62 98.96 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.114 1.366 . . . . 0.0 111.129 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -142.42 -174.07 4.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.456 1.502 . . . . 0.0 108.691 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.409 HG22 ' HA2' ' A' ' 141' ' ' GLY . 4.7 p -147.98 -46.48 0.16 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.212 -0.93 . . . . 0.0 109.107 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.433 ' HA ' HG21 ' A' ' 139' ' ' THR . 28.1 m-20 -83.52 18.56 1.82 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.591 1.556 . . . . 0.0 112.881 172.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.06 111.6 2.26 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.417 -0.802 . . . . 0.0 110.717 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 105.75 17.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.487 ' HA ' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -111.91 129.26 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.763 1.225 . . . . 0.0 110.027 -176.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 175.2 9.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.794 1.238 . . . . 0.0 110.945 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.96 39.76 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.785 -0.572 . . . . 0.0 112.473 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -61.27 -33.15 73.07 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.654 0.782 . . . . 0.0 111.969 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.487 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -70.19 -51.39 39.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.588 176.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.98 66.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 119.192 0.905 . . . . 0.0 112.138 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -28.96 68.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.751 0.821 . . . . 0.0 112.648 171.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.94 -48.95 3.49 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.135 1.374 . . . . 0.0 112.838 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--O 1.233 0.22 0 C-N-CA 126.449 1.9 . . . . 0.0 111.307 177.287 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.7 p . . . . . 0 C--O 1.24 0.57 0 CA-C-O 120.445 0.164 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -45.53 146.7 2.32 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 122.98 0.324 . . . . 0.0 112.295 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 20.1 p -46.59 118.62 2.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.019 1.328 . . . . 0.0 111.567 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.17 85.2 6.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 122.405 1.097 . . . . 0.0 109.182 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 m -75.13 116.04 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.316 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.1 119.0 23.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.634 0.774 . . . . 0.0 109.204 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -93.74 128.81 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -103.11 127.63 50.31 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.04 139.45 46.39 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.287 0.635 . . . . 0.0 110.283 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.465 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -130.57 111.82 12.59 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.274 1.029 . . . . 0.0 110.234 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.64 142.39 27.67 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.137 0.575 . . . . 0.0 110.896 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 C-N-CA 124.462 1.03 . . . . 0.0 112.697 -177.377 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.39 -35.91 9.04 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.693 1.197 . . . . 0.0 112.05 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.03 -29.87 9.05 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 117.863 -1.521 . . . . 0.0 111.908 170.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -49.54 -38.59 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.197 1.399 . . . . 0.0 112.779 171.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -79.82 -38.17 33.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.145 -0.972 . . . . 0.0 111.282 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 129' ' ' ILE . 2.1 mt -71.35 -47.29 57.32 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.411 0.624 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -60.61 -41.21 94.35 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.916 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -59.86 -46.27 89.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.764 1.62 . . . . 0.0 111.796 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -48.91 -62.68 1.39 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.933 0.893 . . . . 0.0 109.738 174.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -21.14 66.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.758 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.44 68.45 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.308 1.443 . . . . 0.0 109.483 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.54 -38.7 87.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.885 1.221 . . . . 0.0 110.011 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB1' ' CZ ' ' A' ' 179' ' ' TYR . . . -65.56 -45.95 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.36 0.664 . . . . 0.0 111.893 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -76.57 -38.84 54.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.266 1.027 . . . . 0.0 112.034 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 78.8 m-20 -64.4 -56.76 12.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 t -58.35 -26.81 63.57 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.689 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.06 -26.73 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.65 53.81 0.28 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.903 1.24 . . . . 0.0 113.03 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.64 -71.49 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.184 0.994 . . . . 0.0 111.079 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.6 mmt -139.73 53.25 1.69 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.77 1.228 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -109.85 2.66 20.04 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.695 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.17 -30.3 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.213 0.911 . . . . 0.0 113.534 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.473 0.68 0 CA-C-N 118.293 1.047 . . . . 0.0 109.707 171.813 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.954 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.3 -67.57 0.38 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.67 0.735 . . . . 0.0 110.501 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -59.3 -33.52 71.19 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.402 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -46.28 90.95 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.668 0.667 . . . . 0.0 111.357 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.549 HG21 HG11 ' A' ' 100' ' ' VAL . 1.1 m -64.3 -42.32 96.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.371 -0.824 . . . . 0.0 110.081 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.418 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -58.33 -50.02 75.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.278 0.944 . . . . 0.0 110.68 177.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -66.88 -40.87 87.91 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 124.563 1.145 . . . . 0.0 111.12 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 8.7 tp -61.47 -52.83 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.355 1.462 . . . . 0.0 110.83 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 65' ' ' THR . 9.1 mt -59.13 -51.32 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.095 -1.003 . . . . 0.0 111.251 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -63.29 -25.8 68.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.593 -0.692 . . . . 0.0 112.737 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.72 21.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.023 1.329 . . . . 0.0 112.743 171.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.59 58.39 5.42 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.787 1.184 . . . . 0.0 111.628 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -123.21 -81.16 0.64 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.46 -59.82 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -136.26 -163.06 1.35 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.755 1.622 . . . . 0.0 110.242 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.58 21.1 1.04 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.756 1.169 . . . . 0.0 112.937 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.7 mmt -90.68 173.72 7.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.594 1.158 . . . . 0.0 112.144 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.22 120.49 13.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.024 0.916 . . . . 0.0 109.576 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 90' ' ' LEU . 2.5 t -98.47 122.72 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -67.82 115.84 7.82 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 166.17 54.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.45 128.09 7.51 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 122.426 -0.455 . . . . 0.0 111.046 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.57 -17.56 29.88 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.679 2.253 . . . . 0.0 113.021 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.01 60.47 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 0.0 112.654 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.45 65.11 1.42 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.423 1.089 . . . . 0.0 112.329 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.56 37.45 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 p -175.43 57.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.477 1.111 . . . . 0.0 111.391 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -90.43 150.17 21.94 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.294 1.045 . . . . 0.0 110.766 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.5 p -136.26 126.06 25.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.451 HD23 HD13 ' A' ' 69' ' ' ILE . 1.8 tm? -96.95 127.35 42.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.935 0.874 . . . . 0.0 108.879 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -101.17 116.71 33.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -72.94 170.76 14.11 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.137 0.494 . . . . 0.0 110.79 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.77 -55.34 6.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.119 0.967 . . . . 0.0 112.43 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.52 152.29 16.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 110.621 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.25 25.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.008 0.813 . . . . 0.0 112.805 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.25 128.68 2.07 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -133.8 136.96 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.991 0.901 . . . . 0.0 108.86 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.37 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.363 1.065 . . . . 0.0 108.252 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 117' ' ' THR . 40.4 t -136.33 111.05 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 65' ' ' THR . 1.1 m -102.81 122.45 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 126.18 14.49 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.042 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -70.34 150.45 64.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.542 1.494 . . . . 0.0 110.688 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -141.11 77.37 1.59 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.026 1.393 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 p -87.51 156.24 19.63 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.933 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.33 0 C-N-CA 123.343 0.657 . . . . 0.0 110.034 176.723 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.78 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -53.61 142.91 21.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.799 1.299 . . . . 0.0 112.099 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.2 p -128.83 104.82 7.83 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.06 0.944 . . . . 0.0 109.314 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 mt -108.07 93.12 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.495 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -67.9 138.25 55.87 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 172.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -135.6 127.66 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -136.34 104.2 5.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.356 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.43 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.824 1.249 . . . . 0.0 111.962 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 173' ' ' ASN . 22.6 m -53.5 107.06 0.75 Allowed Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.23 1.812 . . . . 0.0 107.881 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 20.3 Cg_endo -74.85 -169.47 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.851 1.034 . . . . 0.0 110.768 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -19.14 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.41 -0.806 . . . . 0.0 113.112 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 t -77.95 -46.29 21.59 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.097 -1.627 . . . . 0.0 111.076 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.24 -28.48 62.18 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.12 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -52.92 -28.84 25.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.817 1.644 . . . . 0.0 111.329 176.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.4 -55.68 6.03 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 C-N-CA 125.972 1.709 . . . . 0.0 110.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 m -60.31 -44.1 95.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.226 -1.546 . . . . 0.0 113.2 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 36' ' ' LEU . 35.7 mm -56.57 -42.79 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.737 1.615 . . . . 0.0 109.772 171.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.504 ' HB2' HG12 ' A' ' 154' ' ' VAL . 3.7 p -65.32 -45.35 84.65 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 119.187 0.903 . . . . 0.0 112.42 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.9 m -60.55 -30.02 69.52 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.873 1.269 . . . . 0.0 110.904 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.91 -32.85 13.5 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 123.567 0.603 . . . . 0.0 113.493 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.5 tpp -74.39 -24.77 59.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.997 1.398 . . . . 0.0 111.304 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 p -66.46 -24.18 66.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.805 1.642 . . . . 0.0 111.494 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -70.47 -4.92 25.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.793 1.237 . . . . 0.0 113.491 171.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.61 48.44 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.548 1.139 . . . . 0.0 111.103 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -40.53 -51.63 3.79 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.743 1.163 . . . . 0.0 114.711 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.75 73.53 0.48 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.791 1.186 . . . . 0.0 112.307 169.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.455 HG21 HG12 ' A' ' 142' ' ' ILE . 3.3 m -69.55 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.629 0.772 . . . . 0.0 110.452 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t 172.86 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.256 1.422 . . . . 0.0 111.794 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 150' ' ' THR . . . -177.78 73.74 0.07 OUTLIER Glycine 0 C--N 1.341 0.848 0 O-C-N 121.78 -0.575 . . . . 0.0 113.667 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 13.2 mt -94.64 99.68 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.996 0.919 . . . . 0.0 111.708 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -91.95 94.81 9.47 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.874 -0.516 . . . . 0.0 110.691 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.5 mt -68.85 153.12 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.24 1.016 . . . . 0.0 110.489 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -52.68 116.92 2.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.931 -1.106 . . . . 0.0 110.498 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.86 -43.96 0.99 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.412 1.006 . . . . 0.0 113.835 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.59 34.34 0.53 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.869 2.068 . . . . 0.0 111.682 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -46.32 93.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.837 1.655 . . . . 0.0 111.886 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -113.94 -168.22 1.32 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.104 1.361 . . . . 0.0 109.565 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.435 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.4 p -138.7 -49.71 0.53 Allowed 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.818 -0.551 . . . . 0.0 110.856 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 20.25 2.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.541 1.537 . . . . 0.0 112.25 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -45.23 126.12 5.98 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-O 121.559 0.695 . . . . 0.0 111.061 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -117.91 70.62 0.8 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 122.33 1.062 . . . . 0.0 108.391 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 130' ' ' SER . 13.0 t -91.68 130.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.93 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.44 176.1 7.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.91 1.284 . . . . 0.0 110.412 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.33 58.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.653 0.66 . . . . 0.0 112.078 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -61.51 -32.53 72.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.703 0.801 . . . . 0.0 112.551 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.469 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -73.35 -50.69 29.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.458 1.027 . . . . 0.0 111.476 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 p -69.39 -32.0 70.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.299 0.64 . . . . 0.0 111.87 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.7 t -92.4 -50.94 5.38 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.31 1.044 . . . . 0.0 112.18 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 . . . . . 0 C--O 1.234 0.241 0 C-N-CA 127.265 2.226 . . . . 0.0 111.867 179.95 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 35.06 -135.51 0.39 Allowed Glycine 0 C--N 1.339 0.734 0 O-C-N 124.394 1.059 . . . . 0.0 111.57 -174.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.1 p -149.03 123.84 9.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.434 ' HB3' HG23 ' A' ' 121' ' ' VAL . 4.9 t-20 -76.83 136.23 38.92 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.118 -0.988 . . . . 0.0 110.749 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 m -109.47 112.46 24.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.22 109.86 10.72 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -81.98 135.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 179' ' ' TYR . 0.6 OUTLIER -100.67 120.26 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -97.94 144.36 27.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.105 0.562 . . . . 0.0 111.586 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.2 t80 -142.67 105.71 4.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.336 0.654 . . . . 0.0 111.594 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.19 140.13 37.76 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.392 0.677 . . . . 0.0 110.386 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.046 -1.419 . . . . 0.0 111.896 178.24 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.1 -45.13 8.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.684 1.194 . . . . 0.0 110.71 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.31 -27.8 1.92 Allowed Glycine 0 C--O 1.212 -1.251 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.596 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 p -38.3 -43.43 0.8 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.641 1.576 . . . . 0.0 114.756 168.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.12 -35.52 31.48 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.065 0.848 . . . . 0.0 112.493 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 129' ' ' ILE . 16.0 mt -65.09 -50.11 67.39 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.038 0.935 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.5 p -60.08 -38.29 82.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.093 1.357 . . . . 0.0 110.632 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.96 -47.24 81.21 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.017 0.826 . . . . 0.0 112.496 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.58 ' CD1' ' CZ ' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -49.05 -59.04 3.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 109.235 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -66.04 -24.92 66.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.45 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -47.74 73.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 110.184 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -41.05 98.7 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 119.733 1.152 . . . . 0.0 109.051 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.26 96.35 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.767 0.712 . . . . 0.0 112.395 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.12 -31.6 58.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.704 1.202 . . . . 0.0 112.941 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.446 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 8.4 m-80 -75.57 -63.61 1.25 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -17.7 7.13 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.401 1.081 . . . . 0.0 113.063 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -44.42 -35.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.989 1.316 . . . . 0.0 112.194 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.0 26.84 0.14 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.698 1.142 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.1 tpp -86.04 -69.89 0.64 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.042 0.937 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' HB2' ' A' ' 71' ' ' ALA . 3.5 mtt -154.74 60.42 0.67 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.821 1.296 . . . . 0.0 111.002 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -104.1 -29.8 10.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.41 36.13 0.04 OUTLIER Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.615 1.102 . . . . 0.0 111.715 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t . . . . . 0 N--CA 1.473 0.722 0 C-N-CA 123.528 0.731 . . . . 0.0 110.602 176.823 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.922 0 N-CA-C 113.576 0.19 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.98 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.407 -1.055 . . . . 0.0 111.897 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -25.98 68.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.533 0.733 . . . . 0.0 112.364 171.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.429 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 14.2 ttm -58.36 -49.09 78.45 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.499 0.72 . . . . 0.0 110.21 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.693 HG21 HG21 ' A' ' 100' ' ' VAL . 1.4 m -72.8 -41.5 64.88 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.551 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HA ' HG21 ' A' ' 79' ' ' VAL . 11.9 t0 -52.65 -53.43 47.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.006 1.276 . . . . 0.0 111.505 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.403 HG22 ' SD ' ' A' ' 50' ' ' MET . 94.3 m -68.0 -43.21 79.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.054 1.342 . . . . 0.0 110.984 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.55 -47.1 80.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.662 0.785 . . . . 0.0 111.294 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.508 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -60.38 -50.22 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.405 175.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.86 -20.25 55.96 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.158 -0.964 . . . . 0.0 112.448 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 50' ' ' MET . . . -81.54 9.93 6.72 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.48 1.512 . . . . 0.0 113.73 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.93 48.07 84.83 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.422 1.487 . . . . 0.0 112.589 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' ' CB ' ' A' ' 45' ' ' ASN . . . -110.34 -83.86 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.464 0.706 . . . . 0.0 111.275 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -47.15 72.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.796 0.438 . . . . 0.0 111.654 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -156.2 172.7 17.99 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.063 1.345 . . . . 0.0 109.902 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.78 34.77 3.63 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.796 1.189 . . . . 0.0 112.165 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.71 178.81 4.25 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.649 1.18 . . . . 0.0 112.004 -177.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.42 136.99 54.15 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.438 175.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.508 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.4 t -114.57 109.78 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.7 t -57.81 137.06 56.97 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.54 169.24 47.82 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.871 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.74 113.66 46.67 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.755 0.822 . . . . 0.0 111.182 174.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -79.51 -64.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.03 1.82 . . . . 0.0 111.557 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.37 -40.37 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.886 0.874 . . . . 0.0 112.174 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.36 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.023 2.529 . . . . 0.0 112.998 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.69 95.85 0.14 Allowed Glycine 0 N--CA 1.466 0.666 0 C-N-CA 123.47 0.557 . . . . 0.0 111.759 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.8 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.02 2.128 . . . . 0.0 109.149 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.526 ' HB3' HG23 ' A' ' 100' ' ' VAL . . . -62.84 159.14 17.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 110.918 174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -141.88 144.91 34.06 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.743 -1.223 . . . . 0.0 109.518 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.13 124.46 43.12 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 122.538 1.161 . . . . 0.0 109.675 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -88.07 129.5 35.27 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 123.978 0.911 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.6 113.87 18.08 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.538 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.4 t -54.31 -58.45 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.435 0.694 . . . . 0.0 112.0 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -56.35 -55.57 31.8 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 110.011 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.4 141.43 3.19 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 123.671 0.653 . . . . 0.0 111.963 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.79 -178.86 16.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.202 0.906 . . . . 0.0 112.631 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.87 143.78 36.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.551 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mt -130.55 151.76 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.339 1.456 . . . . 0.0 109.178 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 117' ' ' THR . 35.2 t -135.29 110.32 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 65' ' ' THR . 8.0 m -101.26 105.94 18.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.864 1.266 . . . . 0.0 108.466 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.31 146.58 58.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 120.043 -1.661 . . . . 0.0 110.355 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -73.22 151.46 49.04 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.557 1.505 . . . . 0.0 110.587 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -144.79 80.9 1.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.929 1.347 . . . . 0.0 110.435 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -92.29 118.8 31.26 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.151 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.56 0 O-C-N 121.561 -0.712 . . . . 0.0 110.292 176.642 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 CA-C-O 122.149 0.861 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.13 150.94 51.93 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.071 0.948 . . . . 0.0 111.1 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -133.92 115.05 13.95 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.839 0.828 . . . . 0.0 110.344 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.0 mt -120.1 99.81 8.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.6 OUTLIER -70.53 141.59 51.9 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.007 172.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.4 p -134.35 123.76 24.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -134.94 122.46 21.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 109.727 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt 160.38 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.179 2.192 . . . . 0.0 110.325 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.9 m -45.87 103.64 0.36 Allowed Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 125.064 1.478 . . . . 0.0 110.483 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 27.4 Cg_endo -74.23 -172.81 1.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.831 1.688 . . . . 0.0 109.996 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -27.08 34.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.698 -1.252 . . . . 0.0 113.003 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -72.22 -50.17 29.59 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.202 -0.936 . . . . 0.0 111.472 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.49 -13.56 61.07 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 121.902 -0.499 . . . . 0.0 111.197 173.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -30.58 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 119.513 -1.992 . . . . 0.0 110.069 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.411 ' HA ' ' CB ' ' A' ' 159' ' ' ALA . 2.7 t -90.18 -47.02 14.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 124.68 1.192 . . . . 0.0 109.531 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 m -61.26 -39.21 89.51 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.466 1.03 . . . . 0.0 112.708 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.463 HG23 HD21 ' A' ' 36' ' ' LEU . 45.8 mm -70.55 -49.07 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.046 172.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.9 m -57.83 -44.86 86.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 119.71 1.141 . . . . 0.0 112.563 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 m -59.44 -43.47 93.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.903 1.281 . . . . 0.0 111.476 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.51 -24.68 69.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.306 0.479 . . . . 0.0 113.517 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.2 25.75 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.963 -1.316 . . . . 0.0 111.338 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 155' ' ' THR . 0.3 OUTLIER -70.22 -26.01 63.67 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.963 1.705 . . . . 0.0 111.972 175.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -27.32 60.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.872 0.869 . . . . 0.0 112.391 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.3 t -154.97 48.64 0.56 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.853 1.661 . . . . 0.0 110.494 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.38 -80.86 0.81 Allowed Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 38.14 43.41 1.38 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 125.934 1.731 . . . . 0.0 114.915 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 151' ' ' ASP . 41.0 m 61.57 144.63 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.711 1.604 . . . . 0.0 112.696 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 t -166.47 -40.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.535 -1.353 . . . . 0.0 110.81 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 178' ' ' ASN . . . 143.18 50.78 0.04 OUTLIER Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.975 1.274 . . . . 0.0 112.236 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.421 ' CG2' HD23 ' A' ' 175' ' ' LEU . 3.1 mt -89.0 100.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.77 95.7 10.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.656 0.382 . . . . 0.0 110.571 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 152' ' ' ALA . 36.8 mt -69.39 154.66 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.692 1.197 . . . . 0.0 109.911 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.33 115.75 2.45 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.89 -1.131 . . . . 0.0 111.448 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.98 -40.86 0.7 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.269 0.938 . . . . 0.0 114.538 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -86.28 41.12 0.91 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.324 1.85 . . . . 0.0 110.689 168.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -55.8 93.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.586 1.154 . . . . 0.0 111.05 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -116.96 -168.28 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.445 1.498 . . . . 0.0 109.094 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -136.25 -41.96 0.64 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 110.989 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HA ' HG23 ' A' ' 139' ' ' THR . 32.5 p30 -89.79 20.95 3.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.89 2.076 . . . . 0.0 113.547 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 144' ' ' ILE . . . -62.98 83.91 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 111.076 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 76.9 2.04 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.184 1.394 . . . . 0.0 109.443 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.406 ' HA ' HG21 ' A' ' 158' ' ' ILE . 3.3 m -75.96 154.75 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.009 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 134' ' ' SER . 0.1 OUTLIER -166.94 164.54 16.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.784 1.233 . . . . 0.0 111.021 -172.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.07 -53.34 20.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.881 1.272 . . . . 0.0 112.178 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.78 -34.1 73.97 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.005 0.922 . . . . 0.0 112.143 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -65.83 -51.27 63.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 O-C-N 121.721 -0.612 . . . . 0.0 109.653 175.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -64.36 -21.3 66.58 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.934 0.788 . . . . 0.0 111.312 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.39 65.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 113.211 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.73 -51.24 3.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.187 1.395 . . . . 0.0 112.607 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 . . . . . 0 C--O 1.233 0.226 0 C-N-CA 126.967 2.107 . . . . 0.0 110.843 175.798 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 C--O 1.239 0.539 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -46.18 139.36 6.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.5 p -47.61 120.41 3.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.096 1.358 . . . . 0.0 110.899 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.39 127.44 32.19 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 120.934 -1.104 . . . . 0.0 109.232 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 14.6 m -102.2 111.91 24.37 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 142' ' ' ILE . 0.9 OUTLIER -127.84 109.81 11.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -80.22 132.07 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.58 ' CZ ' ' CD1' ' A' ' 39' ' ' TYR . 2.6 t80 -97.83 115.16 27.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.443 ' HB3' ' HA3' ' A' ' 141' ' ' GLY . 12.9 t-20 -101.27 107.33 18.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.234 0.614 . . . . 0.0 110.002 174.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.8 t80 -77.35 109.21 11.07 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.951 0.901 . . . . 0.0 110.92 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -108.15 106.13 16.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.787 0.835 . . . . 0.0 109.907 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 CA-C-O 117.935 -1.481 . . . . 0.0 112.734 178.06 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.846 0.355 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -92.7 -28.65 16.51 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.493 1.117 . . . . 0.0 110.968 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -19.51 14.22 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 113.569 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t -44.89 -52.44 8.63 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.858 1.329 . . . . 0.0 113.612 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -78.33 -33.9 48.91 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.674 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.515 HD21 HG23 ' A' ' 129' ' ' ILE . 72.0 mt -56.47 -51.58 67.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.771 0.714 . . . . 0.0 110.909 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.5 p -65.95 -34.14 77.43 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.602 1.161 . . . . 0.0 111.079 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.85 -47.55 82.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.159 0.984 . . . . 0.0 112.32 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -57.29 -52.94 63.33 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 120.873 -1.142 . . . . 0.0 111.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -65.14 -24.13 67.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.204 172.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -47.46 81.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.289 0.95 . . . . 0.0 109.465 174.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tt -65.0 -41.64 95.21 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.918 0.781 . . . . 0.0 109.317 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -64.05 -43.24 96.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.39 0.431 . . . . 0.0 111.587 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -35.64 63.17 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.533 1.133 . . . . 0.0 112.132 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.615 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 19.1 m-80 -67.15 -62.42 1.44 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -54.82 -25.92 31.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.936 0.894 . . . . 0.0 111.835 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -31.61 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.244 1.018 . . . . 0.0 112.774 171.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.5 51.67 0.25 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.329 1.442 . . . . 0.0 113.396 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.1 tpt -126.52 -77.02 0.58 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.382 1.073 . . . . 0.0 110.563 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.3 mtt -154.89 58.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.681 1.229 . . . . 0.0 111.235 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -106.38 -5.87 18.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.14 39.37 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.529 1.062 . . . . 0.0 112.579 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.476 0.872 0 O-C-N 122.181 -0.599 . . . . 0.0 110.838 178.101 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.921 0 CA-C-O 120.796 0.109 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.07 -56.0 4.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.801 0.84 . . . . 0.0 109.81 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -25.46 66.84 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.931 171.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -52.01 67.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.631 1.105 . . . . 0.0 111.298 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.623 HG21 HG11 ' A' ' 100' ' ' VAL . 1.1 m -68.63 -39.45 80.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.051 176.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.4 ' HA ' HG21 ' A' ' 79' ' ' VAL . 44.5 t0 -60.04 -48.81 80.17 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 111.026 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.5 m -68.35 -41.45 80.69 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 125.342 1.457 . . . . 0.0 110.286 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.625 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -57.22 -54.09 50.67 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.085 1.311 . . . . 0.0 111.203 172.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.96 -51.28 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.805 -1.184 . . . . 0.0 110.964 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -60.0 -26.13 65.81 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.711 -1.243 . . . . 0.0 112.592 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.7 -14.12 59.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.21 1.004 . . . . 0.0 113.088 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.74 34.13 9.41 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.167 1.365 . . . . 0.0 112.697 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.625 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -92.91 -73.46 0.56 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.065 0.546 . . . . 0.0 111.81 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -63.6 1.21 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.011 0.434 . . . . 0.0 110.22 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -134.24 -164.36 1.49 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.135 1.374 . . . . 0.0 109.698 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.42 23.49 1.37 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.659 1.123 . . . . 0.0 112.732 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.7 mmt -93.19 174.76 7.05 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.104 1.361 . . . . 0.0 112.029 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.01 138.75 58.66 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.35 0.595 . . . . 0.0 110.351 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 66' ' ' ASP . 2.9 t -120.74 132.2 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 t -92.99 150.64 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.66 142.11 12.36 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.05 99.42 46.63 Favored Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 124.545 1.138 . . . . 0.0 108.005 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -74.22 -29.36 9.75 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.523 2.149 . . . . 0.0 112.26 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.81 68.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.452 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.29 -65.23 1.2 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.113 . . . . 0.0 111.818 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.93 52.81 0.24 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.051 1.31 . . . . 0.0 112.382 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.3 m -144.16 105.31 4.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.186 0.995 . . . . 0.0 109.828 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -73.55 145.61 45.39 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 122.111 0.958 . . . . 0.0 110.517 174.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -126.16 127.46 45.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -101.12 135.17 43.02 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.746 0.784 . . . . 0.0 109.261 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -96.21 119.71 35.19 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -171.84 0.9 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.768 0.427 . . . . 0.0 111.339 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -57.92 4.11 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.959 0.904 . . . . 0.0 112.254 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.99 132.99 3.8 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.145 0.978 . . . . 0.0 110.617 173.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.66 -57.61 4.5 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.657 1.123 . . . . 0.0 112.563 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -46.38 139.13 7.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 123.872 0.748 . . . . 0.0 112.611 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -132.64 152.67 51.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.479 1.133 . . . . 0.0 109.601 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -132.97 146.76 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.164 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 117' ' ' THR . 61.4 t -133.15 113.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.623 HG11 HG21 ' A' ' 65' ' ' THR . 1.2 m -95.16 123.72 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.34 40.02 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.546 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -71.52 152.77 60.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.98 1.787 . . . . 0.0 110.784 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -149.66 84.99 1.42 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 123.749 1.738 . . . . 0.0 108.953 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.4 p -89.79 144.33 26.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.143 -1.844 . . . . 0.0 108.907 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 177.109 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 CA-C-O 122.181 0.879 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -129.46 150.26 50.88 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.973 0.909 . . . . 0.0 110.883 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 176' ' ' VAL . 0.2 OUTLIER -146.01 119.16 8.85 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.077 -174.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mt -119.01 115.91 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.351 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.53 ' CB ' HG23 ' A' ' 176' ' ' VAL . 0.7 OUTLIER -78.45 140.82 38.61 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.908 174.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 123.58 25.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -131.82 123.62 27.95 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.455 0.702 . . . . 0.0 110.041 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.434 ' HE3' HG23 ' A' ' 121' ' ' VAL . 0.0 OUTLIER 161.57 -31.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.615 1.966 . . . . 0.0 113.268 -175.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.434 HG23 ' HE3' ' A' ' 120' ' ' LYS . 18.3 t -50.02 111.28 2.01 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.056 176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 36.8 Cg_endo -73.16 -173.72 1.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.946 2.431 . . . . 0.0 110.743 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.75 -24.17 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.876 -1.14 . . . . 0.0 113.076 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -52.68 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.952 0.796 . . . . 0.0 111.211 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.557 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -72.46 -17.05 61.81 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.548 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 14.2 t -62.55 -45.57 92.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 120.902 1.683 . . . . 0.0 109.248 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.35 -45.6 40.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-O 118.216 -0.897 . . . . 0.0 108.998 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -57.74 -43.12 85.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.691 1.587 . . . . 0.0 113.768 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.515 HG23 HD21 ' A' ' 36' ' ' LEU . 46.7 mm -74.32 -44.7 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.073 1.749 . . . . 0.0 110.279 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.1 m -63.84 -26.73 68.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.0 m -82.35 -44.18 16.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.721 2.008 . . . . 0.0 110.258 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.78 -42.65 78.44 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.07 -27.21 67.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.825 1.312 . . . . 0.0 112.774 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.78 -21.77 63.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.206 0.602 . . . . 0.0 111.932 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.55 -25.81 39.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.585 1.154 . . . . 0.0 112.775 174.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -151.81 49.66 0.8 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.393 1.477 . . . . 0.0 110.212 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -36.56 -63.63 0.68 Allowed Glycine 0 C--N 1.344 1.024 0 C-N-CA 125.628 1.585 . . . . 0.0 113.18 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 25.21 78.22 0.01 OUTLIER Glycine 0 C--N 1.346 1.085 0 C-N-CA 126.971 2.224 . . . . 0.0 113.273 167.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 151' ' ' ASP . 23.2 p -51.67 171.31 0.04 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.78 1.632 . . . . 0.0 112.937 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 p 178.92 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.647 0.779 . . . . 0.0 111.811 -170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 171.55 42.68 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.496 0.57 . . . . 0.0 113.949 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 139' ' ' THR . 41.6 mt -80.12 117.07 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 123.321 0.648 . . . . 0.0 109.574 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.472 ' CD ' HG11 ' A' ' 176' ' ' VAL . 0.9 OUTLIER -121.56 104.36 9.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.589 1.155 . . . . 0.0 108.036 -176.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 147' ' ' ASN . 4.3 mm -78.6 168.09 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -50.06 116.22 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.29 1.436 . . . . 0.0 112.439 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.59 28.61 6.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 123.52 0.581 . . . . 0.0 114.11 -173.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.2 t-20 -129.95 38.52 3.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.378 2.271 . . . . 0.0 108.398 -174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.63 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.668 1.987 . . . . 0.0 112.129 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -138.2 -173.43 3.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.624 1.57 . . . . 0.0 109.347 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 141' ' ' GLY . 7.9 p -146.8 -52.14 0.22 Allowed 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.084 -1.01 . . . . 0.0 109.461 -175.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.464 ' HA ' HG21 ' A' ' 139' ' ' THR . 14.7 p-10 -80.03 31.39 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.221 2.209 . . . . 0.0 113.521 171.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 105.43 13.45 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.839 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.88 128.36 35.35 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.13 134.43 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 178.5 7.22 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.959 0.904 . . . . 0.0 110.644 -170.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.54 -54.51 42.22 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 172.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.53 -32.46 72.52 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.899 0.88 . . . . 0.0 111.986 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.31 -54.35 17.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.62 -18.57 64.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.424 1.011 . . . . 0.0 111.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.07 -38.76 92.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.926 0.89 . . . . 0.0 111.945 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.4 m -111.25 -51.6 2.85 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.095 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.468 0.44 0 C-N-CA 126.287 1.835 . . . . 0.0 113.513 178.263 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.573 0.702 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.19 5.68 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 123.72 0.676 . . . . 0.0 113.077 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 46.4 m -152.05 99.52 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.152 1.381 . . . . 0.0 109.171 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -134.16 116.58 15.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.356 1.062 . . . . 0.0 110.123 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.9 m -115.92 107.14 14.62 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.41 ' HG ' HD13 ' A' ' 144' ' ' ILE . 1.1 mp -122.2 123.15 40.82 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.578 0.751 . . . . 0.0 109.103 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 115' ' ' THR . 0.8 OUTLIER -94.79 122.8 46.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -98.93 122.57 42.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.402 0.681 . . . . 0.0 110.046 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.09 138.94 41.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.587 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.462 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -145.05 136.4 25.12 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.888 177.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -48.41 149.64 1.54 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.022 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.914 -179.54 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 t0 . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.647 0.26 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 128' ' ' SER . . . -87.07 -34.13 19.26 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.01 -25.76 2.62 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 120.879 -1.138 . . . . 0.0 114.088 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 p -48.31 -41.6 28.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.822 1.649 . . . . 0.0 114.316 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.497 ' CG ' HD11 ' A' ' 129' ' ' ILE . 3.8 pt-20 -78.43 -34.99 47.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 129' ' ' ILE . 16.9 mt -57.79 -53.28 59.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.141 0.882 . . . . 0.0 112.356 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.9 p -60.76 -36.83 79.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.711 176.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -50.84 72.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.859 1.263 . . . . 0.0 112.42 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' A' ' 118' ' ' THR . 12.2 m-30 -57.98 -46.49 85.07 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.892 -1.13 . . . . 0.0 111.649 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -62.96 -31.96 73.17 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.008 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -45.74 89.22 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 123.663 0.785 . . . . 0.0 109.713 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.504 HD13 ' CD2' ' A' ' 68' ' ' LEU . 1.9 tp -59.47 -49.57 77.29 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 120.374 1.443 . . . . 0.0 110.071 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.53 95.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.98 -33.37 59.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.615 1.166 . . . . 0.0 112.524 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.553 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 9.0 m120 -71.45 -61.12 1.89 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.44 ' HB ' HD13 ' A' ' 68' ' ' LEU . 2.1 t -56.51 -19.75 17.04 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.17 0.988 . . . . 0.0 112.332 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -32.22 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.735 0.814 . . . . 0.0 112.248 171.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.83 45.94 0.17 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.648 1.118 . . . . 0.0 113.009 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -113.64 -66.4 1.09 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.995 0.918 . . . . 0.0 110.128 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.478 ' HG2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -146.02 31.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.693 1.197 . . . . 0.0 112.564 -176.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.36 -21.91 48.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 176.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.07 47.1 0.13 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.302 0.953 . . . . 0.0 112.332 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 123.384 0.674 . . . . 0.0 111.418 178.379 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.937 0 CA-C-O 119.938 -0.368 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.743 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -85.07 -70.0 0.61 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -23.74 50.07 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 123.436 0.695 . . . . 0.0 112.302 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.44 ' SD ' ' HA ' ' A' ' 51' ' ' LYS . 7.4 tpt -53.5 -71.61 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.512 0.725 . . . . 0.0 110.36 172.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.496 HG21 HG11 ' A' ' 100' ' ' VAL . 1.2 m -65.95 -32.98 74.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.494 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.68 -53.05 62.15 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.094 0.861 . . . . 0.0 111.02 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.478 HG22 ' HG2' ' A' ' 50' ' ' MET . 90.1 m -68.18 -41.05 82.04 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.42 1.088 . . . . 0.0 110.891 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.072 0.851 . . . . 0.0 111.754 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -61.18 -52.06 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.067 -1.02 . . . . 0.0 110.48 176.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.06 -20.44 53.28 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.364 -1.46 . . . . 0.0 113.094 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.54 13.65 3.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.509 1.524 . . . . 0.0 113.615 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 53.18 40.8 60.27 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.865 1.698 . . . . 0.0 112.8 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 45' ' ' ASN . . . -100.83 -70.29 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 -54.27 5.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -149.25 178.13 9.03 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.089 1.356 . . . . 0.0 109.538 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.69 31.46 3.38 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 124.787 1.184 . . . . 0.0 112.105 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.38 171.28 8.06 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.353 1.061 . . . . 0.0 111.639 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -61.88 131.44 49.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.446 0.641 . . . . 0.0 110.497 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.6 t -114.13 136.94 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.799 1.24 . . . . 0.0 108.464 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 t -88.02 126.94 35.35 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.75 103.42 2.91 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -50.14 105.39 0.51 Allowed Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.481 1.112 . . . . 0.0 111.373 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.16 -17.25 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.504 2.136 . . . . 0.0 112.388 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.31 -7.09 58.76 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.99 1.316 . . . . 0.0 112.594 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m 60.04 68.45 0.78 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.436 1.494 . . . . 0.0 112.05 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.03 -52.89 0.1 OUTLIER Glycine 0 N--CA 1.467 0.747 0 C-N-CA 124.006 0.812 . . . . 0.0 112.215 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -177.25 124.29 0.14 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.832 1.253 . . . . 0.0 110.965 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.743 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -64.81 164.58 12.06 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 122.355 1.074 . . . . 0.0 112.029 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.6 t -133.86 142.21 47.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.65 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 90' ' ' LEU . 1.6 tm? -109.23 123.84 49.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.059 0.944 . . . . 0.0 109.099 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -82.04 119.56 24.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.802 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -70.27 176.6 3.81 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.282 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.68 -53.65 4.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.036 1.334 . . . . 0.0 113.01 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -149.6 -51.36 0.15 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 0.0 111.779 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.46 98.83 0.86 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.82 132.99 1.57 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 124.012 0.815 . . . . 0.0 111.535 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.03 127.41 50.21 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.81 136.82 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 108.684 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 117' ' ' THR . 21.0 t -124.26 109.49 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 65' ' ' THR . 1.4 m -87.32 122.98 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.97 136.94 18.74 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.337 -0.852 . . . . 0.0 109.209 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -76.08 152.38 35.79 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.734 1.623 . . . . 0.0 110.554 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -143.75 69.04 1.28 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 111.667 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.3 p -97.61 104.53 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.281 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.428 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.184 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -108.18 135.56 49.3 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.507 0.723 . . . . 0.0 110.333 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 p -124.03 102.44 7.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.748 1.261 . . . . 0.0 110.9 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.44 110.25 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.634 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -76.84 141.95 40.44 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.285 173.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 39' ' ' TYR . 5.8 p -133.91 130.32 37.59 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.43 -173.88 3.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.352 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 89.84 -31.11 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.576 2.75 . . . . 0.0 110.418 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.7 t -47.61 104.39 0.41 Allowed Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 127.19 2.196 . . . . 0.0 108.405 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 21.6 Cg_endo -73.66 -170.09 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.991 1.794 . . . . 0.0 110.431 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -59.54 -31.14 69.14 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.873 -1.142 . . . . 0.0 112.277 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.0 p -73.72 -50.54 20.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.501 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.591 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -71.97 -17.83 62.04 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.91 172.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.45 -45.91 92.29 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 120.878 1.672 . . . . 0.0 108.385 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.434 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 3.2 t -72.98 -42.04 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.629 0.649 . . . . 0.0 111.467 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -63.47 -45.1 92.35 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 177.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.497 HD11 ' CG ' ' A' ' 35' ' ' GLU . 11.4 mm -63.25 -52.99 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 C-N-CA 124.957 1.303 . . . . 0.0 109.52 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.7 m -56.26 -42.44 77.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 119.121 0.873 . . . . 0.0 112.226 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -56.8 -52.44 65.04 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.127 1.371 . . . . 0.0 110.969 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.6 -29.01 72.8 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 122.867 0.27 . . . . 0.0 112.682 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -35.3 58.26 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.245 1.018 . . . . 0.0 111.201 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -25.06 65.67 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.929 0.892 . . . . 0.0 112.126 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -60.91 -30.15 70.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.247 0.619 . . . . 0.0 112.605 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 t -153.76 50.75 0.68 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.285 1.034 . . . . 0.0 111.428 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.55 -85.51 1.65 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 44.03 49.91 7.69 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.471 1.034 . . . . 0.0 113.618 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 151' ' ' ASP . 26.2 m 66.22 147.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.529 1.532 . . . . 0.0 112.326 -173.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.1 p -179.7 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.142 -0.974 . . . . 0.0 110.961 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.85 48.62 0.07 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.575 1.083 . . . . 0.0 112.216 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 5.5 mt -88.91 99.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.038 -172.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -90.56 97.08 10.97 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.816 0.446 . . . . 0.0 110.016 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.4 mt -73.87 146.82 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 124.4 1.062 . . . . 0.0 109.516 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -48.36 114.58 0.98 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.467 1.507 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.88 -39.64 0.96 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.302 0.953 . . . . 0.0 113.983 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.57 35.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.265 1.826 . . . . 0.0 111.428 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -51.85 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.378 1.471 . . . . 0.0 110.473 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -123.05 -169.24 1.89 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.976 1.31 . . . . 0.0 109.204 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 p -139.68 -41.69 0.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.784 0.834 . . . . 0.0 110.852 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.432 ' HA ' HG23 ' A' ' 139' ' ' THR . 3.7 p-10 -90.89 24.44 2.76 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.574 1.949 . . . . 0.0 113.412 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.41 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -57.59 125.76 24.37 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.509 0.671 . . . . 0.0 110.079 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -113.39 74.73 0.88 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 122.479 1.133 . . . . 0.0 108.315 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.66 135.18 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.494 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.7 p -136.56 -179.04 5.44 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.072 0.949 . . . . 0.0 111.449 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.29 81.88 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.605 -0.684 . . . . 0.0 112.386 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.56 -35.54 78.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.584 0.754 . . . . 0.0 111.421 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -46.08 36.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.786 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 127' ' ' VAL . . . -60.18 -26.47 66.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.1 0.864 . . . . 0.0 111.124 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -39.26 87.74 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 170.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.36 -31.59 24.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.694 1.597 . . . . 0.0 113.792 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 CA--C 1.539 0.52 0 C-N-CA 125.899 1.68 . . . . 0.0 110.462 178.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.238 0.455 0 CA-C-O 120.627 0.251 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.59 136.05 2.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.746 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 95.3 m -50.81 135.12 24.49 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.26 110.26 20.4 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.0 m -110.77 112.09 23.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.06 109.55 11.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -85.93 137.75 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -111.18 113.01 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.309 0.644 . . . . 0.0 109.726 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -101.46 118.32 36.71 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 109.689 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.46 122.71 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.093 0.957 . . . . 0.0 110.209 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -113.23 95.35 5.33 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.363 1.065 . . . . 0.0 108.91 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.204 0 CA-C-O 118.513 -1.159 . . . . 0.0 112.349 -174.484 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -91.72 -36.18 13.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.398 1.079 . . . . 0.0 111.249 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.92 -26.07 32.64 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.201 -0.777 . . . . 0.0 112.827 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -46.14 -43.34 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.003 1.321 . . . . 0.0 113.196 172.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.19 -34.31 49.58 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.739 -0.601 . . . . 0.0 111.805 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 129' ' ' ILE . 19.6 mt -63.28 -50.82 68.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 110.341 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.6 p -63.48 -38.1 89.83 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.308 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -58.56 -53.12 61.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.896 1.225 . . . . 0.0 112.416 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 177' ' ' PHE . 7.9 t80 -51.25 -52.16 47.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.036 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -67.14 -23.66 65.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.38 69.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.052 1.341 . . . . 0.0 108.685 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 74' ' ' ALA . 1.8 tt -63.57 -41.46 98.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.269 0.94 . . . . 0.0 109.498 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 179' ' ' TYR . . . -59.31 -44.5 92.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 117.978 0.354 . . . . 0.0 111.075 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -78.53 -39.03 39.15 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.241 0.616 . . . . 0.0 112.618 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -60.68 -57.92 10.67 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -41.36 62.33 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.606 1.162 . . . . 0.0 111.089 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -42.89 -31.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.771 1.629 . . . . 0.0 112.996 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -150.62 50.62 0.54 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.307 1.432 . . . . 0.0 112.678 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.7 tpp -137.26 -60.27 0.67 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.026 0.93 . . . . 0.0 110.569 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.1 tpt -162.12 39.67 0.12 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.72 5.66 38.78 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.2 38.02 0.51 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.9 1.238 . . . . 0.0 112.801 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.0 t . . . . . 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 0.0 109.157 -179.624 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.793 0 CA-C-O 119.593 -0.559 . . . . 0.0 113.597 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 -61.49 1.54 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.234 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -61.92 -28.57 69.62 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 123.757 0.823 . . . . 0.0 112.481 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -49.71 74.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.788 0.722 . . . . 0.0 110.322 173.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.26 -41.13 67.1 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.285 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.538 ' HA ' HG21 ' A' ' 79' ' ' VAL . 10.8 t0 -55.84 -52.58 63.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.923 0.868 . . . . 0.0 110.62 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.4 m -68.99 -43.1 75.55 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.933 1.293 . . . . 0.0 110.715 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.88 -43.49 90.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.706 1.593 . . . . 0.0 111.989 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.402 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -63.75 -53.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.282 0.633 . . . . 0.0 111.027 173.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -64.57 -17.2 63.74 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.168 -0.958 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.07 -19.44 30.23 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 112.35 174.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.1 76.17 1.21 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.998 1.285 . . . . 0.0 112.544 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.25 -97.9 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.001 0.52 . . . . 0.0 112.166 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -51.74 -40.69 60.68 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.005 0.922 . . . . 0.0 111.368 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -165.71 -178.77 4.99 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.017 1.727 . . . . 0.0 110.185 173.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.37 18.02 7.83 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.315 1.436 . . . . 0.0 112.783 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.0 ttt -92.45 171.38 9.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.611 1.165 . . . . 0.0 111.553 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.94 145.98 44.05 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.27 -0.894 . . . . 0.0 111.097 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 66' ' ' ASP . 10.3 t -120.67 129.37 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.76 132.68 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.44 136.61 14.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -42.51 113.52 1.29 Allowed Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.907 1.283 . . . . 0.0 112.78 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -76.51 -68.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.943 1.762 . . . . 0.0 111.375 -173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.73 13.18 20.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.762 1.225 . . . . 0.0 112.138 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.24 56.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.225 1.41 . . . . 0.0 111.632 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.02 -56.94 0.78 Allowed Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p 169.79 137.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.676 1.59 . . . . 0.0 110.47 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 87.63 0.19 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.447 0.699 . . . . 0.0 111.049 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 t -63.08 139.22 58.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 110.431 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.414 HD23 HG13 ' A' ' 79' ' ' VAL . 2.5 tm? -114.34 131.57 56.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.401 1.48 . . . . 0.0 108.909 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -91.93 115.54 28.15 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.365 1.066 . . . . 0.0 110.101 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.36 -179.63 2.54 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.61 0.719 . . . . 0.0 112.058 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 -51.51 6.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -45.7 87.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.38 0.672 . . . . 0.0 111.462 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.8 41.68 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.679 1.133 . . . . 0.0 112.705 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -104.97 170.16 17.54 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.155 0.883 . . . . 0.0 111.748 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -123.48 138.97 54.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.753 0.787 . . . . 0.0 109.262 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.13 119.4 56.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.54 115.22 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 132.11 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.34 137.21 9.2 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.987 -0.446 . . . . 0.0 110.899 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.3 154.23 61.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.215 1.943 . . . . 0.0 111.608 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.9 65.42 1.11 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.575 1.655 . . . . 0.0 111.099 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -86.48 172.04 10.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.443 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.382 0 C-N-CA 123.341 0.656 . . . . 0.0 111.111 177.425 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -87.47 155.68 19.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.708 -0.878 . . . . 0.0 111.18 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.456 HG22 HG13 ' A' ' 176' ' ' VAL . 0.1 OUTLIER -143.86 118.21 9.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 122.023 0.916 . . . . 0.0 110.822 -176.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.405 HD13 HD13 ' A' ' 42' ' ' LEU . 5.6 mt -113.57 108.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -71.17 131.34 43.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.125 0.97 . . . . 0.0 108.807 172.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -130.38 124.72 32.83 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -131.15 128.18 39.55 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt 164.74 -38.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.771 2.029 . . . . 0.0 110.872 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -45.19 103.35 0.34 Allowed Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.711 1.604 . . . . 0.0 110.492 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 30.1 Cg_endo -74.82 -172.1 1.14 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 110.363 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -22.54 53.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.545 -1.347 . . . . 0.0 114.324 173.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.8 t -79.34 -52.01 8.66 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.964 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.578 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.32 -23.9 60.32 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 121.866 -0.521 . . . . 0.0 110.86 175.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.26 -27.54 62.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.791 1.178 . . . . 0.0 110.164 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.59 -50.87 11.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 CA-C-O 117.871 -1.062 . . . . 0.0 110.609 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.411 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -53.31 -45.22 68.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.943 1.247 . . . . 0.0 113.38 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.59 HG23 HD21 ' A' ' 36' ' ' LEU . 21.6 mm -62.09 -38.61 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.206 172.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -67.2 -43.78 81.23 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.463 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.4 m -65.15 -27.89 69.03 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.243 1.383 . . . . 0.0 111.957 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.02 20.68 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.227 0.917 . . . . 0.0 113.75 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 1.9 ttp -84.71 -24.78 28.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.289 1.435 . . . . 0.0 112.43 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.6 p -69.59 -21.36 63.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.917 1.287 . . . . 0.0 111.888 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.0 mtt-85 -60.57 -17.91 49.35 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 113.133 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 t -154.04 53.44 0.7 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.255 1.022 . . . . 0.0 110.593 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -38.09 -65.39 0.7 Allowed Glycine 0 C--N 1.345 1.075 0 C-N-CA 125.34 1.448 . . . . 0.0 112.961 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 22.39 72.29 0.01 OUTLIER Glycine 0 C--N 1.347 1.187 0 C-N-CA 126.991 2.234 . . . . 0.0 113.217 167.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.527 HG22 ' CD1' ' A' ' 142' ' ' ILE . 3.9 p -53.28 171.16 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.531 1.532 . . . . 0.0 112.668 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.39 -33.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.67 -0.644 . . . . 0.0 111.315 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 171.12 43.5 0.03 OUTLIER Glycine 0 C--N 1.338 0.643 0 CA-C-O 119.58 -0.567 . . . . 0.0 113.399 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.527 ' CD1' HG22 ' A' ' 139' ' ' THR . 3.0 mt -77.2 116.3 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.166 0.586 . . . . 0.0 110.812 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.79 96.45 5.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.574 1.15 . . . . 0.0 108.897 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 147' ' ' ASN . 10.7 mt -74.96 167.14 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -49.53 115.83 1.51 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.35 1.46 . . . . 0.0 111.981 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.65 27.19 8.6 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 123.444 0.545 . . . . 0.0 114.138 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 0.7 OUTLIER -129.34 39.94 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.06 2.544 . . . . 0.0 107.615 -176.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -42.53 95.91 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.657 1.183 . . . . 0.0 111.593 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -142.8 -173.52 3.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.221 1.408 . . . . 0.0 108.784 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.499 HG22 ' HA2' ' A' ' 141' ' ' GLY . 12.3 p -146.29 -47.57 0.2 Allowed 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.548 -0.72 . . . . 0.0 110.193 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.439 ' C ' HG21 ' A' ' 139' ' ' THR . 1.0 OUTLIER -85.57 18.53 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.259 1.824 . . . . 0.0 112.142 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.97 97.71 0.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.304 -0.873 . . . . 0.0 111.146 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.62 125.1 29.58 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' A' ' 158' ' ' ILE . 2.1 t -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.07 170.06 16.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.151 0.98 . . . . 0.0 110.809 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.05 -37.67 72.12 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.5 -42.3 43.93 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.185 0.994 . . . . 0.0 110.891 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -59.89 -45.51 94.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 173.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.84 -17.95 61.5 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.761 -0.587 . . . . 0.0 111.972 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -40.6 76.67 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.243 -0.91 . . . . 0.0 111.531 172.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 70.1 m -107.96 -58.01 2.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.805 0.842 . . . . 0.0 112.12 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 126.365 1.866 . . . . 0.0 113.037 176.585 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.7 p . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 121.507 0.67 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.07 0.65 Allowed Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 67.4 p -89.28 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.348 1.459 . . . . 0.0 109.7 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.32 84.28 2.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.974 1.71 . . . . 0.0 109.792 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.0 m -77.16 123.87 27.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.199 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.26 112.68 11.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -82.67 131.52 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 171.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.464 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 13.6 m-85 -108.88 111.34 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -85.79 141.82 29.39 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.022 0.439 . . . . 0.0 111.498 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 43' ' ' ALA . 15.2 t80 -142.22 118.71 10.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.824 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.66 142.39 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.677 0.391 . . . . 0.0 110.489 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 C-N-CA 124.276 0.941 . . . . 0.0 113.961 175.262 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 t0 . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.114 0.483 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 128' ' ' SER . . . -84.11 -38.39 20.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.341 1.056 . . . . 0.0 111.24 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.73 -28.85 1.19 Allowed Glycine 0 C--O 1.216 -1.0 0 CA-C-O 117.868 -1.518 . . . . 0.0 113.142 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 t -40.3 -46.15 2.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.293 1.546 . . . . 0.0 113.649 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -73.62 -39.23 64.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.17 0.896 . . . . 0.0 111.517 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mt -66.44 -51.85 52.62 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.848 0.859 . . . . 0.0 112.017 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 p -62.69 -35.76 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.35 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -58.62 -54.44 47.07 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.117 1.326 . . . . 0.0 111.588 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -56.7 -45.63 81.71 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.206 -0.934 . . . . 0.0 111.638 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -65.01 -28.56 69.59 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 112.222 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -43.23 81.61 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 109.688 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.451 ' CD2' HD11 ' A' ' 116' ' ' ILE . 2.3 tt -62.89 -44.09 97.04 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.083 -1.011 . . . . 0.0 109.994 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.75 86.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.455 0.57 . . . . 0.0 112.264 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.34 -30.94 63.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.39 1.076 . . . . 0.0 112.656 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.85 -60.83 2.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 t -55.27 -21.15 13.35 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.948 0.899 . . . . 0.0 112.587 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -47.39 -33.84 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.545 1.138 . . . . 0.0 113.087 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.93 37.31 0.42 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.611 1.101 . . . . 0.0 112.283 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.9 tpt -109.47 -70.41 0.81 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.518 0.727 . . . . 0.0 110.583 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.76 64.03 0.73 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.8 1.286 . . . . 0.0 111.297 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.49 -9.52 15.37 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.68 37.77 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.236 1.398 . . . . 0.0 111.924 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.611 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 CA-C-O 120.134 -0.259 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.617 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -83.07 -49.85 9.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.38 -22.91 34.32 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 123.679 0.791 . . . . 0.0 112.106 169.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -60.46 -51.48 69.28 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.071 0.85 . . . . 0.0 110.076 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.508 ' OG1' HG21 ' A' ' 100' ' ' VAL . 11.4 m -74.85 -40.75 60.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.049 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -56.04 -52.5 64.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.194 0.906 . . . . 0.0 110.738 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.4 m -68.57 -39.64 80.91 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 110.928 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD21 ' HG ' ' A' ' 42' ' ' LEU . 9.4 tp -60.58 -51.29 70.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.626 1.557 . . . . 0.0 111.557 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 65' ' ' THR . 0.9 OUTLIER -62.37 -51.93 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 120.694 -1.253 . . . . 0.0 110.863 176.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -61.88 -18.34 59.8 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.484 -1.385 . . . . 0.0 112.711 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.08 12.11 5.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.493 1.517 . . . . 0.0 113.295 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.62 40.83 80.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.977 1.275 . . . . 0.0 112.743 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.19 -77.73 0.54 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.01 0.524 . . . . 0.0 110.861 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.39 -59.57 2.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -140.04 179.66 6.49 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.178 1.391 . . . . 0.0 109.9 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.16 35.37 2.45 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.104 1.335 . . . . 0.0 112.161 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.2 mtt -103.72 179.77 4.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.801 1.24 . . . . 0.0 111.982 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -69.77 133.74 47.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.587 0.708 . . . . 0.0 110.473 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.26 134.36 59.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.53 1.132 . . . . 0.0 108.515 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.26 152.15 36.59 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.184 0.516 . . . . 0.0 110.803 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.95 158.05 14.54 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -145.36 127.85 8.08 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 122.766 0.426 . . . . 0.0 110.552 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.29 -17.02 27.82 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.639 2.226 . . . . 0.0 112.514 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.1 61.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.508 0.723 . . . . 0.0 112.842 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 t 66.56 63.69 0.51 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 112.296 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.76 41.16 0.02 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.727 -0.608 . . . . 0.0 114.127 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.35 25.39 0.3 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.942 0.897 . . . . 0.0 111.761 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -60.26 126.97 29.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.215 1.007 . . . . 0.0 109.914 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 t -117.58 140.44 49.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.19 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -106.62 127.11 53.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -87.37 113.83 23.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.764 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -74.48 170.55 15.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.769 0.795 . . . . 0.0 111.643 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -87.75 -36.0 17.58 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.078 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -87.73 46.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 112.162 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 46.94 61.25 4.49 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.023 1.297 . . . . 0.0 112.832 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -130.15 160.31 22.92 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 123.774 0.702 . . . . 0.0 112.329 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.43 133.93 48.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.796 1.284 . . . . 0.0 108.95 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.08 135.81 59.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.911 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.48 ' HB ' HG22 ' A' ' 117' ' ' THR . 77.2 t -119.32 110.37 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.508 HG21 ' OG1' ' A' ' 65' ' ' THR . 3.0 m -90.32 125.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.33 125.55 13.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.538 -0.726 . . . . 0.0 109.248 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.86 153.96 58.55 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.488 1.459 . . . . 0.0 111.203 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -147.56 73.14 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.935 1.694 . . . . 0.0 110.852 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.7 p -104.55 82.46 1.91 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.775 1.274 . . . . 0.0 109.807 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.376 0 O-C-N 120.627 -1.295 . . . . 0.0 111.124 -175.21 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.477 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.47 133.05 56.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.085 0.942 . . . . 0.0 109.674 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.0 p -116.55 124.01 48.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 122.135 0.969 . . . . 0.0 108.968 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 42' ' ' LEU . 3.3 mp -120.8 98.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -69.38 135.68 50.66 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.56 172.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.6 p -125.28 121.86 35.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -120.58 175.42 6.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.545 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 84.19 -18.42 0.41 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.959 2.104 . . . . 0.0 111.897 -175.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -49.38 107.68 0.83 Allowed Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.283 1.833 . . . . 0.0 109.011 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -73.71 -174.47 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.352 2.035 . . . . 0.0 110.026 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -59.47 -28.13 66.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.383 -0.823 . . . . 0.0 111.863 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.4 t -70.24 -43.59 70.26 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.497 -1.377 . . . . 0.0 111.524 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 119.425 -0.322 . . . . 0.0 111.387 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -26.94 63.03 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.937 -1.102 . . . . 0.0 111.614 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.02 -53.58 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 124.49 1.116 . . . . 0.0 110.674 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 32' ' ' ALA . 60.4 p -57.08 -44.72 83.4 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.681 1.128 . . . . 0.0 113.249 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.53 -38.4 56.5 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 C-N-CA 124.851 1.26 . . . . 0.0 109.338 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.9 m -73.38 -46.6 48.01 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.963 0.801 . . . . 0.0 112.469 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 m -56.99 -32.36 66.01 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.468 1.485 . . . . 0.0 111.727 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.45 -37.36 9.75 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.105 0.86 . . . . 0.0 113.394 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.3 ttm -74.34 -15.5 60.95 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.003 -1.292 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.2 t -84.84 -21.64 29.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.323 -1.486 . . . . 0.0 111.193 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -62.64 -41.95 99.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.095 0.558 . . . . 0.0 112.086 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.2 t -161.75 55.53 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.178 0.991 . . . . 0.0 110.688 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.25 -83.55 0.19 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.81 149.13 0.01 OUTLIER Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.759 1.2 . . . . 0.0 111.827 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.0 m -49.84 143.03 8.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.986 -1.302 . . . . 0.0 111.555 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.97 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.267 0.627 . . . . 0.0 111.717 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 153.98 54.49 0.01 OUTLIER Glycine 0 C--N 1.337 0.615 0 C-N-CA 123.902 0.763 . . . . 0.0 112.488 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.62 98.38 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.358 0.599 . . . . 0.0 109.941 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -91.42 93.91 9.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.0 tt -77.32 148.87 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 111.027 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.415 ' HB2' ' H ' ' A' ' 174' ' ' THR . 24.6 t30 -54.29 122.43 10.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.669 -0.644 . . . . 0.0 112.23 -174.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.56 -52.73 3.53 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.403 1.001 . . . . 0.0 113.327 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -79.7 31.03 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.983 1.313 . . . . 0.0 111.968 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -48.81 98.18 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.253 1.421 . . . . 0.0 110.676 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -126.22 -165.86 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.915 1.286 . . . . 0.0 109.089 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.6 p -132.2 -37.63 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.009 0.924 . . . . 0.0 110.921 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.95 12.14 18.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.371 1.868 . . . . 0.0 113.646 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.58 137.42 19.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.768 0.794 . . . . 0.0 109.881 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 120.15 25.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.25 133.9 63.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 171.15 12.62 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.333 1.053 . . . . 0.0 110.245 -169.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.16 -52.19 63.41 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 111.784 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.43 -37.65 78.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.879 0.871 . . . . 0.0 111.982 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.74 42.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.322 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.34 67.47 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.581 1.082 . . . . 0.0 111.985 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -34.93 78.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.497 1.119 . . . . 0.0 112.194 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -43.06 8.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.293 1.037 . . . . 0.0 112.299 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--O 1.234 0.277 0 C-N-CA 126.702 2.001 . . . . 0.0 111.113 -179.902 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.7 p . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.439 0.161 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.19 130.73 2.77 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.022 0.82 . . . . 0.0 112.589 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.2 p -45.73 108.24 0.12 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.789 1.636 . . . . 0.0 110.804 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.5 125.94 30.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 145' ' ' ASN . 2.5 m -96.5 108.24 20.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.76 102.17 7.19 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.578 1.151 . . . . 0.0 108.576 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -81.69 131.32 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 173.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -111.39 101.08 9.57 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.777 0.831 . . . . 0.0 109.224 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -87.01 144.16 27.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.41 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -138.59 111.52 7.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.812 1.245 . . . . 0.0 109.912 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.93 129.01 38.99 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.346 0.658 . . . . 0.0 109.408 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.589 0 CA-C-O 116.81 -2.106 . . . . 0.0 115.661 173.534 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.612 0.244 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.9 -42.31 8.37 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.206 1.402 . . . . 0.0 112.07 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.58 -29.25 5.53 Favored Glycine 0 C--O 1.212 -1.27 0 CA-C-O 117.065 -1.964 . . . . 0.0 111.838 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.1 p -40.43 -34.92 0.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.172 2.189 . . . . 0.0 114.743 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.437 ' HG3' HD11 ' A' ' 129' ' ' ILE . 2.3 mm-40 -88.08 -38.03 15.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.25 . . . . 0.0 110.785 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.7 -47.63 30.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.399 1.08 . . . . 0.0 111.032 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -56.87 -40.3 75.9 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 109.763 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -59.13 -51.84 68.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.468 1.486 . . . . 0.0 111.692 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -50.74 -52.04 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.022 -0.424 . . . . 0.0 111.478 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -67.4 -23.91 65.61 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.1 81.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.368 1.467 . . . . 0.0 109.062 176.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.471 HD22 HD13 ' A' ' 116' ' ' ILE . 2.5 tt -67.24 -43.25 82.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.792 0.724 . . . . 0.0 109.7 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -62.59 -43.3 99.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.082 0.239 . . . . 0.0 111.309 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.18 -33.68 59.32 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.065 1.346 . . . . 0.0 112.634 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -67.07 -62.91 1.19 Allowed 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -29.92 59.75 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.79 0.836 . . . . 0.0 111.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.61 -34.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.814 1.246 . . . . 0.0 112.389 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 44.49 0.63 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.178 1.37 . . . . 0.0 112.373 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -134.0 -70.3 0.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.951 0.9 . . . . 0.0 111.46 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.439 ' HG3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -145.67 71.57 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.75 1.262 . . . . 0.0 111.784 -173.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -116.5 14.08 15.49 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.962 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.66 2.52 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.596 1.093 . . . . 0.0 113.032 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.478 0.96 0 CA-C-N 118.103 0.951 . . . . 0.0 111.012 178.312 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.583 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -84.77 -55.44 4.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.47 0.708 . . . . 0.0 111.927 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.56 -27.92 68.97 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.166 170.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -53.8 52.43 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.714 0.688 . . . . 0.0 110.311 175.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.442 ' CB ' HG21 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -70.85 -37.76 73.14 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 118.595 -0.717 . . . . 0.0 112.232 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HA ' HG21 ' A' ' 79' ' ' VAL . 11.0 t0 -57.83 -56.42 22.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.82 0.736 . . . . 0.0 110.834 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.439 HG22 ' HG3' ' A' ' 50' ' ' MET . 9.0 m -68.3 -35.21 77.48 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.019 1.327 . . . . 0.0 110.389 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.425 HD21 ' HG ' ' A' ' 42' ' ' LEU . 15.0 tp -62.29 -50.82 70.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.37 1.441 . . . . 0.0 111.324 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.36 -52.86 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 O-C-N 120.825 -1.172 . . . . 0.0 110.994 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.72 -18.32 62.31 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.701 -1.249 . . . . 0.0 112.38 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.84 10.22 6.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.711 1.604 . . . . 0.0 112.908 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.18 51.25 60.27 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.98 1.276 . . . . 0.0 112.307 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.08 -85.07 0.63 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.512 0.725 . . . . 0.0 111.017 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.49 -52.15 35.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 122.638 0.375 . . . . 0.0 111.646 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -149.98 -179.94 7.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.09 25.22 5.25 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.992 1.282 . . . . 0.0 112.489 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.58 168.6 10.93 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.226 1.01 . . . . 0.0 111.567 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -60.92 136.21 58.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.326 0.584 . . . . 0.0 110.403 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 66' ' ' ASP . 4.0 t -115.94 136.34 53.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.421 1.088 . . . . 0.0 108.347 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.58 128.97 50.76 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.18 154.55 33.04 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -44.69 110.42 1.04 Allowed Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.502 0.721 . . . . 0.0 112.852 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.17 -31.75 4.58 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.508 1.472 . . . . 0.0 111.694 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.73 11.85 21.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.269 1.427 . . . . 0.0 112.606 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m 62.07 98.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 112.996 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.57 38.16 1.49 Allowed Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.914 0.769 . . . . 0.0 114.037 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 p -175.52 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.809 1.244 . . . . 0.0 111.69 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -75.62 100.41 4.6 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.007 -1.058 . . . . 0.0 111.174 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -69.87 134.92 48.99 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.762 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.07 126.3 50.43 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.58 1.552 . . . . 0.0 108.81 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -81.16 111.64 17.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.286 1.035 . . . . 0.0 110.065 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.26 179.09 4.08 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.78 0.8 . . . . 0.0 111.724 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -82.76 -55.23 4.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.115 0.566 . . . . 0.0 111.946 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -83.17 50.77 1.81 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.092 0.957 . . . . 0.0 112.14 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.1 69.7 0.84 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.269 1.414 . . . . 0.0 112.928 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -129.54 163.8 22.56 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 123.28 0.467 . . . . 0.0 112.373 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.48 131.91 42.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.49 120.41 56.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.325 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 117' ' ' THR . 2.6 t -107.23 113.99 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 88' ' ' ALA . 2.1 m -97.63 139.99 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.23 135.57 9.22 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.515 0.726 . . . . 0.0 109.058 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -76.19 150.54 33.34 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 121.809 1.672 . . . . 0.0 111.057 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.23 76.0 1.52 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.224 1.488 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.33 114.53 28.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.764 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 O-C-N 121.476 -0.765 . . . . 0.0 110.87 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.061 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -70.74 120.41 16.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.385 -1.656 . . . . 0.0 111.607 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.6 p -108.63 110.71 22.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.67 1.224 . . . . 0.0 111.428 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.471 HD13 HD22 ' A' ' 42' ' ' LEU . 5.8 mt -117.36 105.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 O-C-N 120.94 -1.1 . . . . 0.0 108.25 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.583 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -74.85 139.94 43.53 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.976 171.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -131.38 122.5 26.44 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -136.29 110.13 8.16 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.796 -0.565 . . . . 0.0 110.61 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.03 -31.47 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.551 1.54 . . . . 0.0 113.058 -173.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.2 m -50.89 109.47 1.36 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.138 1.375 . . . . 0.0 109.878 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.62 -169.55 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.044 2.496 . . . . 0.0 110.692 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -33.93 69.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.646 -1.284 . . . . 0.0 113.413 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.4 p -65.99 -48.13 72.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.528 1.058 . . . . 0.0 111.222 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.45 -34.05 63.06 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.507 0.723 . . . . 0.0 111.144 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.3 t -49.62 -31.46 10.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.445 -1.409 . . . . 0.0 111.099 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.36 -54.98 6.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 124.434 1.093 . . . . 0.0 112.239 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -46.61 72.4 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.007 1.276 . . . . 0.0 113.96 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.437 HD11 ' HG3' ' A' ' 35' ' ' GLU . 51.1 mm -56.37 -38.81 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.638 1.575 . . . . 0.0 110.701 173.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -74.12 -39.67 63.19 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.362 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.4 m -58.45 -35.76 72.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.56 1.527 . . . . 0.0 111.768 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.44 -32.14 28.79 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.833 -0.542 . . . . 0.0 112.122 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 40.9 tpp -78.65 -19.93 51.46 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 118.213 1.007 . . . . 0.0 111.41 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 17.9 p -77.54 -20.5 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.408 -1.432 . . . . 0.0 111.695 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -41.44 93.61 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.069 0.948 . . . . 0.0 112.037 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.3 t -162.1 62.36 0.23 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.34 -77.78 0.15 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.3 143.83 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.408 1.004 . . . . 0.0 111.455 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 151' ' ' ASP . 2.3 p -41.92 111.2 0.21 Allowed 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.632 -1.511 . . . . 0.0 112.804 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 p -145.02 28.49 1.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.228 1.811 . . . . 0.0 110.529 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 63.05 45.76 94.86 Favored Glycine 0 CA--C 1.523 0.542 0 O-C-N 121.276 -0.89 . . . . 0.0 113.102 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.5 mt -83.48 112.52 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.66 0.784 . . . . 0.0 109.947 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -115.63 97.36 6.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.044 0.938 . . . . 0.0 109.108 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 154' ' ' VAL . 88.1 mt -73.95 164.66 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.203 0.601 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -47.15 116.34 1.36 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.71 25.33 6.73 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 123.632 0.634 . . . . 0.0 114.156 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -131.61 37.35 3.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.617 2.767 . . . . 0.0 107.818 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -36.98 90.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.086 1.755 . . . . 0.0 112.924 167.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -142.03 -174.6 4.14 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.36 1.464 . . . . 0.0 109.065 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.472 HG22 ' HA2' ' A' ' 141' ' ' GLY . 11.6 p -146.68 -41.8 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -172.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 139' ' ' THR . 10.4 p-10 -85.87 8.98 18.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.944 2.097 . . . . 0.0 113.864 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.08 136.67 8.45 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.173 0.987 . . . . 0.0 110.448 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 100.31 4.71 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.643 1.211 . . . . 0.0 108.443 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 144' ' ' ILE . 45.8 t -117.79 119.77 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.512 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.457 ' HA ' ' HB3' ' A' ' 134' ' ' SER . 0.6 OUTLIER -108.24 179.92 4.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.346 -174.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.9 62.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.824 -0.548 . . . . 0.0 111.599 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.07 -35.65 80.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.339 0.655 . . . . 0.0 112.287 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.458 HG22 HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -72.87 -52.52 22.19 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.47 67.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.5 1.046 . . . . 0.0 111.934 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.7 m -63.92 -43.98 94.28 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.531 -0.731 . . . . 0.0 111.648 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.5 t -105.54 -56.81 2.12 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.628 0 C-N-CA 126.412 1.885 . . . . 0.0 112.354 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.236 0.386 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.44 -80.56 0.55 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 72.4 p -135.98 116.97 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.11 129.45 34.5 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 109.85 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.3 m -89.8 116.85 28.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.81 122.87 21.48 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.583 0.753 . . . . 0.0 109.266 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -94.06 143.75 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.05 0.54 . . . . 0.0 109.663 174.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.72 114.0 18.72 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.838 0.855 . . . . 0.0 109.642 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -99.61 118.73 36.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.039 0.936 . . . . 0.0 110.966 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.466 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 36.7 t80 -102.11 103.54 14.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.442 0.697 . . . . 0.0 110.955 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -71.94 136.25 46.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.957 0.503 . . . . 0.0 110.838 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.275 0 CA-C-O 117.581 -1.677 . . . . 0.0 113.095 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 129' ' ' ILE . . . -103.02 -29.55 11.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.292 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.48 -32.2 5.33 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.918 0.77 . . . . 0.0 112.833 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -42.2 21.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.114 1.766 . . . . 0.0 113.852 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -68.2 -36.17 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.654 -1.279 . . . . 0.0 113.114 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.85 -48.2 66.8 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.551 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.0 p -64.78 -38.61 91.58 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.943 0.897 . . . . 0.0 110.828 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -58.51 -51.85 68.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.639 1.176 . . . . 0.0 111.17 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 177' ' ' PHE . 10.9 t80 -56.47 -48.26 77.47 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.171 -0.955 . . . . 0.0 112.075 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -26.54 68.58 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -42.12 88.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.459 1.104 . . . . 0.0 109.971 173.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.56 -44.99 92.5 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 117.582 -1.199 . . . . 0.0 108.918 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.75 92.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.159 0.891 . . . . 0.0 111.368 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -38.17 69.27 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.195 -0.94 . . . . 0.0 112.837 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -69.22 -57.0 5.94 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -51.98 -30.9 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.57 1.548 . . . . 0.0 112.008 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.17 -25.46 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.157 1.383 . . . . 0.0 113.373 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.41 25.5 1.85 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.67 1.605 . . . . 0.0 113.617 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -157.8 0.63 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.319 1.048 . . . . 0.0 110.489 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.08 52.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.307 1.843 . . . . 0.0 113.577 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -115.25 -60.69 1.85 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.91 1.284 . . . . 0.0 111.255 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.06 0.66 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.572 1.082 . . . . 0.0 111.03 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 125.665 1.586 . . . . 0.0 108.64 -177.507 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 CA-C-O 119.103 -0.831 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.49 -75.87 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.415 1.108 . . . . 0.0 112.334 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -32.69 70.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.81 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.1 ttp -57.37 -40.57 78.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.903 1.281 . . . . 0.0 111.789 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 69' ' ' ILE . 1.1 m -72.0 -47.36 52.5 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.843 174.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.522 ' HA ' HG21 ' A' ' 79' ' ' VAL . 2.9 t0 -50.09 -49.42 51.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.666 1.121 . . . . 0.0 111.314 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -68.32 -46.63 69.73 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.646 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.43 -42.02 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.199 0.909 . . . . 0.0 110.512 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.628 HD12 HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -63.89 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 121.188 -0.945 . . . . 0.0 110.573 175.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -61.39 -23.55 65.87 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.698 -0.626 . . . . 0.0 111.97 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.8 -3.47 28.75 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.374 1.47 . . . . 0.0 113.439 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.5 50.38 9.8 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.943 1.735 . . . . 0.0 112.487 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.32 -88.75 0.61 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.424 0.689 . . . . 0.0 112.271 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.56 83.43 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 122.94 0.496 . . . . 0.0 111.716 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -160.61 146.89 15.19 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 125.169 1.387 . . . . 0.0 109.586 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.11 55.4 1.13 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.655 1.121 . . . . 0.0 112.824 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 -179.87 5.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.632 1.173 . . . . 0.0 112.349 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.14 141.9 41.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.32 0.581 . . . . 0.0 110.579 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.576 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.5 t -115.44 152.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.491 1.116 . . . . 0.0 109.058 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.57 122.04 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.256 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.73 101.05 2.7 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -56.25 109.78 1.9 Allowed Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.825 0.85 . . . . 0.0 110.992 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.22 -25.0 14.01 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.77 -13.39 59.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.484 1.114 . . . . 0.0 112.661 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.08 75.39 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.344 1.458 . . . . 0.0 111.755 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.03 -53.57 0.07 OUTLIER Glycine 0 N--CA 1.465 0.609 0 C-N-CA 124.135 0.874 . . . . 0.0 111.574 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.7 t -172.16 122.95 0.48 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.122 0.969 . . . . 0.0 111.51 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.56 126.03 28.05 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.498 1.142 . . . . 0.0 110.551 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 p -95.83 138.45 33.46 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.027 -1.045 . . . . 0.0 108.747 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.76 121.19 42.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.54 124.63 29.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.697 0.799 . . . . 0.0 110.815 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.02 109.2 22.01 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -54.84 -53.27 57.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.43 0.692 . . . . 0.0 112.358 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -107.26 47.26 0.89 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 110.634 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.22 -142.16 3.32 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.261 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -114.4 -121.3 3.57 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 124.318 0.961 . . . . 0.0 111.516 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -131.15 148.66 52.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.763 0.792 . . . . 0.0 110.397 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.13 149.93 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.229 1.411 . . . . 0.0 108.561 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.723 ' HB ' HG22 ' A' ' 117' ' ' THR . 24.3 t -133.98 113.03 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 65' ' ' THR . 1.4 m -95.51 114.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 122.368 1.08 . . . . 0.0 108.869 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.68 138.34 31.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 O-C-N 120.473 -1.392 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.98 154.05 47.54 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.078 1.185 . . . . 0.0 110.731 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.34 68.42 1.14 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 123.432 1.586 . . . . 0.0 110.021 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 p -86.78 169.54 12.52 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.117 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 110.451 175.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -117.5 144.85 44.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.882 0.873 . . . . 0.0 110.333 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -134.98 113.32 11.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.444 1.116 . . . . 0.0 111.0 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.0 mt -115.58 108.89 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.7 OUTLIER -78.2 142.09 38.18 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.246 173.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -134.81 125.92 27.84 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.35 98.34 4.85 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -38.87 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.465 1.106 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.5 m -52.62 104.33 0.43 Allowed Pre-proline 0 C--N 1.342 0.256 0 O-C-N 125.304 1.627 . . . . 0.0 108.249 -173.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -74.35 -168.08 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.604 1.536 . . . . 0.0 110.097 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.04 -29.42 65.33 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.118 -0.989 . . . . 0.0 112.502 174.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.2 p -71.73 -40.96 69.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.783 1.174 . . . . 0.0 112.429 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.75 49.97 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.5 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.5 -30.85 13.84 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.037 1.289 . . . . 0.0 109.995 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 159' ' ' ALA . 64.1 t -78.39 -57.87 4.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 123.642 0.777 . . . . 0.0 111.536 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 37.8 m -55.91 -25.09 41.31 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.516 ' CD1' ' HB1' ' A' ' 32' ' ' ALA . 1.3 mp -85.63 -47.84 16.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 C-N-CA 126.215 1.806 . . . . 0.0 110.228 170.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.7 m -58.44 -30.4 66.89 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 121.191 1.814 . . . . 0.0 111.846 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.1 t -86.5 -49.03 7.88 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.098 -1.001 . . . . 0.0 112.044 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.94 91.85 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -33.51 76.1 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 118.555 1.177 . . . . 0.0 110.736 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.34 -20.47 19.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -26.85 65.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.262 1.025 . . . . 0.0 113.296 172.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.5 t -159.03 46.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.451 1.9 . . . . 0.0 110.856 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.3 -86.59 1.72 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.58 49.41 1.81 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 125.67 1.605 . . . . 0.0 114.785 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 151' ' ' ASP . 17.5 m 63.96 142.86 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.657 1.583 . . . . 0.0 112.224 -172.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.95 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.841 -1.162 . . . . 0.0 111.257 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.37 48.52 0.04 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 124.531 1.063 . . . . 0.0 112.269 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 7.1 mt -89.42 102.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -91.87 98.99 11.93 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 122.957 0.503 . . . . 0.0 109.713 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -73.26 141.23 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 123.584 0.753 . . . . 0.0 109.8 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -47.61 119.99 3.07 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.383 -0.823 . . . . 0.0 111.612 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.06 -45.87 1.45 Allowed Glycine 0 CA--C 1.541 1.697 0 O-C-N 120.056 -1.653 . . . . 0.0 114.882 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.48 38.84 0.8 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.347 1.859 . . . . 0.0 111.242 170.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -51.35 95.76 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.968 1.307 . . . . 0.0 110.655 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -118.36 -168.77 1.58 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.099 1.359 . . . . 0.0 108.96 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -139.84 -40.11 0.45 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.723 0.809 . . . . 0.0 110.783 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.472 ' HA ' HG23 ' A' ' 139' ' ' THR . 4.3 p-10 -89.52 17.45 6.32 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.1 1.76 . . . . 0.0 114.026 169.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.528 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -46.01 126.1 7.07 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.587 0.708 . . . . 0.0 110.326 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -113.64 85.49 2.21 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.594 1.187 . . . . 0.0 107.865 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.404 ' HA ' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -110.23 121.47 63.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.399 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 158' ' ' ILE . 2.1 p -131.41 -179.79 5.57 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.809 1.644 . . . . 0.0 110.914 -173.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.35 85.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.57 1.532 . . . . 0.0 114.136 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -58.54 -41.64 86.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.241 0.616 . . . . 0.0 110.765 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 155' ' ' THR . 0.4 OUTLIER -78.98 -36.84 19.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 122.817 0.447 . . . . 0.0 111.039 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 127' ' ' VAL . . . -50.79 -55.29 17.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 p -69.53 -29.33 66.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -66.8 -61.07 2.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.871 0.868 . . . . 0.0 111.065 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.236 0.374 0 C-N-CA 129.381 3.072 . . . . 0.0 108.421 -177.291 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.222 0.534 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -98.68 -46.43 2.12 Favored Glycine 0 N--CA 1.469 0.886 0 O-C-N 121.628 -0.67 . . . . 0.0 111.758 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.0 m -128.83 89.45 2.88 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.33 1.052 . . . . 0.0 108.967 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -79.59 102.49 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.87 0.868 . . . . 0.0 109.057 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.8 m -68.94 105.26 2.33 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.62 1.168 . . . . 0.0 109.879 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.97 112.41 16.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -85.6 137.05 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.467 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 13.0 m-85 -111.86 117.98 34.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -107.9 145.14 34.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 109.727 173.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -142.65 109.01 5.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.696 1.198 . . . . 0.0 109.154 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -100.09 98.19 8.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.539 1.136 . . . . 0.0 109.549 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 124.849 1.214 . . . . 0.0 113.633 178.276 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 111.121 0.045 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.507 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -75.72 -39.98 56.39 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.643 0.777 . . . . 0.0 110.96 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.61 -27.06 0.8 Allowed Glycine 0 C--O 1.216 -0.984 0 CA-C-O 116.326 -2.375 . . . . 0.0 113.311 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -38.55 -48.26 1.4 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.485 2.142 . . . . 0.0 114.341 166.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -30.35 60.51 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.782 -1.199 . . . . 0.0 112.207 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.6 -50.23 18.66 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.046 0.939 . . . . 0.0 111.065 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 t -58.55 -45.16 89.52 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.48 1.112 . . . . 0.0 110.468 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -60.96 -49.68 76.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.309 0.958 . . . . 0.0 112.094 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 177' ' ' PHE . 0.6 OUTLIER -50.35 -59.74 3.68 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.467 0.707 . . . . 0.0 111.348 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -59.6 -27.37 66.24 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 118.805 -0.616 . . . . 0.0 110.795 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 44' ' ' THR . 0.3 OUTLIER -69.05 -46.56 67.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.745 1.218 . . . . 0.0 111.393 177.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 68' ' ' LEU . 3.8 tp -54.65 -44.66 73.44 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 47' ' ' ILE . . . -69.54 -43.48 72.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -68.6 -15.04 63.4 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.981 1.712 . . . . 0.0 112.709 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.577 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 20.9 m-20 -95.47 -52.03 4.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -22.41 2.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.974 0.909 . . . . 0.0 111.84 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 43' ' ' ALA . 14.1 pt -41.8 -41.99 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.634 1.174 . . . . 0.0 113.012 171.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.8 21.46 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.279 0.943 . . . . 0.0 114.375 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.453 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -75.09 -55.38 5.79 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.22 1.008 . . . . 0.0 109.422 177.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.71 21.16 0.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -96.52 80.83 3.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.254 -1.529 . . . . 0.0 110.038 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 44.64 49.47 8.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.595 1.184 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.3 t . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 123.718 0.807 . . . . 0.0 110.384 -172.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 N-CA-C 114.063 0.385 . . . . 0.0 114.063 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 88' ' ' ALA . . . -87.43 -63.26 1.33 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.351 1.86 . . . . 0.0 110.276 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -38.35 66.0 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.269 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -59.77 -51.38 69.99 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 112.342 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.426 HG23 HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -65.83 -36.8 84.5 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.414 -0.327 . . . . 0.0 111.625 175.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -51.52 69.72 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.919 0.887 . . . . 0.0 110.441 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 p -68.18 -35.35 77.88 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 111.384 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.665 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -64.67 -50.08 68.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.791 1.178 . . . . 0.0 110.708 174.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.426 HD12 HG23 ' A' ' 65' ' ' THR . 3.4 mt -63.14 -50.58 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.893 -1.129 . . . . 0.0 110.061 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -60.78 -32.67 72.0 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.096 -1.002 . . . . 0.0 112.321 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.42 65.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.82 0.848 . . . . 0.0 112.848 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.79 4.81 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 124.998 1.285 . . . . 0.0 112.397 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.665 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -100.07 -64.01 1.08 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.59 -63.18 1.38 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.917 0.389 . . . . 0.0 110.247 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -132.61 -170.66 2.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.02 1.328 . . . . 0.0 109.062 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -140.59 16.71 2.87 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.26 0.933 . . . . 0.0 112.831 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.9 ttt -92.58 171.36 9.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.384 1.074 . . . . 0.0 111.329 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.41 141.81 53.75 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.346 0.593 . . . . 0.0 110.603 174.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.481 HG13 HD23 ' A' ' 90' ' ' LEU . 2.8 t -118.89 148.18 21.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 108.583 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.32 130.48 53.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.053 0.541 . . . . 0.0 110.08 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.03 130.71 9.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -114.34 101.61 54.27 Favored Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 124.365 1.066 . . . . 0.0 108.541 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -74.33 -35.82 3.6 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.766 2.31 . . . . 0.0 112.197 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.01 66.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.996 0.918 . . . . 0.0 112.125 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -59.86 1.76 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.916 0.886 . . . . 0.0 111.838 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.27 24.52 7.49 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.819 1.676 . . . . 0.0 113.582 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -135.06 88.33 2.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.647 1.579 . . . . 0.0 108.462 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -55.94 151.43 11.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.833 0.825 . . . . 0.0 111.686 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.0 p -129.06 147.17 50.9 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.719 0.808 . . . . 0.0 108.959 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.481 HD23 HG13 ' A' ' 79' ' ' VAL . 1.5 tm? -127.37 122.22 33.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.716 0.77 . . . . 0.0 109.265 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -80.84 120.82 25.18 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.491 0.716 . . . . 0.0 110.309 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -76.28 132.33 39.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.559 . . . . 0.0 109.861 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t -54.38 -47.64 72.43 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.9 0.48 . . . . 0.0 111.723 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -140.24 76.1 1.54 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 110.591 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.8 -103.23 0.16 Allowed Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.232 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.81 -119.77 0.91 Allowed Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.77 154.81 48.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 122.649 1.214 . . . . 0.0 110.744 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.4 mt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 125.473 1.509 . . . . 0.0 107.789 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.33 116.13 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 125.08 1.352 . . . . 0.0 107.371 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.595 HG22 ' HB3' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -98.6 124.84 52.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.98 145.52 22.65 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.513 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -77.31 154.56 32.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 121.912 1.742 . . . . 0.0 111.213 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.58 74.79 1.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.03 1.732 . . . . 0.0 110.641 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -111.94 140.84 46.28 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.829 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 C-N-CA 123.223 0.609 . . . . 0.0 110.052 -178.767 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.82 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.83 145.39 27.02 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 174.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.5 p -131.57 107.08 8.61 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.838 1.304 . . . . 0.0 110.929 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.21 106.98 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.3 OUTLIER -71.73 135.23 46.7 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.61 0.764 . . . . 0.0 109.545 171.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.6 p -134.39 120.04 19.35 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.67 119.24 26.5 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.72 -0.612 . . . . 0.0 109.697 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.55 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.857 1.663 . . . . 0.0 112.731 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.18 103.03 0.33 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.396 1.878 . . . . 0.0 109.844 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 21.2 Cg_endo -75.17 -167.83 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.384 2.056 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -22.08 65.31 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.745 -1.222 . . . . 0.0 113.549 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.8 p -78.16 -52.0 9.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.917 0.887 . . . . 0.0 110.321 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.581 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -72.61 -21.62 61.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.668 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -52.6 -32.37 41.05 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.697 -1.252 . . . . 0.0 110.187 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.91 -41.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.135 1.374 . . . . 0.0 111.872 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.507 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 19.3 m -59.75 -34.8 73.44 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 119.903 -1.748 . . . . 0.0 113.152 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.72 -34.5 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.551 ' HB2' HG12 ' A' ' 154' ' ' VAL . 26.6 p -63.85 -41.98 97.68 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 120.753 1.615 . . . . 0.0 112.431 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 156' ' ' ALA . 12.4 t -77.07 -39.51 49.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.753 0.821 . . . . 0.0 111.34 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.24 -38.29 71.77 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 5.3 ttm -83.03 -32.21 27.01 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 110.282 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.8 t -62.9 -26.65 68.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.659 1.572 . . . . 0.0 112.413 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -62.74 -26.87 68.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -154.75 46.77 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.68 -83.0 1.71 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 40.5 58.84 2.43 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.76 1.171 . . . . 0.0 113.222 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 151' ' ' ASP . 3.7 m 70.17 135.06 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.4 1.48 . . . . 0.0 111.727 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 p 179.77 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.061 -1.024 . . . . 0.0 111.696 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.01 49.49 23.58 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.42 1.01 . . . . 0.0 113.499 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 2.7 mt -92.07 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.397 0.617 . . . . 0.0 109.999 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -89.3 94.13 9.79 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.037 -0.414 . . . . 0.0 110.449 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.417 HD11 ' HB1' ' A' ' 152' ' ' ALA . 10.0 mt -70.62 144.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.373 1.069 . . . . 0.0 110.467 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -48.33 118.55 2.5 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.01 -48.32 1.69 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.935 0.778 . . . . 0.0 113.466 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.43 36.83 0.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.438 1.895 . . . . 0.0 112.141 172.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -54.22 96.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.565 1.146 . . . . 0.0 110.019 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -119.64 -169.13 1.71 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.378 1.471 . . . . 0.0 109.772 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -134.67 -40.59 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.581 0.753 . . . . 0.0 110.866 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 139' ' ' THR . 5.8 p-10 -91.63 17.81 8.32 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.304 1.842 . . . . 0.0 113.863 170.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -42.77 130.22 4.18 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.628 0.728 . . . . 0.0 111.574 174.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 77.8 1.81 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.328 1.061 . . . . 0.0 109.044 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 130' ' ' SER . 6.1 t -98.68 135.84 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.522 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.2 167.03 22.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.813 1.245 . . . . 0.0 110.673 -172.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 131' ' ' THR . . . -54.83 -34.98 63.45 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.963 -0.461 . . . . 0.0 111.977 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.31 -44.11 22.27 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.073 1.349 . . . . 0.0 110.586 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -52.55 59.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.579 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.6 71.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.016 0.825 . . . . 0.0 111.228 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -45.68 71.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.263 0.625 . . . . 0.0 111.619 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.0 t -85.25 -55.9 3.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.515 0.726 . . . . 0.0 111.937 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 127.531 2.332 . . . . 0.0 112.756 -178.934 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 C--O 1.24 0.574 0 CA-C-O 120.711 0.291 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -48.21 160.41 0.57 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.379 0.433 . . . . 0.0 112.085 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 60.3 p -43.07 126.72 4.04 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.493 1.117 . . . . 0.0 110.982 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.43 87.4 3.39 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.725 -1.235 . . . . 0.0 108.812 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.5 m -83.53 125.13 31.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.12 102.32 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.831 1.252 . . . . 0.0 108.146 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -76.5 131.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 38.8 m-85 -107.59 111.87 24.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.063 0.545 . . . . 0.0 109.907 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.28 106.35 18.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.018 0.913 . . . . 0.0 110.335 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.494 ' CG ' ' HB1' ' A' ' 43' ' ' ALA . 90.5 t80 -86.49 110.33 19.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 110.362 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -123.72 145.51 48.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.76 1.224 . . . . 0.0 109.893 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.217 0 C-N-CA 124.438 1.018 . . . . 0.0 113.122 176.377 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.51 0.671 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -128.96 -66.13 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 43.61 -140.97 2.83 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 69.11 -62.1 0.41 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.072 2.149 . . . . 0.0 111.835 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -134.97 137.89 43.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 128.405 2.682 . . . . 0.0 109.833 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.59 -9.75 58.71 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.743 1.217 . . . . 0.0 112.849 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.51 ' HB1' ' CD1' ' A' ' 129' ' ' ILE . . . -95.51 -35.74 11.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.366 1.066 . . . . 0.0 110.932 177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.17 -30.25 10.35 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 124.271 0.938 . . . . 0.0 113.205 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -39.89 -47.1 2.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.012 1.325 . . . . 0.0 113.891 168.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -75.32 -39.0 59.97 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.239 0.927 . . . . 0.0 112.449 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 129' ' ' ILE . 10.9 mt -58.4 -47.78 82.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.361 0.6 . . . . 0.0 110.394 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.3 p -66.48 -37.69 85.66 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 117.669 -1.158 . . . . 0.0 110.725 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -59.06 -54.55 45.81 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.274 1.397 . . . . 0.0 112.203 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' A' ' 118' ' ' THR . 15.5 m-30 -57.13 -46.22 82.87 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.011 -1.055 . . . . 0.0 111.339 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.4 -27.48 68.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.516 0.726 . . . . 0.0 112.619 173.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -49.34 71.18 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.671 1.188 . . . . 0.0 108.861 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 116' ' ' ILE . 3.2 tt -61.99 -40.55 96.04 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 118.933 0.788 . . . . 0.0 109.669 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -62.4 -42.85 99.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.726 0.694 . . . . 0.0 111.895 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -33.12 47.54 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.126 0.97 . . . . 0.0 113.121 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -70.31 -64.04 0.97 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.224 -0.922 . . . . 0.0 108.523 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.87 -21.18 27.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.801 1.24 . . . . 0.0 112.64 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -44.93 -33.26 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.196 0.999 . . . . 0.0 111.98 171.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.04 50.93 0.2 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.68 1.134 . . . . 0.0 112.868 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.5 tpt -113.71 -63.82 1.4 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.694 0.798 . . . . 0.0 111.121 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.44 34.32 0.46 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.693 1.197 . . . . 0.0 112.357 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 31.48 0.27 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.637 1.175 . . . . 0.0 113.165 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.16 49.14 2.29 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.245 0.926 . . . . 0.0 112.108 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.69 57.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.737 1.615 . . . . 0.0 110.456 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.96 -50.02 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.939 1.296 . . . . 0.0 110.841 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.79 73.03 1.27 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.804 0.716 . . . . 0.0 111.571 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -104.52 168.58 8.99 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.81 1.244 . . . . 0.0 111.927 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.27 166.8 5.82 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.842 0.457 . . . . 0.0 111.171 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 58.66 166.25 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 122.736 1.255 . . . . 0.0 113.214 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 92.9 m -80.61 -35.02 34.64 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.629 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m 49.51 53.78 12.11 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.102 0.961 . . . . 0.0 112.188 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.34 4.5 6.41 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.082 0.849 . . . . 0.0 114.195 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.713 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -107.17 -62.75 1.37 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.052 0.941 . . . . 0.0 113.018 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -25.58 60.05 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.372 172.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mtp -53.47 -57.14 11.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.908 0.883 . . . . 0.0 111.867 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.512 HG23 HD12 ' A' ' 69' ' ' ILE . 1.1 m -69.73 -40.12 76.39 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.37 176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' HA ' HG21 ' A' ' 79' ' ' VAL . 19.2 t70 -50.73 -47.24 59.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -70.16 -42.33 72.65 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.0 111.14 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tp -59.27 -51.44 69.95 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.889 1.222 . . . . 0.0 112.014 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.563 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -61.12 -52.41 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 120.766 -1.209 . . . . 0.0 110.015 177.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -62.27 -23.58 66.78 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.907 -1.121 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -2.9 23.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 113.796 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.65 78.88 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.089 1.804 . . . . 0.0 112.886 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.11 -76.9 0.24 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 117.73 0.765 . . . . 0.0 111.289 -177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.39 -50.66 36.33 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 111.8 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.45 132.42 8.78 Favored 'General case' 0 C--O 1.211 -0.926 0 C-N-CA 124.703 1.201 . . . . 0.0 109.85 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.63 59.37 4.6 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 119.419 1.008 . . . . 0.0 113.251 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.06 176.73 7.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.102 0.961 . . . . 0.0 112.475 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.16 147.64 38.34 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.705 -0.622 . . . . 0.0 110.685 172.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.563 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.3 t -121.23 157.51 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 109.007 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.9 OUTLIER -107.38 101.93 11.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.74 112.91 4.76 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -35.92 115.79 0.6 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.603 1.161 . . . . 0.0 113.341 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -71.49 -18.14 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.301 1.334 . . . . 0.0 112.026 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.33 -4.79 41.42 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.86 1.264 . . . . 0.0 113.262 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.48 86.42 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.133 1.373 . . . . 0.0 113.057 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.77 -40.57 0.02 OUTLIER Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.182 -0.949 . . . . 0.0 114.136 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 p -158.37 114.31 2.71 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.307 1.443 . . . . 0.0 111.638 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.713 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -60.66 161.38 7.86 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-O 122.743 1.258 . . . . 0.0 111.811 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 80' ' ' SER . 3.7 t -135.85 127.46 28.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.528 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.465 HD23 HD13 ' A' ' 69' ' ' ILE . 2.0 tm? -99.41 136.75 38.89 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.304 1.05 . . . . 0.0 109.403 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -93.26 104.64 16.8 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.574 1.15 . . . . 0.0 110.651 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.31 112.09 23.54 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.319 0.648 . . . . 0.0 110.168 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -57.86 5.84 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.641 -0.662 . . . . 0.0 111.815 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -68.03 -46.21 71.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.128 0.571 . . . . 0.0 112.002 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.84 -123.08 0.11 Allowed Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.337 0.97 . . . . 0.0 111.923 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -143.65 -98.09 0.26 Allowed Glycine 0 N--CA 1.465 0.596 0 O-C-N 122.093 -0.651 . . . . 0.0 112.266 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.53 149.29 52.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.062 0.934 . . . . 0.0 110.261 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 mt -130.63 145.24 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.362 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.633 ' HB ' HG22 ' A' ' 117' ' ' THR . 21.9 t -132.27 109.59 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.512 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 1.9 m -94.93 122.0 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.54 131.74 11.95 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.054 -1.029 . . . . 0.0 109.446 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.5 152.4 43.37 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.179 1.253 . . . . 0.0 110.797 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -145.82 66.85 1.21 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.476 1.911 . . . . 0.0 111.038 -175.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.9 p -100.14 97.96 8.72 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.319 1.057 . . . . 0.0 109.251 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.57 113.91 4.89 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.849 -1.157 . . . . 0.0 110.84 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.03 73.8 1.23 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -110.59 165.85 12.29 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.324 0.964 . . . . 0.0 112.057 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.8 p -142.1 -43.95 0.34 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.945 0.898 . . . . 0.0 111.772 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.13 58.05 0.71 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 125.685 1.612 . . . . 0.0 111.38 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 53.68 43.12 31.54 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.992 0.901 . . . . 0.0 112.632 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -92.68 115.98 28.6 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.642 -0.661 . . . . 0.0 109.765 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -102.72 138.82 39.11 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.344 0.658 . . . . 0.0 109.792 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.57 112.46 3.97 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -107.33 135.81 48.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.258 1.529 . . . . 0.0 109.033 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.7 p -122.06 116.77 24.86 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.282 1.033 . . . . 0.0 110.654 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.463 ' CD1' HD22 ' A' ' 42' ' ' LEU . 16.2 mt -124.41 104.5 13.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.633 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.8 OUTLIER -75.84 142.55 42.18 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.248 173.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 39' ' ' TYR . 2.6 p -140.66 128.28 21.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.87 0.843 . . . . 0.0 108.989 -177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.72 99.6 4.67 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -172.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.89 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.514 1.126 . . . . 0.0 112.393 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.2 t -48.61 101.95 0.29 Allowed Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 127.001 2.12 . . . . 0.0 109.09 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 28.8 Cg_endo -73.13 -171.21 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.773 1.649 . . . . 0.0 110.758 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.4 tm0? -59.81 -44.25 94.08 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.944 -1.097 . . . . 0.0 112.544 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 p -56.54 -42.4 78.45 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.051 -1.03 . . . . 0.0 112.002 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -78.97 -29.37 43.84 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.057 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -30.41 14.45 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.895 1.68 . . . . 0.0 110.496 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.42 -55.78 6.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 125.451 1.5 . . . . 0.0 111.335 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 31.2 m -57.64 -48.73 78.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.778 1.172 . . . . 0.0 113.327 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.613 HG23 HD21 ' A' ' 36' ' ' LEU . 36.6 mm -56.13 -47.2 80.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 C-N-CA 125.615 1.566 . . . . 0.0 110.981 171.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -62.92 -45.69 91.31 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 117.999 -1.0 . . . . 0.0 112.167 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.4 m -51.01 -42.47 60.44 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 111.365 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.06 -39.23 33.07 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 121.933 -0.479 . . . . 0.0 113.137 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 11.4 ttm -67.85 -20.5 65.15 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.467 -1.608 . . . . 0.0 112.466 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 -28.17 57.44 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.753 1.221 . . . . 0.0 111.888 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -16.14 63.34 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 112.836 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.08 46.94 0.92 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.386 1.474 . . . . 0.0 110.716 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -35.58 -64.88 0.49 Allowed Glycine 0 C--N 1.345 1.037 0 C-N-CA 125.571 1.558 . . . . 0.0 113.293 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 17.78 75.59 0.01 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 127.308 2.385 . . . . 0.0 113.355 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 151' ' ' ASP . 20.4 p -51.54 167.2 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.897 1.679 . . . . 0.0 112.466 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -33.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.502 -0.749 . . . . 0.0 111.812 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 170.79 51.0 0.04 OUTLIER Glycine 0 C--N 1.339 0.721 0 C-N-CA 123.636 0.636 . . . . 0.0 112.891 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.4 mt -86.84 113.42 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -119.46 103.15 9.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 108.362 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -80.87 166.95 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -51.9 119.18 4.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.008 1.323 . . . . 0.0 112.675 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.28 27.44 5.53 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.484 0.564 . . . . 0.0 113.909 -173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.72 32.85 4.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.877 2.071 . . . . 0.0 109.024 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -36.62 98.96 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.114 1.366 . . . . 0.0 111.129 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -142.42 -174.07 4.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.456 1.502 . . . . 0.0 108.691 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.409 HG22 ' HA2' ' A' ' 141' ' ' GLY . 4.7 p -147.98 -46.48 0.16 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.212 -0.93 . . . . 0.0 109.107 -175.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.433 ' HA ' HG21 ' A' ' 139' ' ' THR . 28.1 m-20 -83.52 18.56 1.82 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.591 1.556 . . . . 0.0 112.881 172.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.06 111.6 2.26 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.417 -0.802 . . . . 0.0 110.717 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 105.75 17.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.487 ' HA ' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -111.91 129.26 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.763 1.225 . . . . 0.0 110.027 -176.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.09 175.2 9.82 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.794 1.238 . . . . 0.0 110.945 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.96 39.76 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.785 -0.572 . . . . 0.0 112.473 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -61.27 -33.15 73.07 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.654 0.782 . . . . 0.0 111.969 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.487 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -70.19 -51.39 39.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.632 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.588 176.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.98 66.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 119.192 0.905 . . . . 0.0 112.138 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -28.96 68.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.751 0.821 . . . . 0.0 112.648 171.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.94 -48.95 3.49 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.135 1.374 . . . . 0.0 112.838 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -51.77 -47.07 64.31 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.449 1.9 . . . . 0.0 111.307 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 35.5 m -81.98 133.73 35.32 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.4 m -54.55 155.22 4.19 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.786 1.234 . . . . 0.0 110.516 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -39.7 -56.75 1.65 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.791 1.236 . . . . 0.0 112.499 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -177.21 117.05 0.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.158 1.783 . . . . 0.0 109.512 172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 170' ' ' THR . 55.3 m-20 -125.24 38.09 4.25 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.381 1.072 . . . . 0.0 110.743 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 53.79 -99.22 0.05 OUTLIER Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.302 1.429 . . . . 0.0 112.281 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -100.68 79.89 2.13 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.037 1.335 . . . . 0.0 110.415 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 167' ' ' ASN . 35.7 p -56.8 156.94 5.96 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.869 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -45.53 146.7 2.32 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 122.98 0.324 . . . . 0.0 112.295 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 20.1 p -46.59 118.62 2.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.019 1.328 . . . . 0.0 111.567 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.17 85.2 6.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 122.405 1.097 . . . . 0.0 109.182 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 m -75.13 116.04 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.316 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.1 119.0 23.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.634 0.774 . . . . 0.0 109.204 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 117' ' ' THR . 0.8 OUTLIER -93.74 128.81 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -103.11 127.63 50.31 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.04 139.45 46.39 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.287 0.635 . . . . 0.0 110.283 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.465 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -130.57 111.82 12.59 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.274 1.029 . . . . 0.0 110.234 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.64 142.39 27.67 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.137 0.575 . . . . 0.0 110.896 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 C-N-CA 124.462 1.03 . . . . 0.0 112.697 -177.377 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.328 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -168.59 161.89 11.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.421 1.088 . . . . 0.0 110.601 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.35 153.77 15.46 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.375 0.512 . . . . 0.0 111.978 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -135.74 -66.96 0.54 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.265 1.026 . . . . 0.0 110.664 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -148.68 179.77 7.58 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.698 1.599 . . . . 0.0 111.468 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.43 -40.61 73.71 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.318 1.047 . . . . 0.0 111.944 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.39 -35.91 9.04 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.693 1.197 . . . . 0.0 112.05 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.03 -29.87 9.05 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 117.863 -1.521 . . . . 0.0 111.908 170.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -49.54 -38.59 31.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.197 1.399 . . . . 0.0 112.779 171.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -79.82 -38.17 33.5 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.145 -0.972 . . . . 0.0 111.282 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 129' ' ' ILE . 2.1 mt -71.35 -47.29 57.32 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.411 0.624 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -60.61 -41.21 94.35 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.916 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -59.86 -46.27 89.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.764 1.62 . . . . 0.0 111.796 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -48.91 -62.68 1.39 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.933 0.893 . . . . 0.0 109.738 174.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -21.14 66.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.758 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -46.44 68.45 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.308 1.443 . . . . 0.0 109.483 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.54 -38.7 87.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 119.885 1.221 . . . . 0.0 110.011 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB1' ' CZ ' ' A' ' 179' ' ' TYR . . . -65.56 -45.95 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.36 0.664 . . . . 0.0 111.893 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -76.57 -38.84 54.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.266 1.027 . . . . 0.0 112.034 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 78.8 m-20 -64.4 -56.76 12.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 t -58.35 -26.81 63.57 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.689 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.06 -26.73 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.65 53.81 0.28 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.903 1.24 . . . . 0.0 113.03 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.64 -71.49 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.184 0.994 . . . . 0.0 111.079 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.6 mmt -139.73 53.25 1.69 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.77 1.228 . . . . 0.0 111.146 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -109.85 2.66 20.04 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.695 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.17 -30.3 0.08 OUTLIER Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.213 0.911 . . . . 0.0 113.534 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -48.15 120.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.293 1.047 . . . . 0.0 109.707 171.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 t70 65.0 110.74 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.163 1.385 . . . . 0.0 113.18 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.8 158.35 34.57 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.332 -0.855 . . . . 0.0 112.764 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -154.27 100.41 2.3 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.282 1.033 . . . . 0.0 109.878 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.95 166.69 25.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.162 0.985 . . . . 0.0 111.113 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.59 162.79 28.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.322 1.049 . . . . 0.0 110.556 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.4 m 57.17 86.16 0.07 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 122.544 1.164 . . . . 0.0 111.488 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.06 81.12 1.65 Allowed 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.89 -55.59 0.06 OUTLIER Glycine 0 N--CA 1.47 0.931 0 CA-C-O 119.288 -0.729 . . . . 0.0 113.954 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.3 -67.57 0.38 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.67 0.735 . . . . 0.0 110.501 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -59.3 -33.52 71.19 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.402 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -46.28 90.95 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.668 0.667 . . . . 0.0 111.357 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.549 HG21 HG11 ' A' ' 100' ' ' VAL . 1.1 m -64.3 -42.32 96.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 118.371 -0.824 . . . . 0.0 110.081 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.418 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -58.33 -50.02 75.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.278 0.944 . . . . 0.0 110.68 177.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -66.88 -40.87 87.91 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 124.563 1.145 . . . . 0.0 111.12 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 8.7 tp -61.47 -52.83 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.355 1.462 . . . . 0.0 110.83 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 65' ' ' THR . 9.1 mt -59.13 -51.32 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.095 -1.003 . . . . 0.0 111.251 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -63.29 -25.8 68.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.593 -0.692 . . . . 0.0 112.737 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.99 -1.72 21.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.023 1.329 . . . . 0.0 112.743 171.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.59 58.39 5.42 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.787 1.184 . . . . 0.0 111.628 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -123.21 -81.16 0.64 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.46 -59.82 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -136.26 -163.06 1.35 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.755 1.622 . . . . 0.0 110.242 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.58 21.1 1.04 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.756 1.169 . . . . 0.0 112.937 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.7 mmt -90.68 173.72 7.88 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.594 1.158 . . . . 0.0 112.144 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.22 120.49 13.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.024 0.916 . . . . 0.0 109.576 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 90' ' ' LEU . 2.5 t -98.47 122.72 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -67.82 115.84 7.82 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.15 166.17 54.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -146.45 128.09 7.51 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 122.426 -0.455 . . . . 0.0 111.046 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.57 -17.56 29.88 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.679 2.253 . . . . 0.0 113.021 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.01 60.47 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 0.0 112.654 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.45 65.11 1.42 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.423 1.089 . . . . 0.0 112.329 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.56 37.45 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 p -175.43 57.8 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.477 1.111 . . . . 0.0 111.391 -171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -90.43 150.17 21.94 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.294 1.045 . . . . 0.0 110.766 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.5 p -136.26 126.06 25.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.451 HD23 HD13 ' A' ' 69' ' ' ILE . 1.8 tm? -96.95 127.35 42.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.935 0.874 . . . . 0.0 108.879 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -101.17 116.71 33.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -72.94 170.76 14.11 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.137 0.494 . . . . 0.0 110.79 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.77 -55.34 6.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.119 0.967 . . . . 0.0 112.43 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -162.52 152.29 16.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 110.621 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.84 47.25 25.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.008 0.813 . . . . 0.0 112.805 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.25 128.68 2.07 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -133.8 136.96 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.991 0.901 . . . . 0.0 108.86 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.37 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.363 1.065 . . . . 0.0 108.252 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 117' ' ' THR . 40.4 t -136.33 111.05 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 65' ' ' THR . 1.1 m -102.81 122.45 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.72 126.18 14.49 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.042 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -70.34 150.45 64.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.542 1.494 . . . . 0.0 110.688 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -141.11 77.37 1.59 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.026 1.393 . . . . 0.0 110.261 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 p -87.51 156.24 19.63 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.933 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -126.43 130.82 51.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.343 0.657 . . . . 0.0 110.034 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.96 39.86 2.75 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.075 1.321 . . . . 0.0 111.849 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.02 -89.98 0.93 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 78.3 p -134.98 38.49 3.0 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.772 1.272 . . . . 0.0 111.399 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.03 -148.91 5.97 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.317 1.437 . . . . 0.0 111.055 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -163.02 33.55 0.1 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.17 0.988 . . . . 0.0 111.523 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -91.1 147.97 22.7 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 120.531 -1.356 . . . . 0.0 109.972 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' ND2' ' CE2' ' A' ' 114' ' ' PHE . 13.1 t30 -121.93 133.8 54.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.921 0.888 . . . . 0.0 109.846 175.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.49 78.21 0.24 Allowed Glycine 0 CA--C 1.526 0.78 0 C-N-CA 126.127 1.822 . . . . 0.0 110.888 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CE2' ' ND2' ' A' ' 112' ' ' ASN . 42.5 m-85 -53.61 142.91 21.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.799 1.299 . . . . 0.0 112.099 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.2 p -128.83 104.82 7.83 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.06 0.944 . . . . 0.0 109.314 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 mt -108.07 93.12 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.495 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -67.9 138.25 55.87 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 172.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -135.6 127.66 29.75 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -136.34 104.2 5.54 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.356 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.43 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.824 1.249 . . . . 0.0 111.962 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 173' ' ' ASN . 22.6 m -53.5 107.06 0.75 Allowed Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.23 1.812 . . . . 0.0 107.881 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 20.3 Cg_endo -74.85 -169.47 0.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.851 1.034 . . . . 0.0 110.768 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -19.14 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.41 -0.806 . . . . 0.0 113.112 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 t -77.95 -46.29 21.59 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.097 -1.627 . . . . 0.0 111.076 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.24 -28.48 62.18 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.12 176.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -52.92 -28.84 25.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.817 1.644 . . . . 0.0 111.329 176.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.6 t -89.4 -55.68 6.03 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 C-N-CA 125.972 1.709 . . . . 0.0 110.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 m -60.31 -44.1 95.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.226 -1.546 . . . . 0.0 113.2 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 36' ' ' LEU . 35.7 mm -56.57 -42.79 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.737 1.615 . . . . 0.0 109.772 171.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.504 ' HB2' HG12 ' A' ' 154' ' ' VAL . 3.7 p -65.32 -45.35 84.65 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 119.187 0.903 . . . . 0.0 112.42 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.9 m -60.55 -30.02 69.52 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.873 1.269 . . . . 0.0 110.904 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.91 -32.85 13.5 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 123.567 0.603 . . . . 0.0 113.493 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.5 tpp -74.39 -24.77 59.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.997 1.398 . . . . 0.0 111.304 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 p -66.46 -24.18 66.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.805 1.642 . . . . 0.0 111.494 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -70.47 -4.92 25.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.793 1.237 . . . . 0.0 113.491 171.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.61 48.44 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.548 1.139 . . . . 0.0 111.103 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -40.53 -51.63 3.79 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.743 1.163 . . . . 0.0 114.711 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.75 73.53 0.48 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.791 1.186 . . . . 0.0 112.307 169.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.455 HG21 HG12 ' A' ' 142' ' ' ILE . 3.3 m -69.55 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.629 0.772 . . . . 0.0 110.452 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t 172.86 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.256 1.422 . . . . 0.0 111.794 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 150' ' ' THR . . . -177.78 73.74 0.07 OUTLIER Glycine 0 C--N 1.341 0.848 0 O-C-N 121.78 -0.575 . . . . 0.0 113.667 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 13.2 mt -94.64 99.68 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.996 0.919 . . . . 0.0 111.708 -176.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -91.95 94.81 9.47 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.874 -0.516 . . . . 0.0 110.691 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.5 mt -68.85 153.12 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.24 1.016 . . . . 0.0 110.489 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -52.68 116.92 2.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.931 -1.106 . . . . 0.0 110.498 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.86 -43.96 0.99 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.412 1.006 . . . . 0.0 113.835 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -84.59 34.34 0.53 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.869 2.068 . . . . 0.0 111.682 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -46.32 93.36 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.837 1.655 . . . . 0.0 111.886 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -113.94 -168.22 1.32 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.104 1.361 . . . . 0.0 109.565 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.435 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.4 p -138.7 -49.71 0.53 Allowed 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.818 -0.551 . . . . 0.0 110.856 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.84 20.25 2.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.541 1.537 . . . . 0.0 112.25 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -45.23 126.12 5.98 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-O 121.559 0.695 . . . . 0.0 111.061 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -117.91 70.62 0.8 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 122.33 1.062 . . . . 0.0 108.391 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 130' ' ' SER . 13.0 t -91.68 130.45 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.93 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.44 176.1 7.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.91 1.284 . . . . 0.0 110.412 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.65 -53.33 58.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.653 0.66 . . . . 0.0 112.078 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -61.51 -32.53 72.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.703 0.801 . . . . 0.0 112.551 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.469 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -73.35 -50.69 29.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.458 1.027 . . . . 0.0 111.476 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 p -69.39 -32.0 70.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.299 0.64 . . . . 0.0 111.87 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.7 t -92.4 -50.94 5.38 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.31 1.044 . . . . 0.0 112.18 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -55.56 -51.53 66.77 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 127.265 2.226 . . . . 0.0 111.867 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 78.2 m -80.31 72.78 7.17 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.186 0.993 . . . . 0.0 110.211 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.77 160.84 24.97 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.771 1.228 . . . . 0.0 110.406 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 65.08 -174.91 0.18 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.093 1.357 . . . . 0.0 112.473 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -124.72 72.89 1.23 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.404 1.482 . . . . 0.0 109.964 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -76.28 131.66 39.37 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.703 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -63.17 -40.01 98.62 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 112.134 -0.386 . . . . 0.0 112.134 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -174.39 59.5 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.032 1.733 . . . . 0.0 111.742 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.23 125.32 24.67 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.365 -0.834 . . . . 0.0 112.094 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 35.06 -135.51 0.39 Allowed Glycine 0 C--N 1.339 0.734 0 O-C-N 124.394 1.059 . . . . 0.0 111.57 -174.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.1 p -149.03 123.84 9.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.434 ' HB3' HG23 ' A' ' 121' ' ' VAL . 4.9 t-20 -76.83 136.23 38.92 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.118 -0.988 . . . . 0.0 110.749 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.4 m -109.47 112.46 24.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.22 109.86 10.72 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -81.98 135.05 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 179' ' ' TYR . 0.6 OUTLIER -100.67 120.26 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -97.94 144.36 27.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.105 0.562 . . . . 0.0 111.586 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.2 t80 -142.67 105.71 4.56 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.336 0.654 . . . . 0.0 111.594 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.19 140.13 37.76 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.392 0.677 . . . . 0.0 110.386 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.046 -1.419 . . . . 0.0 111.896 178.24 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.532 0.682 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -160.73 149.28 16.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.145 0.978 . . . . 0.0 109.619 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.1 171.2 28.18 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.51 0.576 . . . . 0.0 111.98 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.92 -64.92 0.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 O-C-N 122.088 -0.654 . . . . 0.0 112.095 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -57.89 165.59 1.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.049 0.94 . . . . 0.0 110.275 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -94.12 -39.74 10.42 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 111.688 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.1 -45.13 8.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.684 1.194 . . . . 0.0 110.71 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.31 -27.8 1.92 Allowed Glycine 0 C--O 1.212 -1.251 0 CA-C-O 118.689 -1.062 . . . . 0.0 112.596 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 p -38.3 -43.43 0.8 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.641 1.576 . . . . 0.0 114.756 168.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.12 -35.52 31.48 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.065 0.848 . . . . 0.0 112.493 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 129' ' ' ILE . 16.0 mt -65.09 -50.11 67.39 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.038 0.935 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.5 p -60.08 -38.29 82.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.093 1.357 . . . . 0.0 110.632 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.96 -47.24 81.21 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.017 0.826 . . . . 0.0 112.496 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.58 ' CD1' ' CZ ' ' A' ' 177' ' ' PHE . 0.0 OUTLIER -49.05 -59.04 3.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.33 1.052 . . . . 0.0 109.235 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -66.04 -24.92 66.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.45 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -47.74 73.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 110.184 173.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -41.05 98.7 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 119.733 1.152 . . . . 0.0 109.051 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.26 96.35 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.767 0.712 . . . . 0.0 112.395 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.12 -31.6 58.73 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.704 1.202 . . . . 0.0 112.941 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.446 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 8.4 m-80 -75.57 -63.61 1.25 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -17.7 7.13 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.401 1.081 . . . . 0.0 113.063 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -44.42 -35.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.989 1.316 . . . . 0.0 112.194 171.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.0 26.84 0.14 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.698 1.142 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.1 tpp -86.04 -69.89 0.64 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.042 0.937 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' HB2' ' A' ' 71' ' ' ALA . 3.5 mtt -154.74 60.42 0.67 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.821 1.296 . . . . 0.0 111.002 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -104.1 -29.8 10.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.41 36.13 0.04 OUTLIER Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.615 1.102 . . . . 0.0 111.715 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.56 -29.09 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.528 0.731 . . . . 0.0 110.602 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -46.52 76.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.616 0.766 . . . . 0.0 111.678 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.86 82.99 0.44 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-O 118.891 -0.95 . . . . 0.0 111.541 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 59.78 165.95 0.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.874 1.27 . . . . 0.0 113.302 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.45 175.21 14.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.668 0.787 . . . . 0.0 111.353 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.43 -65.34 0.7 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.531 0.733 . . . . 0.0 111.705 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -102.38 56.59 0.79 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.293 1.037 . . . . 0.0 108.612 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.3 m -56.64 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.885 1.674 . . . . 0.0 111.703 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.12 -61.31 0.29 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.803 1.192 . . . . 0.0 113.576 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.98 10.13 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.407 -1.055 . . . . 0.0 111.897 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -25.98 68.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.533 0.733 . . . . 0.0 112.364 171.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.429 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 14.2 ttm -58.36 -49.09 78.45 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.499 0.72 . . . . 0.0 110.21 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.693 HG21 HG21 ' A' ' 100' ' ' VAL . 1.4 m -72.8 -41.5 64.88 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.551 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HA ' HG21 ' A' ' 79' ' ' VAL . 11.9 t0 -52.65 -53.43 47.19 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.006 1.276 . . . . 0.0 111.505 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.403 HG22 ' SD ' ' A' ' 50' ' ' MET . 94.3 m -68.0 -43.21 79.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.054 1.342 . . . . 0.0 110.984 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.55 -47.1 80.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.662 0.785 . . . . 0.0 111.294 172.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.508 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -60.38 -50.22 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.687 -1.258 . . . . 0.0 111.405 175.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.86 -20.25 55.96 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.158 -0.964 . . . . 0.0 112.448 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 50' ' ' MET . . . -81.54 9.93 6.72 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.48 1.512 . . . . 0.0 113.73 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.93 48.07 84.83 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.422 1.487 . . . . 0.0 112.589 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' ' CB ' ' A' ' 45' ' ' ASN . . . -110.34 -83.86 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.464 0.706 . . . . 0.0 111.275 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.96 -47.15 72.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.796 0.438 . . . . 0.0 111.654 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -156.2 172.7 17.99 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.063 1.345 . . . . 0.0 109.902 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -122.78 34.77 3.63 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.796 1.189 . . . . 0.0 112.165 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.71 178.81 4.25 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.649 1.18 . . . . 0.0 112.004 -177.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.42 136.99 54.15 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.438 175.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.508 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.4 t -114.57 109.78 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.7 t -57.81 137.06 56.97 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.54 169.24 47.82 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.871 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -82.74 113.66 46.67 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.755 0.822 . . . . 0.0 111.182 174.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -79.51 -64.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.03 1.82 . . . . 0.0 111.557 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.37 -40.37 71.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.886 0.874 . . . . 0.0 112.174 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.36 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.023 2.529 . . . . 0.0 112.998 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.69 95.85 0.14 Allowed Glycine 0 N--CA 1.466 0.666 0 C-N-CA 123.47 0.557 . . . . 0.0 111.759 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -179.8 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.02 2.128 . . . . 0.0 109.149 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.526 ' HB3' HG23 ' A' ' 100' ' ' VAL . . . -62.84 159.14 17.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.72 1.248 . . . . 0.0 110.918 174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -141.88 144.91 34.06 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.743 -1.223 . . . . 0.0 109.518 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.13 124.46 43.12 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 122.538 1.161 . . . . 0.0 109.675 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -88.07 129.5 35.27 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 123.978 0.911 . . . . 0.0 108.838 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.6 113.87 18.08 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.538 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.4 t -54.31 -58.45 7.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.435 0.694 . . . . 0.0 112.0 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -56.35 -55.57 31.8 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.048 0.451 . . . . 0.0 110.011 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.4 141.43 3.19 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 123.671 0.653 . . . . 0.0 111.963 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.79 -178.86 16.32 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.202 0.906 . . . . 0.0 112.631 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -139.87 143.78 36.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.551 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mt -130.55 151.76 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.339 1.456 . . . . 0.0 109.178 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 117' ' ' THR . 35.2 t -135.29 110.32 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.693 HG21 HG21 ' A' ' 65' ' ' THR . 8.0 m -101.26 105.94 18.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.864 1.266 . . . . 0.0 108.466 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.31 146.58 58.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 120.043 -1.661 . . . . 0.0 110.355 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -73.22 151.46 49.04 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.557 1.505 . . . . 0.0 110.587 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -144.79 80.9 1.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.929 1.347 . . . . 0.0 110.435 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 112' ' ' ASN . 4.0 p -92.29 118.8 31.26 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.151 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.48 144.68 28.57 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.561 -0.712 . . . . 0.0 110.292 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -122.01 41.94 1.75 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.736 1.16 . . . . 0.0 111.551 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.37 -144.91 7.49 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.78 1.181 . . . . 0.0 112.558 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -49.71 -48.85 49.63 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.238 1.015 . . . . 0.0 112.459 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.49 -146.23 3.7 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.49 29.09 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.804 0.811 . . . . 0.0 111.753 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -82.33 162.05 22.37 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.062 -1.024 . . . . 0.0 110.772 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.541 ' HB2' HG22 ' A' ' 104' ' ' THR . 10.2 p30 -114.31 133.97 55.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.649 174.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.62 -179.3 19.21 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 122.149 0.861 . . . . 0.0 111.481 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.13 150.94 51.93 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.071 0.948 . . . . 0.0 111.1 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.3 p -133.92 115.05 13.95 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.839 0.828 . . . . 0.0 110.344 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.0 mt -120.1 99.81 8.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.6 OUTLIER -70.53 141.59 51.9 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.007 172.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.4 p -134.35 123.76 24.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -134.94 122.46 21.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.396 0.678 . . . . 0.0 109.727 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt 160.38 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.179 2.192 . . . . 0.0 110.325 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.9 m -45.87 103.64 0.36 Allowed Pre-proline 0 N--CA 1.471 0.603 0 O-C-N 125.064 1.478 . . . . 0.0 110.483 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 27.4 Cg_endo -74.23 -172.81 1.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.831 1.688 . . . . 0.0 109.996 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -27.08 34.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.698 -1.252 . . . . 0.0 113.003 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -72.22 -50.17 29.59 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.202 -0.936 . . . . 0.0 111.472 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.49 -13.56 61.07 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 121.902 -0.499 . . . . 0.0 111.197 173.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -30.58 70.68 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 119.513 -1.992 . . . . 0.0 110.069 176.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.411 ' HA ' ' CB ' ' A' ' 159' ' ' ALA . 2.7 t -90.18 -47.02 14.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 C-N-CA 124.68 1.192 . . . . 0.0 109.531 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.9 m -61.26 -39.21 89.51 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.466 1.03 . . . . 0.0 112.708 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.463 HG23 HD21 ' A' ' 36' ' ' LEU . 45.8 mm -70.55 -49.07 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.046 172.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.9 m -57.83 -44.86 86.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 119.71 1.141 . . . . 0.0 112.563 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 m -59.44 -43.47 93.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.903 1.281 . . . . 0.0 111.476 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.51 -24.68 69.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 123.306 0.479 . . . . 0.0 113.517 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.2 25.75 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.963 -1.316 . . . . 0.0 111.338 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 155' ' ' THR . 0.3 OUTLIER -70.22 -26.01 63.67 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.963 1.705 . . . . 0.0 111.972 175.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -27.32 60.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.872 0.869 . . . . 0.0 112.391 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.3 t -154.97 48.64 0.56 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.853 1.661 . . . . 0.0 110.494 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -80.38 -80.86 0.81 Allowed Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 38.14 43.41 1.38 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 125.934 1.731 . . . . 0.0 114.915 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 151' ' ' ASP . 41.0 m 61.57 144.63 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.711 1.604 . . . . 0.0 112.696 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 t -166.47 -40.74 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.535 -1.353 . . . . 0.0 110.81 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 178' ' ' ASN . . . 143.18 50.78 0.04 OUTLIER Glycine 0 C--N 1.337 0.596 0 C-N-CA 124.975 1.274 . . . . 0.0 112.236 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.421 ' CG2' HD23 ' A' ' 175' ' ' LEU . 3.1 mt -89.0 100.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.77 95.7 10.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.656 0.382 . . . . 0.0 110.571 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 152' ' ' ALA . 36.8 mt -69.39 154.66 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.692 1.197 . . . . 0.0 109.911 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -55.33 115.75 2.45 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.89 -1.131 . . . . 0.0 111.448 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.98 -40.86 0.7 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.269 0.938 . . . . 0.0 114.538 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -86.28 41.12 0.91 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.324 1.85 . . . . 0.0 110.689 168.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -55.8 93.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.586 1.154 . . . . 0.0 111.05 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -116.96 -168.28 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.445 1.498 . . . . 0.0 109.094 -175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -136.25 -41.96 0.64 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 110.989 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HA ' HG23 ' A' ' 139' ' ' THR . 32.5 p30 -89.79 20.95 3.79 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.89 2.076 . . . . 0.0 113.547 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 144' ' ' ILE . . . -62.98 83.91 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 111.076 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 76.9 2.04 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.184 1.394 . . . . 0.0 109.443 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.406 ' HA ' HG21 ' A' ' 158' ' ' ILE . 3.3 m -75.96 154.75 5.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.009 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 134' ' ' SER . 0.1 OUTLIER -166.94 164.54 16.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.784 1.233 . . . . 0.0 111.021 -172.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.07 -53.34 20.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.881 1.272 . . . . 0.0 112.178 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -60.78 -34.1 73.97 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.005 0.922 . . . . 0.0 112.143 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -65.83 -51.27 63.5 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 O-C-N 121.721 -0.612 . . . . 0.0 109.653 175.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -64.36 -21.3 66.58 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.934 0.788 . . . . 0.0 111.312 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.39 65.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 113.211 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.73 -51.24 3.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.187 1.395 . . . . 0.0 112.607 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -54.48 -58.31 7.95 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.967 2.107 . . . . 0.0 110.843 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 5.7 m -78.55 115.38 18.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.19 146.4 6.66 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.419 1.488 . . . . 0.0 111.275 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -78.89 116.23 19.08 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.847 0.459 . . . . 0.0 110.183 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.35 137.5 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.148 1.379 . . . . 0.0 112.455 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.71 -44.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.602 -1.311 . . . . 0.0 111.553 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.33 -47.3 1.06 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.618 1.58 . . . . 0.0 111.504 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.16 76.09 0.69 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.292 1.837 . . . . 0.0 109.943 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.0 p -56.4 135.93 53.87 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.245 173.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -46.18 139.36 6.78 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.5 p -47.61 120.41 3.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.096 1.358 . . . . 0.0 110.899 -174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.39 127.44 32.19 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 120.934 -1.104 . . . . 0.0 109.232 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 14.6 m -102.2 111.91 24.37 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 142' ' ' ILE . 0.9 OUTLIER -127.84 109.81 11.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -80.22 132.07 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 172.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.58 ' CZ ' ' CD1' ' A' ' 39' ' ' TYR . 2.6 t80 -97.83 115.16 27.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 172.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.443 ' HB3' ' HA3' ' A' ' 141' ' ' GLY . 12.9 t-20 -101.27 107.33 18.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.234 0.614 . . . . 0.0 110.002 174.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 177' ' ' PHE . 16.8 t80 -77.35 109.21 11.07 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.951 0.901 . . . . 0.0 110.92 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -108.15 106.13 16.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.787 0.835 . . . . 0.0 109.907 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 CA-C-O 117.935 -1.481 . . . . 0.0 112.734 178.06 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.51 159.86 1.55 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.63 1.572 . . . . 0.0 110.266 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.46 118.47 4.4 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 -94.05 0.48 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.239 1.016 . . . . 0.0 109.638 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -110.75 169.14 8.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.965 1.306 . . . . 0.0 110.454 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.69 -45.04 84.32 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.262 0.625 . . . . 0.0 111.168 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -92.7 -28.65 16.51 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.493 1.117 . . . . 0.0 110.968 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -19.51 14.22 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 113.569 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 t -44.89 -52.44 8.63 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.858 1.329 . . . . 0.0 113.612 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -78.33 -33.9 48.91 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.674 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.515 HD21 HG23 ' A' ' 129' ' ' ILE . 72.0 mt -56.47 -51.58 67.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.771 0.714 . . . . 0.0 110.909 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.5 p -65.95 -34.14 77.43 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.602 1.161 . . . . 0.0 111.079 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.85 -47.55 82.88 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.159 0.984 . . . . 0.0 112.32 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -57.29 -52.94 63.33 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 120.873 -1.142 . . . . 0.0 111.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -65.14 -24.13 67.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.204 172.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -47.46 81.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.289 0.95 . . . . 0.0 109.465 174.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tt -65.0 -41.64 95.21 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.918 0.781 . . . . 0.0 109.317 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -64.05 -43.24 96.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.39 0.431 . . . . 0.0 111.587 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -35.64 63.17 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.533 1.133 . . . . 0.0 112.132 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.615 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 19.1 m-80 -67.15 -62.42 1.44 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -54.82 -25.92 31.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.936 0.894 . . . . 0.0 111.835 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -31.61 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.244 1.018 . . . . 0.0 112.774 171.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.5 51.67 0.25 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.329 1.442 . . . . 0.0 113.396 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.1 tpt -126.52 -77.02 0.58 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.382 1.073 . . . . 0.0 110.563 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.3 mtt -154.89 58.96 0.67 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.681 1.229 . . . . 0.0 111.235 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -106.38 -5.87 18.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.14 39.37 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.529 1.062 . . . . 0.0 112.579 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.9 -28.73 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 122.181 -0.599 . . . . 0.0 110.838 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.31 105.44 5.01 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.678 1.591 . . . . 0.0 109.767 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.76 64.89 2.06 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -69.68 143.68 53.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.766 0.793 . . . . 0.0 110.505 174.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.21 93.79 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -44.15 159.56 0.04 OUTLIER 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 111.962 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m 74.62 170.43 0.29 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.887 0.742 . . . . 0.0 109.117 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.56 -68.12 0.14 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.984 1.714 . . . . 0.0 111.776 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.3 21.14 32.02 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.46 1.505 . . . . 0.0 113.137 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.07 -56.0 4.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.801 0.84 . . . . 0.0 109.81 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -25.46 66.84 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.931 171.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -52.01 67.06 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.631 1.105 . . . . 0.0 111.298 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.623 HG21 HG11 ' A' ' 100' ' ' VAL . 1.1 m -68.63 -39.45 80.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.051 176.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.4 ' HA ' HG21 ' A' ' 79' ' ' VAL . 44.5 t0 -60.04 -48.81 80.17 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.745 0.702 . . . . 0.0 111.026 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.5 m -68.35 -41.45 80.69 Favored 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 125.342 1.457 . . . . 0.0 110.286 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.625 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -57.22 -54.09 50.67 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.085 1.311 . . . . 0.0 111.203 172.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.6 mt -60.96 -51.28 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.805 -1.184 . . . . 0.0 110.964 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -60.0 -26.13 65.81 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.711 -1.243 . . . . 0.0 112.592 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.7 -14.12 59.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.21 1.004 . . . . 0.0 113.088 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.74 34.13 9.41 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.167 1.365 . . . . 0.0 112.697 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.625 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -92.91 -73.46 0.56 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.065 0.546 . . . . 0.0 111.81 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -63.6 1.21 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.011 0.434 . . . . 0.0 110.22 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -134.24 -164.36 1.49 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.135 1.374 . . . . 0.0 109.698 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.42 23.49 1.37 Allowed Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.659 1.123 . . . . 0.0 112.732 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.7 mmt -93.19 174.76 7.05 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.104 1.361 . . . . 0.0 112.029 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.01 138.75 58.66 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.35 0.595 . . . . 0.0 110.351 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 66' ' ' ASP . 2.9 t -120.74 132.2 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 t -92.99 150.64 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.66 142.11 12.36 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.05 99.42 46.63 Favored Pre-proline 0 N--CA 1.466 0.327 0 C-N-CA 124.545 1.138 . . . . 0.0 108.005 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -74.22 -29.36 9.75 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.523 2.149 . . . . 0.0 112.26 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.81 68.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.452 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.29 -65.23 1.2 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.113 . . . . 0.0 111.818 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.93 52.81 0.24 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.051 1.31 . . . . 0.0 112.382 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.3 m -144.16 105.31 4.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.186 0.995 . . . . 0.0 109.828 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -73.55 145.61 45.39 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 122.111 0.958 . . . . 0.0 110.517 174.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -126.16 127.46 45.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -101.12 135.17 43.02 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.746 0.784 . . . . 0.0 109.261 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -96.21 119.71 35.19 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -171.84 0.9 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.768 0.427 . . . . 0.0 111.339 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -57.92 4.11 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.959 0.904 . . . . 0.0 112.254 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.99 132.99 3.8 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.145 0.978 . . . . 0.0 110.617 173.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.66 -57.61 4.5 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.657 1.123 . . . . 0.0 112.563 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -46.38 139.13 7.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 123.872 0.748 . . . . 0.0 112.611 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -132.64 152.67 51.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.479 1.133 . . . . 0.0 109.601 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -132.97 146.76 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.164 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 117' ' ' THR . 61.4 t -133.15 113.22 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.623 HG11 HG21 ' A' ' 65' ' ' THR . 1.2 m -95.16 123.72 47.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.34 40.02 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.546 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -71.52 152.77 60.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.98 1.787 . . . . 0.0 110.784 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -149.66 84.99 1.42 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 123.749 1.738 . . . . 0.0 108.953 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.528 HG22 ' HB2' ' A' ' 112' ' ' ASN . 3.4 p -89.79 144.33 26.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.143 -1.844 . . . . 0.0 108.907 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.88 143.56 47.28 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.34 -41.68 3.9 Favored Glycine 0 N--CA 1.469 0.884 0 C-N-CA 123.093 0.378 . . . . 0.0 113.066 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.94 -158.23 0.51 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.691 1.138 . . . . 0.0 113.196 172.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -34.8 7.64 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.97 -1.014 . . . . 0.0 112.958 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -32.62 94.17 0.01 OUTLIER Glycine 0 C--N 1.344 1.003 0 C-N-CA 126.47 1.986 . . . . 0.0 112.56 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.35 18.11 4.0 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.135 0.974 . . . . 0.0 110.883 -176.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -107.08 147.31 30.16 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.621 1.568 . . . . 0.0 110.025 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.528 ' HB2' HG22 ' A' ' 104' ' ' THR . 7.8 p30 -116.86 125.87 52.18 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.941 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.92 -176.35 19.14 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 122.181 0.879 . . . . 0.0 111.215 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -129.46 150.26 50.88 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.973 0.909 . . . . 0.0 110.883 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 176' ' ' VAL . 0.2 OUTLIER -146.01 119.16 8.85 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.077 -174.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.1 mt -119.01 115.91 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.351 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.53 ' CB ' HG23 ' A' ' 176' ' ' VAL . 0.7 OUTLIER -78.45 140.82 38.61 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.908 174.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 123.58 25.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -131.82 123.62 27.95 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.455 0.702 . . . . 0.0 110.041 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.434 ' HE3' HG23 ' A' ' 121' ' ' VAL . 0.0 OUTLIER 161.57 -31.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.615 1.966 . . . . 0.0 113.268 -175.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.434 HG23 ' HE3' ' A' ' 120' ' ' LYS . 18.3 t -50.02 111.28 2.01 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.056 176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 36.8 Cg_endo -73.16 -173.72 1.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.946 2.431 . . . . 0.0 110.743 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.75 -24.17 67.48 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.876 -1.14 . . . . 0.0 113.076 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -52.68 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.952 0.796 . . . . 0.0 111.211 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.557 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -72.46 -17.05 61.81 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.548 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 14.2 t -62.55 -45.57 92.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 120.902 1.683 . . . . 0.0 109.248 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.35 -45.6 40.25 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-O 118.216 -0.897 . . . . 0.0 108.998 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -57.74 -43.12 85.13 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.691 1.587 . . . . 0.0 113.768 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.515 HG23 HD21 ' A' ' 36' ' ' LEU . 46.7 mm -74.32 -44.7 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.073 1.749 . . . . 0.0 110.279 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.1 m -63.84 -26.73 68.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.0 m -82.35 -44.18 16.49 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.721 2.008 . . . . 0.0 110.258 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.78 -42.65 78.44 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.07 -27.21 67.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.825 1.312 . . . . 0.0 112.774 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.78 -21.77 63.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.206 0.602 . . . . 0.0 111.932 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.55 -25.81 39.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.585 1.154 . . . . 0.0 112.775 174.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -151.81 49.66 0.8 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.393 1.477 . . . . 0.0 110.212 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -36.56 -63.63 0.68 Allowed Glycine 0 C--N 1.344 1.024 0 C-N-CA 125.628 1.585 . . . . 0.0 113.18 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 25.21 78.22 0.01 OUTLIER Glycine 0 C--N 1.346 1.085 0 C-N-CA 126.971 2.224 . . . . 0.0 113.273 167.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 151' ' ' ASP . 23.2 p -51.67 171.31 0.04 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.78 1.632 . . . . 0.0 112.937 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 p 178.92 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.647 0.779 . . . . 0.0 111.811 -170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 171.55 42.68 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.496 0.57 . . . . 0.0 113.949 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 139' ' ' THR . 41.6 mt -80.12 117.07 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 123.321 0.648 . . . . 0.0 109.574 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.472 ' CD ' HG11 ' A' ' 176' ' ' VAL . 0.9 OUTLIER -121.56 104.36 9.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.589 1.155 . . . . 0.0 108.036 -176.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 147' ' ' ASN . 4.3 mm -78.6 168.09 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -50.06 116.22 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.29 1.436 . . . . 0.0 112.439 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 48.59 28.61 6.92 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 123.52 0.581 . . . . 0.0 114.11 -173.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.2 t-20 -129.95 38.52 3.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.378 2.271 . . . . 0.0 108.398 -174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.63 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.668 1.987 . . . . 0.0 112.129 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -138.2 -173.43 3.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.624 1.57 . . . . 0.0 109.347 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.471 HG22 ' HA2' ' A' ' 141' ' ' GLY . 7.9 p -146.8 -52.14 0.22 Allowed 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.084 -1.01 . . . . 0.0 109.461 -175.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.464 ' HA ' HG21 ' A' ' 139' ' ' THR . 14.7 p-10 -80.03 31.39 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.221 2.209 . . . . 0.0 113.521 171.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 105.43 13.45 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.839 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.88 128.36 35.35 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.13 134.43 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 178.5 7.22 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.959 0.904 . . . . 0.0 110.644 -170.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.54 -54.51 42.22 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 172.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.53 -32.46 72.52 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.899 0.88 . . . . 0.0 111.986 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.31 -54.35 17.71 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.62 -18.57 64.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.424 1.011 . . . . 0.0 111.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.07 -38.76 92.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.926 0.89 . . . . 0.0 111.945 173.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.4 m -111.25 -51.6 2.85 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-O 117.771 -1.109 . . . . 0.0 112.095 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -55.0 -49.46 71.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.287 1.835 . . . . 0.0 113.513 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.16 -38.05 75.88 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.426 0.632 . . . . 0.0 111.009 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.4 m -76.92 152.65 35.24 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.553 1.541 . . . . 0.0 110.305 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -165.99 -68.89 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 119.523 -1.986 . . . . 0.0 110.06 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -153.44 30.83 0.47 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.715 1.206 . . . . 0.0 112.452 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -154.03 106.71 2.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.397 1.079 . . . . 0.0 109.504 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.84 115.6 8.17 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.9 mtm105 53.81 68.65 0.81 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.301 1.041 . . . . 0.0 112.226 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p -46.28 152.26 0.44 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.059 0.944 . . . . 0.0 111.863 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.19 5.68 Favored Glycine 0 N--CA 1.47 0.918 0 C-N-CA 123.72 0.676 . . . . 0.0 113.077 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 46.4 m -152.05 99.52 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.152 1.381 . . . . 0.0 109.171 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -134.16 116.58 15.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.356 1.062 . . . . 0.0 110.123 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.9 m -115.92 107.14 14.62 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.41 ' HG ' HD13 ' A' ' 144' ' ' ILE . 1.1 mp -122.2 123.15 40.82 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.578 0.751 . . . . 0.0 109.103 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 115' ' ' THR . 0.8 OUTLIER -94.79 122.8 46.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -98.93 122.57 42.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.402 0.681 . . . . 0.0 110.046 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.09 138.94 41.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.587 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.462 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -145.05 136.4 25.12 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.888 177.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -48.41 149.64 1.54 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.686 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.022 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.914 -179.54 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.228 0.537 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 19.9 t90 -165.46 157.02 14.53 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.196 0.998 . . . . 0.0 109.712 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.97 152.46 18.57 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.941 0.781 . . . . 0.0 111.537 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -127.76 -69.55 0.73 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.17 0.988 . . . . 0.0 110.518 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -130.0 175.39 8.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.229 1.412 . . . . 0.0 110.246 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -90.26 -43.4 10.41 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.248 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 128' ' ' SER . . . -87.07 -34.13 19.26 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.01 -25.76 2.62 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 120.879 -1.138 . . . . 0.0 114.088 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 p -48.31 -41.6 28.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.822 1.649 . . . . 0.0 114.316 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' CG ' HD11 ' A' ' 129' ' ' ILE . 3.8 pt-20 -78.43 -34.99 47.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 129' ' ' ILE . 16.9 mt -57.79 -53.28 59.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.141 0.882 . . . . 0.0 112.356 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.9 p -60.76 -36.83 79.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.711 176.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -50.84 72.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.859 1.263 . . . . 0.0 112.42 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' A' ' 118' ' ' THR . 12.2 m-30 -57.98 -46.49 85.07 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.892 -1.13 . . . . 0.0 111.649 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -62.96 -31.96 73.17 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.008 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.53 -45.74 89.22 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 123.663 0.785 . . . . 0.0 109.713 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.504 HD13 ' CD2' ' A' ' 68' ' ' LEU . 1.9 tp -59.47 -49.57 77.29 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 120.374 1.443 . . . . 0.0 110.071 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.53 95.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.98 -33.37 59.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.615 1.166 . . . . 0.0 112.524 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.553 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 9.0 m120 -71.45 -61.12 1.89 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.44 ' HB ' HD13 ' A' ' 68' ' ' LEU . 2.1 t -56.51 -19.75 17.04 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.17 0.988 . . . . 0.0 112.332 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -32.22 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.735 0.814 . . . . 0.0 112.248 171.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.83 45.94 0.17 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.648 1.118 . . . . 0.0 113.009 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -113.64 -66.4 1.09 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.995 0.918 . . . . 0.0 110.128 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.478 ' HG2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -146.02 31.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.693 1.197 . . . . 0.0 112.564 -176.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -78.36 -21.91 48.75 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 176.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.07 47.1 0.13 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.302 0.953 . . . . 0.0 112.332 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.22 -32.7 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.384 0.674 . . . . 0.0 111.418 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -115.99 116.71 28.4 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.58 -163.28 0.11 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.594 0.616 . . . . 0.0 112.021 170.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 58.32 77.25 0.3 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.145 0.974 . . . . 0.0 112.615 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.19 156.33 32.44 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.724 -0.61 . . . . 0.0 111.399 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 -59.02 1.77 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.864 0.866 . . . . 0.0 111.245 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.8 m -121.61 144.99 48.43 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.827 1.251 . . . . 0.0 108.94 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 t -128.22 65.99 1.38 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.612 1.165 . . . . 0.0 109.727 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.56 -46.6 0.1 OUTLIER Glycine 0 N--CA 1.47 0.937 0 C-N-CA 124.181 0.895 . . . . 0.0 112.354 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.743 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -85.07 -70.0 0.61 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -23.74 50.07 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 123.436 0.695 . . . . 0.0 112.302 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.44 ' SD ' ' HA ' ' A' ' 51' ' ' LYS . 7.4 tpt -53.5 -71.61 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.512 0.725 . . . . 0.0 110.36 172.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.496 HG21 HG11 ' A' ' 100' ' ' VAL . 1.2 m -65.95 -32.98 74.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.494 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -56.68 -53.05 62.15 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.094 0.861 . . . . 0.0 111.02 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.478 HG22 ' HG2' ' A' ' 50' ' ' MET . 90.1 m -68.18 -41.05 82.04 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.42 1.088 . . . . 0.0 110.891 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.072 0.851 . . . . 0.0 111.754 171.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -61.18 -52.06 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.067 -1.02 . . . . 0.0 110.48 176.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.06 -20.44 53.28 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.364 -1.46 . . . . 0.0 113.094 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.54 13.65 3.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.509 1.524 . . . . 0.0 113.615 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 53.18 40.8 60.27 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.865 1.698 . . . . 0.0 112.8 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 45' ' ' ASN . . . -100.83 -70.29 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 -54.27 5.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -149.25 178.13 9.03 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.089 1.356 . . . . 0.0 109.538 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.69 31.46 3.38 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 124.787 1.184 . . . . 0.0 112.105 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.38 171.28 8.06 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.353 1.061 . . . . 0.0 111.639 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -61.88 131.44 49.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.446 0.641 . . . . 0.0 110.497 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.6 t -114.13 136.94 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.799 1.24 . . . . 0.0 108.464 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 t -88.02 126.94 35.35 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.75 103.42 2.91 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -50.14 105.39 0.51 Allowed Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.481 1.112 . . . . 0.0 111.373 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.16 -17.25 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.504 2.136 . . . . 0.0 112.388 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.31 -7.09 58.76 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.99 1.316 . . . . 0.0 112.594 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m 60.04 68.45 0.78 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.436 1.494 . . . . 0.0 112.05 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.03 -52.89 0.1 OUTLIER Glycine 0 N--CA 1.467 0.747 0 C-N-CA 124.006 0.812 . . . . 0.0 112.215 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -177.25 124.29 0.14 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.832 1.253 . . . . 0.0 110.965 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.743 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -64.81 164.58 12.06 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 122.355 1.074 . . . . 0.0 112.029 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.6 t -133.86 142.21 47.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.65 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 90' ' ' LEU . 1.6 tm? -109.23 123.84 49.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.059 0.944 . . . . 0.0 109.099 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -82.04 119.56 24.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.802 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -70.27 176.6 3.81 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.282 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.68 -53.65 4.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.036 1.334 . . . . 0.0 113.01 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -149.6 -51.36 0.15 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 0.0 111.779 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.46 98.83 0.86 Allowed Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.82 132.99 1.57 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 124.012 0.815 . . . . 0.0 111.535 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.03 127.41 50.21 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.81 136.82 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.347 1.059 . . . . 0.0 108.684 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 117' ' ' THR . 21.0 t -124.26 109.49 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 65' ' ' THR . 1.4 m -87.32 122.98 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.97 136.94 18.74 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 121.337 -0.852 . . . . 0.0 109.209 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -76.08 152.38 35.79 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.734 1.623 . . . . 0.0 110.554 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -143.75 69.04 1.28 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.645 1.578 . . . . 0.0 111.667 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.3 p -97.61 104.53 16.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.281 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.05 95.2 5.61 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.24 84.07 1.23 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.76 59.15 4.73 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.869 1.224 . . . . 0.0 112.633 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 p -92.42 -49.22 6.25 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.288 1.435 . . . . 0.0 111.9 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.36 43.2 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.304 0.954 . . . . 0.0 112.675 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.22 175.83 5.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.989 1.316 . . . . 0.0 111.176 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -63.7 137.92 58.28 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.139 0.495 . . . . 0.0 111.088 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -64.37 143.46 57.88 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.892 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -103.8 116.13 5.3 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -108.18 135.56 49.3 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.507 0.723 . . . . 0.0 110.333 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 p -124.03 102.44 7.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.748 1.261 . . . . 0.0 110.9 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.44 110.25 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.634 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -76.84 141.95 40.44 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.285 173.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 39' ' ' TYR . 5.8 p -133.91 130.32 37.59 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.43 -173.88 3.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.352 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 89.84 -31.11 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.576 2.75 . . . . 0.0 110.418 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.7 t -47.61 104.39 0.41 Allowed Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 127.19 2.196 . . . . 0.0 108.405 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 21.6 Cg_endo -73.66 -170.09 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.991 1.794 . . . . 0.0 110.431 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -59.54 -31.14 69.14 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.873 -1.142 . . . . 0.0 112.277 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.0 p -73.72 -50.54 20.26 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.501 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.591 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -71.97 -17.83 62.04 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.91 172.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.45 -45.91 92.29 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 120.878 1.672 . . . . 0.0 108.385 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.434 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 3.2 t -72.98 -42.04 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.629 0.649 . . . . 0.0 111.467 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -63.47 -45.1 92.35 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 177.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.497 HD11 ' CG ' ' A' ' 35' ' ' GLU . 11.4 mm -63.25 -52.99 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 C-N-CA 124.957 1.303 . . . . 0.0 109.52 172.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.7 m -56.26 -42.44 77.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 119.121 0.873 . . . . 0.0 112.226 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -56.8 -52.44 65.04 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.127 1.371 . . . . 0.0 110.969 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.6 -29.01 72.8 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 122.867 0.27 . . . . 0.0 112.682 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -35.3 58.26 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.245 1.018 . . . . 0.0 111.201 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -25.06 65.67 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.929 0.892 . . . . 0.0 112.126 175.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -60.91 -30.15 70.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.247 0.619 . . . . 0.0 112.605 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 t -153.76 50.75 0.68 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.285 1.034 . . . . 0.0 111.428 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.55 -85.51 1.65 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 44.03 49.91 7.69 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.471 1.034 . . . . 0.0 113.618 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 151' ' ' ASP . 26.2 m 66.22 147.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.529 1.532 . . . . 0.0 112.326 -173.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.1 p -179.7 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.142 -0.974 . . . . 0.0 110.961 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.85 48.62 0.07 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.575 1.083 . . . . 0.0 112.216 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 5.5 mt -88.91 99.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.428 0.691 . . . . 0.0 110.038 -172.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -90.56 97.08 10.97 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.816 0.446 . . . . 0.0 110.016 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.4 mt -73.87 146.82 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 124.4 1.062 . . . . 0.0 109.516 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -48.36 114.58 0.98 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.467 1.507 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.88 -39.64 0.96 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.302 0.953 . . . . 0.0 113.983 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.57 35.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.265 1.826 . . . . 0.0 111.428 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -51.85 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.378 1.471 . . . . 0.0 110.473 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -123.05 -169.24 1.89 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.976 1.31 . . . . 0.0 109.204 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 p -139.68 -41.69 0.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.784 0.834 . . . . 0.0 110.852 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.432 ' HA ' HG23 ' A' ' 139' ' ' THR . 3.7 p-10 -90.89 24.44 2.76 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.574 1.949 . . . . 0.0 113.412 171.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.41 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -57.59 125.76 24.37 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.509 0.671 . . . . 0.0 110.079 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -113.39 74.73 0.88 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 122.479 1.133 . . . . 0.0 108.315 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.66 135.18 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.494 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.7 p -136.56 -179.04 5.44 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.072 0.949 . . . . 0.0 111.449 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.29 81.88 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.605 -0.684 . . . . 0.0 112.386 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.56 -35.54 78.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.584 0.754 . . . . 0.0 111.421 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -46.08 36.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.786 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 127' ' ' VAL . . . -60.18 -26.47 66.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 119.1 0.864 . . . . 0.0 111.124 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -39.26 87.74 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 170.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.36 -31.59 24.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.694 1.597 . . . . 0.0 113.792 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -84.01 -56.47 3.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.899 1.68 . . . . 0.0 110.462 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 78.8 m -94.56 62.34 2.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.919 1.688 . . . . 0.0 109.588 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.1 m -77.79 155.89 30.85 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.736 1.214 . . . . 0.0 110.313 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 55.43 175.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.765 1.226 . . . . 0.0 113.095 -171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -130.76 70.62 1.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.651 0.78 . . . . 0.0 110.251 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -21.74 65.42 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.424 -0.797 . . . . 0.0 112.417 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.25 -48.33 3.4 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.674 1.607 . . . . 0.0 112.378 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.56 50.46 1.25 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.034 1.734 . . . . 0.0 111.952 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.5 p -64.17 165.74 8.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.103 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.59 136.05 2.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.746 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 95.3 m -50.81 135.12 24.49 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.515 1.126 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.26 110.26 20.4 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.968 0.907 . . . . 0.0 109.897 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.0 m -110.77 112.09 23.71 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.06 109.55 11.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -85.93 137.75 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -111.18 113.01 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.309 0.644 . . . . 0.0 109.726 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -101.46 118.32 36.71 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 109.689 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.46 122.71 41.28 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.093 0.957 . . . . 0.0 110.209 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -113.23 95.35 5.33 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.363 1.065 . . . . 0.0 108.91 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.204 0 CA-C-O 118.513 -1.159 . . . . 0.0 112.349 -174.484 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.834 0.826 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -171.62 147.16 2.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.061 1.745 . . . . 0.0 108.669 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.02 91.99 0.18 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -0.27 50.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.335 0.654 . . . . 0.0 112.328 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -109.22 141.3 41.68 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.892 1.677 . . . . 0.0 108.719 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.8 -27.61 44.46 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.522 0.729 . . . . 0.0 112.253 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -91.72 -36.18 13.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.398 1.079 . . . . 0.0 111.249 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.92 -26.07 32.64 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.201 -0.777 . . . . 0.0 112.827 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.6 p -46.14 -43.34 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.003 1.321 . . . . 0.0 113.196 172.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.19 -34.31 49.58 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.739 -0.601 . . . . 0.0 111.805 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 129' ' ' ILE . 19.6 mt -63.28 -50.82 68.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 110.341 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.6 p -63.48 -38.1 89.83 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.308 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -58.56 -53.12 61.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.896 1.225 . . . . 0.0 112.416 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 177' ' ' PHE . 7.9 t80 -51.25 -52.16 47.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.036 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -67.14 -23.66 65.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.38 69.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.052 1.341 . . . . 0.0 108.685 175.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 74' ' ' ALA . 1.8 tt -63.57 -41.46 98.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.269 0.94 . . . . 0.0 109.498 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 179' ' ' TYR . . . -59.31 -44.5 92.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 117.978 0.354 . . . . 0.0 111.075 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -78.53 -39.03 39.15 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.241 0.616 . . . . 0.0 112.618 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -60.68 -57.92 10.67 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -41.36 62.33 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.606 1.162 . . . . 0.0 111.089 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -42.89 -31.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.771 1.629 . . . . 0.0 112.996 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -150.62 50.62 0.54 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.307 1.432 . . . . 0.0 112.678 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.7 tpp -137.26 -60.27 0.67 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.026 0.93 . . . . 0.0 110.569 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.1 tpt -162.12 39.67 0.12 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.72 5.66 38.78 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.2 38.02 0.51 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.9 1.238 . . . . 0.0 112.801 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.0 t -69.54 109.89 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 0.0 109.157 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.47 -54.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.181 1.392 . . . . 0.0 110.557 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.2 -43.32 0.78 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.328 1.442 . . . . 0.0 112.725 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -138.75 55.95 1.72 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.618 1.567 . . . . 0.0 110.838 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.86 159.07 1.8 Allowed 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.844 -1.16 . . . . 0.0 112.432 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.76 -64.45 1.06 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.504 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -148.06 -61.39 0.26 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 117.692 -1.147 . . . . 0.0 109.437 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 76.1 p 38.91 71.71 0.16 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.842 1.339 . . . . 0.0 111.135 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.94 -1.69 30.23 Favored Glycine 0 N--CA 1.468 0.793 0 O-C-N 121.436 -0.79 . . . . 0.0 113.597 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 -61.49 1.54 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.305 1.042 . . . . 0.0 110.234 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -61.92 -28.57 69.62 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 123.757 0.823 . . . . 0.0 112.481 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -49.71 74.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.788 0.722 . . . . 0.0 110.322 173.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.26 -41.13 67.1 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.285 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.538 ' HA ' HG21 ' A' ' 79' ' ' VAL . 10.8 t0 -55.84 -52.58 63.54 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.923 0.868 . . . . 0.0 110.62 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.4 m -68.99 -43.1 75.55 Favored 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 124.933 1.293 . . . . 0.0 110.715 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.88 -43.49 90.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.706 1.593 . . . . 0.0 111.989 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.402 HG21 ' CG2' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -63.75 -53.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.282 0.633 . . . . 0.0 111.027 173.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -64.57 -17.2 63.74 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.168 -0.958 . . . . 0.0 111.867 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.07 -19.44 30.23 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 112.35 174.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.1 76.17 1.21 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.998 1.285 . . . . 0.0 112.544 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -148.25 -97.9 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.001 0.52 . . . . 0.0 112.166 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -51.74 -40.69 60.68 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.005 0.922 . . . . 0.0 111.368 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -165.71 -178.77 4.99 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.017 1.727 . . . . 0.0 110.185 173.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.37 18.02 7.83 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 125.315 1.436 . . . . 0.0 112.783 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.0 ttt -92.45 171.38 9.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.611 1.165 . . . . 0.0 111.553 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.94 145.98 44.05 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.27 -0.894 . . . . 0.0 111.097 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 66' ' ' ASP . 10.3 t -120.67 129.37 75.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.76 132.68 38.2 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.44 136.61 14.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -42.51 113.52 1.29 Allowed Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.907 1.283 . . . . 0.0 112.78 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -76.51 -68.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.943 1.762 . . . . 0.0 111.375 -173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.73 13.18 20.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.762 1.225 . . . . 0.0 112.138 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.24 56.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.225 1.41 . . . . 0.0 111.632 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.02 -56.94 0.78 Allowed Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.1 p 169.79 137.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.676 1.59 . . . . 0.0 110.47 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 87.63 0.19 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.447 0.699 . . . . 0.0 111.049 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 t -63.08 139.22 58.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.314 0.578 . . . . 0.0 110.431 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.414 HD23 HG13 ' A' ' 79' ' ' VAL . 2.5 tm? -114.34 131.57 56.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.401 1.48 . . . . 0.0 108.909 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -91.93 115.54 28.15 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.365 1.066 . . . . 0.0 110.101 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.36 -179.63 2.54 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.61 0.719 . . . . 0.0 112.058 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.51 -51.51 6.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -45.7 87.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.38 0.672 . . . . 0.0 111.462 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.8 41.68 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.679 1.133 . . . . 0.0 112.705 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -104.97 170.16 17.54 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.155 0.883 . . . . 0.0 111.748 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -123.48 138.97 54.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.753 0.787 . . . . 0.0 109.262 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.13 119.4 56.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.54 115.22 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 132.11 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.34 137.21 9.2 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.987 -0.446 . . . . 0.0 110.899 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -71.3 154.23 61.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.215 1.943 . . . . 0.0 111.608 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.9 65.42 1.11 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.575 1.655 . . . . 0.0 111.099 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -86.48 172.04 10.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.443 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.24 147.01 35.79 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.341 0.656 . . . . 0.0 111.111 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.22 39.72 92.83 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.893 -0.948 . . . . 0.0 113.413 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 48.92 -103.72 0.08 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.189 1.376 . . . . 0.0 113.105 -173.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.6 p -108.91 175.74 5.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.31 1.844 . . . . 0.0 111.961 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 115.66 -50.86 0.75 Allowed Glycine 0 N--CA 1.47 0.9 0 O-C-N 120.802 -1.186 . . . . 0.0 111.869 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.46 -177.96 3.66 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.394 1.077 . . . . 0.0 111.775 176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -66.55 163.09 19.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.736 0.779 . . . . 0.0 111.277 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -91.77 144.68 25.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.775 172.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.56 104.05 1.44 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -87.47 155.68 19.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.708 -0.878 . . . . 0.0 111.18 175.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.456 HG22 HG13 ' A' ' 176' ' ' VAL . 0.1 OUTLIER -143.86 118.21 9.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 122.023 0.916 . . . . 0.0 110.822 -176.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.405 HD13 HD13 ' A' ' 42' ' ' LEU . 5.6 mt -113.57 108.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.5 OUTLIER -71.17 131.34 43.4 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 124.125 0.97 . . . . 0.0 108.807 172.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -130.38 124.72 32.83 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -131.15 128.18 39.55 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt 164.74 -38.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.771 2.029 . . . . 0.0 110.872 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -45.19 103.35 0.34 Allowed Pre-proline 0 N--CA 1.467 0.414 0 C-N-CA 125.711 1.604 . . . . 0.0 110.492 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 30.1 Cg_endo -74.82 -172.1 1.14 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 110.363 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -22.54 53.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.545 -1.347 . . . . 0.0 114.324 173.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.8 t -79.34 -52.01 8.66 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.667 -0.646 . . . . 0.0 110.964 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.578 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -73.32 -23.9 60.32 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 121.866 -0.521 . . . . 0.0 110.86 175.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.26 -27.54 62.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.791 1.178 . . . . 0.0 110.164 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.59 -50.87 11.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.658 0 CA-C-O 117.871 -1.062 . . . . 0.0 110.609 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.411 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -53.31 -45.22 68.89 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.943 1.247 . . . . 0.0 113.38 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.59 HG23 HD21 ' A' ' 36' ' ' LEU . 21.6 mm -62.09 -38.61 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 125.45 1.5 . . . . 0.0 111.206 172.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -67.2 -43.78 81.23 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.463 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.4 m -65.15 -27.89 69.03 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.243 1.383 . . . . 0.0 111.957 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.02 20.68 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.227 0.917 . . . . 0.0 113.75 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 1.9 ttp -84.71 -24.78 28.77 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.289 1.435 . . . . 0.0 112.43 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.6 p -69.59 -21.36 63.6 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.917 1.287 . . . . 0.0 111.888 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.0 mtt-85 -60.57 -17.91 49.35 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 113.133 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 t -154.04 53.44 0.7 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.255 1.022 . . . . 0.0 110.593 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -38.09 -65.39 0.7 Allowed Glycine 0 C--N 1.345 1.075 0 C-N-CA 125.34 1.448 . . . . 0.0 112.961 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 22.39 72.29 0.01 OUTLIER Glycine 0 C--N 1.347 1.187 0 C-N-CA 126.991 2.234 . . . . 0.0 113.217 167.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.527 HG22 ' CD1' ' A' ' 142' ' ' ILE . 3.9 p -53.28 171.16 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.531 1.532 . . . . 0.0 112.668 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.39 -33.64 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.67 -0.644 . . . . 0.0 111.315 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 171.12 43.5 0.03 OUTLIER Glycine 0 C--N 1.338 0.643 0 CA-C-O 119.58 -0.567 . . . . 0.0 113.399 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.527 ' CD1' HG22 ' A' ' 139' ' ' THR . 3.0 mt -77.2 116.3 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.166 0.586 . . . . 0.0 110.812 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.79 96.45 5.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.574 1.15 . . . . 0.0 108.897 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 147' ' ' ASN . 10.7 mt -74.96 167.14 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -49.53 115.83 1.51 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.35 1.46 . . . . 0.0 111.981 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.65 27.19 8.6 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 123.444 0.545 . . . . 0.0 114.138 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 0.7 OUTLIER -129.34 39.94 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.06 2.544 . . . . 0.0 107.615 -176.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -42.53 95.91 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.657 1.183 . . . . 0.0 111.593 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -142.8 -173.52 3.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.221 1.408 . . . . 0.0 108.784 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.499 HG22 ' HA2' ' A' ' 141' ' ' GLY . 12.3 p -146.29 -47.57 0.2 Allowed 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.548 -0.72 . . . . 0.0 110.193 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.439 ' C ' HG21 ' A' ' 139' ' ' THR . 1.0 OUTLIER -85.57 18.53 2.76 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.259 1.824 . . . . 0.0 112.142 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.97 97.71 0.18 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.304 -0.873 . . . . 0.0 111.146 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.62 125.1 29.58 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' HG21 ' A' ' 158' ' ' ILE . 2.1 t -122.75 129.81 74.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.07 170.06 16.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.151 0.98 . . . . 0.0 110.809 -170.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.05 -37.67 72.12 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.5 -42.3 43.93 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.185 0.994 . . . . 0.0 110.891 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -59.89 -45.51 94.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 173.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.84 -17.95 61.5 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.761 -0.587 . . . . 0.0 111.972 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -40.6 76.67 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.243 -0.91 . . . . 0.0 111.531 172.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 70.1 m -107.96 -58.01 2.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.805 0.842 . . . . 0.0 112.12 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -82.76 63.32 6.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.365 1.866 . . . . 0.0 113.037 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 2.5 t 176.47 -45.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 110.624 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 m -95.94 156.24 16.41 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.305 1.042 . . . . 0.0 109.527 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 62.48 154.89 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.314 1.446 . . . . 0.0 112.336 -169.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.7 t70 81.1 7.04 1.25 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.39 1.476 . . . . 0.0 112.576 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.49 -45.04 0.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.336 1.454 . . . . 0.0 111.187 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.18 -43.13 1.88 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.472 1.51 . . . . 0.0 112.366 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -162.78 67.79 0.22 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.492 1.117 . . . . 0.0 111.737 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.7 p -47.86 128.69 13.63 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.507 0.67 . . . . 0.0 111.158 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.07 0.65 Allowed Glycine 0 N--CA 1.467 0.734 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 67.4 p -89.28 101.97 14.64 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.348 1.459 . . . . 0.0 109.7 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.32 84.28 2.12 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.974 1.71 . . . . 0.0 109.792 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.0 m -77.16 123.87 27.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.199 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.26 112.68 11.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -82.67 131.52 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 171.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.464 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 13.6 m-85 -108.88 111.34 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -85.79 141.82 29.39 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.022 0.439 . . . . 0.0 111.498 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 43' ' ' ALA . 15.2 t80 -142.22 118.71 10.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.824 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.66 142.39 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.677 0.391 . . . . 0.0 110.489 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 C-N-CA 124.276 0.941 . . . . 0.0 113.961 175.262 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.244 0.545 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.69 168.49 2.59 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.405 1.482 . . . . 0.0 110.408 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 110.96 0.22 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -105.85 -78.29 0.58 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.717 0.807 . . . . 0.0 110.063 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -137.67 172.15 13.39 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.271 1.428 . . . . 0.0 110.893 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -65.32 -46.07 81.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.218 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 128' ' ' SER . . . -84.11 -38.39 20.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.341 1.056 . . . . 0.0 111.24 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.73 -28.85 1.19 Allowed Glycine 0 C--O 1.216 -1.0 0 CA-C-O 117.868 -1.518 . . . . 0.0 113.142 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 t -40.3 -46.15 2.26 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.293 1.546 . . . . 0.0 113.649 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -73.62 -39.23 64.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.17 0.896 . . . . 0.0 111.517 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mt -66.44 -51.85 52.62 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.848 0.859 . . . . 0.0 112.017 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.3 p -62.69 -35.76 80.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 117.46 -1.257 . . . . 0.0 110.35 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -58.62 -54.44 47.07 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.117 1.326 . . . . 0.0 111.588 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -56.7 -45.63 81.71 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.206 -0.934 . . . . 0.0 111.638 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -65.01 -28.56 69.59 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.132 0.573 . . . . 0.0 112.222 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -43.23 81.61 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 109.688 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.451 ' CD2' HD11 ' A' ' 116' ' ' ILE . 2.3 tt -62.89 -44.09 97.04 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.083 -1.011 . . . . 0.0 109.994 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.75 86.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.455 0.57 . . . . 0.0 112.264 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.34 -30.94 63.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.39 1.076 . . . . 0.0 112.656 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.85 -60.83 2.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 t -55.27 -21.15 13.35 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.948 0.899 . . . . 0.0 112.587 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 tp -47.39 -33.84 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.545 1.138 . . . . 0.0 113.087 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.93 37.31 0.42 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.611 1.101 . . . . 0.0 112.283 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.9 tpt -109.47 -70.41 0.81 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.518 0.727 . . . . 0.0 110.583 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.76 64.03 0.73 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.8 1.286 . . . . 0.0 111.297 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.49 -9.52 15.37 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.68 37.77 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.236 1.398 . . . . 0.0 111.924 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.75 125.96 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.2 t70 74.23 -46.1 0.61 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.397 1.879 . . . . 0.0 112.712 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -44.93 140.23 4.54 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.913 1.72 . . . . 0.0 112.934 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.19 120.81 43.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.296 1.038 . . . . 0.0 110.358 -172.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 49.87 -163.82 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.762 0.825 . . . . 0.0 111.393 -172.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 48.02 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.983 1.313 . . . . 0.0 113.19 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.6 t -52.36 154.23 2.56 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.122 0.963 . . . . 0.0 111.854 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.0 m -71.08 -52.96 16.45 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.413 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.24 -89.97 0.91 Allowed Glycine 0 N--CA 1.469 0.863 0 O-C-N 120.915 -1.116 . . . . 0.0 112.651 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.617 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -83.07 -49.85 9.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.38 -22.91 34.32 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 123.679 0.791 . . . . 0.0 112.106 169.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -60.46 -51.48 69.28 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 119.071 0.85 . . . . 0.0 110.076 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.508 ' OG1' HG21 ' A' ' 100' ' ' VAL . 11.4 m -74.85 -40.75 60.82 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 118.322 -0.846 . . . . 0.0 111.049 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -56.04 -52.5 64.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.194 0.906 . . . . 0.0 110.738 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.4 m -68.57 -39.64 80.91 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 110.928 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD21 ' HG ' ' A' ' 42' ' ' LEU . 9.4 tp -60.58 -51.29 70.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.626 1.557 . . . . 0.0 111.557 174.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 65' ' ' THR . 0.9 OUTLIER -62.37 -51.93 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 120.694 -1.253 . . . . 0.0 110.863 176.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -61.88 -18.34 59.8 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.484 -1.385 . . . . 0.0 112.711 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.08 12.11 5.5 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.493 1.517 . . . . 0.0 113.295 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.62 40.83 80.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.977 1.275 . . . . 0.0 112.743 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.19 -77.73 0.54 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.01 0.524 . . . . 0.0 110.861 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.39 -59.57 2.67 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -140.04 179.66 6.49 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 125.178 1.391 . . . . 0.0 109.9 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.16 35.37 2.45 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.104 1.335 . . . . 0.0 112.161 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.2 mtt -103.72 179.77 4.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.801 1.24 . . . . 0.0 111.982 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -69.77 133.74 47.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.587 0.708 . . . . 0.0 110.473 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.26 134.36 59.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.53 1.132 . . . . 0.0 108.515 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.26 152.15 36.59 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.184 0.516 . . . . 0.0 110.803 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.95 158.05 14.54 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -145.36 127.85 8.08 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 122.766 0.426 . . . . 0.0 110.552 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -72.29 -17.02 27.82 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.639 2.226 . . . . 0.0 112.514 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.1 61.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.508 0.723 . . . . 0.0 112.842 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 t 66.56 63.69 0.51 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 112.296 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.76 41.16 0.02 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.727 -0.608 . . . . 0.0 114.127 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.35 25.39 0.3 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.942 0.897 . . . . 0.0 111.761 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -60.26 126.97 29.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.215 1.007 . . . . 0.0 109.914 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 t -117.58 140.44 49.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.19 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -106.62 127.11 53.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -87.37 113.83 23.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.764 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -74.48 170.55 15.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.769 0.795 . . . . 0.0 111.643 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 t -87.75 -36.0 17.58 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.078 175.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -87.73 46.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 112.162 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 46.94 61.25 4.49 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.023 1.297 . . . . 0.0 112.832 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -130.15 160.31 22.92 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 123.774 0.702 . . . . 0.0 112.329 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.43 133.93 48.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.796 1.284 . . . . 0.0 108.95 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.08 135.81 59.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.911 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.48 ' HB ' HG22 ' A' ' 117' ' ' THR . 77.2 t -119.32 110.37 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.508 HG21 ' OG1' ' A' ' 65' ' ' THR . 3.0 m -90.32 125.79 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.33 125.55 13.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.538 -0.726 . . . . 0.0 109.248 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.86 153.96 58.55 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.488 1.459 . . . . 0.0 111.203 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -147.56 73.14 1.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.935 1.694 . . . . 0.0 110.852 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.7 p -104.55 82.46 1.91 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.775 1.274 . . . . 0.0 109.807 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.14 95.07 2.66 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.627 -1.295 . . . . 0.0 111.124 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.65 88.14 2.02 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.5 143.29 14.81 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.218 0.913 . . . . 0.0 111.452 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -101.36 -48.15 4.46 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.881 1.272 . . . . 0.0 111.326 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.25 -92.66 2.27 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.186 1.374 . . . . 0.0 110.576 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.75 29.44 0.83 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.977 0.894 . . . . 0.0 112.871 -176.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -86.27 114.65 23.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.219 1.008 . . . . 0.0 109.803 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -95.4 153.47 17.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.397 170.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.99 119.26 6.14 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.47 133.05 56.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.085 0.942 . . . . 0.0 109.674 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.0 p -116.55 124.01 48.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 122.135 0.969 . . . . 0.0 108.968 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 42' ' ' LEU . 3.3 mp -120.8 98.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -69.38 135.68 50.66 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.56 172.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.6 p -125.28 121.86 35.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -120.58 175.42 6.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.545 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 84.19 -18.42 0.41 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.959 2.104 . . . . 0.0 111.897 -175.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -49.38 107.68 0.83 Allowed Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.283 1.833 . . . . 0.0 109.011 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -73.71 -174.47 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.352 2.035 . . . . 0.0 110.026 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -59.47 -28.13 66.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.383 -0.823 . . . . 0.0 111.863 171.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.4 t -70.24 -43.59 70.26 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.497 -1.377 . . . . 0.0 111.524 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 119.425 -0.322 . . . . 0.0 111.387 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -26.94 63.03 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.937 -1.102 . . . . 0.0 111.614 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.02 -53.58 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 124.49 1.116 . . . . 0.0 110.674 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.469 ' HB2' ' CB ' ' A' ' 32' ' ' ALA . 60.4 p -57.08 -44.72 83.4 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.681 1.128 . . . . 0.0 113.249 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.53 -38.4 56.5 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 C-N-CA 124.851 1.26 . . . . 0.0 109.338 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.9 m -73.38 -46.6 48.01 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.963 0.801 . . . . 0.0 112.469 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 m -56.99 -32.36 66.01 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.468 1.485 . . . . 0.0 111.727 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.45 -37.36 9.75 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.105 0.86 . . . . 0.0 113.394 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.3 ttm -74.34 -15.5 60.95 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.003 -1.292 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.2 t -84.84 -21.64 29.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.323 -1.486 . . . . 0.0 111.193 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -62.64 -41.95 99.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.095 0.558 . . . . 0.0 112.086 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.2 t -161.75 55.53 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.178 0.991 . . . . 0.0 110.688 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.25 -83.55 0.19 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 60.81 149.13 0.01 OUTLIER Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.759 1.2 . . . . 0.0 111.827 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.0 m -49.84 143.03 8.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.986 -1.302 . . . . 0.0 111.555 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.97 -41.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.267 0.627 . . . . 0.0 111.717 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 153.98 54.49 0.01 OUTLIER Glycine 0 C--N 1.337 0.615 0 C-N-CA 123.902 0.763 . . . . 0.0 112.488 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.62 98.38 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.358 0.599 . . . . 0.0 109.941 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -91.42 93.91 9.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.0 tt -77.32 148.87 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 111.027 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.415 ' HB2' ' H ' ' A' ' 174' ' ' THR . 24.6 t30 -54.29 122.43 10.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.669 -0.644 . . . . 0.0 112.23 -174.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.56 -52.73 3.53 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.403 1.001 . . . . 0.0 113.327 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -79.7 31.03 0.24 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.983 1.313 . . . . 0.0 111.968 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -48.81 98.18 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.253 1.421 . . . . 0.0 110.676 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -126.22 -165.86 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.915 1.286 . . . . 0.0 109.089 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.6 p -132.2 -37.63 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.009 0.924 . . . . 0.0 110.921 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.95 12.14 18.37 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.371 1.868 . . . . 0.0 113.646 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.58 137.42 19.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.768 0.794 . . . . 0.0 109.881 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 120.15 25.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.25 133.9 63.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 171.15 12.62 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.333 1.053 . . . . 0.0 110.245 -169.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.16 -52.19 63.41 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 111.784 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -59.43 -37.65 78.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.879 0.871 . . . . 0.0 111.982 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -50.74 42.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.322 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.34 67.47 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.581 1.082 . . . . 0.0 111.985 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -34.93 78.63 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.497 1.119 . . . . 0.0 112.194 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.59 -43.06 8.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.293 1.037 . . . . 0.0 112.299 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.11 -50.86 72.45 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.702 2.001 . . . . 0.0 111.113 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 59.2 m -84.13 90.38 7.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.346 1.07 . . . . 0.0 109.306 173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.2 p -72.34 141.92 48.8 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.203 1.401 . . . . 0.0 111.382 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 43.83 -157.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.241 1.019 . . . . 0.0 112.341 -173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.26 68.47 1.04 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -51.28 -25.16 5.32 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.583 -0.698 . . . . 0.0 111.901 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.75 104.47 1.43 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.97 51.85 3.56 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.849 0.833 . . . . 0.0 111.116 -173.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.7 p -49.96 159.57 0.4 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.201 1.001 . . . . 0.0 111.322 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -40.19 130.73 2.77 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.022 0.82 . . . . 0.0 112.589 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.2 p -45.73 108.24 0.12 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.789 1.636 . . . . 0.0 110.804 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.5 125.94 30.11 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 145' ' ' ASN . 2.5 m -96.5 108.24 20.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.76 102.17 7.19 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.578 1.151 . . . . 0.0 108.576 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -81.69 131.32 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 173.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -111.39 101.08 9.57 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.777 0.831 . . . . 0.0 109.224 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -87.01 144.16 27.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.41 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -138.59 111.52 7.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.812 1.245 . . . . 0.0 109.912 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.93 129.01 38.99 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.346 0.658 . . . . 0.0 109.408 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.589 0 CA-C-O 116.81 -2.106 . . . . 0.0 115.661 173.534 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.72 170.66 1.95 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.032 1.733 . . . . 0.0 110.375 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.92 90.17 0.61 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 123.616 0.627 . . . . 0.0 111.59 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.5 -64.4 1.32 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.392 0.677 . . . . 0.0 110.879 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -133.97 175.78 9.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.647 1.579 . . . . 0.0 110.545 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.84 -43.0 5.67 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.45 0.7 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.9 -42.31 8.37 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.206 1.402 . . . . 0.0 112.07 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.58 -29.25 5.53 Favored Glycine 0 C--O 1.212 -1.27 0 CA-C-O 117.065 -1.964 . . . . 0.0 111.838 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.1 p -40.43 -34.92 0.38 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.172 2.189 . . . . 0.0 114.743 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.437 ' HG3' HD11 ' A' ' 129' ' ' ILE . 2.3 mm-40 -88.08 -38.03 15.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.826 1.25 . . . . 0.0 110.785 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.7 -47.63 30.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.399 1.08 . . . . 0.0 111.032 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -56.87 -40.3 75.9 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 109.763 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -59.13 -51.84 68.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.468 1.486 . . . . 0.0 111.692 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -50.74 -52.04 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.022 -0.424 . . . . 0.0 111.478 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -67.4 -23.91 65.61 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.1 81.75 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.368 1.467 . . . . 0.0 109.062 176.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.471 HD22 HD13 ' A' ' 116' ' ' ILE . 2.5 tt -67.24 -43.25 82.43 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.792 0.724 . . . . 0.0 109.7 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 179' ' ' TYR . . . -62.59 -43.3 99.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.082 0.239 . . . . 0.0 111.309 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.18 -33.68 59.32 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.065 1.346 . . . . 0.0 112.634 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -67.07 -62.91 1.19 Allowed 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -29.92 59.75 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.79 0.836 . . . . 0.0 111.79 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.61 -34.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.814 1.246 . . . . 0.0 112.389 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 44.49 0.63 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.178 1.37 . . . . 0.0 112.373 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -134.0 -70.3 0.52 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.951 0.9 . . . . 0.0 111.46 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.439 ' HG3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -145.67 71.57 1.28 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.75 1.262 . . . . 0.0 111.784 -173.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -116.5 14.08 15.49 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.962 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.66 2.52 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.596 1.093 . . . . 0.0 113.032 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.92 -36.29 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.103 0.951 . . . . 0.0 111.012 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.47 101.76 11.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.572 1.549 . . . . 0.0 109.717 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 117.89 -48.35 0.95 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.57 1.081 . . . . 0.0 112.497 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.9 t80 50.37 38.57 18.28 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.826 1.25 . . . . 0.0 113.38 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.58 69.05 0.13 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 120.983 -1.073 . . . . 0.0 112.096 -171.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -165.06 164.43 20.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.337 1.055 . . . . 0.0 111.167 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.7 m -118.75 -33.13 4.33 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.61 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.9 m -47.49 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.594 1.557 . . . . 0.0 111.765 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.74 19.9 17.98 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 123.848 0.737 . . . . 0.0 112.283 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.583 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -84.77 -55.44 4.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.47 0.708 . . . . 0.0 111.927 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.56 -27.92 68.97 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.166 170.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -53.8 52.43 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 118.714 0.688 . . . . 0.0 110.311 175.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.442 ' CB ' HG21 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -70.85 -37.76 73.14 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 118.595 -0.717 . . . . 0.0 112.232 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HA ' HG21 ' A' ' 79' ' ' VAL . 11.0 t0 -57.83 -56.42 22.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.82 0.736 . . . . 0.0 110.834 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.439 HG22 ' HG3' ' A' ' 50' ' ' MET . 9.0 m -68.3 -35.21 77.48 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 125.019 1.327 . . . . 0.0 110.389 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.425 HD21 ' HG ' ' A' ' 42' ' ' LEU . 15.0 tp -62.29 -50.82 70.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.37 1.441 . . . . 0.0 111.324 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.36 -52.86 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 O-C-N 120.825 -1.172 . . . . 0.0 110.994 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.72 -18.32 62.31 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.701 -1.249 . . . . 0.0 112.38 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.84 10.22 6.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.711 1.604 . . . . 0.0 112.908 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.18 51.25 60.27 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.98 1.276 . . . . 0.0 112.307 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.08 -85.07 0.63 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.512 0.725 . . . . 0.0 111.017 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.49 -52.15 35.46 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 122.638 0.375 . . . . 0.0 111.646 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -149.98 -179.94 7.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.09 25.22 5.25 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.992 1.282 . . . . 0.0 112.489 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.58 168.6 10.93 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.226 1.01 . . . . 0.0 111.567 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -60.92 136.21 58.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.326 0.584 . . . . 0.0 110.403 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 66' ' ' ASP . 4.0 t -115.94 136.34 53.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.421 1.088 . . . . 0.0 108.347 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.58 128.97 50.76 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.18 154.55 33.04 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -44.69 110.42 1.04 Allowed Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.502 0.721 . . . . 0.0 112.852 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.17 -31.75 4.58 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.508 1.472 . . . . 0.0 111.694 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.73 11.85 21.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.269 1.427 . . . . 0.0 112.606 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m 62.07 98.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 112.996 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.57 38.16 1.49 Allowed Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.914 0.769 . . . . 0.0 114.037 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 p -175.52 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.809 1.244 . . . . 0.0 111.69 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . . . -75.62 100.41 4.6 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.007 -1.058 . . . . 0.0 111.174 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 t -69.87 134.92 48.99 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.762 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.07 126.3 50.43 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.58 1.552 . . . . 0.0 108.81 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -81.16 111.64 17.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.286 1.035 . . . . 0.0 110.065 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.26 179.09 4.08 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.78 0.8 . . . . 0.0 111.724 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -82.76 -55.23 4.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.115 0.566 . . . . 0.0 111.946 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -83.17 50.77 1.81 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.092 0.957 . . . . 0.0 112.14 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.1 69.7 0.84 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.269 1.414 . . . . 0.0 112.928 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -129.54 163.8 22.56 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 123.28 0.467 . . . . 0.0 112.373 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.48 131.91 42.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.49 120.41 56.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.325 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 117' ' ' THR . 2.6 t -107.23 113.99 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 88' ' ' ALA . 2.1 m -97.63 139.99 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.23 135.57 9.22 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.515 0.726 . . . . 0.0 109.058 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -76.19 150.54 33.34 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 121.809 1.672 . . . . 0.0 111.057 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.23 76.0 1.52 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.224 1.488 . . . . 0.0 110.473 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.33 114.53 28.77 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.764 -175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.81 138.75 19.03 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.476 -0.765 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.56 96.28 0.54 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -44.05 -73.6 0.25 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.576 1.084 . . . . 0.0 113.988 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -80.16 49.49 1.11 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.033 1.733 . . . . 0.0 112.302 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.69 95.9 0.13 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.614 1.102 . . . . 0.0 112.038 -174.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -68.48 26.63 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.55 1.54 . . . . 0.0 114.319 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -88.35 130.0 35.26 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.318 1.447 . . . . 0.0 109.551 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -99.59 132.25 45.05 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.927 0.891 . . . . 0.0 108.648 172.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -107.8 89.28 0.57 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.459 1.028 . . . . 0.0 111.395 171.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -70.74 120.41 16.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.385 -1.656 . . . . 0.0 111.607 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.6 p -108.63 110.71 22.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.67 1.224 . . . . 0.0 111.428 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.471 HD13 HD22 ' A' ' 42' ' ' LEU . 5.8 mt -117.36 105.73 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 O-C-N 120.94 -1.1 . . . . 0.0 108.25 -178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.583 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -74.85 139.94 43.53 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.976 171.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.7 p -131.38 122.5 26.44 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -136.29 110.13 8.16 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.796 -0.565 . . . . 0.0 110.61 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.03 -31.47 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.551 1.54 . . . . 0.0 113.058 -173.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.2 m -50.89 109.47 1.36 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.138 1.375 . . . . 0.0 109.878 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.62 -169.55 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.044 2.496 . . . . 0.0 110.692 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.98 -33.93 69.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.646 -1.284 . . . . 0.0 113.413 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 44.4 p -65.99 -48.13 72.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.528 1.058 . . . . 0.0 111.222 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.45 -34.05 63.06 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.507 0.723 . . . . 0.0 111.144 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.3 t -49.62 -31.46 10.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.445 -1.409 . . . . 0.0 111.099 175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.36 -54.98 6.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 124.434 1.093 . . . . 0.0 112.239 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -46.61 72.4 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.007 1.276 . . . . 0.0 113.96 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.437 HD11 ' HG3' ' A' ' 35' ' ' GLU . 51.1 mm -56.37 -38.81 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.638 1.575 . . . . 0.0 110.701 173.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -74.12 -39.67 63.19 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.362 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.4 m -58.45 -35.76 72.63 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.56 1.527 . . . . 0.0 111.768 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.44 -32.14 28.79 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.833 -0.542 . . . . 0.0 112.122 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 40.9 tpp -78.65 -19.93 51.46 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 118.213 1.007 . . . . 0.0 111.41 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 17.9 p -77.54 -20.5 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.408 -1.432 . . . . 0.0 111.695 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -41.44 93.61 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.069 0.948 . . . . 0.0 112.037 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.3 t -162.1 62.36 0.23 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.327 1.051 . . . . 0.0 109.458 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.34 -77.78 0.15 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 59.3 143.83 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.408 1.004 . . . . 0.0 111.455 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 151' ' ' ASP . 2.3 p -41.92 111.2 0.21 Allowed 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.632 -1.511 . . . . 0.0 112.804 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 p -145.02 28.49 1.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.228 1.811 . . . . 0.0 110.529 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 150' ' ' THR . . . 63.05 45.76 94.86 Favored Glycine 0 CA--C 1.523 0.542 0 O-C-N 121.276 -0.89 . . . . 0.0 113.102 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.5 mt -83.48 112.52 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.66 0.784 . . . . 0.0 109.947 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -115.63 97.36 6.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.044 0.938 . . . . 0.0 109.108 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 154' ' ' VAL . 88.1 mt -73.95 164.66 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.203 0.601 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -47.15 116.34 1.36 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 49.71 25.33 6.73 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 123.632 0.634 . . . . 0.0 114.156 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -131.61 37.35 3.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.617 2.767 . . . . 0.0 107.818 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -36.98 90.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.086 1.755 . . . . 0.0 112.924 167.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -142.03 -174.6 4.14 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.36 1.464 . . . . 0.0 109.065 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.472 HG22 ' HA2' ' A' ' 141' ' ' GLY . 11.6 p -146.68 -41.8 0.19 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -172.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 139' ' ' THR . 10.4 p-10 -85.87 8.98 18.09 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.944 2.097 . . . . 0.0 113.864 168.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.08 136.67 8.45 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.173 0.987 . . . . 0.0 110.448 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 100.31 4.71 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.643 1.211 . . . . 0.0 108.443 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 144' ' ' ILE . 45.8 t -117.79 119.77 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.512 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.457 ' HA ' ' HB3' ' A' ' 134' ' ' SER . 0.6 OUTLIER -108.24 179.92 4.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.346 -174.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.9 62.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.824 -0.548 . . . . 0.0 111.599 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -63.07 -35.65 80.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.339 0.655 . . . . 0.0 112.287 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.458 HG22 HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -72.87 -52.52 22.19 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.44 -23.47 67.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.5 1.046 . . . . 0.0 111.934 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.7 m -63.92 -43.98 94.28 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.531 -0.731 . . . . 0.0 111.648 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.5 t -105.54 -56.81 2.12 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.79 67.7 2.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.412 1.885 . . . . 0.0 112.354 172.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 175.96 -56.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.671 1.988 . . . . 0.0 109.398 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.8 m -90.94 157.24 17.42 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.196 0.998 . . . . 0.0 109.159 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 71.59 -47.44 0.66 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.043 1.737 . . . . 0.0 113.422 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -76.26 42.64 0.27 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.622 1.969 . . . . 0.0 112.937 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.483 ' HB3' HG22 ' A' ' 170' ' ' THR . 0.6 OUTLIER -172.14 -39.16 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.293 1.437 . . . . 0.0 110.584 -178.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.05 113.86 0.02 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.467 1.508 . . . . 0.0 112.122 -174.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 48.7 63.8 1.96 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.211 1.004 . . . . 0.0 112.013 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 167' ' ' ASN . 12.9 p -54.68 125.15 18.72 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.279 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.44 -80.56 0.55 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 72.4 p -135.98 116.97 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.11 129.45 34.5 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.74 -0.6 . . . . 0.0 109.85 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.3 m -89.8 116.85 28.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.81 122.87 21.48 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.583 0.753 . . . . 0.0 109.266 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -94.06 143.75 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.05 0.54 . . . . 0.0 109.663 174.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.72 114.0 18.72 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.838 0.855 . . . . 0.0 109.642 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -99.61 118.73 36.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.039 0.936 . . . . 0.0 110.966 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.466 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 36.7 t80 -102.11 103.54 14.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.442 0.697 . . . . 0.0 110.955 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -71.94 136.25 46.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.957 0.503 . . . . 0.0 110.838 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.275 0 CA-C-O 117.581 -1.677 . . . . 0.0 113.095 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -170.68 155.89 5.02 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.534 1.134 . . . . 0.0 109.19 172.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.91 -169.57 45.41 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 121.536 0.52 . . . . 0.0 112.001 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.36 -82.14 0.54 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.098 0.959 . . . . 0.0 110.133 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -141.45 -178.49 5.65 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.925 1.69 . . . . 0.0 110.935 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -34.44 75.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.161 0.985 . . . . 0.0 112.916 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 129' ' ' ILE . . . -103.02 -29.55 11.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.1 -0.954 . . . . 0.0 112.292 175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.48 -32.2 5.33 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.918 0.77 . . . . 0.0 112.833 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.36 -42.2 21.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.114 1.766 . . . . 0.0 113.852 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -68.2 -36.17 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.654 -1.279 . . . . 0.0 113.114 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -67.85 -48.2 66.8 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.551 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.0 p -64.78 -38.61 91.58 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.943 0.897 . . . . 0.0 110.828 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -58.51 -51.85 68.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.639 1.176 . . . . 0.0 111.17 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 177' ' ' PHE . 10.9 t80 -56.47 -48.26 77.47 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.171 -0.955 . . . . 0.0 112.075 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -26.54 68.58 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -42.12 88.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.459 1.104 . . . . 0.0 109.971 173.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.56 -44.99 92.5 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 117.582 -1.199 . . . . 0.0 108.918 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.75 92.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.159 0.891 . . . . 0.0 111.368 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -38.17 69.27 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.195 -0.94 . . . . 0.0 112.837 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -69.22 -57.0 5.94 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -51.98 -30.9 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.57 1.548 . . . . 0.0 112.008 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.17 -25.46 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.157 1.383 . . . . 0.0 113.373 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.41 25.5 1.85 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.67 1.605 . . . . 0.0 113.617 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -102.09 -157.8 0.63 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.319 1.048 . . . . 0.0 110.489 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.08 52.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.307 1.843 . . . . 0.0 113.577 175.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -115.25 -60.69 1.85 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.91 1.284 . . . . 0.0 111.255 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.06 0.66 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.572 1.082 . . . . 0.0 111.03 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.96 52.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.665 1.586 . . . . 0.0 108.64 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.24 -56.83 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.249 -0.907 . . . . 0.0 111.096 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.58 -57.83 0.5 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.926 1.25 . . . . 0.0 111.77 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -156.85 41.16 0.34 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.395 1.078 . . . . 0.0 112.284 -172.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.26 157.09 3.77 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.192 -0.942 . . . . 0.0 112.603 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.94 111.03 15.88 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.848 0.859 . . . . 0.0 110.543 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.7 m 62.93 134.94 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.178 1.466 . . . . 0.0 112.012 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.5 p -133.91 76.03 1.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 O-C-N 120.579 -1.326 . . . . 0.0 108.783 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -159.47 -61.41 0.01 OUTLIER Glycine 0 N--CA 1.47 0.911 0 CA-C-O 119.103 -0.831 . . . . 0.0 113.828 173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.49 -75.87 0.06 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.415 1.108 . . . . 0.0 112.334 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -32.69 70.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.81 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.1 ttp -57.37 -40.57 78.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.903 1.281 . . . . 0.0 111.789 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.628 HG23 HD12 ' A' ' 69' ' ' ILE . 1.1 m -72.0 -47.36 52.5 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.843 174.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.522 ' HA ' HG21 ' A' ' 79' ' ' VAL . 2.9 t0 -50.09 -49.42 51.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.666 1.121 . . . . 0.0 111.314 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -68.32 -46.63 69.73 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.646 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.43 -42.02 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.199 0.909 . . . . 0.0 110.512 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.628 HD12 HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -63.89 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 121.188 -0.945 . . . . 0.0 110.573 175.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -61.39 -23.55 65.87 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.698 -0.626 . . . . 0.0 111.97 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.8 -3.47 28.75 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.374 1.47 . . . . 0.0 113.439 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.5 50.38 9.8 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.943 1.735 . . . . 0.0 112.487 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.32 -88.75 0.61 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.424 0.689 . . . . 0.0 112.271 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.56 83.43 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 122.94 0.496 . . . . 0.0 111.716 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -160.61 146.89 15.19 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 125.169 1.387 . . . . 0.0 109.586 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.11 55.4 1.13 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.655 1.121 . . . . 0.0 112.824 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.27 -179.87 5.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.632 1.173 . . . . 0.0 112.349 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.14 141.9 41.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.32 0.581 . . . . 0.0 110.579 172.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.576 ' CG2' HG21 ' A' ' 69' ' ' ILE . 2.5 t -115.44 152.77 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.491 1.116 . . . . 0.0 109.058 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.57 122.04 30.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.256 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.73 101.05 2.7 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -56.25 109.78 1.9 Allowed Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.825 0.85 . . . . 0.0 110.992 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.22 -25.0 14.01 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.519 2.146 . . . . 0.0 112.483 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.77 -13.39 59.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.484 1.114 . . . . 0.0 112.661 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.08 75.39 0.37 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.344 1.458 . . . . 0.0 111.755 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.03 -53.57 0.07 OUTLIER Glycine 0 N--CA 1.465 0.609 0 C-N-CA 124.135 0.874 . . . . 0.0 111.574 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.7 t -172.16 122.95 0.48 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.122 0.969 . . . . 0.0 111.51 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.56 126.03 28.05 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.498 1.142 . . . . 0.0 110.551 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 p -95.83 138.45 33.46 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.027 -1.045 . . . . 0.0 108.747 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.76 121.19 42.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.54 124.63 29.66 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.697 0.799 . . . . 0.0 110.815 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.02 109.2 22.01 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -54.84 -53.27 57.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.43 0.692 . . . . 0.0 112.358 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -107.26 47.26 0.89 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 110.634 174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.22 -142.16 3.32 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.261 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -114.4 -121.3 3.57 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 124.318 0.961 . . . . 0.0 111.516 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -131.15 148.66 52.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.763 0.792 . . . . 0.0 110.397 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.13 149.93 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.229 1.411 . . . . 0.0 108.561 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.723 ' HB ' HG22 ' A' ' 117' ' ' THR . 24.3 t -133.98 113.03 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 65' ' ' THR . 1.4 m -95.51 114.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 122.368 1.08 . . . . 0.0 108.869 -175.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.68 138.34 31.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 O-C-N 120.473 -1.392 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.98 154.05 47.54 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.078 1.185 . . . . 0.0 110.731 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.34 68.42 1.14 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 123.432 1.586 . . . . 0.0 110.021 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 p -86.78 169.54 12.52 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.117 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.8 145.95 33.74 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 110.451 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.26 38.0 3.27 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.542 1.068 . . . . 0.0 111.9 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.37 -132.23 0.06 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.371 1.462 . . . . 0.0 112.372 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.2 t -136.37 33.95 2.77 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 123.195 1.474 . . . . 0.0 111.962 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.1 -158.25 10.04 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.614 1.102 . . . . 0.0 111.404 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -154.37 26.01 0.46 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.056 1.342 . . . . 0.0 111.871 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 -97.61 111.37 23.67 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -56.78 131.09 48.29 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.01 115.31 4.44 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -117.5 144.85 44.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.882 0.873 . . . . 0.0 110.333 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -134.98 113.32 11.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.444 1.116 . . . . 0.0 111.0 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.0 mt -115.58 108.89 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.723 HG22 ' HB ' ' A' ' 99' ' ' VAL . 0.7 OUTLIER -78.2 142.09 38.18 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.246 173.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -134.81 125.92 27.84 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.35 98.34 4.85 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.69 -38.87 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.465 1.106 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.5 m -52.62 104.33 0.43 Allowed Pre-proline 0 C--N 1.342 0.256 0 O-C-N 125.304 1.627 . . . . 0.0 108.249 -173.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -74.35 -168.08 0.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.604 1.536 . . . . 0.0 110.097 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.04 -29.42 65.33 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.118 -0.989 . . . . 0.0 112.502 174.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.2 p -71.73 -40.96 69.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.783 1.174 . . . . 0.0 112.429 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.75 49.97 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.5 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.5 -30.85 13.84 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 120.037 1.289 . . . . 0.0 109.995 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 159' ' ' ALA . 64.1 t -78.39 -57.87 4.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 123.642 0.777 . . . . 0.0 111.536 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 37.8 m -55.91 -25.09 41.31 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.516 ' CD1' ' HB1' ' A' ' 32' ' ' ALA . 1.3 mp -85.63 -47.84 16.48 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 C-N-CA 126.215 1.806 . . . . 0.0 110.228 170.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.7 m -58.44 -30.4 66.89 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 121.191 1.814 . . . . 0.0 111.846 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.1 t -86.5 -49.03 7.88 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.098 -1.001 . . . . 0.0 112.044 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.94 91.85 Favored Glycine 0 C--O 1.217 -0.945 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -33.51 76.1 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 118.555 1.177 . . . . 0.0 110.736 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.34 -20.47 19.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -26.85 65.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.262 1.025 . . . . 0.0 113.296 172.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.5 t -159.03 46.42 0.29 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.451 1.9 . . . . 0.0 110.856 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.3 -86.59 1.72 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.58 49.41 1.81 Allowed Glycine 0 N--CA 1.469 0.87 0 C-N-CA 125.67 1.605 . . . . 0.0 114.785 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 151' ' ' ASP . 17.5 m 63.96 142.86 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.657 1.583 . . . . 0.0 112.224 -172.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.95 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.841 -1.162 . . . . 0.0 111.257 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.37 48.52 0.04 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 124.531 1.063 . . . . 0.0 112.269 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 7.1 mt -89.42 102.13 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -91.87 98.99 11.93 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 122.957 0.503 . . . . 0.0 109.713 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.417 HG21 ' HB ' ' A' ' 164' ' ' THR . 30.5 mm -73.26 141.23 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 123.584 0.753 . . . . 0.0 109.8 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -47.61 119.99 3.07 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.383 -0.823 . . . . 0.0 111.612 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.06 -45.87 1.45 Allowed Glycine 0 CA--C 1.541 1.697 0 O-C-N 120.056 -1.653 . . . . 0.0 114.882 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.48 38.84 0.8 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.347 1.859 . . . . 0.0 111.242 170.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -51.35 95.76 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.968 1.307 . . . . 0.0 110.655 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -118.36 -168.77 1.58 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.099 1.359 . . . . 0.0 108.96 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -139.84 -40.11 0.45 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.723 0.809 . . . . 0.0 110.783 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.472 ' HA ' HG23 ' A' ' 139' ' ' THR . 4.3 p-10 -89.52 17.45 6.32 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.1 1.76 . . . . 0.0 114.026 169.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.528 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -46.01 126.1 7.07 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.587 0.708 . . . . 0.0 110.326 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -113.64 85.49 2.21 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.594 1.187 . . . . 0.0 107.865 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.404 ' HA ' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -110.23 121.47 63.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.399 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 158' ' ' ILE . 2.1 p -131.41 -179.79 5.57 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 125.809 1.644 . . . . 0.0 110.914 -173.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.35 85.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.57 1.532 . . . . 0.0 114.136 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -58.54 -41.64 86.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.241 0.616 . . . . 0.0 110.765 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 155' ' ' THR . 0.4 OUTLIER -78.98 -36.84 19.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 122.817 0.447 . . . . 0.0 111.039 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 127' ' ' VAL . . . -50.79 -55.29 17.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.3 p -69.53 -29.33 66.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -66.8 -61.07 2.14 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.871 0.868 . . . . 0.0 111.065 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 167.06 92.57 0.0 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 129.381 3.072 . . . . 0.0 108.421 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 32.0 p -41.8 143.37 0.53 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.417 ' HB ' HG21 ' A' ' 144' ' ' ILE . 2.0 m -48.9 152.9 0.94 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.428 0.691 . . . . 0.0 109.793 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 63.57 131.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.33 1.452 . . . . 0.0 113.673 -168.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.68 145.08 50.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.206 1.002 . . . . 0.0 110.776 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.554 ' HB2' HG22 ' A' ' 170' ' ' THR . 5.7 m120 -160.63 39.99 0.16 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.892 0.877 . . . . 0.0 111.407 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 52.34 -91.69 0.01 OUTLIER Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.141 1.353 . . . . 0.0 113.081 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -104.06 81.79 1.89 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.559 1.544 . . . . 0.0 111.503 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 167' ' ' ASN . 5.8 p -70.05 126.84 30.85 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.749 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -98.68 -46.43 2.12 Favored Glycine 0 N--CA 1.469 0.886 0 O-C-N 121.628 -0.67 . . . . 0.0 111.758 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.0 m -128.83 89.45 2.88 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.33 1.052 . . . . 0.0 108.967 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -79.59 102.49 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.87 0.868 . . . . 0.0 109.057 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.8 m -68.94 105.26 2.33 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.62 1.168 . . . . 0.0 109.879 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.97 112.41 16.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -85.6 137.05 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.467 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 13.0 m-85 -111.86 117.98 34.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -107.9 145.14 34.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 109.727 173.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -142.65 109.01 5.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.696 1.198 . . . . 0.0 109.154 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -100.09 98.19 8.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.539 1.136 . . . . 0.0 109.549 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 124.849 1.214 . . . . 0.0 113.633 178.276 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 175.73 166.02 0.37 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.558 1.943 . . . . 0.0 110.351 177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.4 108.48 0.44 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -146.86 109.19 4.49 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.594 1.157 . . . . 0.0 109.636 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm 62.31 166.91 0.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.896 1.679 . . . . 0.0 112.088 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.57 -48.33 14.0 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.422 -0.799 . . . . 0.0 111.121 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.507 ' CB ' ' HB3' ' A' ' 128' ' ' SER . . . -75.72 -39.98 56.39 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.643 0.777 . . . . 0.0 110.96 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.61 -27.06 0.8 Allowed Glycine 0 C--O 1.216 -0.984 0 CA-C-O 116.326 -2.375 . . . . 0.0 113.311 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -38.55 -48.26 1.4 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.485 2.142 . . . . 0.0 114.341 166.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -30.35 60.51 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 120.782 -1.199 . . . . 0.0 112.207 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.6 -50.23 18.66 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.046 0.939 . . . . 0.0 111.065 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 t -58.55 -45.16 89.52 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.48 1.112 . . . . 0.0 110.468 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -60.96 -49.68 76.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.309 0.958 . . . . 0.0 112.094 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 177' ' ' PHE . 0.6 OUTLIER -50.35 -59.74 3.68 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.467 0.707 . . . . 0.0 111.348 176.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -59.6 -27.37 66.24 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 118.805 -0.616 . . . . 0.0 110.795 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 44' ' ' THR . 0.3 OUTLIER -69.05 -46.56 67.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.745 1.218 . . . . 0.0 111.393 177.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 68' ' ' LEU . 3.8 tp -54.65 -44.66 73.44 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 47' ' ' ILE . . . -69.54 -43.48 72.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -68.6 -15.04 63.4 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.981 1.712 . . . . 0.0 112.709 177.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.577 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 20.9 m-20 -95.47 -52.03 4.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 173.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -22.41 2.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.974 0.909 . . . . 0.0 111.84 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 43' ' ' ALA . 14.1 pt -41.8 -41.99 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.634 1.174 . . . . 0.0 113.012 171.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.8 21.46 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.279 0.943 . . . . 0.0 114.375 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.453 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -75.09 -55.38 5.79 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.22 1.008 . . . . 0.0 109.422 177.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.71 21.16 0.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -96.52 80.83 3.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 120.254 -1.529 . . . . 0.0 110.038 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 44.64 49.47 8.72 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.595 1.184 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.21 -73.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.718 0.807 . . . . 0.0 110.384 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.06 98.7 2.14 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.528 1.131 . . . . 0.0 109.915 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.26 144.26 9.29 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.573 1.082 . . . . 0.0 111.632 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -52.18 111.78 0.68 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.013 0.925 . . . . 0.0 112.069 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.94 100.09 7.92 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.209 0.603 . . . . 0.0 109.41 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -65.55 178.68 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 122.418 1.104 . . . . 0.0 112.258 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -52.68 177.89 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.481 1.512 . . . . 0.0 112.12 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.3 m 60.88 60.17 1.92 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.465 -0.772 . . . . 0.0 109.667 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.97 46.42 0.22 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.064 1.792 . . . . 0.0 114.063 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 88' ' ' ALA . . . -87.43 -63.26 1.33 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.351 1.86 . . . . 0.0 110.276 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -38.35 66.0 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.269 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -59.77 -51.38 69.99 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 112.342 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.426 HG23 HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -65.83 -36.8 84.5 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.414 -0.327 . . . . 0.0 111.625 175.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -51.52 69.72 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.919 0.887 . . . . 0.0 110.441 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 p -68.18 -35.35 77.88 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.432 1.093 . . . . 0.0 111.384 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.665 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -64.67 -50.08 68.45 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.791 1.178 . . . . 0.0 110.708 174.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.426 HD12 HG23 ' A' ' 65' ' ' THR . 3.4 mt -63.14 -50.58 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.893 -1.129 . . . . 0.0 110.061 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -60.78 -32.67 72.0 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.096 -1.002 . . . . 0.0 112.321 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.35 -20.42 65.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.82 0.848 . . . . 0.0 112.848 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.79 4.81 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 124.998 1.285 . . . . 0.0 112.397 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.665 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -100.07 -64.01 1.08 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.59 -63.18 1.38 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.917 0.389 . . . . 0.0 110.247 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -132.61 -170.66 2.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.02 1.328 . . . . 0.0 109.062 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -140.59 16.71 2.87 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.26 0.933 . . . . 0.0 112.831 174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.9 ttt -92.58 171.36 9.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.384 1.074 . . . . 0.0 111.329 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.41 141.81 53.75 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.346 0.593 . . . . 0.0 110.603 174.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.481 HG13 HD23 ' A' ' 90' ' ' LEU . 2.8 t -118.89 148.18 21.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 108.583 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.32 130.48 53.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.053 0.541 . . . . 0.0 110.08 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.03 130.71 9.48 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -114.34 101.61 54.27 Favored Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 124.365 1.066 . . . . 0.0 108.541 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -74.33 -35.82 3.6 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.766 2.31 . . . . 0.0 112.197 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.01 66.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.996 0.918 . . . . 0.0 112.125 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -59.86 1.76 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.916 0.886 . . . . 0.0 111.838 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.27 24.52 7.49 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.819 1.676 . . . . 0.0 113.582 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -135.06 88.33 2.41 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.647 1.579 . . . . 0.0 108.462 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB3' HG22 ' A' ' 100' ' ' VAL . . . -55.94 151.43 11.73 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.833 0.825 . . . . 0.0 111.686 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.0 p -129.06 147.17 50.9 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.719 0.808 . . . . 0.0 108.959 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.481 HD23 HG13 ' A' ' 79' ' ' VAL . 1.5 tm? -127.37 122.22 33.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.716 0.77 . . . . 0.0 109.265 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -80.84 120.82 25.18 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.491 0.716 . . . . 0.0 110.309 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -76.28 132.33 39.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.806 -0.559 . . . . 0.0 109.861 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.0 t -54.38 -47.64 72.43 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.9 0.48 . . . . 0.0 111.723 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -140.24 76.1 1.54 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 110.591 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.8 -103.23 0.16 Allowed Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.232 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.81 -119.77 0.91 Allowed Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.77 154.81 48.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 122.649 1.214 . . . . 0.0 110.744 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.4 mt -121.79 153.05 25.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 125.473 1.509 . . . . 0.0 107.789 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.33 116.13 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 125.08 1.352 . . . . 0.0 107.371 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.595 HG22 ' HB3' ' A' ' 88' ' ' ALA . 0.9 OUTLIER -98.6 124.84 52.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.98 145.52 22.65 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 121.454 -0.779 . . . . 0.0 109.513 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -77.31 154.56 32.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 121.912 1.742 . . . . 0.0 111.213 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.58 74.79 1.37 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.03 1.732 . . . . 0.0 110.641 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 p -111.94 140.84 46.28 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.829 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.26 107.46 3.6 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.223 0.609 . . . . 0.0 110.052 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.52 66.87 1.81 Allowed Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.81 138.62 14.34 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.739 0.685 . . . . 0.0 111.893 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 p -145.99 -71.04 0.25 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.203 1.001 . . . . 0.0 111.327 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.8 46.77 0.64 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.128 1.346 . . . . 0.0 111.879 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.87 170.91 15.01 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.425 1.49 . . . . 0.0 111.603 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.82 162.74 3.84 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.003 0.906 . . . . 0.0 111.843 170.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -91.02 169.08 11.17 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.152 173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -105.48 113.1 4.16 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.83 145.39 27.02 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.346 -1.091 . . . . 0.0 110.569 174.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.5 p -131.57 107.08 8.61 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 122.838 1.304 . . . . 0.0 110.929 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.21 106.98 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 0.3 OUTLIER -71.73 135.23 46.7 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.61 0.764 . . . . 0.0 109.545 171.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.6 p -134.39 120.04 19.35 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.67 119.24 26.5 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.72 -0.612 . . . . 0.0 109.697 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.55 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.857 1.663 . . . . 0.0 112.731 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.18 103.03 0.33 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.396 1.878 . . . . 0.0 109.844 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 21.2 Cg_endo -75.17 -167.83 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.384 2.056 . . . . 0.0 110.776 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -22.08 65.31 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.745 -1.222 . . . . 0.0 113.549 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 87.8 p -78.16 -52.0 9.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.917 0.887 . . . . 0.0 110.321 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.581 ' HB3' ' HD2' ' A' ' 122' ' ' PRO . . . -72.61 -21.62 61.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.668 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -52.6 -32.37 41.05 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.697 -1.252 . . . . 0.0 110.187 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 t -93.91 -41.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.135 1.374 . . . . 0.0 111.872 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.507 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . 19.3 m -59.75 -34.8 73.44 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 119.903 -1.748 . . . . 0.0 113.152 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.72 -34.5 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.551 ' HB2' HG12 ' A' ' 154' ' ' VAL . 26.6 p -63.85 -41.98 97.68 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 120.753 1.615 . . . . 0.0 112.431 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 156' ' ' ALA . 12.4 t -77.07 -39.51 49.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.753 0.821 . . . . 0.0 111.34 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.24 -38.29 71.77 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 5.3 ttm -83.03 -32.21 27.01 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 110.282 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.8 t -62.9 -26.65 68.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.659 1.572 . . . . 0.0 112.413 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -62.74 -26.87 68.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -154.75 46.77 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.68 -83.0 1.71 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 40.5 58.84 2.43 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.76 1.171 . . . . 0.0 113.222 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 151' ' ' ASP . 3.7 m 70.17 135.06 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.4 1.48 . . . . 0.0 111.727 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.8 p 179.77 39.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.061 -1.024 . . . . 0.0 111.696 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.01 49.49 23.58 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.42 1.01 . . . . 0.0 113.499 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 152' ' ' ALA . 2.7 mt -92.07 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.397 0.617 . . . . 0.0 109.999 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -89.3 94.13 9.79 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.037 -0.414 . . . . 0.0 110.449 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.417 HD11 ' HB1' ' A' ' 152' ' ' ALA . 10.0 mt -70.62 144.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.373 1.069 . . . . 0.0 110.467 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -48.33 118.55 2.5 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.01 -48.32 1.69 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.935 0.778 . . . . 0.0 113.466 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -80.43 36.83 0.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.438 1.895 . . . . 0.0 112.141 172.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -54.22 96.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.565 1.146 . . . . 0.0 110.019 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -119.64 -169.13 1.71 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.378 1.471 . . . . 0.0 109.772 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -134.67 -40.59 0.78 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.581 0.753 . . . . 0.0 110.866 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 139' ' ' THR . 5.8 p-10 -91.63 17.81 8.32 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.304 1.842 . . . . 0.0 113.863 170.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 142' ' ' ILE . . . -42.77 130.22 4.18 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.628 0.728 . . . . 0.0 111.574 174.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.57 77.8 1.81 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.328 1.061 . . . . 0.0 109.044 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 130' ' ' SER . 6.1 t -98.68 135.84 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.522 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.2 167.03 22.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.813 1.245 . . . . 0.0 110.673 -172.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 131' ' ' THR . . . -54.83 -34.98 63.45 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.963 -0.461 . . . . 0.0 111.977 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.31 -44.11 22.27 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.073 1.349 . . . . 0.0 110.586 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -52.55 59.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.579 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.6 71.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.016 0.825 . . . . 0.0 111.228 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -45.68 71.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.263 0.625 . . . . 0.0 111.619 169.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.0 t -85.25 -55.9 3.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.515 0.726 . . . . 0.0 111.937 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -52.18 -57.8 8.52 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.531 2.332 . . . . 0.0 112.756 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 52.9 m -79.06 77.29 5.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.193 0.997 . . . . 0.0 109.386 170.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.3 m -62.59 157.15 21.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.706 1.202 . . . . 0.0 110.44 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.99 -29.93 69.97 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.71 155.1 1.2 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.286 1.035 . . . . 0.0 111.228 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.5 m120 55.07 79.73 0.14 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.403 0.681 . . . . 0.0 110.455 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -41.7 -39.09 2.49 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 124.374 0.988 . . . . 0.0 114.019 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.49 87.56 2.74 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.201 1.8 . . . . 0.0 109.351 167.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.1 p -50.59 152.99 1.77 Allowed 'General case' 0 C--O 1.24 0.574 0 O-C-N 121.118 -0.989 . . . . 0.0 110.431 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -48.21 160.41 0.57 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.379 0.433 . . . . 0.0 112.085 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 60.3 p -43.07 126.72 4.04 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.493 1.117 . . . . 0.0 110.982 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.43 87.4 3.39 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.725 -1.235 . . . . 0.0 108.812 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.5 m -83.53 125.13 31.45 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.12 102.32 5.96 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.831 1.252 . . . . 0.0 108.146 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -76.5 131.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 38.8 m-85 -107.59 111.87 24.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.063 0.545 . . . . 0.0 109.907 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -89.28 106.35 18.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 122.018 0.913 . . . . 0.0 110.335 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.494 ' CG ' ' HB1' ' A' ' 43' ' ' ALA . 90.5 t80 -86.49 110.33 19.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.733 0.813 . . . . 0.0 110.362 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -123.72 145.51 48.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.76 1.224 . . . . 0.0 109.893 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.217 0 C-N-CA 124.438 1.018 . . . . 0.0 113.122 176.377 . . . . . . . . 0 0 . 1 stop_ save_